2775 genotypes with 3024 annotations displayed
of selected term and subterms
|
Searched Term: abnormal cell proliferation
|
917M/917M+
(C57BL/6-917M)
|
decreased osteoblast proliferation
|
J:99483
|
2310065F04Riktm1.1Boet/2310065F04Riktm1.1Boet
(involves: C57BL/6 * SJL)
|
increased skeletal muscle satellite cell proliferation
|
J:306156
|
A1cftm1Ddsn/A1cftm1Ddsn
(involves: 129X1/SvJ)
|
decreased cell proliferation
|
J:114732
|
A4gnttm1Jnaka/A4gnttm1Jnaka
(B6.129S6-A4gnttm1Jnaka)
|
increased cell proliferation
|
J:184485
|
AabprNZB/Slc/?
(involves: NZB/Slc * NZW/Slc)
|
increased B cell proliferation
|
J:87690
|
AatfGt(pGT1.8geo)3Pgr/AatfGt(pGT1.8geo)3Pgr
(either: (involves: 129/Sv * C57BL/6) or (involves: 129/Sv * NMRI))
|
decreased cell proliferation
|
J:65741
|
Abattm1c(EUCOMM)Hmgu/Abattm1c(EUCOMM)Hmgu Tg(Cd4-cre)1Cwi/0
(involves: 129S4/SvJaeSor * C57BL/6 * C57BL/6N * DBA/2)
|
decreased T cell proliferation
|
J:333883
|
Abcb4tm1Bor/Abcb4tm1Bor Portm1Wolf/Portm1Wolf Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129P2/OlaHsd * C57BL/6 * DBA * FVB/N)
|
increased hepatocyte proliferation
|
J:215915
|
Abcb5tm1.2Nyf/Abcb5tm1.2Nyf
(involves: 129S6/SvEvTac * C57BL/6)
|
increased cell proliferation
|
J:213708
|
Abi1tm1Pen/Abi1+ Abi2tm1Pen/Abi2tm1Pen
(Not Specified)
|
decreased T cell proliferation
|
J:104623
|
Abi3bptm1Tac/Abi3bptm1Tac
(involves: 129S5/SvEvBrd)
|
increased cell proliferation
|
J:251000
|
Abl1tm1Mlg/Abl1tm1Mlg
(B6.129-Abl1tm1Mlg)
|
increased fetal cardiomyocyte proliferation
|
J:156743
|
Abl1tm2.1Goff/Abl1tm2.1Goff Abl2tm1Ajk/Abl2tm1Ajk Tg(Nes-cre)1Kln/0
(involves: 129 * C57BL/6 * C57BL/6J * SJL)
|
decreased cerebellar granule cell precursor proliferation
|
J:166211
|
Acacatm1Dejs/Acacatm1Dejs Tg(Cd4-cre)1Cwi/? Tg(TcraTcrb)1100Mjb/?
(involves: C57BL/6 * DBA/2)
|
increased T cell proliferation
|
J:209886
|
Acer1tm1a(EUCOMM)Wtsi/Acer1tm1a(EUCOMM)Wtsi
(C57BL/6N-Acer1tm1a(EUCOMM)Wtsi)
|
increased keratinocyte proliferation
|
J:235775
|
Ackr4tm1.1Rjbn/Ackr4tm1.1Rjbn
(B6.129S6-Ackr4tm1.1Rjbn)
|
decreased T cell proliferation
|
J:166490
|
Acp1tm1Lex/Acp1tm1Lex
(involves: 129S5/SvEvBrd * C57BL/6J)
|
increased fibroblast proliferation
|
J:171883
|
Actl6atm1.1Grc/Actl6atm1.1Grc Tg(Mx1-cre)1Cgn/0
(involves: 129S6/SvEvTac * C57BL/6J * CBA)
|
decreased hematopoietic stem cell proliferation
|
J:192124
|
Actn2em1Kage/Actn2em1Kage
(C57BL/6-Actn2em1Kage)
|
decreased fetal cardiomyocyte proliferation
|
J:334092
|
Acvr1tm2.1Vlcg/Acvr1+ Tg(Prrx1-cre)1Cjt/0
(involves: C57BL/6J * C57BL/6NTac * SJL/J)
|
increased chondrocyte proliferation
|
J:239136
|
Adatm1Mw/Adatm1Mw
(involves: 129S7/SvEvBrd)
|
increased vascular smooth muscle cell proliferation
|
J:231559
|
Adam17tm1.1Srj/Adam17tm1.1Srj
(involves: 129S/SvEv * C57BL/6 * SJL)
|
abnormal enterocyte proliferation
|
J:163380
|
Adam17tm1.1Wesh/Adam17tm1.1Wesh Tg(Scgb1a1-rtTA)2Jaw/0 Tg(tetO-cre)1Jaw/0
(involves: 129 * C57BL/6 * FVB/N)
|
decreased cell proliferation
|
J:210193
|
Adam17tm1.1Wesh/Adam17tm1.1Wesh Tg(Scgb1a1-rtTA)2Jaw/0 Tg(tetO-cre)1Jaw/0 Twist2tm1.1(cre)Dor/Twist2+
(involves: 129X1/SvJ * C57BL/6 * FVB/N)
|
decreased cell proliferation
|
J:210193
|
Adam17tm1Imx/Adam17tm1Imx
(involves: 129 * C57BL/6)
|
abnormal fetal cardiomyocyte proliferation
|
J:85547
|
Adamts7tm1a(KOMP)Wtsi/Adamts7tm1a(KOMP)Wtsi
(involves: C57BL/6N)
|
decreased vascular endothelial cell proliferation
|
J:230573
|
Adamts7tm1a(KOMP)Wtsi/Adamts7tm1a(KOMP)Wtsi
(C57BL/6-Adamts7tm1a(KOMP)Wtsi)
|
decreased hepatocyte proliferation
|
J:221183
|
Adamts14Gt(511E11)Cmhd/Adamts14Gt(511E11)Cmhd Adamts2tm1Prc/Adamts2tm1Prc
(involves: 129 * 129S1/Sv * 129X1/SvJ * C57BL/6)
|
increased keratinocyte proliferation
|
J:271185
|
increased T cell proliferation
|
J:271185
|
Adra2btm1Gsb/Adra2btm1Gsb
(B6.129-Adra2btm1Gsb)
|
increased mesenchymal cell proliferation involved in lung development
|
J:166788
|
Aebp1tm1Mdl/Aebp1tm1Mdl
(involves: 129S2/SvPas * C57BL/6)
|
decreased cell proliferation
|
J:70416
|
Agap2tm1.1Kye/Agap2tm1.1Kye
(involves: C57BL/6)
|
decreased mammary gland epithelial cell proliferation
|
J:158376
|
Agertm1.1Arnd/Agertm1.1Arnd
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased vascular smooth muscle cell proliferation
|
J:82620
|
Agertm1.1Hyam/Agertm1.1Hyam
(involves: 129P2/OlaHsd * C57BL/6J * CD-1)
|
abnormal cell proliferation
|
J:116507
|
Ago2tm1.1Tara/Ago2tm1.1Tara Tg(Ins2-cre)23Herr/0
(involves: 129P2/OlaHsd * C57BL/6J * CBA/J)
|
decreased pancreatic beta cell proliferation
|
J:210552
|
Agr2tm1.1Lex/Agr2tm1.1Lex
(involves: 129S5/SvEvBrd * BALB/cJ * C57BL/6)
|
increased cell proliferation
|
J:195573
|
Agr2tm1.1Lpkn/Agr2tm1.1Lpkn Gt(ROSA)26Sortm1(cre/ERT)Nat/Gt(ROSA)26Sor+
(involves: 129 * 129S6/SvEvTac * C57BL/6)
|
abnormal enterocyte proliferation
|
J:156704
|
Agr2tm1Lex/Agr2tm1Lex Gt(ROSA)26Sortm1(cre/ERT2)Tyj/Gt(ROSA)26Sor+
(involves: 129S4/SvJae * 129S5/SvEvBrd * C57BL/6)
|
increased cell proliferation
|
J:195573
|
Ahctf1tm1Taga/Ahctf1tm1Taga
(involves: C57BL/6 * CBA)
|
absent inner cell mass proliferation
|
J:98254
|
Ahnaktm1Vtm/Ahnaktm1Vtm
(involves: 129S1/Sv * C57BL/6)
|
decreased T cell proliferation
|
J:131148
|
Aifm2tm1Hbsh/Aifm2tm1Hbsh
(involves: 129S6/SvEvTac)
|
abnormal cell proliferation
|
J:105660
|
Airetm1Pltn/Airetm1Pltn
(involves: 129S4/SvJae * C57BL/6)
|
increased T cell proliferation
|
J:77873
|
Aktiptm1a(EUCOMM)Hmgu/Aktiptm1a(EUCOMM)Hmgu
(C57BL/6N-Aktiptm1a(EUCOMM)Hmgu)
|
decreased fibroblast proliferation
|
J:276210
|
Aktiptm1a(EUCOMM)Hmgu/Aktiptm1a(EUCOMM)Hmgu Trp53tm1Tyj/Trp53+
(involves: 129S2/SvPas * C57BL/6N)
|
increased fibroblast proliferation
|
J:276210
|
Albtm1(cre/ERT2)Mtz/Alb+ Polr2mtm1.1Rgr/Polr2mtm1.1Rgr Trp53tm1Tyj/Trp53tm1Tyj
(involves: 129S2/SvPas * C57BL/6)
|
increased hepatocyte proliferation
|
J:291184
|
Aldh1b1tm1.1(KOMP)Vlcg/Aldh1b1tm1.1(KOMP)Vlcg
(involves: C57BL/6J * C57BL/6NTac * CBA)
|
increased pancreatic beta cell proliferation
|
J:232360
|
Aldh3a2tm1b(EUCOMM)Wtsi/Aldh3a2tm1b(EUCOMM)Wtsi
(involves: C57BL * C57BL/6J * C57BL/6N * DBA)
|
increased keratinocyte proliferation
|
J:234695
|
Alg2tm1Lex/Alg2+
(B6;129S5-Alg2tm1Lex/Mmucd)
|
decreased dermal fibroblast proliferation
|
J:171883
|
Alms1L2131X/Alms1L2131X
(involves: C57BL/6 * NOD)
|
increased kidney cell proliferation
|
J:118221
|
Alpltm1(cre)Nagy/Alpl+ Pknox1tm1.1Rygo/Pknox1tm1.1Rygo
(involves: 129 * C57BL/6 * C57BL/6JJcl)
|
abnormal spermatogonia proliferation
|
J:258387
|
Ambra1Gt(pGT1.8geo)1Fcec/Ambra1Gt(pGT1.8geo)1Fcec
(involves: C57BL/6)
|
increased cell proliferation
|
J:122795
|
Amhr2tm3(cre)Bhr/Amhr2+ Nr5a1tm1Klp/Nr5a1tm2Klp
(involves: 129P2/OlaHsd * 129S7/SvEvBrd)
|
decreased granulosa cell proliferation
|
J:145805
|
Amhr2tm3(cre)Bhr/Amhr2+ Stk11tm1Rdp/Stk11tm1Rdp
(involves: 129S6/SvEvTac * 129S7/SvEvBrd * C57BL/6)
|
increased Sertoli cell proliferation
|
J:187754
|
Amhr2tm3(cre)Bhr/Amhr2+ Tsc1tm1Djk/Tsc1tm1Djk
(involves: 129S4/SvJae * 129S7/SvEvBrd * C57BL/6)
|
increased Sertoli cell proliferation
|
J:187754
|
Amhr2tm3(cre)Bhr/Amhr2+ Tsc2tm1.1Mjg/Tsc2tm1.1Mjg
(involves: 129S1/Sv * 129S7/SvEvBrd * 129X1/SvJ * C57BL/6)
|
increased Sertoli cell proliferation
|
J:187754
|
Anapc2tm1Kna/Anapc2tm1Kna Tg(Ttr-cre/Esr1*)1Vco/0
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2)
|
increased hepatocyte proliferation
|
J:87782
|
Anapc2tm1Kna/Anapc2tm2Kna Tg(Mx1-cre)1Cgn/0
(involves: 129P2/OlaHsd * C57BL/6 * CBA)
|
increased hepatocyte proliferation
|
J:87782
|
Angtm1Dats/Angtm1Dats
(Not Specified)
|
increased hematopoietic stem cell proliferation
|
J:236081
|
Anxa1tm1Rjf/Anxa1tm1Rjf
(involves: 129 * C57BL/6)
|
decreased vascular endothelial cell proliferation
|
J:153690
|
Ap1m2tm1.1Ohno/Ap1m2tm1.1Ohno
(involves: 129P2/OlaHsd * C57BL/6 * CD-1)
|
abnormal small intestinal crypt cell proliferation
|
J:226582
|
Apaf1tm1Mak/Apaf1tm1Mak
(either: (involves: 129P2/OlaHsd * C57BL/6) or (involves: 129P2/OlaHsd * CD-1))
|
increased cell proliferation
|
J:49841
|
ApcMin/Apc+
(involves: C57BL/6J)
|
abnormal enterocyte proliferation
|
J:118600
|
ApcMin/Apc+ Esr1tm1.1Mma/Esr1+
(involves: 129S2/SvPas * C57BL/6J)
|
abnormal enterocyte proliferation
|
J:118600
|
ApcMin/Apc+ Esr2tm1Mma/Esr2+
(involves: 129S2/SvPas * C57BL/6J)
|
abnormal enterocyte proliferation
|
J:118600
|
ApcMin/Apc+ Esr2tm1Mma/Esr2tm1Mma
(involves: 129S2/SvPas * C57BL/6J)
|
abnormal enterocyte proliferation
|
J:118600
|
ApcMin/Apc+ Tgfbr1tm1Bopa/Tgfbr1+
(involves: 129S1/SvImJ * C57BL/6J)
|
increased cell proliferation
|
J:143706
|
ApcMin/Apctm1.1Klne
(B6.Cg-ApcMin/Apctm1.1Klne)
|
abnormal enterocyte proliferation
|
J:186132
|
Apctm1.1Alew/Apc+
(B6.129-Apctm1.1Alew)
|
increased cell proliferation
|
J:180275
|
Apctm1.1Klne/Apctm1.1Klne
(B6.129-Apctm1.1Klne)
|
abnormal enterocyte proliferation
|
J:186132
|
Apctm2Rak/Apctm2Rak Tg(KRT14-cre)8Brn/0
(involves: 129/Sv * C57BL/6J * FVB/N * SJL)
|
abnormal cell proliferation
|
J:114152
|
Apex2tm1Yun/Y
(B6.129S-Apex2tm1Yun)
|
decreased splenocyte proliferation
|
J:95267
|
Apoetm1Unc/Apoetm1Unc Cdkn1atm1Tyj/Cdkn1atm1Tyj
(B6.129-Apoetm1Unc Cdkn1atm1Tyj)
|
increased vascular smooth muscle cell proliferation
|
J:125247
|
Appl1Gt(XM073)Byg/Appl1Gt(XM073)Byg
(B6.129P2-Appl1Gt(XM073)Byg)
|
increased T cell proliferation
|
J:164696
|
Appl1tm1.2Test/Appl1tm1.2Test
(involves: 129X1/SvJ)
|
increased T cell proliferation
|
J:164696
|
Arb2aTg(Tyr)TpNpin/Arb2aTg(Tyr)TpNpin
(involves: FVB/N)
|
decreased cell proliferation
|
J:260599
|
decreased neural crest cell proliferation
|
J:260599
|
Arhgap1tm1Yizh/Arhgap1tm1Yizh
(involves: 129S6/SvEvTac * C57BL/6)
|
decreased fibroblast proliferation
|
J:119516
|
Arhgdiatm1Ytk/Arhgdiatm1Ytk Arhgdibtm1Miyo/Arhgdibtm1Miyo
(involves: 129S/SvEv)
|
decreased T cell proliferation
|
J:140671
|
increased B cell proliferation
|
J:140671
|
Arhgdibtm1Len/Arhgdibtm1Len
(involves: 129S4/SvJae * C57BL/6)
|
increased B cell proliferation
|
J:42604
|
Arhgef1tm1Kdf/Arhgef1tm1Kdf
(involves: 129S1/Sv * 129X1/SvJ)
|
decreased B cell proliferation
|
J:99463
|
increased T cell proliferation
|
J:99463
|
Arhgef6tm1Kdf/Arhgef6tm1Kdf
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased B cell proliferation
|
J:137269
|
decreased T cell proliferation
|
J:137269
|
Arhgef11tm1Sgkd/Arhgef11tm1Sgkd Arhgef12tm1Sgkd/Arhgef12tm1Sgkd
(involves: 129 * C57BL/6J)
|
abnormal fibroblast proliferation
|
J:198274
|
decreased fibroblast proliferation
|
J:198274
|
Arhgef12tm1.1Wet/Arhgef12tm1.1Wet Tg(Lck-cre)548Jxm/0
(involves: 129 * C57BL/6 * CBA)
|
abnormal T cell proliferation
|
J:149560
|
Arid2tm1a(EUCOMM)Wtsi/Arid2tm1a(EUCOMM)Wtsi
(involves: C57BL/6J * C57BL/6N)
|
decreased fetal cardiomyocyte proliferation
|
J:223458
|
Arl13btm1c(EUCOMM)Wtsi/Arl13btm1c(EUCOMM)Wtsi Tg(Cdh16-cre)91Igr/0
(involves: C57BL/6J * C57BL/6N * ICR)
|
increased kidney cell proliferation
|
J:240795
|
Arrb1tm1Jse/Arrb1tm1Jse Arrb2tm1Rjl/Arrb2tm1Rjl
(involves: 129X1/SvJ * C57BL/6)
|
decreased mesenchymal cell proliferation involved in lung development
|
J:159121
|
Ascl1tm1And/Ascl1tm1And
(involves: 129)
|
decreased neuronal precursor proliferation
|
J:203419
|
Asxl1tm1.1Mjxu/Asxl1+
(involves: 129 * C57BL/6)
|
increased cell proliferation
|
J:208085
|
Asxl1tm1.1Mjxu/Asxl1tm1.1Mjxu
(involves: 129 * C57BL/6)
|
increased cell proliferation
|
J:208085
|
Atf2tm2Nicj/Atf2tm2Nicj Atf7tm1Nicj/Atf7tm1Nicj
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased cell proliferation
|
J:123909
|
Atf4tm1Tow/Atf4+ Ptprvtm1Asmi/Ptprv+
(either: (involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * C57BL/6J * NIH Black Swiss) or (involves: 129P2/OlaHsd * C57BL/6J * NIH Black Swiss))
|
increased pancreatic beta cell proliferation
|
J:152695
|
Atf4tm1Tow/Atf4tm1Tow
(involves: 129S1/Sv * 129X1/SvJ * NIH Black Swiss)
|
decreased cell proliferation
|
J:74479
|
Atf4tm1Tow/Atf4tm1Tow
(either: (involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * C57BL/6J * NIH Black Swiss) or (involves: 129P2/OlaHsd * C57BL/6J * NIH Black Swiss))
|
increased pancreatic beta cell proliferation
|
J:152695
|
Atf6tm1.1Rjk/Atf6tm1.1Rjk
(involves: C57BL/6 * FVB/N)
|
decreased cell proliferation
|
J:124971
|
Atg3tm1.1Ywh/Atg3tm1.1Ywh Tg(Lck-cre)548Jxm/0
(involves: 129S/SvEv * 129S4/SvJaeSor * C57BL/6 * CBA)
|
decreased T cell proliferation
|
J:172749
|
Atg5tm1Nmz/Atg5tm1Nmz Tg(Cd4-cre)1Cwi/?
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA/2)
|
decreased T cell proliferation
|
J:211733
|
Atg7tm1Tchi/Atg7tm1Tchi Tg(Mx1-cre)1Cgn/0
(involves: C57BL/6 * CBA)
|
increased hepatocyte proliferation
|
J:130839
|
Atg7tm1Tchi/Atg7tm1Tchi Tg(Tyr-cre)1Lru/Y
(involves: C57BL/6 * C57BL/6NCrlj * CBA/JNCrlj * DBA/2)
|
abnormal melanocyte proliferation
|
J:220623
|
Atictm1c(EUCOMM)Hmgu/Atictm1c(EUCOMM)Hmgu Gt(ROSA)26Sortm1(cre/ERT2)Tyj/Gt(ROSA)26Sor+
(involves: 129S4/SvJae * C57BL/6J * C57BL/6N)
|
decreased vascular smooth muscle cell proliferation
|
J:338121
|
Atictm1c(EUCOMM)Hmgu/Atictm1c(EUCOMM)Hmgu X/Tg(Myh11-icre/ERT2)1Soff
(involves: 129S4/SvJaeSor * C57BL/6J * C57BL/6N * FVB/N)
|
decreased vascular smooth muscle cell proliferation
|
J:338121
|
Atmtm1.1Mmpl/Atmtm1.1Mmpl
(involves: 129S4/SvJaeSor * 129S6/SvEvTac * C57BL/6J)
|
decreased cell proliferation
|
J:226414
|
Atmtm1Awb/Atmtm1Awb
(either: 129S6/SvEvTac-Atmtm1Awb or (involves: 129S6/SvEvTac * NIH Black Swiss))
|
decreased fibroblast proliferation
|
J:34193
|
Atmtm1Bal/Atmtm1Bal
(involves: 129S4/SvJae)
|
decreased fibroblast proliferation
|
J:42324
|
Atmintm1.1Axbe/Atmintm1.1Axbe
(involves: BALB/c * C57BL/6)
|
decreased cell proliferation
|
J:167331
|
Atoh1tm3Hzo/Atoh1+ Gt(ROSA)26Sortm1(cre/ERT)Nat/Gt(ROSA)26Sortm1(Smo/EYFP)Amc
(involves: 129 * 129S7/SvEvBrd * 129X1/SvJ)
|
abnormal neuronal precursor proliferation
|
J:155047
|
Atoh1tm3Hzo/Atoh1tm1Hzo Gt(ROSA)26Sortm1(cre/ERT)Nat/Gt(ROSA)26Sortm1(Smo/EYFP)Amc
(involves: 129 * 129S7/SvEvBrd * 129X1/SvJ)
|
abnormal neuronal precursor proliferation
|
J:155047
|
Atoh1tm3Hzo/Atoh1tm3Hzo
(involves: 129S7/SvEvBrd)
|
decreased neuronal precursor proliferation
|
J:155047
|
Atp6v0d1em1Nju/Atp6v0d1em1Nju Tg(Adipoq-cre)1Evdr/0
(involves: FVB/NJ)
|
increased fibroblast proliferation
|
J:346448
|
Atrtm1Bal/Atrtm2Bal Ndor1Tg(UBC-cre/ERT2)1Ejb/0
(involves: 129S/SvEv * 129S2/SvPas * C57BL/6)
|
decreased cell proliferation
|
J:123200
|
Atrtm1Ofc/Atrtm1Ofc
(involves: 129 * C57BL/6)
|
decreased granulosa cell proliferation
|
J:307570
|
increased granulosa cell proliferation
|
J:307570
|
Atrtm2Bal/Atrtm2Bal Tg(CAG-cre/Esr1*)5Amc/0
(involves: 129S2/SvPas * C57BL/6 * CBA)
|
abnormal neuron proliferation
|
J:181920
|
Atrtm2Bal/Atrtm2Bal Tg(Nes-cre)1Kln/0
(involves: 129S2/SvPas * C57BL/6 * SJL)
|
abnormal neuron proliferation
|
J:181920
|
decreased cerebellar granule cell precursor proliferation
|
J:181920
|
Atrtm2Bal/Atrtm2Bal Trp53tm1Tyj/Trp53tm1Tyj Tg(Nes-cre)1Kln/0
(involves: 129S2/SvPas * C57BL/6 * SJL)
|
abnormal neuron proliferation
|
J:181920
|
Atrxtm1Rjg/Y Tg(Gata1-cre)1Sho/0
(involves: 129P2/OlaHsd * C57BL/6 * CD-1)
|
decreased cell proliferation
|
J:115836
|
Aurkatm1.1Tvd/Aurkatm1.1Tvd Gt(ROSA)26Sortm1(cre/ERT)Nat/Gt(ROSA)26Sortm1Sor
(involves: 129 * 129P2/OlaHsd * 129S4/SvJaeSor * C57BL/6J)
|
decreased cell proliferation
|
J:145744
|
Axd/Axd
(involves: BALB/c * BALB/cAnNCrl * C3H/HeN * C57BL/6)
|
decreased cell proliferation
|
J:170759
|
Axin2tm1.1(cre/ERT2/tdTomato)Eem/Axin2+ Ctnnb1tm2Kem/Ctnnb1tm2Kem
(involves: 129S2/SvPas * C57BL/6)
|
decreased cell proliferation
|
J:204142
|
Axin2tm1Wbm/Axin2tm1Wbm
(involves: 129P2/OlaHsd * C57BL/6)
|
increased osteoblast proliferation
|
J:98523
|
Axltm1Grl/Axltm1Grl Mertktm1Grl/Mertktm1Grl Tyro3tm1Grl/Tyro3tm1Grl
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
increased B cell proliferation
|
J:70420
|
increased T cell proliferation
|
J:70420
|
B2mtm1Jae/B2mtm1Jae Rr94tm3.2Litt/Rr94tm3.2Litt
(involves: 129P2/OlaHsd * 129S2/SvPas * FVB/N)
|
increased T cell proliferation
|
J:158962
|
B2mtm1Unc/B2mtm1Unc H2-Ab1b-tm1Doi/H2-Ab1b-tm1Doi
(involves: 129P2/OlaHsd * 129S2/SvPas)
|
abnormal neuron proliferation
|
J:170591
|
B3gnt2Gt(OST237555)Lex/B3gnt2Gt(OST237555)Lex
(involves: 129S5/SvEvBrd * C57BL/6N)
|
increased T cell proliferation
|
J:125556
|
B3gnt6tm1Lx/B3gnt6tm1Lx
(involves: 129S1/Sv * C57BL/6J)
|
abnormal enterocyte proliferation
|
J:123826
|
B9d2/Tgfb1tm1Flv/Tgfb1tm2Flv Tg(Cd4-cre)1Cwi/0
(involves: 129S6/SvEvTac * C57BL/6 * DBA/2)
|
increased T cell proliferation
|
J:123547
|
B9d2/Tgfb1tm1Flv/Tgfb1tm2Flv Tnfrsf4tm2(cre)Nik/Tnfrsf4+
(involves: 129S6/SvEvTac * 129X1/SvJ)
|
abnormal enterocyte proliferation
|
J:169839
|
B9d2/Tgfb1tm1Flv/B9d2+ Tnfrsf4tm2(cre)Nik/Tnfrsf4+
(involves: 129S6/SvEvTac * 129X1/SvJ)
|
abnormal enterocyte proliferation
|
J:169839
|
Babam1Gt(IST11207B9)Tigm/Babam1Gt(IST11207B9)Tigm
(involves: C57BL/6N)
|
increased hematopoietic stem cell proliferation
|
J:223526
|
Babam2tm1b(EUCOMM)Wtsi/Babam2tm1b(EUCOMM)Wtsi
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
decreased fibroblast proliferation
|
J:235690
|
Bag6tm1Pmc/Bag6tm1Pmc
(involves: 129S1/Sv * C57BL/6)
|
increased kidney cell proliferation
|
J:119857
|
Bank1tm1Kuro/Bank1tm1Kuro
(Not Specified)
|
increased B cell proliferation
|
J:113321
|
Barx1tm1Shiv/Barx1tm1Shiv
(either: B6.Cg-Barx1tm1Shiv or 129S.Cg-Barx1tm1Shiv or (involves: CD-1))
|
decreased cell proliferation
|
J:180393
|
increased cell proliferation
|
J:180393
|
Baxtm1Sjk/Bax+ KitlSl/KitlSl Tg(Pou5f1-GFP)1Scho/?
(involves: 129X1/SvJ * C3H * CD-1 * FVB)
|
abnormal primordial germ cell proliferation
|
J:115283
|
Baxtm1Sjk/Baxtm1Sjk KitlSl/KitlSl Tg(Pou5f1-GFP)1Scho/?
(involves: 129X1/SvJ * C3H * CD-1 * FVB)
|
abnormal primordial germ cell proliferation
|
J:115283
|
Bbs1tm1Vcs/Bbs1tm1Vcs
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal neuronal precursor proliferation
|
J:194096
|
Bbs1tm2Vcs/Bbs1tm2Vcs Tg(Pdgfra-cre)1Clc/0
(involves: 129S6/SvEvTac * C57BL/6)
|
decreased neuronal precursor proliferation
|
J:194096
|
BC004004em1Nju/BC004004em1Nju
(C57BL/6J-BC004004em1Nju)
|
decreased lung fibroblast proliferation
|
J:328326
|
Bcap31tm1.1Bwang/Bcap31tm1.1Bwang Tg(Lck-cre)548Jxm/0
(involves: C57BL/6 * CBA)
|
decreased T cell proliferation
|
J:274469
|
Bcl2tm1Lbox/Bcl2tm1Lbox
(involves: 129S1/Sv * 129X1/SvJ * FVB/N)
|
decreased B cell proliferation
|
J:114637
|
Bcl2tm1Sjk/Bcl2tm1Sjk
(involves: 129S2/SvPas * C57BL/6)
|
increased kidney cell proliferation
|
J:15224,
J:34504
|
Bcl2l1tm1Cant/Bcl2l1tm1Cant
(involves: 129S6/SvEvTac)
|
decreased T cell proliferation
|
J:77507
|
Bcl2l11tm1.1Ast/Bcl2l11tm1.1Ast
(involves: 129S1/Sv * C57BL/6)
|
abnormal B cell proliferation
|
J:90963
|
Bcl2l11tm1.1Ast/Bcl2l11tm1.1Ast Faslpr/Faslpr
(B6.Cg-Bcl2l11tm1.1Ast Faslpr)
|
increased kidney cell proliferation
|
J:132217
|
Bcl3tm1Sbn/Bcl3tm1Sbn
(involves: 129S4/SvJae)
|
decreased B cell proliferation
|
J:207111
|
increased B cell proliferation
|
J:207111
|
Bcl6tm1.1Toka/Bcl6+ Tg(TcraTcrb)425Cbn/0
(involves: BALB/c * C57BL/6 * NZB)
|
decreased T cell proliferation
|
J:174014
|
Bcl6tm2Rdf/Bcl6tm2Rdf
(involves: 129S1/Sv)
|
decreased B cell proliferation
|
J:40769
|
Bcl6btm1Dtf/Bcl6btm1Dtf
(involves: 129P2/OlaHsd)
|
decreased T cell proliferation
|
J:99818
|
Bcl10tm1Mak/Bcl10tm1Mak
(involves: 129P2/OlaHsd)
|
decreased B cell proliferation
|
J:109545,
J:67297
|
decreased T cell proliferation
|
J:109545,
J:67297
|
Bcl10tm1Swm/Bcl10tm1Swm
(involves: 129P2/OlaHsd)
|
decreased B cell proliferation
|
J:85147
|
Bclaf1tm1Raz/Bclaf1+
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased T cell proliferation
|
J:158087
|
Bclaf1tm1Raz/Bclaf1tm1Raz
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased T cell proliferation
|
J:158087
|
Bcortm1.1Vjba/Y
(involves: 129S1/Sv)
|
increased cell proliferation
|
J:231455
|
Becn1tm1.1Bflu/Becn1tm1.1Bflu Tg(Cd4-cre)1Cwi/0
(involves: 129S1/Sv * C57BL/6 * DBA/2)
|
decreased T cell proliferation
|
J:203090
|
Bglap/Bglap2tm1Kry/Bglap/Bglap2tm1Kry
(involves: 129S7/SvEvBrd)
|
decreased pancreatic beta cell proliferation
|
J:126780
|
Bglap/Bglap2tm1Kry/Bglap/Bglap2tm1Kry
(involves: 129S7/SvEvBrd)
|
decreased pancreatic beta cell proliferation
|
J:126780
|
Bgntm1Mfy/Y Fmodtm1Aol/Fmodtm1Aol
(involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ)
|
decreased chondrocyte proliferation
|
J:117908
|
Bgntm1Mfy/Bgntm1Mfy Fmodtm1Aol/Fmodtm1Aol
(involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ)
|
decreased chondrocyte proliferation
|
J:117908
|
Bhlhe40tm1Tan/Bhlhe40tm1Tan
(either: (involves: 129S1/Sv * 129X1/SvJ) or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6))
|
decreased T cell proliferation
|
J:72651
|
Bhlhe41tm1.2Cdon/Bhlhe41tm1.2Cdon
(B6.129S6-Bhlhe41tm1.2Cdon)
|
decreased T cell proliferation
|
J:157740
|
Bin1tm1Gcp/Bin1tm2Gcp Tg(MMTV-Myc)141-3Led/0 Tg(Wap-cre)11738Mam/0
(involves: 129S6/SvEvTac * C57BL/6 * CD-1 * FVB/N * SJL)
|
increased cell proliferation
|
J:117330
|
Birc2tm2.1Jda/Birc2tm2.1Jda
(B6.Cg-Birc2tm2.1Jda)
|
increased T cell proliferation
|
J:199221
|
Birc3tm1Jda/Birc3tm1Jda
(B6.Cg-Birc3tm1Jda)
|
increased B cell proliferation
|
J:166899
|
Birc3tm1Jda/Birc3tm1Jda
(involves: 129 * C57BL/6)
|
increased T cell proliferation
|
J:199221
|
Birc6tm1Sjen/Birc6tm1Sjen
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
decreased cell proliferation
|
J:94169
|
Blnktm1Achn/Blnk+
(involves: 129S4/SvJae * 129X1/SvJ * BALB/c * C3H * C57BL/6)
|
decreased B cell proliferation
|
J:82430
|
Blnktm1Achn/Blnk+ Btktm1Wk/Btktm1Wk Tg(IGH-Btk)1Witt/0
(involves: 129S4/SvJae * 129X1/SvJ * BALB/c * C3H * C57BL/6)
|
decreased B cell proliferation
|
J:82430
|
Blnktm1Dkit/Blnktm1Dkit Prkcdtm1Kin/Prkcdtm1Kin
(involves: 129P2/OlaHsd * C57BL/6 * NZB)
|
abnormal B cell proliferation
|
J:143854
|
Blnktm1Kplm/Blnktm1Kplm
(involves: 129P2/OlaHsd)
|
decreased B cell proliferation
|
J:61130
|
Bloc1s2tm1Wli/Bloc1s2tm1Wli
(involves: 129 * C57BL/6J)
|
increased hematopoietic stem cell proliferation
|
J:238623
|
increased neuronal precursor proliferation
|
J:238623
|
Bmi1tm1Brn/Bmi1tm1Brn
(either: (involves: 129P2/OlaHsd) or (involves: 129P2/OlaHsd * FVB))
|
decreased splenocyte proliferation
|
J:17712
|
Bmi1tm1Brn/Bmi1tm1Brn
(involves: 129P2/OlaHsd)
|
decreased cell proliferation
|
J:134271
|
Bmi1tm1Brn/Bmi1tm1Brn
(involves: 129P2/OlaHsd * C57BL/6J * FVB/N)
|
decreased granulosa cell proliferation
|
J:287217
|
Bmi1tm1Brn/Bmi1tm1Brn E2f6tm1Lees/E2f6tm1Lees
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6)
|
decreased cell proliferation
|
J:134271
|
Bmp8btm1Blh/Bmp8btm1Blh
(involves: 129/Sv * Black Swiss)
|
abnormal spermatogonia proliferation
|
J:34057
|
Bmp10tm1.1(Gdf2)Minh/Bmp10tm1.1(Gdf2)Minh
(C57BL/6N-Bmp10tm1.1(Gdf2)Minh)
|
decreased fetal cardiomyocyte proliferation
|
J:222016
|
Bmpr1atm1Bhr/Bmpr1atm1Bhr
(involves: 129S7/SvEvBrd * C57BL/6)
|
decreased embryonic epiblast cell proliferation
|
J:30426
|
Bmpr1atm1Bhr/Bmpr1atm1Bhr
(B6.129S7-Bmpr1atm1Bhr)
|
decreased embryonic epiblast cell proliferation
|
J:30426
|
Bmpr1atm1Bhr/Bmpr1atm1Bhr
(involves: 129S7/SvEvBrd * Swiss)
|
decreased embryonic epiblast cell proliferation
|
J:30426
|
Bmpr1atm1Bhr/Bmpr1atm1Bhr
(129S7/SvEvBrd-Bmpr1atm1Bhr)
|
decreased embryonic epiblast cell proliferation
|
J:30426
|
Bmpr1atm2.1Bhr/Bmpr1atm2.2Bhr Isl1tm1(cre)Sev/Isl1+
(involves: 129S4/SvJae * 129S7/SvEvBrd)
|
abnormal fetal cardiomyocyte proliferation
|
J:107396
|
decreased cell proliferation
|
J:107396
|
Bmpr1bTg(ACTB-FLP)4917Dym/Bmpr1bTg(ACTB-FLP)4917Dym
(involves: C57BL/6 * SJL)
|
decreased cell proliferation
|
J:59288
|
Bmpr2tm1.1Enl/Bmpr2tm1.1Enl Tg(Acvrl1-cre)L1Spo/0
(involves: 129S4/SvJae * FVB)
|
increased lung endothelial cell proliferation
|
J:158116
|
increased vascular smooth muscle cell proliferation
|
J:158116
|
Borcs6tm1.1(KOMP)Vlcg/Borcs6tm1.1(KOMP)Vlcg
(B6N(Cg)-Borcs6tm1.1(KOMP)Vlcg/J)
|
decreased embryonic epiblast cell proliferation
|
J:329966
|
BptfGt(XG023)Byg/BptfGt(XG023)Byg
(involves: 129P2/OlaHsd)
|
decreased cell proliferation
|
J:147414
|
Bptftm1.1Cwu/Bptftm1.1Cwu Emx1tm1(cre)Krj/Emx1+
(involves: 129S1/Sv * 129S2/SvPas * C57BL/6)
|
abnormal neuronal precursor proliferation
|
J:334252
|
Braftm1Cpri/Braf+
(involves: 129P2/OlaHsd)
|
increased cell proliferation
|
J:187371
|
Braftm1Cpri/Braftm1Cpri
(involves: 129P2/OlaHsd * C57BL/6)
|
increased fibroblast proliferation
|
J:104375
|
Braftm1Sva/Braftm1Sva Krastm1Bbd/Kras+ Polr2atm1(cre/ERT2)Bbd/Polr2atm1(cre/ERT2)Bbd
(involves: 129S1/Sv * 129X1/SvJ)
|
decreased cell proliferation
|
J:172200
|
Braftm1Sva/Braftm1Sva Krastm1Bbd/Kras+ Polr2atm1(cre/ERT2)Bbd/Polr2atm1(cre/ERT2)Bbd Raf1tm2Bacc/Raf1tm2Bacc
(involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ)
|
decreased cell proliferation
|
J:172200
|
Braftm2.1Urr/Braftm2.1Urr Tg(Nes-cre)1Kln/0
(involves: 129 * C57BL/6 * SJL)
|
increased neuronal precursor proliferation
|
J:199842
|
Braftm2Cpri/Braf+ Krastm4Tyj/Kras+
(involves: 129S4/SvJae * C57BL/6)
|
increased fibroblast proliferation
|
J:187371
|
Braftm2Urr/Braftm2Urr Tg(Nes-cre)1Kln/0
(involves: 129 * C57BL/6 * SJL)
|
abnormal neuronal precursor proliferation
|
J:199842
|
Brca1tm1Bhk/Brca1+
(C.129P2-Brca1tm1Bhk)
|
decreased mammary gland epithelial cell proliferation
|
J:198018
|
Brca1tm1Brn/Brca1tm1Brn
(involves: 129P2/OlaHsd)
|
decreased cell proliferation
|
J:117113
|
Brca1tm1Brn/Brca1tm1Brn Trp53tm1Brn/Trp53tm1Brn
(involves: 129P2/OlaHsd)
|
increased cell proliferation
|
J:117113
|
Brca1tm1Cxd/Brca1tm2Cxd Tg(KRT5-cre)5132Jlj/0
(involves: 129S6/SvEvTac * C57BL/6)
|
increased keratinocyte proliferation
|
J:85354
|
Brca1tm1Cxd/Brca1tm2Cxd Tg(KRT5-cre)5132Jlj/0 Tg(KRT5-E2F1)2Dgj/0
(involves: 129S6/SvEvTac * C57BL/6 * SJL)
|
increased keratinocyte proliferation
|
J:85354
|
Brca1tm1Cxd/Brca1tm2Cxd Tg(KRT5-E2F1)2Dgj/0
(involves: 129S6/SvEvTac * C57BL/6 * SJL)
|
increased keratinocyte proliferation
|
J:85354
|
Brca1tm1Whl/Brca1tm1Whl
(involves: 129P2/OlaHsd * C57BL/6J)
|
decreased cell proliferation
|
J:34458
|
Brca1tm2.1Cxd/Brca1tm2.1Cxd
(involves: 129S6/SvEvTac * C57BL/6)
|
decreased fibroblast proliferation
|
J:177853
|
Brca1tm2.1Cxd/Brca1tm2.1Cxd Parp1tm1Zqw/Parp1tm1Zqw
(involves: 129S2/SvPas * 129S6/SvEvTac)
|
decreased cell proliferation
|
J:139260
|
Brca1tm2.1Cxd/Brca1tm2.1Cxd Trp53tm1Brd/Trp53+
(involves: 129S6/SvEvTac * 129S7/SvEvBrd)
|
increased fibroblast proliferation
|
J:70271
|
Brca1tm2.1Cxd/Brca1tm2.1Cxd Trp53tm1Brd/Trp53+
(involves: 129S6/SvEvTac * 129S7/SvEvBrd * Black Swiss * FVB)
|
decreased cell proliferation
|
J:81559
|
Brca1tm2Cxd/Brca1+ Tg(KRT5-E2F1)2Dgj/0
(involves: 129S6/SvEvTac * C57BL/6 * SJL)
|
increased keratinocyte proliferation
|
J:85354
|
Brca1tm2Cxd/Brca1tm2Cxd Tg(MMTV-cre)4Mam/0
(involves: 129S6/SvEvTac * C57BL/6 * FVB)
|
increased mammary gland epithelial cell proliferation
|
J:132088
|
Brca1tm2Cxd/Brca1tm2Cxd Trp53tm1Brd/Trp53+ Tg(MMTV-cre)4Mam/0
(involves: 129S6/SvEvTac * 129S7/SvEvBrd * C57BL/6 * FVB)
|
increased mammary gland epithelial cell proliferation
|
J:132088
|
Brca1tm2Mak/Brca1tm2Mak Tg(Lck-cre)548Jxm/?
(involves: 129P2/OlaHsd * C57BL/6 * CBA)
|
decreased T cell proliferation
|
J:63282
|
Brca1tm2Mak/Brca1tm2Mak Tg(Lck-cre)548Jxm/? Tg(TcrLCMV)327Sdz/?
(involves: 129P2/OlaHsd * C57BL/6 * CBA)
|
decreased T cell proliferation
|
J:63282
|
Brca1tm2Rjbr/Brca1tm2Rjbr
(involves: 129 * C57BL/6)
|
decreased fibroblast proliferation
|
J:177853
|
Brca1tm5.1Cxd/Brca1tm5.1Cxd
(involves: 129S6/SvEvTac * FVB/N)
|
increased mammary gland epithelial cell proliferation
|
J:155810
|
Brca2tm1Cbl/Brca2tm1Cbl
(either: (involves: 129S2/SvPas * C57BL/10) or (involves: 129S2/SvPas * C57BL/6 * DBA/2))
|
decreased fibroblast proliferation
|
J:44386
|
Brd2Gt(RRE050)Byg/Brd2+
(involves: 129P2/OlaHsd * C57BL/6J)
|
decreased cell proliferation
|
J:147040
|
Brd2Gt(RRE050)Byg/Brd2Gt(RRE050)Byg
(involves: 129P2/OlaHsd * C57BL/6J)
|
decreased cell proliferation
|
J:147040
|
Brip1Gt(RRI409)Byg/Brip1Gt(RRI409)Byg
(involves: 129P2/OlaHsd)
|
abnormal spermatogonia proliferation
|
J:227337
|
decreased cell proliferation
|
J:227337
|
decreased primordial germ cell proliferation
|
J:227337
|
Brpf1tm1c(EUCOMM)Wtsi/Brpf1tm1c(EUCOMM)Wtsi Emx1tm1(cre)Krj/Emx1+
(involves: 129S2/SvPas * C57BL/6J * C57BL/6N)
|
decreased neuronal precursor proliferation
|
J:224155,
J:241490
|
Bsgtm1.1Znc/Bsgtm1.1Znc Tg(Lck-cre)19Hhan/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA)
|
increased T cell proliferation
|
J:207886
|
Btg1tm1Ftir/Btg1tm1Ftir
(Not Specified)
|
decreased neuronal precursor proliferation
|
J:217516
|
Btktm1Wk/Btktm1Wk
(involves: 129S4/SvJae * C57BL/6)
|
decreased B cell proliferation
|
J:82298
|
Btktm1Wk/Btktm1Wk Cd40tm1Geha/Cd40tm1Geha
(involves: 129S4/SvJae * C57BL/6)
|
decreased B cell proliferation
|
J:82298
|
Btktm1Wk/Btktm1Wk Tectm1Welm/Tectm1Welm
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased B cell proliferation
|
J:66080
|
Btktm1Wk/Btktm1Wk Tg(IGH-Btk)1Witt/0
(involves: 129S4/SvJae * 129X1/SvJ * BALB/c * C3H * C57BL/6)
|
decreased B cell proliferation
|
J:82430
|
Btkxid/Y
(CBA/HN-Btkxid)
|
decreased B cell proliferation
|
J:81429
|
Btkxid/Y
(involves: CBA/HN * DBA/2N)
|
decreased B cell proliferation
|
J:81429
|
Btkxid/?
(involves: BALB/c * CBA/N)
|
decreased B cell proliferation
|
J:108696
|
Btkxid/? Ptpn6me/Ptpn6me
(involves: C57BL/6J * CBA/N * NFS)
|
increased splenocyte proliferation
|
J:30994
|
Btkxid/? Tg(IGH-Btk)1Witt/0
(involves: BALB/c * C3H * C57BL/6 * CBA/N)
|
decreased B cell proliferation
|
J:108696
|
Btkxid/? Tg(IGH-Btk)1Witt/Tg(IGH-Btk)1Witt
(involves: BALB/c * C3H * C57BL/6 * CBA/N)
|
decreased B cell proliferation
|
J:108696
|
Btkxid/Btkxid
(involves: CBA/HN * DBA/2N)
|
abnormal B cell proliferation
|
J:81429
|
Btkxid/Btkxid
(CBA/HN-Btkxid)
|
decreased B cell proliferation
|
J:81429
|
Btlatm1Kmm/Btlatm1Kmm
(involves: 129S/SvEv)
|
increased B cell proliferation
|
J:84084
|
increased T cell proliferation
|
J:84084
|
Btlatm1Kmm/Btlatm1Kmm
(B6.129S-Btlatm1Kmm)
|
decreased T cell proliferation
|
J:119356
|
increased T cell proliferation
|
J:119356
|
Btlatm1Kmm/Btlatm1Kmm Pdcd1tm1Hon/Pdcd1tm1Hon
(B6.129S-Pdcd1tm1Hon Btlatm1Kmm)
|
increased T cell proliferation
|
J:119356
|
Btlatm1Kmm/Btlatm1Kmm Tg(DO11.10)10Dlo/?
(involves: 129S/SvEv * BALB/c * C3H * C57BL/6)
|
increased T cell proliferation
|
J:84084
|
Btrctm1Kin/Btrctm1Kin
(involves: C57BL/6)
|
decreased fibroblast proliferation
|
J:84639
|
Bub1tm1.1Tvd/Bub1tm1.1Tvd
(involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6J)
|
decreased fibroblast proliferation
|
J:143035
|
Bub1tm1Ssta/Bub1tm1.1Ssta Tg(CAG-cre/Esr1*)5Amc/?
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA)
|
decreased cell proliferation
|
J:128455
|
Bub1btm1.1Hsl/Bub1b+
(involves: 129 * C57BL/6)
|
increased B cell proliferation
|
J:201641
|
Bub3tm1Jvd/Bub3+ Rae1tm1Jvd/Rae1+
(Not Specified)
|
decreased cell proliferation
|
J:81546
|
C1qbptm1.1Tuch/C1qbptm1.1Tuch
(involves: C57BL/6)
|
decreased cell proliferation
|
J:196232
|
C3tm1Crr/C3tm1Crr
(involves: 129S4/SvJae * C57BL/6)
|
decreased hepatocyte proliferation
|
J:152533
|
C3tm1Crr/C3tm1Crr Cd59atm1Bpm/Cd59atm1Bpm
(B6.129-Cd59atm1Bpm C3tm1Crr)
|
increased T cell proliferation
|
J:122201
|
C3tm1Crr/C3tm1Crr Tg(Ins2-TFRC/OVA)296Wehi/0
(involves: 129S4/SvJae * C57BL/6)
|
increased T cell proliferation
|
J:122114
|
Cacfd1tm1.1Geno/Cacfd1tm1.1Geno
(involves: 129S2/SvPas * C57BL/6J)
|
decreased cell proliferation
|
J:184968
|
Cacna1dtm1Hssh/Cacna1dtm1Hssh
(involves: 129S4/SvJae * C57BL/6J)
|
decreased pancreatic beta cell proliferation
|
J:72316
|
CacybpGT(OST39970)Lex/CacybpGT(OST39970)Lex
(involves: 129S5/SvEvBrd)
|
increased fibroblast proliferation
|
J:110899
|
Cadm1Gt(Ayu21-W34)Imeg/Cadm1Gt(Ayu21-W34)Imeg
(involves: C57BL/6 * CBA/JNCrlj)
|
decreased T cell proliferation
|
J:178612
|
Cadm1tm1.2Brd/Cadm1tm1.2Brd
(involves: 129S7/SvEvBrd)
|
increased pancreatic beta cell proliferation
|
J:210552
|
Calcrltm1Kmca/Calcrltm1Kmca
(129S6/SvEvTac-Calcrltm1Kmca)
|
abnormal fetal cardiomyocyte proliferation
|
J:106927
|
Calrtm1.2Osb/Calrtm1.1Osb Tg(Zp3-cre)93Knw/0
(involves: 129S2/SvPas * C57BL/6J)
|
decreased granulosa cell proliferation
|
J:250114
|
Camk2atm1Sva/Camk2a+
(B6.129P2-Camk2atm1Sva/J)
|
increased cell proliferation
|
J:263327
|
Cant1tm1.2Aros/Cant1tm1.2Aros
(involves: 129 * C57BL/6J)
|
increased chondrocyte proliferation
|
J:282272
|
Card11em1Welu/Card11em1Welu
(involves: C57BL/6)
|
decreased B cell proliferation
|
J:292926
|
Card11em2Welu/Card11em2Welu
(involves: C57BL/6)
|
increased B cell proliferation
|
J:292926
|
Card11m1Btlr/Card11m1Btlr
(C57BL/6J-Card11m1Btlr)
|
decreased B cell proliferation
|
J:149767,
J:139069
|
decreased T cell proliferation
|
J:149767,
J:139069
|
Card11tm1Litt/Card11tm1Litt
(involves: 129P2/OlaHsd)
|
abnormal B cell proliferation
|
J:89322
|
abnormal T cell proliferation
|
J:89322
|
Card11tm1Pngr/Card11tm1Pngr
(involves: 129P2/OlaHsd)
|
decreased B cell proliferation
|
J:84036
|
Card11tm1Vmd/Card11+
(involves: 129S6/SvEvTac * C57BL/6N)
|
decreased B cell proliferation
|
J:95800
|
Card11tm1Vmd/Card11tm1Vmd
(involves: 129S6/SvEvTac * C57BL/6N)
|
decreased B cell proliferation
|
J:95800
|
decreased T cell proliferation
|
J:95800
|
Card14em9Lutzy/Card14+
(C57BL/6J-Card14em9Lutzy/J)
|
increased keratinocyte proliferation
|
J:262723
|
Card19tm1Rwen/Card19tm1Rwen Tg(IghelMD4)4Ccg/0 Tg(ML5sHEL)5Ccg/0
(involves: 129P2/OlaHsd * C57BL/6 * C57BL/6JSfd)
|
decreased B cell proliferation
|
J:336763
|
Carmil2bas/Carmil2bas
(involves: C3HeB/FeJ * C57BL/6)
|
decreased T cell proliferation
|
J:205441
|
Carmil2bas/Carmil2tm1a(KOMP)Mbp
(involves: C3HeB/FeJ * C57BL/6 * C57BL/6N)
|
decreased T cell proliferation
|
J:205441
|
Casp3tm1Mak/Casp3tm1Mak Tg(TcrLCMV)327Sdz/0
(B6.Cg-Casp3tm1Mak Tg(TcrLCMV)327Sdz)
|
decreased cell proliferation
|
J:97650
|
Casp8tm1Hed/Casp8tm1Hed Cd19tm1(cre)Cgn/Cd19+
(involves: 129P2/OlaHsd)
|
decreased B cell proliferation
|
J:116713
|
Casp8tm1Raz/Casp8tm1Raz Tg(Lck-cre)548Jxm/0
(involves: 129P2/OlaHsd * C57BL/6 * CBA)
|
abnormal T cell proliferation
|
J:107455
|
decreased T cell proliferation
|
J:82759
|
Casrtm1Wch/Casrtm1Wch Tg(Vil1-cre)997Gum/0
(involves: 129S4/SvJae * C57BL/6J * SJL)
|
abnormal enterocyte proliferation
|
J:179672
|
Casz1Gt(CJ0565)Wtsi/Casz1Gt(CJ0565)Wtsi
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased fetal cardiomyocyte proliferation
|
J:242127
|
Casz1tm1.1Flc/Casz1tm1.1Flc Nkx2-5tm1(cre)Rjs/Nkx2-5+
(involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6 * C57BL/6J * SJL)
|
decreased fetal cardiomyocyte proliferation
|
J:221324
|
Cav1tm1Kur/Cav1tm1Kur
(involves: 129X1/SvJ * C57BL/6)
|
decreased hepatocyte proliferation
|
J:112452
|
increased lung endothelial cell proliferation
|
J:71760
|
Cav1tm1Mls/Cav1tm1Mls Cdkn2atm1Rdp/Cdkn2atm1Rdp
(involves: 129/Sv * C57BL/6 * SJL)
|
increased fibroblast proliferation
|
J:90334
|
Cbltm2Hua/Cbltm2Hua Cblbtm1Hua/Cblbtm1Hua Tg(Lck-cre)I57Jxm/0
(involves: 129P2/OlaHsd * C57BL/6 * ICR)
|
increased T cell proliferation
|
J:80427
|
Cblbtm1Hua/Cblbtm1Hua
(Not Specified)
|
increased T cell proliferation
|
J:89761
|
Cblbtm1Hua/Cblbtm1Hua
(B6.129P2-Cblbtm1Hua)
|
increased T cell proliferation
|
J:94685
|
Cblbtm1Hua/Cblbtm1Hua Ubash3btm1Jni/Ubash3btm1Jni Ubash3atm1Jni/Ubash3atm1Jni
(Not Specified)
|
increased T cell proliferation
|
J:89761
|
Cblbtm1Pngr/Cblbtm1Pngr
(B6.129P2-Cblbtm1Pngr)
|
increased T cell proliferation
|
J:141390
|
Cbx2tm1Cim/Cbx2tm1Cim
(involves: 129P2/OlaHsd * BALB/c)
|
decreased fibroblast proliferation
|
J:38487
|
decreased splenocyte proliferation
|
J:38487
|
Cbx7tm1Afus/Cbx7tm1Afus
(involves: C57BL/6J)
|
increased fibroblast proliferation
|
J:184383
|
Ccdc6tm1Afus/Ccdc6tm1Afus
(involves: 129 * C57BL/6J)
|
decreased fibroblast proliferation
|
J:301625
|
Ccdc80tm1Ppal/Ccdc80+
(Not Specified)
|
increased fibroblast proliferation
|
J:217742
|
Ccdc80tm1Ppal/Ccdc80tm1Ppal
(Not Specified)
|
increased fibroblast proliferation
|
J:217742
|
Ccdc88bm1Pgrs/Ccdc88bm1Pgrs
(involves: C57BL/6J * C57BL/10J)
|
decreased T cell proliferation
|
J:230618
|
Ccdc134tm1.2Jhua/Ccdc134tm1.2Jhua
(involves: C57BL/6NTac)
|
decreased hepatocyte proliferation
|
J:256995
|
Ccl5tm1Hso/Ccl5tm1Hso
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased T cell proliferation
|
J:75842
|
Ccm2ltm1Mlkn/Ccm2ltm1Mlkn Heg1tm1Mlkn/Heg1tm1Mlkn
(involves: 129 * C57BL/6)
|
decreased fetal cardiomyocyte proliferation
|
J:187714
|
Ccn2tm1Kml/Ccn2tm1Kml
(involves: 129X1/SvJ * BALB/cJ)
|
decreased mesenchymal cell proliferation involved in lung development
|
J:130165
|
Ccn3tm1Hko/Ccn3tm1Hko
(B6.129-Ccn3tm1Hko)
|
increased vascular smooth muscle cell proliferation
|
J:172144
|
Ccna1tm1Djw/Ccna1tm1Djw Ccna2tm1.1Pisc/Ccna2tm1.1Pisc
(involves: 129S7/SvEvBrd)
|
decreased cell proliferation
|
J:155178
|
Ccna1tm1Djw/Ccna1tm1Djw Ccna2tm1.1Pisc/Ccna2tm1.2Pisc
(involves: 129S4/SvJaeSor * 129S7/SvEvBrd)
|
decreased cell proliferation
|
J:155178
|
Ccnd3tm1.1(Ccnd2)Iaai/Ccnd3tm1.1(Ccnd2)Iaai
(involves: 129S6/SvEvTac)
|
decreased B cell proliferation
|
J:192031
|
decreased T cell proliferation
|
J:192031
|
Ccnd3tm1Pisc/Ccnd3tm1Pisc
(Not Specified)
|
decreased B cell proliferation
|
J:192031
|
decreased T cell proliferation
|
J:88120,
J:192031
|
Ccnd3tm1Pisc/Ccnd3tm1Pisc Cdkn1btm1Mlf/Cdkn1btm1Mlf
(involves: 129S4/SvJaeSor)
|
decreased T cell proliferation
|
J:192031
|
Ccnd3tm1Pisc/Ccnd3tm1Pisc Rag2tm1Fwa/Rag2tm1Fwa
(involves: 129S/SvEv)
|
increased T cell proliferation
|
J:88120
|
Ccnd3tm1Pisc/Ccnd3tm1Pisc Rb1tm2Brn/Rb1tm2Brn Tg(Mx1-cre)1Cgn/0
(involves: 129 * C57BL/6 * CBA)
|
decreased T cell proliferation
|
J:192031
|
Ccndbp1tm1Riet/Ccndbp1tm1Riet
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased hepatocyte proliferation
|
J:121623
|
Ccne1tm1Clur/Ccne1tm1Clur
(involves: 129S4/SvJae)
|
increased mammary gland epithelial cell proliferation
|
J:136692
|
Ccne1tm1Jro/? Cdkn1atm1Led/Cdkn1atm1Led
(either: (involves: 129S4/SvJaeSor * 129S6/SvEvTac * C57BL/6J) or (involves: 129S4/SvJaeSor * 129S6/SvEvTac * C57BL/6 * C57BL/6J))
|
decreased fibroblast proliferation
|
J:99695
|
Ccne1tm1Jro/? Trp53tm1Tyj/Trp53tm1Tyj
(either: (involves: 129S2/SvPas * 129S4/SvJaeSor * C57BL/6J) or (involves: 129S2/SvPas * 129S4/SvJaeSor * C57BL/6 * C57BL/6J))
|
increased fibroblast proliferation
|
J:99695
|
Ccne1tm1Jro/Ccne1tm1Jro
(either: 129-Ccne1tm1Jro or B6.129-Ccne1tm1Jro)
|
increased splenocyte proliferation
|
J:99695
|
Ccne1tm1Jro/Ccne1tm1Jro
(involves: 129/Sv * 129S4/SvJaeSor)
|
increased mammary gland epithelial cell proliferation
|
J:136692
|
Ccnftm1.1Sje/Ccnftm1.1Sje
(involves: 129S7/SvEvBrd * C57BL/6)
|
decreased cell proliferation
|
J:89060
|
Ccr2tm1Ifc/Ccr2tm1Ifc
(involves: 129S4/SvJae * C57BL/6)
|
decreased splenocyte proliferation
|
J:75838
|
decreased T cell proliferation
|
J:75838
|
Ccr5tm1Sush/Ccr5tm1Sush
(B6.129P2-Ccr5tm1Sush)
|
decreased T cell proliferation
|
J:94937
|
Ccr6tm1(EGFP)Irw/Ccr6tm1(EGFP)Irw
(involves: 129S6/SvEvTac * C57BL/6)
|
increased T cell proliferation
|
J:85086
|
Cd2aptm1Shaw/Cd2aptm1Shaw
(involves: 129X1/SvJ)
|
decreased T cell proliferation
|
J:57971
|
Cd3gtm1Amk/Cd3gtm1Amk
(involves: 129P2/OlaHsd)
|
abnormal T cell proliferation
|
J:77504
|
Cd4tm1Litt/Cd4tm1Litt
(involves: 129S2/SvPas)
|
decreased T cell proliferation
|
J:50435
|
Cd4tm1Litt/Cd4tm1Nik Tg(Lck-cre)3778Nik/0
(involves: 129S2/SvPas * 129X1/SvJ * C57BL/6 * DBA/2)
|
decreased T cell proliferation
|
J:73479
|
Cd4tm1Litt/Cd4tm1Nik Tg(Lck-cre)3785Nik/0
(involves: 129S2/SvPas * 129X1/SvJ * C57BL/6 * DBA/2)
|
increased T cell proliferation
|
J:73479
|
Cd4tm1Litt/Cd4tm1Nik Tg(Lck-icre)3779Nik/0
(involves: 129S2/SvPas * 129X1/SvJ * C57BL/6 * DBA/2)
|
decreased T cell proliferation
|
J:73479
|
Cd5tm1.1Chra/Cd5tm1.1Chra
(involves: C57BL/6 * FVB/N)
|
decreased T cell proliferation
|
J:189919
|
increased T cell proliferation
|
J:189919
|
Cd5tm1.1Chra/Cd5tm1.1Chra Tg(Tcra2D2,Tcrb2D2)1Kuch/0
(involves: C57BL/6 * FVB/N)
|
decreased T cell proliferation
|
J:189919
|
Cd5tm1Cgn/Cd5tm1Cgn
(B6.129P2-Cd5tm1Cgn)
|
increased T cell proliferation
|
J:189919
|
Cd6tm1Linf/Cd6tm1Linf
(D1.Cg-Cd6tm1Linf)
|
decreased B cell proliferation
|
J:238478
|
Cd8am2Btlr/Cd8am2Btlr
(C57BL/6J-Cd8am2Btlr)
|
increased CD8-positive, alpha-beta memory T cell proliferation
|
J:236677
|
Cd19tm1(cre)Cgn/Cd19+ Ctnnbl1tm1.1Crad/Ctnnbl1tm1.1Crad
(involves: 129P2/OlaHsd * C57BL/6 * SJL)
|
decreased B cell proliferation
|
J:232010
|
Cd19tm1(cre)Cgn/Cd19+ Ep300tm2Reck/Ep300+
(involves: 129/Sv * 129P2/OlaHsd * C57BL/6)
|
decreased B cell proliferation
|
J:147840
|
Cd19tm1(cre)Cgn/Cd19+ Gt(ROSA)26Sortm1(ITK/SYK)Jrld/Gt(ROSA)26Sor+
(involves: 129P2/OlaHsd)
|
increased T cell proliferation
|
J:160931
|
Cd19tm1(cre)Cgn/Cd19+ Gt(ROSA)26Sortm2(CARD11*L225LI)Jrld/Gt(ROSA)26Sor+
(involves: 129P2/OlaHsd)
|
increased B cell proliferation
|
J:228288
|
Cd19tm1(cre)Cgn/Cd19+ Gt(ROSA)26Sortm4(Ikbkb)Rsky/Gt(ROSA)26Sor+
(involves: 129P2/OlaHsd * C57BL/6)
|
increased cell proliferation
|
J:113365
|
Cd19tm1(cre)Cgn/Cd19+ Igbp1tm1Imku/Y
(involves: 129P2/OlaHsd)
|
decreased B cell proliferation
|
J:74619
|
Cd19tm1(cre)Cgn/Cd19+ Ikbkbtm1Cgn/Ikbkbtm1.1Cgn
(involves: 129P2/OlaHsd * C57BL/6)
|
increased B cell proliferation
|
J:79132
|
Cd19tm1(cre)Cgn/Cd19+ Ikbkbtm2Mka/Ikbkbtm2Mka
(involves: 129/Sv * 129P2/OlaHsd * C57BL/6)
|
decreased B cell proliferation
|
J:82995
|
Cd19tm1(cre)Cgn/Cd19+ Ikbkgtm1.1Mpa/Y
(involves: 129P2/OlaHsd * C57BL/6)
|
increased B cell proliferation
|
J:79132
|
Cd19tm1(cre)Cgn/Cd19+ Inpp5dtm1Rav/Inpp5dtm1Rav Ptentm1Hwu/Ptentm1Hwu
(involves: 129P2/OlaHsd * 129S4/SvJae)
|
increased B cell proliferation
|
J:166155
|
Cd19tm1(cre)Cgn/Cd19+ Map3k7tm1Aki/Map3k7tm1.1Aki
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased B cell proliferation
|
J:112597
|
Cd19tm1(cre)Cgn/Cd19+ Myd88em1.1Rsky/Myd88em1.1Rsky
(involves: C57BL/6NTac)
|
increased B cell proliferation
|
J:308792
|
Cd19tm1(cre)Cgn/Cd19+ Ptentm1Hwu/Ptentm1Hwu
(involves: 129P2/OlaHsd * 129S4/SvJae)
|
increased B cell proliferation
|
J:155314,
J:83213
|
Cd19tm1(cre)Cgn/Cd19+ Ptpn6tm1Rsky/Ptpn6tm1Rsky
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased B cell proliferation
|
J:123568
|
Cd19tm1(cre)Cgn/Cd19+ Slc3a2tm1.1Mgin/Slc3a2tm1.1Mgin
(involves: 129 * C57BL/6 * SJL)
|
decreased B cell proliferation
|
J:148000
|
Cd19tm1(cre)Cgn/Cd19+ Tnfaip3tm1.1Awai/Tnfaip3tm1.1Awai
(involves: 129P2/OlaHsd)
|
increased B cell proliferation
|
J:175422
|
Cd19tm1(cre)Cgn/Cd19+ Ube2ntm1Aki/Ube2ntm1Aki
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased B cell proliferation
|
J:112287
|
Cd19tm1Tft/Cd19tm1Tft
(Not Specified)
|
decreased B cell proliferation
|
J:27236
|
Cd19tm1Tft/Cd19tm1Tft
(involves: 129 * C57BL/6)
|
decreased B cell proliferation
|
J:71174
|
Cd19tm1Tft/Cd19tm1Tft Lyntm1Sor/Lyntm1Sor
(involves: 129S4/SvJaeSor * C57BL/6)
|
decreased B cell proliferation
|
J:71174
|
Cd22tm1Eac/Cd22tm1Eac
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal B cell proliferation
|
J:37451,
J:132991
|
Cd22tm1Tft/Cd22tm1Tft
(involves: 129P2/OlaHsd * C57BL/6)
|
increased B cell proliferation
|
J:92736
|
Cd22tm2Tft/Cd22tm2Tft
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
decreased B cell proliferation
|
J:92736
|
increased B cell proliferation
|
J:92736
|
Cd22tm2Tft/Cd22tm2Tft
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
decreased B cell proliferation
|
J:208364
|
Cd22tm3Tft/Cd22tm3Tft
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
decreased B cell proliferation
|
J:92736
|
increased B cell proliferation
|
J:92736
|
Cd28tm1Jmg/Cd28tm1Mak
(involves: 129S2/SvPas * 129X1/SvJ * C57BL/6)
|
decreased T cell proliferation
|
J:149888,
J:124570
|
Cd28tm1Ltu/Cd28tm1Ltu Foxp3tm4(YFP/icre)Ayr/Foxp3+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
decreased T cell proliferation
|
J:194503
|
Cd28tm1Mak/Cd28tm1Mak
(involves: 129S2/SvPas * C57BL/6 * DBA/2)
|
decreased T cell proliferation
|
J:14194
|
Cd28tm1Mak/Cd28tm1Mak
(NOD.129S2-Cd28tm1Mak)
|
increased T cell proliferation
|
J:93421
|
Cd28tm1Mak/Cd28tm1Mak
(involves: 129S2/SvPas)
|
decreased T cell proliferation
|
J:205441,
J:130882,
J:123989
|
Cd28tm1Mak/Cd28tm1Mak
(involves: 129S2/SvPas * NOD)
|
decreased T cell proliferation
|
J:35353
|
Cd28tm1Mak/Cd28tm1Mak
(involves: 129S2/SvPas * C57BL/6)
|
decreased T cell proliferation
|
J:149888
|
Cd28tm1Mak/Cd28tm1Mak Tg(Cd4-cre)1Cwi/? Traf6tm2Ywc/Traf6tm2Ywc
(involves: 129S2/SvPas * C57BL/6 * DBA/2)
|
decreased T cell proliferation
|
J:130882
|
Cd28tm1Mak/Cd28tm1Mak Tg(TcrLCMV)327Sdz/0
(involves: 129S2/SvPas * C57BL/6 * DBA/2)
|
decreased splenocyte proliferation
|
J:123989
|
decreased T cell proliferation
|
J:123989
|
Cd28tm1Pjl/Cd28tm1Pjl
(involves: 129P2/OlaHsd * C57BL/6)
|
increased splenocyte proliferation
|
J:83722
|
Cd28tm1Pjl/Cd28tm1Pjl Tg(DO11.10)10Dlo/0
(involves: 129P2/OlaHsd * BALB/c * C3H * C57BL/6)
|
abnormal T cell proliferation
|
J:25536
|
Cd28tm1Pjl/Cd28tm1Pjl Tnfrsf9tm1Byk/Tnfrsf9tm1Byk
(either: B6.Cg-Cd28tm1Pjl Tnfrsf9tm1Byk or C.Cg-Cd28tm1Pjl Tnfrsf9tm1Byk)
|
decreased splenocyte proliferation
|
J:83722
|
Cd28tm1Shr/Cd28tm1Shr
(involves: 129S4/SvJae * BALB/c * C57BL/6)
|
decreased T cell proliferation
|
J:68642
|
Cd28tm1Shr/Cd28tm1Shr Ctla4tm1Shr/Ctla4tm1Shr
(C.129S4-Cd28tm1Shr Ctla4tm1Shr)
|
decreased T cell proliferation
|
J:68642
|
Cd34tm1Szk/Cd34tm1Szk
(involves: 129P2/OlaHsd * C57BL/6J)
|
decreased cell proliferation
|
J:121305
|
Cd44tm1.1Ugu/Cd44tm1.1Ugu
(SJL.129(Cg)-Cd44tm1.1Ugu)
|
decreased T cell proliferation
|
J:199279
|
Cd44tm1Mak/Cd44tm1Mak
(involves: 129P2/OlaHsd * C57BL/6J)
|
decreased fibroblast proliferation
|
J:105319
|
Cd44tm2.1Ugu/Cd44tm2.1Ugu
(B6.129-Cd44tm2.1Ugu)
|
decreased T cell proliferation
|
J:199279
|
Cd48tm1Rsr/Cd48tm1Rsr
(B6.129S4-Cd48tm1Rsr)
|
decreased T cell proliferation
|
J:53718
|
Cd59atm1Bpm/Cd59atm1Bpm
(B6.129-Cd59atm1Bpm)
|
decreased B cell proliferation
|
J:119703
|
increased T cell proliferation
|
J:122201
|
Cd72c/Cd72c
(involves: C57BL/6 * MRL)
|
increased B cell proliferation
|
J:204782
|
Cd72tm1Jrp/Cd72tm1Jrp
(either: (involves: 129P2/OlaHsd) or (involves: 129P2/OlaHsd * C57BL/6))
|
increased B cell proliferation
|
J:76990
|
Cd72tm1Tsub/Cd72tm1Tsub
(involves: C57BL/6J)
|
increased B cell proliferation
|
J:204782
|
Cd74tm1Eae/Cd74tm1Eae
(involves: 129S2/SvPas)
|
decreased B cell proliferation
|
J:113050,
J:132865
|
decreased cell proliferation
|
J:147772
|
Cd74tm1Liz/Cd74tm1Liz
(involves: 129S/SvEv * C57BL/6J)
|
decreased T cell proliferation
|
J:72243
|
Cd74tm1Liz/Cd74tm1Liz
(B6.129S-Cd74tm1Liz)
|
decreased T cell proliferation
|
J:28966
|
Cd74tm1Liz/Cd74tm1Liz
(involves: 129S/SvEv * BALB/c * C57BL)
|
abnormal T cell proliferation
|
J:110927
|
Cd74tm1Liz/Cd74tm1Liz
(involves: 129S/SvEv * C57BL * C57BL/10 * C57BR)
|
abnormal T cell proliferation
|
J:110927
|
Cd74tm2Liz/Cd74tm1Liz
(involves: 129S/SvEv * C57BL/6)
|
increased T cell proliferation
|
J:28966
|
Cd79atm1(cre)Reth/Cd79a+ Ctnnbl1tm1.1Crad/Ctnnbl1tm1.1Crad
(involves: 129P2/OlaHsd * BALB/c * C57BL/6 * SJL)
|
abnormal B cell proliferation
|
J:232010
|
decreased B cell proliferation
|
J:232010
|
Cd79atm1(cre)Reth/Cd79a+ Huwe1tm1.1Mak/Y
(B6.Cg-Cd79atm1(cre)Reth Huwe1tm1.1Mak)
|
decreased B cell proliferation
|
J:181705
|
Cd79atm1(cre)Reth/Cd79a+ Nr4a1tm1Pcn/Nr4a1tm1Pcn
(involves: 129 * BALB/c)
|
increased B cell proliferation
|
J:306652
|
Cd79atm1(cre)Reth/Cd79a+ Nr4a1tm1Pcn/Nr4a1tm1Pcn Nr4a3em1Juz/Nr4a3em1Juz
(involves: 129 * BALB/c * C57BL/6)
|
increased B cell proliferation
|
J:306652
|
Cd79atm1(cre)Reth/Cd79a+ Orai1tm1Smua/Orai1tm1Smua Orai3em1.1Treb/Orai3em1.1Treb
(involves: BALB/c * C57BL/6J * C57BL/6N)
|
decreased B cell proliferation
|
J:345485
|
Cd79atm1(cre)Reth/Cd79a+ Wastm1.1Ldn/Was+
(involves: BALB/c * C57BL/6)
|
abnormal B cell proliferation
|
J:182528
|
Cd79atm6Cgn/Cd79atm6Cgn
(involves: C57BL/6)
|
decreased B cell proliferation
|
J:113407
|
Cd79btm3Mnz/Cd79btm3Mnz
(involves: 129/Sv * C57BL/6)
|
decreased B cell proliferation
|
J:128768
|
Cd80tm1Shr/Cd80tm1Shr
(involves: 129S4/SvJae)
|
decreased B cell proliferation
|
J:74662
|
Cd80tm1Shr/Cd80tm1Shr Cd86tm1Shr/Cd86tm1Shr
(B6.129S4-Cd80tm1Shr Cd86tm1Shr)
|
decreased T cell proliferation
|
J:57613
|
Cd80tm1Shr/Cd80tm1Shr Cd86tm2Shr/Cd86tm2Shr
(involves: 129S4/SvJae)
|
abnormal T cell proliferation
|
J:57090
|
Cd80tm1Shr/Cd80tm1Shr Cd86tm2Shr/Cd86tm2Shr
(129.SJL-Cd86tm2Shr)
|
decreased cell proliferation
|
J:78992
|
Cd80tm1Shr/Cd80tm1Shr Cd86tm2Shr/Cd86tm2Shr
(involves: 129S4/SvJae * C57BL/6J * SJL)
|
decreased cell proliferation
|
J:78992
|
Cd80tm1Shr/Cd80tm1Shr Cd86tm2Shr/Cd86tm2Shr Ctla4tm1Shr/Ctla4tm1Shr
(involves: 129S4/SvJae * BALB/c)
|
increased T cell proliferation
|
J:57090
|
Cd81tm1Geha/Cd81tm1Geha
(involves: 129S4/SvJae * C57BL/6)
|
increased B cell proliferation
|
J:43975
|
Cd81tm1Tmiy/Cd81tm1Tmiy
(involves: 129/Sv * C57BL/6)
|
abnormal T cell proliferation
|
J:41830
|
decreased B cell proliferation
|
J:41830
|
increased B cell proliferation
|
J:41830
|
Cd83lcd4/Cd83lcd4
(involves: C57BL/6J)
|
decreased T cell proliferation
|
J:92721
|
Cd86tm1Shr/Cd86tm1Shr
(NOD.129S4-Cd86tm1Shr)
|
abnormal T cell proliferation
|
J:142046
|
decreased T cell proliferation
|
J:93421
|
Cd86tm1Shr/Cd86tm1Shr
(B6.129S4-Cd86tm1Shr)
|
decreased T cell proliferation
|
J:57613
|
Cd151tm1Lka/Cd151tm1Lka
(C57BL/6-Cd151tm1Lka)
|
abnormal T cell proliferation
|
J:91605
|
Cd151tm2Nki/Cd151tm2Nki
(FVB.129P2-Cd151tm2Nki)
|
decreased keratinocyte proliferation
|
J:205736
|
Cd151tm2Nki/Cd151tm2Nki Itga3tm1Son/Itga3+ Krt14tm1(cre)Wbm/?
(FVB.129P2-Cd151tm2Nki Itga3tm1Son Krt14tm1(cre)Wbm)
|
decreased keratinocyte proliferation
|
J:205736
|
Cd151tm2Nki/Cd151tm2Nki Krt14tm1(cre)Wbm/?
(FVB.129P2-Cd151tm2Nki Krt14tm1(cre)Wbm)
|
decreased keratinocyte proliferation
|
J:205736
|
Cd163tm1(KOMP)Vlcg/Cd163tm1(KOMP)Vlcg
(involves: C57BL/6NTac)
|
abnormal skeletal muscle satellite cell proliferation
|
J:224919
|
Cd209atm1.1Cfg/Cd209atm1.1Cfg
(involves: C57BL/6)
|
increased T cell proliferation
|
J:217719
|
Cd209dtm1.1Cfg/Cd209dtm1.1Cfg
(involves: C57BL/6)
|
increased B cell proliferation
|
J:217719
|
Cd226tm1.1Cln/Cd226tm1.1Cln
(B6.129P2-Cd226tm1.1Cln)
|
decreased T cell proliferation
|
J:159749
|
Cd226tm1.1Cln/Cd226tm1.1Cln Tg(TcraTcrb)1100Mjb/0
(B6.Cg-Cd226tm1.1Cln Tg(TcraTcrb)1100Mjb)
|
decreased T cell proliferation
|
J:159749
|
Cd247tm1Mhu/Cd247tm1Mhu
(involves: 129S7/SvEvBrd * C57BL/6)
|
decreased splenocyte proliferation
|
J:15579
|
decreased T cell proliferation
|
J:15579
|
Cd247tm1Tks/Cd247tm1Tks
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal T cell proliferation
|
J:15271
|
Cd274tm1Lpc/Cd274tm1Lpc
(C.129S-Cd274tm1Lpc)
|
increased T cell proliferation
|
J:165841
|
Cd276tm1Mak/Cd276tm1Mak
(involves: 129P2/OlaHsd * C57BL/6)
|
increased T cell proliferation
|
J:84973
|
Cd300c2tm1Shib/Cd300c2tm1Shib
(B6.Cg-Cd300c2tm1Shib)
|
increased B cell proliferation
|
J:177613
|
Cdc20tm1.1Mama/Cdc20tm1.2Mama Polr2atm1(cre/ERT2)Bbd/Polr2a+
(involves: 129/Sv * BALB/cJ * C57BL/6 * CD-1 * SJL)
|
decreased cell proliferation
|
J:167609
|
Cdc20tm1.1Pzg/Cdc20tm1.1Pzg
(involves: 129S7/SvEvBrd * C57BL/6)
|
decreased cell proliferation
|
J:150421
|
Cdc25am1Rfp/Cdc25am1Rfp
(multiple strains)
|
increased cell proliferation
|
J:80142
|
Cdc25atm1Hpw/Cdc25atm1.1Hpw Cdc25btm1Pjd/Cdc25btm1Pjd Cdc25ctm1Hpw/Cdc25ctm1Hpw Tg(Vil1-cre/ERT2)23Syr/0
(involves: 129X1/SvJ * C57BL/6 * DBA/2)
|
abnormal small intestinal crypt cell proliferation
|
J:169457
|
Cdc25atm1Hpw/Cdc25atm1.1Hpw Cdc25btm1Pjd/Cdc25btm1Pjd Tg(Vil1-cre/ERT2)23Syr/0
(involves: 129X1/SvJ * C57BL/6 * DBA/2)
|
abnormal small intestinal crypt cell proliferation
|
J:169457
|
Cdc25atm1Kiyo/Cdc25a+ Tg(MMTV-Erbb2)NK1Mul/?
(involves: 129/Sv * C57BL/6 * FVB/N)
|
decreased cell proliferation
|
J:123144
|
Cdc42tm1.1Rac/Cdc42tm1.1Rac Tg(Nes-cre)1Kln/0
(involves: 129P2/OlaHsd * C57BL/6 * FVB/N * SJL)
|
abnormal neuronal precursor proliferation
|
J:197886
|
Cdc45tm1Dta/Cdc45tm1Dta
(involves: 129S4/SvJae * C57BL/6)
|
absent inner cell mass proliferation
|
J:70008
|
Cdc73Gt(RRE190)Byg/Cdc73Gt(RRE190)Byg
(involves: 129P2/OlaHsd)
|
absent inner cell mass proliferation
|
J:135255
|
absent trophectoderm cell proliferation
|
J:135255
|
Cdc73tm1Btt/Cdc73tm1Btt Tg(CAG-cre/Esr1*)5Amc/0
(involves: 129S4/SvJae * C57BL/6 * CBA)
|
decreased cell proliferation
|
J:135255
|
Cdh1tm2Kem/Cdh1tm2Kem Tg(Ins2-cre)23Herr/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * CBA/J)
|
increased pancreatic beta cell proliferation
|
J:196410
|
Cdhr5tm1Lex/Cdhr5tm1Lex
(involves: 129S5/SvEvBrd * C57BL/6)
|
abnormal enterocyte proliferation
|
J:301471
|
Cdk1tm2.1Kald/Cdk1tm2.1Kald Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129 * C57BL/6 * DBA * SJL)
|
decreased hepatocyte proliferation
|
J:182141
|
Cdk1tm2.1Kald/Cdk1tm2.1Kald Tg(CAG-cre/Esr1*)5Amc/0
(involves: 129 * C57BL/6 * CBA * SJL)
|
decreased cell proliferation
|
J:182141
|
Cdk2tm1Kald/Cdk2tm1Kald
(involves: 129S1/Sv)
|
decreased hepatocyte proliferation
|
J:141249
|
Cdk2tm1Kald/Cdk2tm1Kald Cdk4tm1Kiyo/Cdk4tm1Kiyo
(involves: 129S1/Sv * C57BL/6)
|
abnormal fetal cardiomyocyte proliferation
|
J:108720
|
decreased cell proliferation
|
J:108720
|
Cdk2tm1Kald/Cdk2tm1Kald Cdk4tm1Kiyo/Cdk4tm1Kiyo Cdkn1btm1Ako/Cdkn1btm1Ako
(involves: 129S1/Sv * C57BL/6)
|
decreased cell proliferation
|
J:108720
|
Cdk2tm1Sgo/Cdk2tm1Sgo Cdk4tm1Bbd/Cdk4tm1Bbd Cdk6tm1Bbd/Cdk6tm1Bbd
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
decreased cell proliferation
|
J:124678
|
Cdk2tm1Sgo/Cdk2tm1Sgo Cdk4tm2.1Bbd/Cdk4tm2.1Bbd
(involves: 129S1/Sv * 129X1/SvJ * BALB/cJ * C57BL/6 * SJL)
|
abnormal fetal cardiomyocyte proliferation
|
J:125217
|
decreased fibroblast proliferation
|
J:125217
|
Cdk4tm1.1Bbd/Cdk4tm1.1Bbd Tg(Tyr-NRAS*Q61K)1Bee/0
(FVB.Cg-Cdk4tm1.1Bbd Tg(Tyr-NRAS*Q61K)1Bee)
|
abnormal melanocyte proliferation
|
J:222847
|
Cdk4tm2.1Bbd/Cdk4tm2.1Bbd Krastm1Bbd/Krastm2Bbd Polr2atm1(cre/ERT2)Bbd/Polr2atm1(cre/ERT2)Bbd
(involves: 129S1/Sv * 129X1/SvJ)
|
decreased cell proliferation
|
J:161780
|
Cdk4tm2.2Bbd/Cdk4tm2.1Bbd Krastm1Bbd/Krastm2Bbd Polr2atm1(cre/ERT2)Bbd/Polr2atm1(cre/ERT2)Bbd
(involves: 129S1/Sv * 129X1/SvJ)
|
decreased cell proliferation
|
J:161780
|
Cdk5rap2an/Cdk5rap2an
(B6.Cg-Cdk5rap2an)
|
abnormal neuron proliferation
|
J:160533
|
Cdk5rap3tm1b(EUCOMM)Hmgu/Cdk5rap3tm1b(EUCOMM)Hmgu
(involves: C57BL/6N * FVB/N)
|
decreased hepatocyte proliferation
|
J:272566
|
Cdk6tm1Bbd/Cdk6tm1Bbd
(involves: 129S1/Sv * 129X1/SvJ * CD-1)
|
decreased T cell proliferation
|
J:92529
|
Cdk7Gt(D032B11)1.1Wrst/Cdk7Gt(D032B11)1.1Wrst
(involves: 129S2/SvPas * C57BL/6 * SJL)
|
absent fibroblast proliferation
|
J:183925
|
Cdk11btm1Vjk/Cdk11btm1Vjk
(involves: 129S6/SvEv * C57BL/6)
|
decreased cell proliferation
|
J:89908
|
Cdk19em1Smoc/Cdk19em1Smoc
(C57BL/6J-Cdk19em1Smoc/Smoc)
|
decreased hematopoietic stem cell proliferation
|
J:322947
|
Cdkn1atm1Led/Cdkn1atm1Led
(involves: 129S6/SvEvTac)
|
increased fibroblast proliferation
|
J:57882
|
increased T cell proliferation
|
J:76041
|
Cdkn1atm1Led/Cdkn1atm1Led Gadd45atm1Ajf/Gadd45atm1Ajf
(either: (involves: 129P2/OlaHsd * 129S6/SvEvTac * C57BL/6) or (involves: 129S6/SvEvTac * 129X1/SvJ * C57BL/6))
|
increased fibroblast proliferation
|
J:57882
|
increased kidney cell proliferation
|
J:76041
|
increased T cell proliferation
|
J:76041
|
Cdkn1atm1Tyj/Cdkn1atm1Tyj
(involves: 129S2/SvPas)
|
abnormal neuronal precursor proliferation
|
J:90479
|
increased cell proliferation
|
J:180692
|
Cdkn1atm1Tyj/Cdkn1atm1Tyj
(involves: 129S2/SvPas * C57BL/6)
|
increased T cell proliferation
|
J:60292
|
Cdkn1atm1Tyj/Cdkn1atm1Tyj Cdkn1btm1Mlf/Cdkn1btm1Mlf
(involves: 129S2/SvPas * 129S4/SvJaeSor)
|
abnormal enterocyte proliferation
|
J:111081
|
Cdkn1atm1Tyj/Cdkn1atm1Tyj Cdkn2atm1Rdp/Cdkn2atm1Rdp
(involves: 129/Sv * 129S2/SvPas * C57BL/6 * C57BL/6J * SJL)
|
increased keratinocyte proliferation
|
J:72780
|
Cdkn1atm1Tyj/Cdkn1atm1Tyj Csnk1a1tm1.1Ybn/Csnk1a1tm1.1Ybn Tg(Vil1-cre/ERT2)23Syr/0
(involves: 129 * C57BL/6 * CD-1 * DBA/2)
|
abnormal enterocyte proliferation
|
J:204886
|
Cdkn1atm1Tyj/Cdkn1atm1Tyj Fahtm1Mgo/Fahtm1Mgo
(involves: 129S2/SvPas * 129S7/SvEvBrd * C57BL/6)
|
increased hepatocyte proliferation
|
J:138701
|
Cdkn1btm1Ako/Cdkn1btm1Ako
(involves: 129S1/Sv * C57BL)
|
abnormal fetal cardiomyocyte proliferation
|
J:57380
|
Cdkn1btm1Jro/Cdkn1btm1Jro
(involves: 129S4/SvJaeSor * C57BL/6)
|
decreased cell proliferation
|
J:71780
|
decreased keratinocyte proliferation
|
J:71780
|
decreased T cell proliferation
|
J:71780
|
Cdkn1btm1Kin/Cdkn1btm1Kin Zfp949tm1Htno/Zfp949tm1Htno
(involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ)
|
decreased cell proliferation
|
J:259302
|
Cdkn1btm1Mlf/Cdkn1btm1Mlf
(involves: 129S4/SvJaeSor * C57BL/6J)
|
increased T cell proliferation
|
J:33400
|
Cdkn1btm1Mlf/Cdkn1btm1Mlf
(involves: 129S4/SvJaeSor * C57BL/6NHsd)
|
abnormal cell proliferation
|
J:53290
|
Cdkn1btm1Mlf/Cdkn1btm1Mlf Cdkn2dtm1Maro/Cdkn2dtm1Maro
(involves: 129X1/SvJ * C57BL/6)
|
increased cell proliferation
|
J:58522
|
Cdkn1btm1Mlf/Cdkn1btm1Mlf Myctm1Atp/Myc+
(involves: 129P2/OlaHsd * 129S4/SvJaeSor * FVB/N)
|
decreased T cell proliferation
|
J:73369
|
Cdkn2atm1Cjs/Cdkn2atm1Cjs
(involves: 129X1/SvJ * C57BL/6)
|
increased fibroblast proliferation
|
J:44427
|
Cdkn2atm1Cjs/Cdkn2atm1Cjs Gt(ROSA)26Sortm1.1(MYC/ERT2)Gev/Gt(ROSA)26Sortm1.1(MYC/ERT2)Gev
(involves: 129X1/SvJ * C57BL/6 * FVB/N)
|
increased cell proliferation
|
J:142030
|
Cdkn2atm1Cjs/Cdkn2atm1Cjs Tacstd2tm1Lsm/Tacstd2tm1Lsm
(involves: 129X1/SvJ * C57BL/6)
|
increased keratinocyte proliferation
|
J:182647
|
Cdkn2atm1Rdp/Cdkn2a+ Lig4tm1Fwa/Lig4tm1Fwa
(involves: 129/Sv * 129S6/SvEvTac * C57BL/6J * SJL)
|
decreased cell proliferation
|
J:63078
|
Cdkn2atm1Rdp/Cdkn2atm1Rdp
(involves: 129/Sv * C57BL/6 * SJL)
|
increased fibroblast proliferation
|
J:53805
|
Cdkn2atm1Rdp/Cdkn2atm1Rdp Dicer1tm1Snj/Dicer1tm1Snj
(involves: 129/Sv * 129S7/SvEvBrd * C57BL/6 * SJL)
|
increased cell proliferation
|
J:139257
|
Cdkn2atm1Rdp/Cdkn2atm1Rdp Lig4tm1Fwa/Lig4tm1Fwa
(involves: 129/Sv * 129S6/SvEvTac * C57BL/6J * SJL)
|
decreased cell proliferation
|
J:63078
|
Cdkn2atm1Rdp/Cdkn2atm1Rdp Terctm1Rdp/Terctm1Rdp
(involves: 129/Sv * C57BL/6J * SJL)
|
decreased cell proliferation
|
J:120065
|
Cdkn2atm2.1Nesh/Cdkn2atm2.1Nesh Nrastm1.1Nesh/Nrastm1.1Nesh Tg(Tyr-cre/ERT2)13Bos/0
(B6J.Cg-Tg(Tyr-cre/ERT2)13Bos Nrastm1.1Nesh Cdkn2atm2.1Nesh)
|
abnormal melanocyte proliferation
|
J:220627
|
Cdkn2atm2.1Nesh/Cdkn2atm2.1Nesh Nrastm1Tyj/Nrastm1Tyj Tg(Tyr-cre/ERT2)13Bos/0
(B6J.Cg-Tg(Tyr-cre/ERT2)13Bos Nrastm1Tyj Cdkn2atm2.1Nesh)
|
abnormal melanocyte proliferation
|
J:220627
|
Cdkn2atm2.1Rdp/Cdkn2atm2.1Rdp
(involves: 129S6/SvEvTac * FVB/N)
|
increased splenocyte proliferation
|
J:71394
|
Cdkn2atm2Brn/Cdkn2atm2Brn Krastm4Tyj/Kras+ Tg(Pdx1-cre)6Tuv/0
(involves: 129P2/OlaHsd * 129S4/SvJae * FVB/N)
|
increased cell proliferation
|
J:195229
|
Cdkn2btm1Bbd/Cdkn2btm1Bbd
(involves: 129S1/Sv * C57BL/6)
|
increased fibroblast proliferation
|
J:63299
|
Cdkn2btm1Bbd/Cdkn2btm1Bbd Cdkn2ctm1Bbd/Cdkn2ctm1Bbd
(involves: 129S1/Sv * C57BL/6)
|
increased fibroblast proliferation
|
J:63299
|
Cdontm1Rsk/Cdontm1Rsk
(B6.129-Cdontm1Rsk)
|
abnormal neuronal precursor proliferation
|
J:109070
|
Cdontm2Rsk/Cdontm2Rsk
(B6.129-Cdontm2Rsk)
|
abnormal neuronal precursor proliferation
|
J:109070
|
Cdx2tm1Mmt/Cdx2tm1Mmt
(involves: 129X1/SvJ * C57BL/6)
|
absent inner cell mass proliferation
|
J:47050
|
Ceacam1tm1Rsb/Ceacam1tm1Rsb Tg(Lck-cre)1Cwi/0
(involves: 129)
|
increased T cell proliferation
|
J:116136
|
Cebpatm1Gonz/Cebpatm1Gonz Cebpbtm1Es/Cebpbtm1Es Tg(KRT14-cre/ERT)20Efu/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CD-1)
|
increased keratinocyte proliferation
|
J:158721
|
Cebpatm1Gonz/Cebpatm1Gonz Cebpbtm1Nerl/Cebpbtm1Nerl Tg(KRT14-cre)1Cgn/0
(involves: 129P2/OlaHsd * 129X1/SvJ * C57BL/6 * DBA/2)
|
increased keratinocyte proliferation
|
J:154022
|
Cebpatm1Gonz/Cebpatm1Gonz Tg(KRT14-cre/ERT)20Efu/0
(involves: 129X1/SvJ * C57BL/6 * CD-1)
|
increased keratinocyte proliferation
|
J:158721
|
Cebpatm1Gonz/Cebpatm2Nerl Cebpbtm1Nerl/Cebpbtm1Nerl Tg(KRT14-cre)1Cgn/0
(involves: 129P2/OlaHsd * 129X1/SvJ * C57BL/6 * DBA/2)
|
increased keratinocyte proliferation
|
J:154022
|
Cebpatm1Gonz/Cebpatm9Nerl Cebpbtm1Nerl/Cebpbtm1Nerl Tg(KRT14-cre)1Cgn/0
(involves: 129P2/OlaHsd * 129X1/SvJ * C57BL/6 * DBA/2)
|
increased keratinocyte proliferation
|
J:154022
|
Cebpatm1Timc/Cebpatm1Timc
(Not Specified)
|
decreased hepatocyte proliferation
|
J:163725
|
Cebpbtm1Es/Cebpbtm1Es Tg(KRT14-cre/ERT)20Efu/0
(involves: 129S1/Sv * C57BL/6 * CD-1)
|
increased keratinocyte proliferation
|
J:158721
|
Cebpbtm2.1Acle/Cebpbtm2.1Acle
(involves: 129P2/OlaHsd * BALB/cJ * C57BL/6)
|
decreased cell proliferation
|
J:155795
|
Cebpdtm1Pfj/Cebpdtm1Pfj
(involves: 129S1/Sv)
|
increased mammary gland epithelial cell proliferation
|
J:103094
|
Cend1tm1.1Rmat/Cend1tm1.1Rmat
(involves: 129P2/OlaHsd * BALB/cJ * C57BL/6)
|
abnormal neuron proliferation
|
J:164148
|
Cenpetm1Dwc/Cenpetm1Dwc
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal inner cell mass proliferation
|
J:81046
|
Cenpftm1Dbdr/Cenpftm1Dbdr Tg(Tnnt2-cre)5Blh/0
(involves: C57BL/6 * DBA/2 * ICR)
|
decreased fetal cardiomyocyte proliferation
|
J:185133
|
Cep55em1.1Hyli/Cep55em1.1Hyli
(involves: C57BL/6)
|
decreased cell proliferation
|
J:313163
|
Cep120tm1.1Blnw/Cep120tm1.2Blnw Tg(Nes-cre)1Atp/0
(involves: 129S6/SvEvTac * C57BL/6 * FVB/N)
|
decreased cerebellar granule cell precursor proliferation
|
J:220629
|
Cep135em2Mama/Cep135em2Mama
(involves: C57BL/6 * C57BL/6J * CBA)
|
decreased cell proliferation
|
J:310617
|
Cert1Gt(RRF047)Byg/Cert1Gt(RRF047)Byg
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased cell proliferation
|
J:146172
|
Cfl1tm1.1Wit/Cfl1tm1.1Wit
(involves: 129 * C57BL/6 * SJL)
|
abnormal neuronal precursor proliferation
|
J:125317
|
Chd4em1Flc/Chd4em1Flc
(C57BL/6J-Chd4em1Flc)
|
increased fetal cardiomyocyte proliferation
|
J:338019
|
Chd4tm1.1Kge/Chd4tm1.2Kge Tg(CAG-Bgeo/GFP)21Lbe/0 Tg(Lck-cre)1Cwi/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL)
|
decreased T cell proliferation
|
J:109547
|
Chd4tm1.2Kge/Chd4tm1.2Kge Tg(Lck-cre)1Cwi/0
(involves: C57BL/6 * DBA/2 * SJL)
|
decreased T cell proliferation
|
J:109547
|
Chd7Gt(S20-7E1)Sor/Chd7+
(involves: 129S4/SvJaeSor)
|
abnormal neuronal precursor proliferation
|
J:164582
|
Chd7Gt(S20-7E1)Sor/Chd7+
(129S1.129S4(B6)-Chd7Gt(S20-7E1)Sor)
|
decreased cell proliferation
|
J:174086
|
Chd7Gt(S20-7E1)Sor/Chd7Gt(S20-7E1)Sor
(involves: 129S4/SvJaeSor)
|
abnormal neuronal precursor proliferation
|
J:164582
|
Chd7Gt(S20-7E1)Sor/Chd7Gt(S20-7E1)Sor
(129S1.129S4(B6)-Chd7Gt(S20-7E1)Sor)
|
decreased cell proliferation
|
J:174086
|
Chd7Gt(S20-7E1)Sor/Chd7tm1.1Dmm Foxg1tm1(cre)Skm/Foxg1+
(involves: 129 * C57BL/6 * Swiss Webster)
|
abnormal neuronal precursor proliferation
|
J:164582
|
Chd7tm2a(EUCOMM)Wtsi/Chd7tm2a(EUCOMM)Wtsi
(involves: 129S6/SvEvTac * C57BL/6N)
|
decreased fetal cardiomyocyte proliferation
|
J:207089
|
Chd7tm2c(EUCOMM)Wtsi/Chd7tm2c(EUCOMM)Wtsi Tg(Atoh1-cre)1Bfri/0
(involves: C57BL/6 * C57BL/6J * C57BL/6N * CBA)
|
decreased cerebellar granule cell precursor proliferation
|
J:242933
|
Chek1tm1Jmr/Chek1+ Tg(Wap-cre)11738Mam/0
(involves: C57BL/6)
|
increased cell proliferation
|
J:91266
|
Chek1tm1Jmr/Chek1tm1Jmr Tg(Wap-cre)11738Mam/0
(involves: C57BL/6)
|
decreased cell proliferation
|
J:91266
|
Chek1tm1Mkt/Chek1tm1Mkt
(involves: 129P2/OlaHsd * C57BL/6J)
|
abnormal inner cell mass proliferation
|
J:62918
|
absent inner cell mass proliferation
|
J:62918
|
Chek1tm1Sje/Chek1tm1Sje
(Not Specified)
|
decreased cell proliferation
|
J:62919
|
Chi3l1tm1Eli/Chi3l1tm1Eli
(B6.Cg-Chi3l1tm1Eli)
|
decreased splenocyte proliferation
|
J:148490
|
Chmp1aGt(XC472)Byg/Chmp1aGt(XC472)Byg
(B6.129P2-Chmp1aGt(XC472)Byg)
|
decreased cerebellar granule cell precursor proliferation
|
J:271138
|
decreased neuronal precursor proliferation
|
J:271138
|
Chordc1tm1Mbra/Chordc1tm1Mbra
(Not Specified)
|
abnormal trophoblast giant cell proliferation
|
J:159109
|
absent inner cell mass proliferation
|
J:159109
|
Chrnb2tm1Jpc/Chrnb2tm1Jpc
(involves: 129P2/OlaHsd * C57BL/6)
|
increased B cell proliferation
|
J:103908
|
Chst3tm1Tmu/Chst3tm1Tmu
(involves: 129S2/SvPas)
|
increased T cell proliferation
|
J:217719
|
Chst14tm1.1Msch/Chst14tm1.1Msch
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
increased Schwann cell proliferation
|
J:203583
|
Chuktm1Yhu/Chuktm1Yhu Tg(KRT5-cre)5132Jlj/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
increased keratinocyte proliferation
|
J:141162
|
Chuktm2Yhu/Chuktm2Yhu
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
increased keratinocyte proliferation
|
J:197037
|
Cib1tm1Prse/Cib1tm1Prse
(involves: 129S6/SvEvTac * C57BL/6)
|
decreased cell proliferation
|
J:114645
|
Ciitatm1Ccum/Ciitatm1Ccum
(involves: 129S2/SvPas * C57BL/6J)
|
decreased T cell proliferation
|
J:31601
|
Cilk1tm1.1Zfu/Cilk1tm1.1Zfu
(B6.Cg-Cilk1tm1.1Zfu/Zfu)
|
decreased mesenchymal cell proliferation involved in lung development
|
J:309653
|
Cimap2Retro/Cimap2Retro
(involves: C57BL/6J)
|
increased T cell proliferation
|
J:223336
|
Cinda1BALB/c/?
(involves: BALB/c * CcS-4/Dem)
|
increased T cell proliferation
|
J:40728
|
Cinda2STS/A/?
(involves: BALB/c * CcS-4/Dem)
|
increased T cell proliferation
|
J:40728
|
Cinda3O20/A/Cinda3O20/A
(involves: O20/A * OcB-9/Dem)
|
decreased T cell proliferation
|
J:95917
|
Cinda3OcB9/Dem/Cinda3O20/A
(involves: O20/A * OcB-9/Dem)
|
increased T cell proliferation
|
J:95917
|
Cinda4OcB9/Dem/Cinda4O20/A
(involves: O20/A * OcB-9/Dem)
|
increased T cell proliferation
|
J:95917
|
Cinda4OcB9/Dem/Cinda4OcB9/Dem
(involves: O20/A * OcB-9/Dem)
|
increased T cell proliferation
|
J:95917
|
Cinda5OcB9/Dem/Cinda5O20/A
(involves: O20/A * OcB-9/Dem)
|
increased T cell proliferation
|
J:95917
|
Cinda5OcB9/Dem/Cinda5OcB9/Dem
(involves: O20/A * OcB-9/Dem)
|
increased T cell proliferation
|
J:95917
|
Cirbptm1Jfuji/Cirbptm1Jfuji
(B6.129S2-Cirbptm1Jfuji)
|
abnormal spermatogonia proliferation
|
J:186425
|
decreased fibroblast proliferation
|
J:186425
|
Cishtm1.2Cdon/Cishtm1.2Cdon
(B6.129S6(Cg)-Cishtm1.2Cdon)
|
increased T cell proliferation
|
J:204829
|
Cittm1Fdc/Cittm1Fdc
(either: (involves: 129S1/Sv * 129X1/SvJ) or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6))
|
abnormal spermatogonia proliferation
|
J:80899
|
Cks1btm1Sir/Cks1btm1Sir Tg(IghMyc)22Bri/?
(involves: C57BL * C57BL/6 * SJL)
|
decreased B cell proliferation
|
J:121564
|
Cldn4tm1.1Yham/Cldn4tm1.1Yham
(B6.129S2-Cldn4tm1.1Yham)
|
increased kidney cell proliferation
|
J:195766
|
Cldn15tm1Sats/Cldn15tm1Sats
(involves: C57BL/6)
|
abnormal enterocyte proliferation
|
J:135596
|
Clec1atm1Yiw/Clec1atm1Yiw
(involves: C57BL/6J * C57BL/6NSlc)
|
decreased CD8-positive, alpha-beta memory T cell proliferation
|
J:329240
|
Clec4a2tm1.1Cfg/Clec4a2tm1.1Cfg
(involves: C57BL/6)
|
increased B cell proliferation
|
J:217719
|
Clec4dtm1.1Cfg/Clec4dtm1.1Cfg
(involves: C57BL/6)
|
decreased B cell proliferation
|
J:217719
|
decreased T cell proliferation
|
J:217719
|
ClppGt(IST11134F10)Tigm/ClppGt(IST11134F10)Tigm
(involves: C57BL/6N)
|
decreased fibroblast proliferation
|
J:203140
|
ClppGt(IST13563G11)Tigm/ClppGt(IST13563G11)Tigm
(involves: C57BL/6N)
|
decreased fibroblast proliferation
|
J:203140
|
Clspntm1(KOMP)Vlcg/Clspn+
(C57BL/6N-Clspntm1(KOMP)Vlcg)
|
increased hepatocyte proliferation
|
J:332163
|
Cmahtm1Ykoz/Cmahtm1Ykoz
(B6.129P2-Cmahtm1Ykoz)
|
increased B cell proliferation
|
J:121365
|
Cmtm7tm2a(EUCOMM)Hmgu/Cmtm7+ Rag1tm1Fwa/Rag1tm1Fwa
(chimera involves: C57BL/6 * C57BL/6N)
|
decreased B cell proliferation
|
J:207033
|
Cnr1tm1Map/Cnr1tm1Map
(involves: 129S1/Sv * 129X1/SvJ * CD-1)
|
abnormal neuronal precursor proliferation
|
J:102006
|
Cntftm1Vlcg/Cntftm1Vlcg
(involves: 129S6/SvEvTac * C57BL/6NTac)
|
abnormal neuron proliferation
|
J:186611
|
Col1a1tm1(tetO-CTNNB1)Tcd/Col1a1+ Gt(ROSA)26Sortm1(rtTA*M2)Jae/Gt(ROSA)26Sor+
(involves: 129S4/SvJae * C57BL/6 * C57BL/6J)
|
abnormal enterocyte proliferation
|
J:193365
|
Col1a1tm1(tetO-EWSR1/ATF1)Yasu/Col1a1+ Gt(ROSA)26Sortm1(rtTA*M2)Jae/Gt(ROSA)26Sor+
(involves: 129S4/SvJae * C57BL/6)
|
decreased fibroblast proliferation
|
J:194505
|
Col1a1tm1(tetO-Fos)Wag/Col1a1+ Tg(KRT5-rtTA)T2D6Sgkd/0
(involves: 129S4/SvJae * C57BL/6 * FVB/N)
|
increased keratinocyte proliferation
|
J:201145
|
Col1a1tm1(tetO-Lin28a)Gqda/Col1a1+
(involves: 129S4/SvJae * C57BL/6 * CD-1)
|
increased cell proliferation
|
J:166568
|
increased hepatocyte proliferation
|
J:166568
|
Col1a1tm1(tetO-SOX2)Mjm/Col1a1+ Gt(ROSA)26Sortm1(tTA)Roos/Gt(ROSA)26Sor+ Lgr5tm1(cre/ERT2)Cle/Lgr5+
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6 * DBA/2J)
|
increased cell proliferation
|
J:199754
|
Col1a1tm1(tetO-Tcfap2c)Hsc/Col1a1+ Gt(ROSA)26Sortm1(rtTA*M2)Jae/Gt(ROSA)26Sor+
(involves: 129S4/SvJae * C57BL/6)
|
abnormal enterocyte proliferation
|
J:174049
|
increased hepatocyte proliferation
|
J:174049
|
Col1a1tm1(tetO-YAP1*)Fcam/Col1a1+ Gt(ROSA)26Sortm1(rtTA*M2)Jae/Gt(ROSA)26Sor+
(involves: 129S4/SvJae * C57BL/6)
|
abnormal enterocyte proliferation
|
J:141457
|
increased cell proliferation
|
J:141457
|
Col1a1tm1(tetO-YAP1*)Fcam/Col1a1+ Gt(ROSA)26Sortm1(rtTA,EGFP)Nagy/Gt(ROSA)26Sor+ Tg(KRT14-cre)1Amc/0
(involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ * C57BL/6 * CBA)
|
increased cell proliferation
|
J:171057
|
Col1a1tm1(tetO-YAP1*)Fcam/Col1a1+ Tg(Cebpb-tTA)#Bjd/0
(involves: 129S4/SvJae * C57BL/6)
|
increased hepatocyte proliferation
|
J:141457
|
Col1a1tm2(tetO-IDH2*R140Q)Ppp/Col1a1tm2(tetO-IDH2*R140Q)Ppp Gt(ROSA)26Sortm1(rtTA*M2)Jae/?
(involves: 129S4/SvJae * C57BL/6)
|
abnormal hematopoietic stem cell proliferation
|
J:210097
|
increased hematopoietic stem cell proliferation
|
J:210097
|
Col1a1tm2(tetO-Pou5f1)Jae/Col1a1+ Gt(ROSA)26Sortm1(rtTA*M2)Jae/Gt(ROSA)26Sor+
(involves: 129S4/SvJae * C57BL/6)
|
abnormal cell proliferation
|
J:98920
|
Col1a1tm2(tetO-Pou5f1)Jae/Col1a1+ Gt(ROSA)26Sortm1(tTA)Roos/Gt(ROSA)26Sor+ Lgr5tm1(cre/ERT2)Cle/Lgr5+
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6 * DBA/2J)
|
increased cell proliferation
|
J:199754
|
Col1a1tm10(tetO*-RFP/RNAi:Rpa3)Slowe/Col1a1+ Gt(ROSA)26Sortm1(rtTA*M2)Jae/Gt(ROSA)26Sortm1(rtTA*M2)Jae
(involves: 129S4/SvJae * C57BL/6)
|
abnormal small intestinal crypt cell proliferation
|
J:171348
|
Col1a1tm11(tetO*-RFP/RNAi:Rpa3)Slowe/Col1a1+ Gt(ROSA)26Sortm1(rtTA*M2)Jae/Gt(ROSA)26Sortm1(rtTA*M2)Jae
(involves: 129S4/SvJae * C57BL/6)
|
abnormal small intestinal crypt cell proliferation
|
J:171348
|
Col1a1tm17(tetO-GFP,-cas9*)Slowe/Col1a1+ Gt(ROSA)26Sortm1(rtTA*M2)Jae/Gt(ROSA)26Sor+
(involves: 129S4/SvJae * C57BL/6)
|
abnormal small intestinal crypt cell proliferation
|
J:222595
|
Col1a1tm19(tetO-GFP,-cas9*)Slowe/Col1a1+ Gt(ROSA)26Sortm1(rtTA*M2)Jae/Gt(ROSA)26Sor+
(involves: 129S4/SvJae * C57BL/6)
|
abnormal small intestinal crypt cell proliferation
|
J:222595
|
Col1a1tm20(tetO-GFP,-cas9*D10A)Slowe/Col1a1+ Gt(ROSA)26Sortm1(rtTA*M2)Jae/Gt(ROSA)26Sor+
(involves: 129S4/SvJae * C57BL/6)
|
abnormal small intestinal crypt cell proliferation
|
J:222595
|
Col2a1tm1(SOX9)Crm/Col2a1+
(129S/Sv-Col2a1tm1(SOX9)Crm)
|
decreased chondrocyte proliferation
|
J:90567
|
Col9a1tm1Jae/Col9a1tm1Jae
(either: (involves: 129S2/SvPas * BALB/c) or (involves: 129S2/SvPas * C57BL))
|
increased chondrocyte proliferation
|
J:18628
|
Col17a1tm1Tiin/Col17a1tm1Tiin
(involves: C57BL/6)
|
increased fibroblast proliferation
|
J:220622
|
Colgalt1tm1.1Gpt/Colgalt1tm1.1Gpt
(Not Specified)
|
decreased hepatocyte proliferation
|
J:283330
|
Comptm1Mbri/Comp+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
decreased chondrocyte proliferation
|
J:125086
|
Comptm1Mbri/Comptm1Mbri
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
decreased chondrocyte proliferation
|
J:125086
|
Copb2em1Rstot/Copb2em2Rstot
(involves: C57BL/6 * C57BL/6J * CD-1 * DBA/2)
|
abnormal neuron proliferation
|
J:252710
|
increased neuronal precursor proliferation
|
J:252710
|
Cops2tm1Nwe/Cops2tm1Nwe
(involves: 129 * C57BL/6J)
|
absent inner cell mass proliferation
|
J:85761
|
Cops5tm1Fxc/Cops5+
(involves: 129S7/SvEvBrd * C57BL/6J)
|
decreased cell proliferation
|
J:166561
|
Cops5tm1Fxc/Cops5tm1Fxc
(involves: 129S7/SvEvBrd * C57BL/6J)
|
decreased inner cell mass proliferation
|
J:166561
|
Cops5tm1Jka/Cops5tm1Jka
(involves: 129S4/SvJae * C57BL/6)
|
abnormal trophoblast giant cell proliferation
|
J:93979
|
absent inner cell mass proliferation
|
J:93979
|
Cops8tm1.1Nwe/Cops8tm1.1Nwe
(involves: C57BL/6)
|
abnormal inner cell mass proliferation
|
J:126339
|
Cops8tm1Nwe/Cops8tm1.1Nwe Tg(Cd4-cre)1Cwi/?
(involves: 129S1/Sv * C57BL/6 * DBA/2)
|
decreased T cell proliferation
|
J:126339
|
Coq7tm1Tsh/Coq7tm1Tsh
(involves: C57BL/6)
|
decreased cell proliferation
|
J:73111
|
Coro1atm1Jpie/Coro1atm1Jpie
(involves: 129 * C57BL/6)
|
decreased T cell proliferation
|
J:133258
|
Cpa3tm3(icre)Hrr/Cpa3+ Fgfr1tm1Upir/Fgfr1tm1Upir Fgfr2tm1Dor/Fgfr2tm1Dor Tg(KRT5-cre)5132Jlj/0
(involves: 129P2/OlaHsd * 129X1/SvJ * C57BL/6 * C57BL/6J * DBA/2J)
|
increased keratinocyte proliferation
|
J:221184
|
Cpeb3em1Gaoxu/Cpeb3em1Gaoxu
(C57BL/6J-Cpeb3em1Gaoxu)
|
decreased granulosa cell proliferation
|
J:323073
|
Cpt1atm1.1Pec/Cpt1atm1.1Pec Tg(Cdh5-cre/ERT2)1Rha/0
(Not Specified)
|
decreased vascular endothelial cell proliferation
|
J:220527
|
Creb1tm1.1Berd/Creb1tm1.1Berd
(B6NHsd.129S4-Creb1tm1.1Berd)
|
increased myoblast proliferation
|
J:177923
|
Crhtm1Maj/Crhtm1Maj
(involves: 129S2/SvPas * C57BL/6)
|
decreased T cell proliferation
|
J:98419
|
increased mesenchymal cell proliferation involved in lung development
|
J:53721
|
Criptotm1Eda/Criptotm1Eda
(either: (involves: 129S1/Sv * 129X1/SvJ) or (involves: 129S1/Sv * 129X1/SvJ * Black Swiss) or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6))
|
decreased fibroblast proliferation
|
J:51595
|
Crlf2tm1Wjl/Crlf2tm1Wjl
(involves: BALB/c)
|
abnormal T cell proliferation
|
J:107431
|
decreased splenocyte proliferation
|
J:107431
|
Crmp1tm1Pako/Crmp1tm1Pako
(involves: 129/Sv * ICR)
|
abnormal neuronal precursor proliferation
|
J:119127
|
Crtamtm1Achn/Crtamtm1Achn
(involves: 129 * C57BL/6)
|
increased T cell proliferation
|
J:145314
|
Crybb2tm1Itl/Crybb2tm1Itl
(C57BL/6-Crybb2tm1Itl)
|
decreased granulosa cell proliferation
|
J:220082
|
Csf2rbtm1Clsc/Csf2rbtm1Clsc Csf2rb2tm1Cgb/Csf2rb2tm1Cgb
(C.129S1-Csf2rb2tm1Cgb Csf2rbtm1Clsc)
|
decreased T cell proliferation
|
J:130939
|
Csgalnact1tm1Nari/Csgalnact1tm1Nari Csgalnact2tm1.1Staka/Csgalnact2tm1.1Staka Tg(Col2a1-cre)1Bhr/0
(involves: C57BL/6 * C57BL/6J * SJL)
|
decreased chondrocyte proliferation
|
J:256718
|
Csnk1a1tm1.1Ybn/Csnk1a1tm1.1Ybn Tg(Vil1-cre/ERT2)23Syr/0 Trp53tm1Brn/Trp53tm1Brn
(involves: 129 * C57BL/6 * CD-1 * DBA/2)
|
abnormal enterocyte proliferation
|
J:204886
|
Csnk1a1tm1.1Ybn/Csnk1a1tm1.1Ybn Tg(Vil1-cre/ERT2)23Syr/0 Trp53tm3.1Tyj/Trp53tm3.1Tyj
(involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ * C57BL/6 * DBA/2)
|
abnormal enterocyte proliferation
|
J:291671
|
Csnk1a1tm1.1Ybn/Csnk1a1tm1.1Ybn Trp53tm1Brn/Trp53tm1Brn Tg(Vil1-cre/ERT2)23Syr/0
(involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA/2)
|
abnormal enterocyte proliferation
|
J:291671
|
Csnk1a1tm1.1Ybn/Csnk1a1tm1.1Ybn Trp53tm2.1Tyj/Trp53tm2.1Tyj Tg(Vil1-cre/ERT2)23Syr/0
(involves: 129S1/Sv * 129X1/SvJ * 129S4/SvJae * C57BL/6 * DBA/2)
|
abnormal enterocyte proliferation
|
J:291671
|
Cspg4tm1Wbst/Cspg4tm1Wbst
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
decreased cell proliferation
|
J:54319
|
Cst6ichq/Cst6+
(involves: BALB/cJ)
|
increased keratinocyte proliferation
|
J:41426
|
Csta1em1Gpt/Csta1em1Gpt
(C57BL/6JGpt-Csta1em1Gpt)
|
decreased keratinocyte proliferation
|
J:340112
|
Ctc1tm1.1Schg/Ctc1tm1.1Schg
(involves: 129S7/SvEvBrd * C57BL/6)
|
decreased cell proliferation
|
J:184809
|
decreased fibroblast proliferation
|
J:184809
|
decreased splenocyte proliferation
|
J:184809
|
Ctdp1em1Ntw/Ctdp1em1Ntw
(involves: C57BL/6 * FVB)
|
decreased fibroblast proliferation
|
J:320982
|
Cthrc1tm1Haak/Cthrc1tm1Haak
(B6.129S-Cthrc1tm1Haak)
|
decreased osteoblast proliferation
|
J:143940
|
Ctla4tm1All/Ctla4tm1All Rag1tm1Mom/Rag1tm1Mom Tg(TcrAND)53Hed/0
(involves: 129S/Sv * 129X1/SvJ * C57BL/6 * SJL)
|
increased T cell proliferation
|
J:119845
|
Ctla4tm1Shr/Ctla4tm1Shr
(either: (involves: 129S4/SvJae * BALB/c) or (involves: 129S4/SvJae * C57BL/6))
|
increased T cell proliferation
|
J:30393
|
Ctla4tm1Shr/Ctla4tm1Shr Tg(DO11.10)10Dlo/0
(involves: 129S4/SvJae * BALB/c * C3H * C57BL/6)
|
increased T cell proliferation
|
J:57090
|
Ctnna1tm1Efu/Ctnna1tm1Efu Tg(KRT14-cre)1Efu/?
(involves: 129X1/SvJ)
|
increased keratinocyte proliferation
|
J:67797
|
Ctnnb1tm1Mmt/Ctnnb1+
(involves: 129S1/Sv * 129S4/SvJaeSor * 129X1/SvJ)
|
abnormal small intestinal crypt cell proliferation
|
J:169830
|
Ctnnb1tm1Mmt/Ctnnb1+ Ptentm1Hwu/Ptentm1Hwu Tg(CYP19A1-cre)1Jri/0
(involves: 129S4/SvJae * 129X1/SvJ * C57BL/6)
|
increased granulosa cell proliferation
|
J:186144
|
Ctnnb1tm2Kem/Ctnnb1tm2Kem Tg(Dct-lacZ)A12Jkn/0 Tg(Tyr-cre)1Lru/0
(B6.Cg-Ctnnb1tm2Kem Tg(Tyr-cre)1Lru Tg(Dct-lacZ)A12Jkn)
|
decreased melanoblast proliferation
|
J:176245
|
Ctnnb1tm2Kem/Ctnnb1tm2Kem Tg(Hoxb7-cre)5526Cmb/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
decreased kidney cell proliferation
|
J:136068
|
Ctnnb1tm2Kem/Ctnnb1tm2Kem Tg(KRT14-cre)#Smr/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * SJL/J)
|
decreased cell proliferation
|
J:242196
|
Ctnnb1tm2Kem/Ctnnb1tm2Kem Tg(KRT14-rtTA)F42Efu/0 Tg(tetO-EDN1,-lacZ)9Mhus/0 Tg(Tyr-cre/ERT2)13Bos/0
(involves: C57BL/6J * FVB)
|
abnormal melanocyte proliferation
|
J:231435
|
Ctnnd1tm1Abre/Ctnnd1tm1Abre
(involves: 129S6/SvEvTac)
|
decreased cell proliferation
|
J:143096
|
Ctnnd1tm1Lfr/Ctnnd1tm1Lfr Tg(Pax3-cre)1Joe/0
(involves: 129X1/SvJ * C57BL/6 * SJL)
|
increased kidney cell proliferation
|
J:171425
|
Ctps1tm1c(KOMP)Wtsi/Ctps1tm1c(KOMP)Wtsi Commd10Tg(Vav1-icre)A2Kio/0
(B6.Cg-Ctps1tm1c(KOMP)Wtsi Commd10Tg(Vav1-icre)A2Kio)
|
decreased T cell proliferation
|
J:348981
|
Ctps1tm1c(KOMP)Wtsi/Ctps1tm1c(KOMP)Wtsi Ctps2tm1c(EUCOMM)Hmgu/Ctps2+ Tg(Cd4-cre)1Cwi/0
(involves: 129S/Sv * C57BL/6 * DBA/2)
|
decreased T cell proliferation
|
J:348981
|
Ctps1tm1c(KOMP)Wtsi/Ctps1tm1c(KOMP)Wtsi Ctps2tm1c(EUCOMM)Hmgu/Ctps2tm1c(EUCOMM)Hmgu Tg(Cd4-cre)1Cwi/0
(involves: 129S/Sv * C57BL/6 * DBA/2)
|
decreased T cell proliferation
|
J:348981
|
Ctps1tm1c(KOMP)Wtsi/Ctps1tm1c(KOMP)Wtsi Gt(ROSA)26Sortm1(cre/ERT2)Tyj/Gt(ROSA)26Sor+
(B6.Cg-Ctps1tm1c(KOMP)Wtsi Gt(ROSA)26Sortm1(cre/ERT2)Tyj)
|
decreased T cell proliferation
|
J:348981
|
Ctps1tm1c(KOMP)Wtsi/Ctps1tm1c(KOMP)Wtsi Tg(Cd4-cre)1Cwi/0
(involves: 129S/Sv * C57BL/6 * DBA/2)
|
decreased T cell proliferation
|
J:348981
|
Ctps1tm1c(KOMP)Wtsi/Ctps1tm1c(KOMP)Wtsi Tg(Cd4-cre)1Cwi/0 Foxp3sf/Y Rag1tm1Mom/Rag1+
(mixed)
|
decreased T cell proliferation
|
J:348981
|
Ctps1tm1c(KOMP)Wtsi/Ctps1tm1c(KOMP)Wtsi Tg(Cd8a-cre)1Itan/0
(B6(129S4)-Ctps1tm1c(KOMP)Wtsi Tg(Cd8a-cre)1Itan)
|
decreased T cell proliferation
|
J:348981
|
Ctsltm1.2Thre/Ctsltm1.2Thre
(involves: C57BL/6 * C57BL/6N)
|
increased keratinocyte proliferation
|
J:216506
|
Ctsltm1Cptr/Ctsltm1Cptr
(involves: 129P2/OlaHsd * C57BL/6J)
|
increased keratinocyte proliferation
|
J:70118
|
Ctsltm1Cptr/Ctsltm1Cptr
(involves: 129P2/OlaHsd)
|
increased keratinocyte proliferation
|
J:216506
|
Cul4atm1.1Pra/Cul4atm1.1Pra
(involves: C57BL/6NTac)
|
decreased fibroblast proliferation
|
J:172043
|
Cul4atm1.1Pra/Cul4atm1.1Pra Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: C57BL/6 * C57BL/6NTac * DBA)
|
decreased hepatocyte proliferation
|
J:172043
|
Cul4btm1.1Pz/Y Tg(CAG-cre)13Miya/0
(involves: 129 * C57BL/6 * C57BL/6J)
|
decreased cell proliferation
|
J:199210
|
Cul4btm1.1Yxg/Y
(involves: 129X1/SvJ * FVB/N)
|
decreased cell proliferation
|
J:199139
|
Cux2Gt(OST440231)Lex/Cux2Gt(OST440231)Lex
(involves: 129S5/SvEvBrd)
|
decreased cell proliferation
|
J:131816
|
Cux2tm1.1Nieto/Cux2tm1.1Nieto
(involves: 129S4/SvJae * C57BL/6 * FVB/N * Swiss Webster)
|
abnormal neuronal precursor proliferation
|
J:156578
|
Cuzd1tm1Bag/Cuzd1tm1Bag
(involves: 129 * C57BL/6)
|
decreased mammary gland epithelial cell proliferation
|
J:242064
|
Cx3cr1tm1Litt/Cx3cr1tm1Litt
(B6.129P2-Cx3cr1tm1Litt)
|
decreased vascular smooth muscle cell proliferation
|
J:124722
|
Cxadrtm1.1Mds/Cxadrtm1.1Mds
(involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ * C57BL/6J)
|
abnormal fetal cardiomyocyte proliferation
|
J:121400
|
Cxcl10tm1Adl/Cxcl10tm1Adl
(involves: 129S4/SvJae * 129X1/SvJ)
|
decreased splenocyte proliferation
|
J:75584
|
Cybbtm1Din/?
(B6.129S-Cybbtm1Din/J)
|
decreased cell proliferation
|
J:306955
|
Cygbtm1Ppam/Cygbtm1Ppam Tg(Myog-cre)1Eno/0
(involves: 129 * C57BL/6)
|
decreased cell proliferation
|
J:206378
|
Cyldtm1Ref/Cyldtm1Ref
(B6.129-Cyldtm1Ref)
|
abnormal keratinocyte proliferation
|
J:108769
|
increased cell proliferation
|
J:108769
|
increased keratinocyte proliferation
|
J:108769
|
Cyp2c23Gt(OST85045)Lex/Cyp2c23Gt(OST85045)Lex
(129-Cyp2c23Gt(OST85045)Lex)
|
decreased lung endothelial cell proliferation
|
J:207597
|
Cyp2g1tm1(rtTA)Lane/Cyp2g1+ Tg(SFTPC-rtTA,tetO-Tnf)320-1Gwho/0
(involves: 129 * C57BL/6 * SJL)
|
decreased cell proliferation
|
J:157842
|
Cyrenem1Vokh/Cyrenem1Vokh
(C57BL/6-Cyrenem1Vokh)
|
decreased neuronal precursor proliferation
|
J:306598
|
Dab2tm1Xxx/Dab2tm1Xxx
(involves: 129S6/SvEvTac * C57BL/6)
|
absent inner cell mass proliferation
|
J:79862
|
Dach1tm1Krs/Dach1tm1Krs
(involves: 129P2/OlaHsd)
|
decreased pancreatic beta cell proliferation
|
J:166952
|
Daglatm1Pado/Dagla+
(C57BL/6-Daglatm1Pado)
|
abnormal neuron proliferation
|
J:157850
|
Daglatm1Pado/Daglatm1Pado
(C57BL/6-Daglatm1Pado)
|
abnormal neuron proliferation
|
J:157850
|
DaglbGt(OST195261)Lex/Daglb+
(B6.129S5-DaglbGt(OST195261)Lex)
|
abnormal neuron proliferation
|
J:157850
|
DaglbGt(OST195261)Lex/DaglbGt(OST195261)Lex
(B6.129S5-DaglbGt(OST195261)Lex)
|
abnormal neuron proliferation
|
J:157850
|
Dapl1em1Nju/Dapl1em1Nju
(C57BL/6J-Dapl1em1Nju)
|
increased cell proliferation
|
J:242244
|
Dapp1Gt(OST111213)Lex/Dapp1Gt(OST111213)Lex
(B6.Cg-Dapp1Gt(OST111213)Lex)
|
decreased B cell proliferation
|
J:110009
|
Dapp1tm1Mnz/Dapp1tm1Mnz
(B6.129P2-Dapp1tm1Mnz)
|
decreased B cell proliferation
|
J:86182
|
Dazap1tm1Pyen/Dazap1tm1Pyen
(involves: 129S6/SvEvTac)
|
abnormal spermatogonia proliferation
|
J:171493
|
DbnlGt(betageo)11Byg/DbnlGt(betageo)11Byg
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased T cell proliferation
|
J:119847
|
Dcaf1tm1.1Yxi/Dcaf1tm1.2Yxi
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased fibroblast proliferation
|
J:140246
|
Dcbld2tm1.1Mhms/Dcbld2tm1.1Mhms
(B6.129S6-Dcbld2tm1.1Mhms)
|
decreased lung endothelial cell proliferation
|
J:207629
|
Dckmemi/Dckmemi
(C57BL/6J-Dckmemi)
|
increased T cell proliferation
|
J:184080
|
Dclre1atm1Rleg/Dclre1atm1Rleg
(involves: 129S7/SvEvBrd)
|
decreased cell proliferation
|
J:102381
|
Dclre1ctm2Mcow/Dclre1ctm2Mcow
(involves: 129/Sv * C57BL/6)
|
decreased B cell proliferation
|
J:96535
|
decreased T cell proliferation
|
J:96535
|
Dcun1d1Gt(RRR261)Byg/Dcun1d1Gt(RRR261)Byg
(involves: 129P2/OlaHsd)
|
decreased fibroblast proliferation
|
J:262901
|
Ddr1tm1Wfv/Ddr1tm1Wfv
(either: (involves: (129S1/Sv * 129X1/SvJ) or (involves: 129S1/Sv * 129X1/SvJ * ICR) or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6))
|
increased mammary gland epithelial cell proliferation
|
J:68368
|
Ddr2tm1Kln/Ddr2tm1Kln
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
decreased cell proliferation
|
J:74580
|
Ddx4tm1Tnc/Ddx4tm1Tnc
(involves: 129P2/OlaHsd * C57BL/6NJcl)
|
decreased primordial germ cell proliferation
|
J:61665
|
Ddx11tm1Jiml/Ddx11tm1Jiml
(involves: 129S/SvEv)
|
decreased inner cell mass proliferation
|
J:158490
|
Del(4C4-C5)1Lap/Del(4C4-C5)1Lap
(involves: 129S6/SvEvTac)
|
increased fibroblast proliferation
|
J:158126
|
increased vascular smooth muscle cell proliferation
|
J:158126
|
Del(4D4Mit190-D4Mit51)2Aam/+
(involves: 129S7/SvEvBrd)
|
increased fibroblast proliferation
|
J:121726
|
Del(5Kit-Cep135)1Utr/Del(5Kit-Cep135)1Utr
(C57BL/6JCrlj-Del(5Kit-Cep135)1Utr)
|
decreased inner cell mass proliferation
|
J:233978
|
Del(7Slx1b-Sept1)4Aam/0
(B6129S-Del(7Slx1b-Sept1)4Aam/J)
|
increased neuronal precursor proliferation
|
J:219859
|
Del(14Trim13-Dleu2)4Rdf/Del(14Trim13-Dleu2)4Rdf
(involves: 129S1/Sv * 129S4/SvJaeSor * C57BL/6)
|
abnormal B cell proliferation
|
J:156946
|
Del(16Es2el-Ufd1l)217Bld/+
(B6.129S7-Del(16Es2el-Ufd1l)217Bld)
|
abnormal neuron proliferation
|
J:201966
|
Del(17Fpr1-Fpr2)1Jimw/Del(17Fpr1-Fpr2)1Jimw
(Not Specified)
|
abnormal enterocyte proliferation
|
J:197568
|
Del(17Hspa1b-Hsp1a)1Dix/Del(17Hspa1b-Hsp1a)1Dix
(involves: 129S7/SvEvBrd)
|
decreased cell proliferation
|
J:87581
|
Dennd1aem1Jgfu/Dennd1aem1Jgfu
(Not Specified)
|
decreased cell proliferation
|
J:276703
|
decreased hepatocyte proliferation
|
J:276703
|
Dgat1tm1Far/Dgat1tm1Far
(B6J.129S4-Dgat1tm1Far)
|
decreased mammary gland epithelial cell proliferation
|
J:128259
|
Dgcr8Gt(XG058)Byg/Dgcr8+
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal neuronal precursor proliferation
|
J:198659
|
Dgkztm1Gak/Dgkztm1Gak
(involves: 129X1/SvJ * C57BL/6)
|
increased T cell proliferation
|
J:85149
|
Dguoktm1.1Anka/Dguoktm1.1Anka
(involves: 129 * C57BL/6N)
|
increased hepatocyte proliferation
|
J:294620
|
Dh/Dh+ H2d/H2d
(NZB.Cg-Dh)
|
decreased B cell proliferation
|
J:12036
|
increased T cell proliferation
|
J:12036
|
DhpsGt(RRM039)Byg/DhpsGt(RRM039)Byg
(involves: 129P2/OlaHsd * C57BL/6J)
|
decreased cell proliferation
|
J:285882
|
Dhx15tm1c(EUCOMM)Wtsi/Dhx15tm1c(EUCOMM)Wtsi Cd19tm1(cre)Cgn/Cd19+
(involves: 129P2/OlaHsd * C3H * C57BL/6N)
|
decreased B cell proliferation
|
J:284624
|
Diaph1tm1.1Sna/Diaph1tm1.1Sna
(B6.Cg-Diaph1tm1.1Sna)
|
decreased T cell proliferation
|
J:126090
|
Dicer1tm1Bdh/Dicer1tm1Bdh Plekha5Tg(AMH-cre)1Flor/Plekha5+
(involves: 129/Sv * C57BL/6 * SJL)
|
increased Sertoli cell proliferation
|
J:145178
|
Dicer1tm1Bdh/Dicer1tm1Bdh Tg(Pax2-cre)1Akg/0
(involves: 129)
|
decreased cell proliferation
|
J:200017
|
Dicer1tm1Dli/Dicer1tm1Dli Tg(Cd4-cre)1Cwi/?
(involves: 129 * C57BL/6 * DBA/2)
|
decreased T cell proliferation
|
J:100546
|
Dicer1tm1Mmk/Dicer1tm1Mmk Shhtm1(EGFP/cre)Cjt/Shh+
(involves: 129 * C57BL/6J)
|
increased mesenchymal cell proliferation involved in lung development
|
J:224791
|
Dicer1tm1Smr/Dicer1tm1Smr Pax8tm1.1(cre)Mbu/Pax8+
(involves: 129P2/OlaHsd * 129S7/SvEvBrd)
|
increased kidney cell proliferation
|
J:229188
|
Dicer1tm1Snj/Dicer1tm1Snj
(involves: 129S7/SvEvBrd * C57BL/6)
|
decreased cell proliferation
|
J:139257
|
Dicer1tm1Snj/Dicer1tm1Snj Trp53tm1Brd/Trp53tm1Brd
(involves: 129S7/SvEvBrd * C57BL/6)
|
increased cell proliferation
|
J:139257
|
Dido1tm2Cmar/Dido1tm2Cmar
(involves: 129S1/Sv * 129X1/SvJ)
|
decreased embryonic epiblast cell proliferation
|
J:183346
|
Dio3tm1Dmst/Dio3tm1Dmst Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: C57BL/6 * DBA)
|
increased hepatocyte proliferation
|
J:218350
|
Dkc1tm1.1Pjma/Y
(B6.129X1(FVB)-Dkc1tm1.1Pjma)
|
decreased fibroblast proliferation
|
J:217050
|
decreased hematopoietic stem cell proliferation
|
J:217050
|
Dkk1tm1.1Svo/Dkk1tm1.2Svo Pax8tm1.1(cre)Mbu/Pax8+
(involves: 129P2/OlaHsd * C57BL/6 * SJL)
|
increased kidney cell proliferation
|
J:173125
|
Dlk1tm1.1Jvs/Dlk1+ Myf5tm3(cre)Sor/Myf5+
(involves: 129P2/SvPas * 129S4/SvJaeSor * C57BL/6 * FVB/N)
|
decreased cell proliferation
|
J:167124
|
Dlx5tm1Levi/Dlx5tm1Levi
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2)
|
abnormal cell proliferation
|
J:56557
|
Dmdmdx/Dmdmdx
(involves: C57BL/10ScSn)
|
abnormal skeletal muscle satellite cell proliferation
|
J:152892
|
Dmdmdx/Dmdmdx Mamstrtm1.2Eno/Mamstrtm1.2Eno
(involves: 129 * C57BL/6 * C57BL/10ScSn)
|
abnormal skeletal muscle satellite cell proliferation
|
J:179880
|
Dmrt1tm1.1Zark/Dmrt1tm1.1Zark
(involves: 129 * C57BL/6)
|
increased Sertoli cell proliferation
|
J:65541
|
Dmrta2tm1.2Fuma/Dmrta2tm1.2Fuma
(involves: C57BL/6 * C57BL/6NCrlj * CBA/JNCrlj * FVB/N * SJL)
|
abnormal neuronal precursor proliferation
|
J:203109
|
Dmrta2tm1Ejbd/Dmrta2tm1Ejbd
(involves: C57BL/6)
|
abnormal neuronal precursor proliferation
|
J:215514
|
Dnajc27Gt(OST374030)Lex/Dnajc27Gt(OST374030)Lex
(involves: 129S5/SvEvBrd * C57BL/6N)
|
abnormal enterocyte proliferation
|
J:210622
|
Dnm1lPy/Dnm1lPy
(involves: BALB/cAnNCrl * C3H/HeH)
|
absent fibroblast proliferation
|
J:161510
|
Dnm1ltm1.2Hise/Dnm1ltm1.2Hise
(involves: 129S/SvEv * C57BL/6 * FVB/N)
|
decreased fibroblast proliferation
|
J:153835
|
Dnm1ltm1.2Miha/Dnm1ltm1.2Miha
(involves: C57BL/6J)
|
decreased fibroblast proliferation
|
J:158142
|
Dnmt1tm1Jae/Dnmt1tm1Jae
(involves: 129S4/SvJae)
|
decreased cell proliferation
|
J:1157
|
Dnmt1tm1Okan/Dnmt1tm2Enl
(involves: 129S4/SvJae)
|
decreased cell proliferation
|
J:129049
|
Dnmt1tm2Enl/Dnmt1tm2Enl
(involves: 129S4/SvJae)
|
decreased cell proliferation
|
J:129049
|
Dock1tm2.1Jfco/Dock1tm2.1Jfco Tg(MMTV-Erbb2*,-cre)1Mul/0
(involves: C57BL/6 * FVB/NJ)
|
decreased cell proliferation
|
J:196659
|
Dock2m1Hsd/Dock2m1Hsd Siaetm1.2Avrk/Siaetm1.2Avrk
(B6NHsd.Cg-Siaetm1.2Avrk Dock2m1Hsd)
|
increased B cell proliferation
|
J:144035
|
Dock8tm1Ysfk/Dock8tm1Ysfk
(B6.Cg-Dock8tm1Ysfk)
|
decreased T cell proliferation
|
J:185165
|
Dok1tm1Ppp/Dok1tm1Ppp
(129S1/Sv-Dok1tm1Ppp)
|
abnormal T cell proliferation
|
J:95640
|
increased fibroblast proliferation
|
J:95640
|
Dok1tm1Yyam/Dok1tm1Yyam
(involves: 129S4/SvJae * C57BL/6)
|
increased B cell proliferation
|
J:95641
|
Dok3tm1Kplm/Dok3tm1Kplm
(involves: 129P2/OlaHsd)
|
increased B cell proliferation
|
J:280795
|
Dot1ltm1.1Tche/Dot1ltm1.1Tche
(either: (involves: C57BL/6) or (involves: 129/Sv * C57BL/6))
|
decreased cell proliferation
|
J:161427
|
Dot1ltm1Tche/Dot1ltm1.1Tche Tg(Myhca-cre)1Abel/0
(Not Specified)
|
increased fetal cardiomyocyte proliferation
|
J:168140
|
Dp(4D4Mit190-D4Mit51)1Aam/0
(involves: 129S7/SvEvBrd)
|
decreased cell proliferation
|
J:121726
|
Dph1tm1Bhr/Dph1tm1Bhr
(involves: 129S4/SvJae)
|
decreased fibroblast proliferation
|
J:188600
|
Dppa2tm1.1Yam/Dppa2tm1.1Yam Dppa4tm1Yam/Dppa4tm1Yam
(involves: 129S4/SvJae)
|
decreased cell proliferation
|
J:178324
|
Dsg2tm1Leu/Dsg2tm1Leu
(either: (involves: 129S1/Sv * 129X1/SvJ) or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6))
|
decreased fibroblast proliferation
|
J:102536
|
Dstncorn1/Dstncorn1
(A.BY-H2bc H2-T18f/SnJ)
|
increased cell proliferation
|
J:31798
|
Dtx1tm1.1Mzl/Dtx1tm1.1Mzl Tg(Cd4-cre)1Cwi/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA/2)
|
increased T cell proliferation
|
J:151605
|
Dtx1tm1.2Mzl/Dtx1tm1.2Mzl
(B6.129-Dtx1tm1.2Mzl)
|
increased B cell proliferation
|
J:151605
|
increased T cell proliferation
|
J:151605
|
Dusp1tm1Brv/Dusp1tm1Brv
(involves: 129S2/SvPas * C57BL/6)
|
decreased myoblast proliferation
|
J:162340
|
Dusp4Gt(XG164)Byg/Dusp4Gt(XG164)Byg
(B6.129P2-Dusp4Gt(XG164)Byg)
|
increased T cell proliferation
|
J:180366
|
Dusp5tm1.1Achn/Dusp5tm1.1Achn
(involves: C57BL/6NCrl)
|
increased T cell proliferation
|
J:218203
|
Dusp5tm1a(KOMP)Wtsi/Dusp5tm1a(KOMP)Wtsi
(C57BL/6-Dusp5tm1a(KOMP)Wtsi)
|
increased T cell proliferation
|
J:240637
|
Dusp10tm1Flv/Dusp10tm1Flv
(involves: 129S6/SvEvTac)
|
decreased T cell proliferation
|
J:92104
|
Dusp14Gt(OST210117)Lex/Dusp14Gt(OST210117)Lex
(B6.129S5-Dusp14Gt(OST210117)Lex)
|
increased T cell proliferation
|
J:209403
|
Dusp22tm1Tht/Dusp22tm1Tht
(B6.129S7-Dusp22tm1Tht)
|
decreased B cell proliferation
|
J:213253
|
increased T cell proliferation
|
J:213253
|
Dync1h1tm1.1Ics/Dync1h1+
(involves: C57BL/6 * C57BL/6N * SJL)
|
abnormal cell proliferation
|
J:334549
|
E2f1tm1Meg/E2f1tm1Meg
(involves: 129S4/SvJae * C57BL/6)
|
decreased T cell proliferation
|
J:76318
|
E2f1tm1Meg/E2f1tm1Meg E2f2tm1Zubi/E2f2tm1Zubi E2f3tm2.1Gle/E2f3tm2.1Gle
(involves: 129 * FVB/N * NIH Black Swiss)
|
decreased cell proliferation
|
J:138289
|
E2f1tm1Meg/E2f1tm1Meg E2f2tm1Zubi/E2f2tm1Zubi E2f3tm3.1Gle/E2f3tm3.1Gle
(involves: 129 * FVB/N * NIH Black Swiss)
|
decreased cell proliferation
|
J:138289
|
E2f1tm1Meg/E2f1tm1Meg E2f3tm2.1Gle/E2f3tm2.1Gle
(involves: 129S4/SvJae * 129S6/SvEvTac * FVB/N * NIH Black Swiss)
|
decreased cell proliferation
|
J:138289
|
E2f1tm1Njd/E2f1tm1Njd E2f3tm2Lees/E2f3tm2Lees
(involves: 129S2/SvPas * 129S4/SvJae * C57BL/6)
|
decreased cell proliferation
|
J:147270
|
E2f2tm1Zubi/E2f2tm1Zubi
(involves: 129S1/Sv * C57BL/6)
|
increased T cell proliferation
|
J:76318
|
E2f2tm1Zubi/E2f2tm1Zubi Tg(TcraH-Y,TcrbH-Y)71Vbo/?
(involves: 129S1/Sv * C57BL/6 * C57BL/6J * DBA/2J)
|
increased T cell proliferation
|
J:76318
|
E2f3tm1Lees/E2f3tm1Lees
(involves: 129S2/SvPas * C57BL/6)
|
decreased cell proliferation
|
J:65128
|
Ebf1tm1.1Rug/Ebf1tm1.1Rug Polr2atm1(cre/ERT2)Bbd/Polr2a+
(involves: C57BL/6 * SJL)
|
decreased B cell proliferation
|
J:182210
|
Ecsittm1Gho/Ecsittm1Gho
(involves: 129S6/SvEvTac * C57BL/6)
|
decreased cell proliferation
|
J:86912
|
Ednrbs-36Pub/Ednrbs-36Pub
(B6.Cg-Ednrbs-36Pub)
|
increased cell proliferation
|
J:125229
|
Ednrbs-l/Ednrbs-l
(involves: C57BL/6J * SSL/Le)
|
abnormal melanocyte proliferation
|
J:19441
|
Ednrbtm1Nrd/Ednrbtm1Nrd Gt(ROSA)26Sortm14(CAG-tdTomato)Hze/Gt(ROSA)26Sor+ Tg(Tyr-cre/ERT2)13Bos/0
(involves: 129S1/Sv * 129S6/SvEvTac * 129X1/SvJ * C57BL/6J)
|
abnormal melanocyte proliferation
|
J:231435
|
Eef1e1Gt(OST377244)Lex/Eef1e1+
(involves: 129S5/SvEvBrd * C57BL/6)
|
increased cell proliferation
|
J:96923
|
increased splenocyte proliferation
|
J:96923
|
Efemp2tm1.2Hiya/Efemp2tm1.2Hiya
(involves: 129S6/SvEvTac * C57BL/6 * SJL)
|
increased vascular endothelial cell proliferation
|
J:170883
|
increased vascular smooth muscle cell proliferation
|
J:170883
|
Egr2tm1Jmi/Egr2tm1Jmi
(Not Specified)
|
increased Schwann cell proliferation
|
J:96641
|
Egr2tm4Pch/Egr2tm4Pch
(involves: BALB/c * C57BL/6)
|
increased Schwann cell proliferation
|
J:137156
|
Ehd4tm1.1Haba/Ehd4tm1.1Haba
(involves: C57BL/6 * C57BL/6J * FVB/N)
|
increased cell proliferation
|
J:160188
|
Eif2ak2tm1Cwe/Eif2ak2tm1Cwe
(involves: 129S/SvEv * C57BL/6)
|
increased T cell proliferation
|
J:66112
|
Eif2s2Gt(XH413)Byg/Eif2s2+
(129-Eif2s2Gt(XH413)Byg Chr 19MOLF/Ei)
|
decreased primordial germ cell proliferation
|
J:146879
|
X/Eif2s3yem2Asah
(involves: C57BL/6 * DBA/2)
|
abnormal spermatogonia proliferation
|
J:244443
|
X/Eif2s3yem#Asah
(involves: C57BL/6 * DBA/2)
|
abnormal spermatogonia proliferation
|
J:244443
|
Eif3etm1Fshb/Eif3e+
(C57BL/6N-Eif3etm1Fshb)
|
decreased fibroblast proliferation
|
J:265010
|
Eif4a1tm1.1Bea/Eif4a1tm1.1Bea Tg(Fcer2a-cre)5Mbu/0
(involves: 129P2/OlaHsd * C57BL/6 * CBA)
|
decreased B cell proliferation
|
J:344730
|
Eif5aGt(RRE174)Byg/Eif5aGt(RRE174)Byg
(involves: 129P2/OlaHsd * C57BL/6J)
|
decreased cell proliferation
|
J:285882
|
Elavl1tm1.1Atas/Elavl1tm1.1Atas Tnfrsf4tm2(cre)Nik/Tnfrsf4+
(involves: 129X1/SvJ * C57BL/6)
|
decreased T cell proliferation
|
J:207013
|
Elavl1tm1Thla/Elavl1tm1Thla Gt(ROSA)26Sortm1(cre/ERT2)Alj/Gt(ROSA)26Sor+
(involves: 129)
|
decreased cell proliferation
|
J:155109
|
Elf4tm1Nim/Elf4tm1Nim
(B6.129S1-Elf4tm1Nim)
|
increased B cell proliferation
|
J:79568
|
increased T cell proliferation
|
J:79568
|
Eloatm1Aso/Eloatm1Aso
(involves: 129S/SvEv * C57BL/6)
|
decreased cell proliferation
|
J:119126
|
Elof1tm1.1(KOMP)Vlcg/Elof1tm1.1(KOMP)Vlcg
(B6N(Cg)-Elof1tm1.1(KOMP)Vlcg/J)
|
decreased embryonic epiblast cell proliferation
|
J:277394
|
Emg1tm1.1Btr/Emg1tm1.1Btr
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CD-1)
|
decreased cell proliferation
|
J:230556
|
Eml1heco/?
(involves: CD-1)
|
abnormal neuronal precursor proliferation
|
J:211342
|
Eml1tm1.2Ics/Eml1tm1.2Ics
(C57BL/6N-Eml1tm1.2Ics)
|
abnormal neuronal precursor proliferation
|
J:294769
|
Emx1tm1(cre)Krj/Emx1+ Esco2tm1.1Ge/Esco2tm1.1Ge
(involves: 129S2/SvPas * C57BL/6 * SJL)
|
abnormal neuronal precursor proliferation
|
J:180371
|
Emx1tm1(cre)Krj/Emx1+ Rbm8atm1Dlsi/Rbm8a+
(involves: C57BL/6J)
|
increased neuronal precursor proliferation
|
J:221648
|
En1tm1(Wnt1)Wrst/En1+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
increased cell proliferation
|
J:91004
|
En1tm1Alj/En1tm8.1Alj En2tm1Alj/En2tm6Alj Gt(ROSA)26Sortm1(cre/ERT2)Alj/Gt(ROSA)26Sor+
(involves: 129S2/SvPas * 129S6/SvEvTac * Swiss Webster)
|
abnormal cerebellar granule cell precursor proliferation
|
J:156169
|
Enpp1ttw/Enpp1ttw
(involves: ICR)
|
abnormal chondrocyte proliferation
|
J:37369
|
Enpp2tm1.1Vart/Enpp2tm1.1Vart
(B6.Cg-Enpp2tm1.1Vart/Flmg)
|
decreased cell proliferation
|
J:159118
|
Entpd5tm1Rre/Entpd5tm1Rre
(involves: 129S5/SvEvBrd * C57BL/6J)
|
increased hepatocyte proliferation
|
J:163795
|
Eomestm1Rob/Eomestm1Rob Sox1tm1(cre)Take/0
(involves: 129S/SvEv * C57BL/6 * CBA)
|
abnormal neuronal precursor proliferation
|
J:138764
|
Ep300tm1Dli/Ep300tm1Dli
(either: 129S4/SvJae or (involves: 129S4/SvJae * C57BL/6))
|
decreased fibroblast proliferation
|
J:47301
|
Epcamtm1.2Msiv/Epcamtm1.2Msiv
(involves: C57BL/6 * FVB/N * SJL)
|
abnormal enterocyte proliferation
|
J:210901
|
Ephb2tm3.1Jf/Ephb2tm3.1Jf Ephb3tm1Kln/Ephb3tm1Kln
(involves: 129S1/Sv * 129S2/SvPas * 129X1/SvJ * CD-1)
|
abnormal small intestinal crypt cell proliferation
|
J:157019
|
Ephb6tm1Jwu/Ephb6tm1Jwu
(involves: 129)
|
decreased T cell proliferation
|
J:94701
|
Epn1tm1.1Wami/Epn1tm1.1Wami Epn2tm1Ocr/Epn2tm1Ocr Tg(Cdh5-cre/ERT2)CIVE23Mlia/0
(involves: 129X1/SvJ * C57BL/6J)
|
increased vascular endothelial cell proliferation
|
J:193966
|
Erap1tm1.1Gnie/Erap1tm1.1Gnie
(involves: 129S6/SvEvTac * C57BL/6)
|
decreased T cell proliferation
|
J:143988
|
Ercc1tm1Jhjh/Ercc1tm1Jhjh
(involves: C57BL/6 * FVB/N)
|
decreased B cell proliferation
|
J:92471
|
Ercc1tm1Jhjh/Ercc1tm1Jhjh
(involves: 129P2/OlaHsd * C57BL/6 * FVB)
|
decreased cell proliferation
|
J:117488
|
decreased hepatocyte proliferation
|
J:117488
|
Ercc1tm2Jhjh/Ercc1tm2Jhjh
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased cell proliferation
|
J:41161
|
Ercc6tm1Gvh/Ercc6tm1Gvh Xpatm1Tnka/Xpatm1Tnka
(involves: 129P2/OlaHsd * C57BL/6 * CBA)
|
decreased cerebellar granule cell precursor proliferation
|
J:72574
|
Ercc6ltm1.2Ajlc/Y
(involves: 129S2/SvPas * C57BL/6J * C57BL/6N * SJL/J)
|
decreased fibroblast proliferation
|
J:271028
|
Ercc6ltm1.2Ajlc/Ercc6l+
(involves: 129S2/SvPas * C57BL/6J * C57BL/6N * SJL/J)
|
decreased fibroblast proliferation
|
J:271028
|
Ergtm1.1Path/Ergtm1.1Path
(Not Specified)
|
increased vascular endothelial cell proliferation
|
J:227456
|
Eri1tm1.2Anse/Eri1tm1.2Anse
(involves: BALB/cJ * C57BL/6 * SJL)
|
decreased cell proliferation
|
J:146701
|
Esco2tm1.1Ge/Esco2tm1.1Ge Tg(CAG-cre/Esr1*)5Amc/0
(involves: 129S2/SvPas * C57BL/6 * CBA * SJL)
|
decreased cell proliferation
|
J:180371
|
Espl1Gt(XL058)Byg/Espl1+ Trp53tm1Tyj/Trp53tm1Tyj
(B6.129-Trp53tm1Tyj Espl1Gt(XL058)Byg)
|
increased splenocyte proliferation
|
J:174926
|
Espl1tm1.1Tno/Espl1+ Pttg1tm1.1Tno/Pttg1tm1.1Tno
(involves: 129S4/SvJae * C57BL/6J)
|
decreased cell proliferation
|
J:107917
|
Espl1tm1.1Tno/Espl1tm1.2Tno
(involves: 129S4/SvJae * C57BL/6J)
|
decreased cell proliferation
|
J:107917
|
Espl1tm1.2Tno/Espl1tm1.2Tno
(involves: 129S4/SvJae * C57BL/6J)
|
abnormal inner cell mass proliferation
|
J:107917
|
Espl1tm2Pzg/Espl1+ Meox2tm1(cre)Sor/Meox2+
(involves: 129S4/SvJaeSor * 129S7/SvEvBrd)
|
decreased primordial germ cell proliferation
|
J:131838
|
Esr2tm1Unc/Esr2tm1Unc
(involves: 129P2/OlaHsd)
|
abnormal enterocyte proliferation
|
J:107308
|
Esrp2tm1(KOMP)Vlcg/Esrp2tm1(KOMP)Vlcg
(involves: C57BL/6J * C57BL/6NTac)
|
increased hepatocyte proliferation
|
J:228040
|
Ets1tm1.1Dds/Ets1tm1.1Dds
(129S6/SvEvTac-Ets1tm1.1Dds)
|
increased cell proliferation
|
J:121460
|
Ets1tm1Fwa/Ets1tm1Fwa
(B6.129S4-Ets1tm1Fwa)
|
decreased B cell proliferation
|
J:93845
|
Ets1tm2Jml/Ets1tm2Jml
(involves: 129X1/SvJ * C57BL/6)
|
decreased T cell proliferation
|
J:50627
|
Etv5tm1Kmm/Etv5tm1Kmm
(involves: 129S6/SvEvTac)
|
abnormal spermatogonia proliferation
|
J:100645
|
Ext1tm1Yama/Ext1tm1Yama
(B6.129S5-Ext1tm1Yama)
|
decreased cranial neural crest cell proliferation
|
J:152572
|
Ext1tm1Yama/Ext1tm1Yama H2az2Tg(Wnt1-cre)11Rth/H2az2+
(B6.Cg-H2az2Tg(Wnt1-cre)11Rth Ext1tm1Yama)
|
decreased cranial neural crest cell proliferation
|
J:152572
|
Extl3tm1.1Okam/Extl3tm1Okam Tg(Ins2-cre)#Okam/0
(involves: 129P2/OlaHsd * ICR)
|
decreased cell proliferation
|
J:148348
|
Eya1tm1Rilm/Eya1tm1Rilm
(involves: 129S1/Sv * 129X1/SvJ)
|
decreased otic epithelial cell proliferation
|
J:119574
|
Eya1tm1Rilm/Eya1tm1Rilm Six1tm1Mair/Six1tm1Mair
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
decreased cell proliferation
|
J:172023
|
Ezh2tm1Jnw/Ezh2tm1Jnw
(involves: 129P2/OlaHsd)
|
absent inner cell mass proliferation
|
J:69977
|
Ezh2tm1Tara/Ezh2tm1Tara Ighg1tm1(cre)Cgn/Ighg1+
(involves: 129P2/OlaHsd)
|
decreased B cell proliferation
|
J:199122
|
F3tm1.1Dwr/F3tm1.1Dwr
(involves: 129S1/Sv * 129X1/SvJ * MF1 * Swiss)
|
increased vascular smooth muscle cell proliferation
|
J:111390
|
Faap100em1Jzc/Faap100em1Jzc
(involves: C57BL/6J * ICR)
|
decreased primordial germ cell proliferation
|
J:339060
|
Faddtm1Mpa/Faddtm1Mpa Tg(Vil1-cre)997Gum/0
(B6.Cg-Faddtm1Mpa Tg(Vil1-cre)997Gum)
|
abnormal enterocyte proliferation
|
J:175865
|
Faddtm2.1Wnt/Faddtm2.1Wnt Tg(Cd4-cre)1Cwi/?
(B6.Cg-Tg(Cd4-cre)1Cwi Faddtm2.1Wnt)
|
abnormal T cell proliferation
|
J:162312
|
Fads1Gt(IST11525H2)Tigm/Fads1+
(C57BL/6-Fads1Gt(IST11525H2)Tigm)
|
abnormal enterocyte proliferation
|
J:186265
|
Fads1Gt(IST11525H2)Tigm/Fads1Gt(IST11525H2)Tigm
(C57BL/6-Fads1Gt(IST11525H2)Tigm)
|
abnormal enterocyte proliferation
|
J:186265
|
Fahtm1Mgo/Fahtm1Mgo
(involves: 129S7/SvEvBrd * C57BL/6)
|
decreased hepatocyte proliferation
|
J:138701
|
Fam20ctm1.1Cqi/Fam20ctm1.1Cqi Edil3Tg(Sox2-cre)1Amc/Edil3+
(involves: 129S6/SvEvTac * C57BL/6 * CBA)
|
decreased chondrocyte proliferation
|
J:185208
|
Fam120bem1Qqlg/Fam120bem1Qqlg
(C57BL/6-Fam120bem1Qqlg)
|
decreased fetal cardiomyocyte proliferation
|
J:318650
|
Fan1tm1a(KOMP)Wtsi/Fan1tm1a(KOMP)Wtsi
(129S1.B6-Fan1tm1a(KOMP)Wtsi)
|
increased kidney cell proliferation
|
J:242198
|
Fanclgcd/Fanclgcd
(involves: C57BL/6J * CBA/J)
|
decreased primordial germ cell proliferation
|
J:80424
|
Faslpr/Faslpr
(MRL/Mp-Faslpr)
|
abnormal T cell proliferation
|
J:8267
|
increased kidney cell proliferation
|
J:27634
|
Faslpr/Faslpr
(C3.MRL-Faslpr)
|
abnormal T cell proliferation
|
J:8267
|
Faslpr/Faslpr Fcer1gtm1Tks/Fcer1gtm1Tks
(MRL.Cg-Fcer1gtm1Tks Faslpr)
|
increased kidney cell proliferation
|
J:106188
|
Faslgld/Faslgld
(C3H/HeJ-Faslgld)
|
abnormal T cell proliferation
|
J:8267
|
Fasltm1.1Cgm/Fasltm1.1Cgm
(involves: 129S2/SvPas * C57BL/6 * C57BL/6N)
|
increased B cell proliferation
|
J:168406
|
increased T cell proliferation
|
J:168406
|
Fat4tm1.1Hmc/Fat4tm1.1Hmc
(involves: 129P2/OlaHsd)
|
decreased kidney cell proliferation
|
J:169135
|
Fblim1tm1.1Chen/Fblim1tm1.1Chen
(involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ)
|
decreased cell proliferation
|
J:186501
|
Fbxo4tm1.1Jadi/Fbxo4tm1.1Jadi
(Not Specified)
|
increased fibroblast proliferation
|
J:178645
|
Fbxo22em1Mkt/Fbxo22em1Mkt
(involves: C57BL/6N)
|
decreased fibroblast proliferation
|
J:236274
|
Fbxw11tm2Nakay/Fbxw11tm1Nakay
(B6.Cg-Fbxw11tm2Nakay Fbxw11tm1Nakay)
|
decreased fibroblast proliferation
|
J:228222
|
Fcer1gtm1Rav/Fcer1gtm1Rav Tg(Ins2-TFRC/OVA)296Wehi/0
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased T cell proliferation
|
J:122114
|
Fcer1gtm1Tks/Fcer1gtm1Tks
(involves: C57BL/6)
|
decreased T cell proliferation
|
J:112160
|
Fcer2atm1Putt/Fcer2atm1Putt
(involves: 129S/SvEv * C57BL/6)
|
abnormal B cell proliferation
|
J:69547
|
Fcs1Pohnpei/Fcs1Pohnpei
(involves: C57BL/6J * Pohnpei)
|
increased cell proliferation
|
J:114559
|
Fcs2Pohnpei/Fcs2Pohnpei
(involves: C57BL/6J * Pohnpei)
|
decreased cell proliferation
|
J:114559
|
Fcs3C57BL/6J/Fcs3Pohnpei Fcs4Pohnpei/Fcs4Pohnpei
(involves: C57BL/6J * Pohnpei)
|
increased cell proliferation
|
J:114559
|
Fcs3Pohnpei/Fcs3Pohnpei Fcs4C57BL/6J/Fcs4Pohnpei
(involves: C57BL/6J * Pohnpei)
|
increased cell proliferation
|
J:114559
|
Fcs3Pohnpei/Fcs3Pohnpei Fcs4Pohnpei/Fcs4Pohnpei
(involves: C57BL/6J * Pohnpei)
|
decreased cell proliferation
|
J:114559
|
Fdxrtm1Xch/Fdxr+
(B6.Cg-Fdxrtm1Xch)
|
increased fibroblast proliferation
|
J:244082
|
Fen1tm1Bhsh/Fen1tm1Bhsh
(involves: 129S1/Sv)
|
decreased cell proliferation
|
J:121378
|
Fen1tm2.1Bhsh/Fen1+
(involves: 129S1/Sv)
|
decreased fibroblast proliferation
|
J:218627
|
Fen1tm2.1Bhsh/Fen1tm2.1Bhsh
(involves: 129S1/Sv)
|
decreased fibroblast proliferation
|
J:218627
|
Fen1tm2Klng/Fen1tm2Klng
(involves: 129X1/SvJ * C57BL/6)
|
decreased cell proliferation
|
J:138901
|
Fendrrtm1Bgh/Fendrrtm2Bgh
(involves: 129S6/SvEvTac * C57BL/6)
|
decreased fetal cardiomyocyte proliferation
|
J:191565
|
Ferd3ltm1Yono/Ferd3ltm1Yono
(involves: C57BL/6)
|
abnormal neuronal precursor proliferation
|
J:160534
|
Fermt1tm1Ref/Fermt1tm1Ref
(involves: 129S1/Sv * 129X1/SvJ)
|
decreased keratinocyte proliferation
|
J:142913
|
Fermt2tm1.1Gxo/Fermt2tm1.1Gxo Tg(Prrx1-cre)1Cjt/0
(B6.Cg-Fermt2tm1.1Gxo Tg(Prrx1-cre)1Cjt)
|
decreased chondrocyte proliferation
|
J:224370
|
Fgf4tm1Gol/Fgf4tm1Gol
(involves: C57BL/6J)
|
decreased inner cell mass proliferation
|
J:22275
|
Fgf8tm2Moon/Fgf8tm1Mrc Mesp1tm2(cre)Ysa/Mesp1+
(involves: C57BL/6 * CBA)
|
decreased cell proliferation
|
J:109475
|
Fgf9tm1Dor/Fgf9tm1Dor
(involves: 129S6/SvEvTac * C57BL/6)
|
abnormal mesenchymal cell proliferation involved in lung development
|
J:69852
|
Fgf9tm1Dor/Fgf9tm1Dor
(involves: C57BL/6J)
|
abnormal fetal cardiomyocyte proliferation
|
J:95803
|
Fgf16tm1Nit/Y
(C57BL/6-Fgf16tm1Nit)
|
abnormal fetal cardiomyocyte proliferation
|
J:139637
|
Fgfr1tm1Jpa/Fgfr1tm1Jpa Fgfr2tm1Dor/Fgfr2tm1Dor Tg(Pax3-cre)1Joe/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL)
|
decreased kidney cell proliferation
|
J:107078
|
Fgfr1tm1Upir/Fgfr1tm1.1Upir
(involves: C57BL/6J)
|
abnormal fetal cardiomyocyte proliferation
|
J:95803
|
Fgfr1tm1Upir/Fgfr1tm1Upir Fgfr2tm1Dor/Fgfr2tm1Dor Tg(KRT5-cre)5132Jlj/0
(involves: 129X1/SvJ * C57BL/6 * C57BL/6J * DBA/2J)
|
increased keratinocyte proliferation
|
J:158802,
J:221184
|
Fgfr1tm2.1Cxd/Fgfr1+
(involves: 129S6/SvEvTac * FVB/N)
|
increased osteoblast proliferation
|
J:63959
|
Fgfr2tm1Dor/Fgfr2tm1.1Dor Twist2tm1(cre)Dor/Twist2+
(involves: 129X1/SvJ)
|
decreased cell proliferation
|
J:90391
|
Fgfr2tm1Dsn/Fgfr2tm1Dsn Tg(KRT5-cre)5132Jlj/0
(involves: 129P2/OlaHsd * C57BL/6J * DBA/2J)
|
increased keratinocyte proliferation
|
J:119723
|
Fgfr2tm1Ewj/Fgfr2+ Tg(EIIa-cre)C5379Lmgd/0
(B6.Cg-Fgfr2tm1Ewj Tg(EIIa-cre)C5379Lmgd)
|
increased osteoblast proliferation
|
J:158773
|
Fgfr2tm2Ewj/Fgfr2+ Tg(EIIa-cre)C5379Lmgd/0
(B6.Cg-Fgfr2tm2Ewj Tg(EIIa-cre)C5379Lmgd)
|
increased osteoblast proliferation
|
J:158773
|
Fgfr2tm3.1Lni/Fgfr2tm3.1Lni
(involves: 129S1/Sv * 129X1/SvJ * BALB/c * C57BL/6)
|
abnormal osteoblast proliferation
|
J:77698
|
Fgfr3tm1.1(FGFR3*)Ytc/Fgfr3+
(involves: 129)
|
decreased chondrocyte proliferation
|
J:287271
|
Fgfr3tm1.1(FGFR3*)Ytc/Fgfr3tm1.1(FGFR3*)Ytc
(involves: 129)
|
decreased chondrocyte proliferation
|
J:287271
|
Fgfr3tm1.1Iwa/Fgfr3+
(involves: 129S6/SvEvTac * FVB/N * NIH Black Swiss)
|
abnormal chondrocyte proliferation
|
J:70061
|
Fgfr3tm3.1Cxd/Fgfr3tm3.1Cxd
(involves: 129S6/SvEvTac)
|
decreased chondrocyte proliferation
|
J:69849
|
Fgfr3tm4.1Cxd/Fgfr3+
(involves: 129S6/SvEvTac * NIH Black Swiss)
|
increased chondrocyte proliferation
|
J:63198
|
increased fibroblast proliferation
|
J:63198
|
Fgfrl1tm1True/Fgfrl1tm1True
(B6.129S6-Fgfrl1tm1True)
|
decreased kidney cell proliferation
|
J:153202
|
Fgl2tm1Pam/Fgl2tm1Pam
(B6.129X1-Fgl2tm1Pam)
|
increased T cell proliferation
|
J:130895
|
Filip1lem1Slib/Filip1lem1Slib Tg(CDX2-cre/ERT2)752Erf/0
(involves: C57BL/6J * SJL/J)
|
abnormal enterocyte proliferation
|
J:312351
|
Flcntm1Baba/Flcntm1.1Lss Tg(Cdh16-cre)91Igr/0
(involves: C57BL/6 * FVB/N * ICR * SJL)
|
increased kidney cell proliferation
|
J:130978
|
Flgft/Flgft
(B6.Cg-Flgft)
|
increased splenocyte proliferation
|
J:151110
|
Fli1tm1.1Dkw/Fli1tm1.1Dkw
(B6.129S6-Fli1tm1.1Dkw)
|
decreased B cell proliferation
|
J:137876
|
Flt1tm1.1Fong/Flt1tm1.1Fong Gt(ROSA)26Sortm1(cre/ERT2)Thl/Gt(ROSA)26Sor+
(involves: 129S6/SvEvTac * C57BL/6NCr * CD-1)
|
increased endothelial cell proliferation
|
J:202202
|
Flvcr2tm1.1Tda/Flvcr2tm1.1Tda Tg(Cdh5-cre/ERT2)1Rha/0
(involves: C57BL/6J)
|
decreased endothelial cell proliferation
|
J:287134
|
Flvcr2tm1.2Tda/Flvcr2tm1.2Tda
(involves: C57BL/6J)
|
decreased endothelial cell proliferation
|
J:287134
|
Fmr1tm1Cgr/Fmr1tm1Cgr
(involves: 129P2/OlaHsd)
|
abnormal neuronal precursor proliferation
|
J:159211
|
Fn1tm1Ksek/Fn1tm1Ksek
(involves: 129P2/OlaHsd * 129/Sv)
|
decreased fibroblast proliferation
|
J:93250
|
Fndc3btm1Maim/Fndc3btm1Maim
(B6.129S2-Fndc3btm1Maim)
|
decreased fibroblast proliferation
|
J:163660
|
Fntbtm1.1Bbd/Fntbtm1.1Bbd
(involves: 129S1/Sv * 129X1/SvJ * CD-1)
|
decreased inner cell mass proliferation
|
J:98944
|
Fntbtm1.1Mbrg/Fntbtm1.1Mbrg
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased fibroblast proliferation
|
J:158937
|
Fntbtm1.1Mbrg/Fntbtm1.1Mbrg Tg(KRT14-cre)1Amc/?
(involves: 129P2/OlaHsd * C57BL/6 * CBA)
|
decreased keratinocyte proliferation
|
J:158528
|
Fntbtm1.1Mbrg/Fntbtm1.2Mbrg
(involves: 129P2/OlaHsd * BALB/cJ * C57BL/6 * FVB/N)
|
decreased fibroblast proliferation
|
J:158937
|
Fntbtm1Bbd/Fntbtm1.1Bbd Polr2atm1(cre/ERT2)Bbd/Polr2atm1(cre/ERT2)Bbd
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CD-1 * SJL)
|
decreased cell proliferation
|
J:98944
|
Fntbtm1Bbd/Fntbtm1Bbd Polr2atm1(cre/ERT2)Bbd/Polr2atm1(cre/ERT2)Bbd
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CD-1 * SJL)
|
decreased cell proliferation
|
J:98944
|
Fostm7Wag/Fostm7Wag Tg(Cd4-cre)1Cwi/0
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2)
|
decreased cell proliferation
|
J:190150
|
Foxa3tm1Khk/Foxa3tm1Khk
(B6.129P2-Foxa3tm1Khk)
|
abnormal primordial germ cell proliferation
|
J:134427
|
Foxc1hith/Foxc1hith
(involves: C57BL/6J)
|
abnormal neuron proliferation
|
J:157301
|
Foxc1hith/Foxc1tm1Blh
(involves: 129S6/SvEvTac * C57BL/6J)
|
abnormal neuron proliferation
|
J:157301
|
Foxc1tm1Blh/Foxc1tm1Blh
(involves: 129S6/SvEvTac)
|
abnormal neuron proliferation
|
J:157301
|
Foxd3tm1.1Lby/Foxd3tm1.1Lby
(either: (involves: 129S6/SvEvTac) or (involves: 129S6/SvEvTac * Black Swiss) or (involves: 129S6/SvEvTac * C57BL/6) or (involves: 129S6/SvEvTac * CD-1))
|
abnormal cell proliferation
|
J:79491
|
Foxd3tm1Lby/Foxd3tm1Lby
(either: (involves: 129S6/SvEvTac) or (involves: 129S6/SvEvTac * Black Swiss) or (involves: 129S6/SvEvTac * C57BL/6) or (involves: 129S6/SvEvTac * CD-1))
|
abnormal cell proliferation
|
J:79491
|
decreased embryonic epiblast cell proliferation
|
J:79491
|
Foxd3tm2Lby/Foxd3tm2Lby
(involves: 129S6/SvEvTac)
|
abnormal cell proliferation
|
J:79491
|
Foxf1em1Vvk/Foxf1+
(involves: C57BL/6 * DBA/2)
|
decreased lung endothelial cell proliferation
|
J:296328
|
Foxg1tm1(cre)Skm/Foxg1+ Lrp2tm1Tew/Lrp2tm1Tew
(involves: 129P2/OlaHsd)
|
decreased cell proliferation
|
J:238249
|
Foxg1tm1Chzh/Foxg1tm1Chzh Tg(Fzd9-cre/ERT)1Chzh/0
(involves: C57BL/6 * FVB)
|
abnormal neuronal precursor proliferation
|
J:182692
|
Foxg1tm1M/Foxg1tm1M
(involves: 129S1/Sv)
|
abnormal neuronal precursor proliferation
|
J:78115
|
Foxj3Gt(XL913)Byg/Foxj3Gt(XL913)Byg
(either: 129P2/OlaHsd-Foxj3Gt(XL913)Byg or B6.129P2-Foxj3 |
abnormal skeletal muscle satellite cell proliferation
|
J:157260
|
Foxl2tm1Tre/Foxl2tm1Tre
(involves: 129P2/OlaHsd * Black Swiss * CD-1)
|
decreased granulosa cell proliferation
|
J:87737
|
Foxm1tm1.1Rhc/Foxm1tm1.1Rhc
(involves: 129X1/SvJ * C57BL/6)
|
decreased mesenchymal cell proliferation involved in lung development
|
J:100263
|
Foxm1tm1.1Rhc/Foxm1tm1.1Rhc
(B6.129X1-Foxm1tm1.1Rhc)
|
decreased fetal cardiomyocyte proliferation
|
J:119481
|
Foxm1tm1Rhc/Foxm1tm1Rhc Tg(Pdx1-cre)89.1Dam/0
(involves: 129X1/SvJ * C57BL/6 * CBA)
|
decreased pancreatic beta cell proliferation
|
J:111026
|
Foxo1tm1.1Stlp/Foxo1tm1.1Stlp Tg(Lck-cre)1Cwi/0
(involves: 129S4/SvJae)
|
decreased T cell proliferation
|
J:154205
|
Foxo1tm1Flv/Foxo1tm1Flv Foxp3tm4(YFP/icre)Ayr/Foxp3+
(involves: 129S1/Sv * 129S6/SvEvTac * 129X1/SvJ)
|
increased T cell proliferation
|
J:189962
|
Foxo1tm1Flv/Foxo1tm1Flv Tg(Cd4-cre)1Cwi/?
(involves: 129S6/SvEvTac * C57BL/6 * DBA/2)
|
increased T cell proliferation
|
J:147057
|
Foxo3Gt(XAO26)Byg/Foxo3Gt(XAO26)Byg
(involves: 129P2/OlaHsd)
|
increased T cell proliferation
|
J:93593
|
Foxp1tm1Eem/Foxp1+ Foxp2tm1Bux/Foxp2tm1Bux
(involves: 129X1/SvJ * C57BL/6)
|
decreased mesenchymal cell proliferation involved in lung development
|
J:121421
|
Foxp1tm2.1Eem/Foxp1tm2.1Eem Nkx2-5tm1(cre)Rjs/Nkx2-5+
(involves: 129 * C57BL/6 * SJL)
|
increased fetal cardiomyocyte proliferation
|
J:163662
|
Foxp1tm2.1Eem/Foxp1tm2.1Eem Tg(Tek-cre)1Ywa/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL)
|
abnormal fetal cardiomyocyte proliferation
|
J:163662
|
Foxp3tm3Tch/Y
(C.129X1-Foxp3tm3Tch)
|
increased T cell proliferation
|
J:120636
|
Fpr2tm1.2Jimw/Fpr2tm1.2Jimw
(involves: 129X1/SvJ)
|
abnormal enterocyte proliferation
|
J:197568
|
fpw/fpw
(involves: C3H/HeJ * C57BL/6J)
|
abnormal spermatogonia proliferation
|
J:151726
|
decreased cell proliferation
|
J:151726
|
decreased hepatocyte proliferation
|
J:151726
|
increased cell proliferation
|
J:151726
|
Fshrtm1Saco/Fshrtm1Saco
(involves: 129)
|
abnormal spermatogonia proliferation
|
J:70680
|
Fts/Fts
(involves: C3H * C57BL/6 * SJL)
|
decreased primordial germ cell proliferation
|
J:168037
|
Furintm1Jwmc/Furintm1Jwmc Tg(Gdf9-icre)5092Coo/0
(involves: 129P2/OlaHsd * C57BL/6J * CBA/J)
|
decreased granulosa cell proliferation
|
J:272231
|
Furintm1Jwmc/Furintm1Jwmc Tg(Zp3-cre)3Mrt/0
(involves: 129P2/OlaHsd * C57BL/6J * CBA/J)
|
decreased granulosa cell proliferation
|
J:272231
|
Fxnem8Lutzy/Fxnem8Lutzy
(C57BL/6J-Fxnem8Lutzy)
|
decreased fibroblast proliferation
|
J:299300
|
Fyb1tm1Gak/Fyb1tm1Gak
(involves: 129S1/Sv * 129X1/SvJ)
|
decreased T cell proliferation
|
J:111368,
J:126545
|
Fyntm1Rmp/Fyntm1Rmp
(involves: 129S2/SvPas * C57BL/6)
|
decreased T cell proliferation
|
J:70886
|
Fyntm1Sor/Fyntm1Sor
(either: 129S7/SvEvBrd-Fyntm1Sor or (involves: 129S7/SvEvBrd * C57BL/6J))
|
decreased T cell proliferation
|
J:2242
|
Fyntm1Sor/Fyntm1Sor
(B6.129S7-Fyntm1Sor)
|
abnormal T cell proliferation
|
J:93886
|
Fyntm1Sor/Fyntm1Sor Lcktm1Litt/Lcktm1.1Litt Tnfrsf4tm2(cre)Nik/Tnfrsf4+
(involves: 129S7/SvEvBrd * 129X1/SvJ)
|
decreased T cell proliferation
|
J:152472
|
Fzd9tm1Uta/Fzd9tm1Uta
(involves: 129X1/SvJ)
|
decreased osteoblast proliferation
|
J:169924
|
Fzr1Gt(RRJ067)Byg/Fzr1Gt(RRJ067)Byg
(involves: 129P2/OlaHsd)
|
decreased cell proliferation
|
J:138545
|
Fzr1tm1.1Mama/Fzr1tm1.1Mama
(involves: BALB/cJ * C57BL/6 * SJL)
|
decreased cell proliferation
|
J:137456
|
G3bp1tm1Tazi/G3bp1tm1Tazi
(involves: 129S2/SvPas)
|
decreased cell proliferation
|
J:101358
|
G6pc2tm1.1Pesa/G6pc2tm1.1Pesa
(NOD.129S2-G6pc2tm1.1Pesa)
|
decreased T cell proliferation
|
J:160286
|
Gabpatm1Agro/Gabpatm1Agro
(involves: 129)
|
decreased fibroblast proliferation
|
J:126422
|
Gabpb2Gt(RRJ488)Byg/Gabpb2Gt(RRJ488)Byg
(involves: 129P2/OlaHsd)
|
increased B cell proliferation
|
J:141846
|
Gad1tm1.1Tama/Gad1+ Pcntm239Asp/Pcntm239Asp
(involves: C57BL/6 * C57BL/6J * CBA * FVB/N)
|
abnormal neuronal precursor proliferation
|
J:158418
|
Gadd45atm1Ajf/Gadd45atm1Ajf
(either: (involves: 129P2/OlaHsd * C57BL/6) or (involves: 129X1/SvJ * C57BL/6))
|
increased fibroblast proliferation
|
J:57882
|
increased kidney cell proliferation
|
J:76041
|
increased T cell proliferation
|
J:76041
|
Gadd45atm1Ajf/Gadd45atm1Ajf Gadd45btm1Daa/Gadd45btm1Daa Gadd45gtm1Mhol/Gadd45gtm1Mhol
(either: (involves: 129X1/SvJ) or (involves: 129P2/OlaHsd * 129X1/SvJ))
|
increased cell proliferation
|
J:110650
|
Gadd45btm1Flv/Gadd45btm1Flv
(B6.129S6-Gadd45btm1Flv)
|
increased T cell proliferation
|
J:118837
|
Gadd45gip1tm1Kong/Gadd45gip1tm1Kong
(involves: 129P2/OlaHsd * C57BL/6)
|
absent inner cell mass proliferation
|
J:156583
|
decreased cell proliferation
|
J:156583
|
Gadd45gip1tm2Kong/Gadd45gip1tm2Kong Tg(Ins2-cre)25Mgn/0
(involves: 129P2/OlaHsd * C57BL/6 * DBA)
|
decreased pancreatic beta cell proliferation
|
J:220742
|
Gadd45gip1tm2Kong/Gadd45gip1tm2Kong Tg(Vil1-cre)997Gum/0
(involves: 129P2/OlaHsd * C57BL/6J * SJL)
|
abnormal small intestinal crypt cell proliferation
|
J:156319
|
Gaktm2Legr/Gaktm2Legr Tg(Nes-cre)1Kln/0
(involves: 129S6/SvEvTac * C57BL/6 * SJL)
|
abnormal neuronal precursor proliferation
|
J:180119
|
Galnt1tm1.1Jxm/Galnt1tm1.1Jxm
(B6NHsd.Cg-Galnt1tm1.1Jxm)
|
increased cell proliferation
|
J:242253
|
Gap43tm1Kmr/Gap43tm1Kmr
(B6.129S1-Gap43tm1Kmr)
|
abnormal neuronal precursor proliferation
|
J:126908
|
Gapttm1.1Wz/Gapttm1.1Wz
(Not Specified)
|
increased B cell proliferation
|
J:138146
|
Gas2l3tm1c(EUCOMM)Hmgu/Gas2l3tm1c(EUCOMM)Hmgu Gt(ROSA)26Sortm2(cre/ERT2)Brn/Gt(ROSA)26Sor+
(involves: 129P2/OlaHsd * 129S4/SvJaeSor * C57BL/6N)
|
abnormal fetal cardiomyocyte proliferation
|
J:244087
|
Gas2l3tm1d(EUCOMM)Hmgu/Gas2l3tm1d(EUCOMM)Hmgu
(involves: 129S4/SvJaeSor * C57BL/6J * C57BL/6N)
|
abnormal fetal cardiomyocyte proliferation
|
J:244087
|
Gas6tm1Hiar/Gas6tm1Hiar
(B6.129P2-Gas6tm1Hiar)
|
decreased kidney cell proliferation
|
J:112430
|
Gata4tm1.1Sad/Gata4tm1.1Sad Gata6tm2.1Sad/Gata6tm2.1Sad Tg(Wt1-cre)1Jbeb/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
decreased fetal cardiomyocyte proliferation
|
J:206877
|
Gata4tm1.1Wtp/Gata4tm1.1Wtp Nkx2-5tm1(cre)Rjs/Nkx2-5+
(involves: 129S7/SvEvBrd)
|
abnormal fetal cardiomyocyte proliferation
|
J:99203
|
Gata4tm1.1Wtp/Gata4tm1.1Wtp Tg(Myh6-cre)2182Mds/0
(involves: FVB/N)
|
abnormal fetal cardiomyocyte proliferation
|
J:99203
|
Gata4tm1Eno/Gata4+ Gata6tm1Eno/Gata6+
(involves: 129/Sv * 129S7/SvEvBrd * C57BL/6)
|
abnormal fetal cardiomyocyte proliferation
|
J:111824
|
Gata4tm1Grg/Gata4+
(involves: 129 * C57BL/6)
|
decreased fetal cardiomyocyte proliferation
|
J:185124
|
Gata4tm1Grg/Gata4tm1Grg
(involves: 129 * C57BL/6)
|
decreased fetal cardiomyocyte proliferation
|
J:185124
|
Gata4tm1Jml/Gata4+ Gata5tm1Eem/Gata5tm1Eem
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
decreased fetal cardiomyocyte proliferation
|
J:155855
|
Gata4tm1Wtp/Gata4tm1Wtp
(involves: 129 * C57BL/6)
|
decreased fetal cardiomyocyte proliferation
|
J:94637
|
Gata6tm1Gsv/Gata6tm1Gsv
(either: (involves: 129P2/OlaHsd * C57BL/6) or (involves: 129P2/OlaHsd * FVB))
|
decreased inner cell mass proliferation
|
J:52029
|
Gata6osem3Zfa/Gata6osem3Zfa Gt(ROSA)26Sortm1Sor/Gt(ROSA)26Sor+ Lgr5tm1(cre/ERT2)Cle/Lgr5+
(involves: 129P2/OlaHsd * 129S4/SvJaeSor * C57BL/6)
|
abnormal enterocyte proliferation
|
J:268724
|
Gatmem1Btlr/Gatmem1Btlr
(C57BL/6J-Gatmem1Btlr)
|
abnormal enterocyte proliferation
|
J:252049
|
Gbe1m1Yty/Gbe1m1Yty
(C3HeB/FeJ-Gbe1m1Yty)
|
abnormal fetal cardiomyocyte proliferation
|
J:167233
|
Gcgrem2Smoc/Gcgrem2Smoc
(C57BL/6J-Gcgrem2Smoc)
|
increased pancreatic alpha cell proliferation
|
J:300368
|
Gcgrtm1Jcp/Gcgrtm1Jcp
(DBA/1LacJ-Gcgrtm1Jcp)
|
increased pancreatic beta cell proliferation
|
J:176507
|
Gcgrtm1Mjch/Gcgrtm1Mjch
(involves: 129 * C57BL/6J * SJL)
|
increased pancreatic alpha cell proliferation
|
J:208604
|
Gcgrtm2.1Mjch/Gcgrtm2.1Mjch Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: C57BL/6 * DBA * SJL)
|
increased pancreatic alpha cell proliferation
|
J:208604
|
Gcktm1Ydor/Gck+ Tg(Ins2-cre)25Mgn/0
(involves: C57BL/6 * C57BL/6J * DBA)
|
increased pancreatic beta cell proliferation
|
J:302600
|
Gclctm1Mwl/Gclctm1Mwl
(involves: 129S7/SvEvBrd * C57BL/6)
|
decreased cell proliferation
|
J:62177
|
Gclmtm1Tjka/Gclmtm1Tjka
(B6.129-Gclmtm1Tjka)
|
increased granulosa cell proliferation
|
J:226942
|
Gcm1tm1Jcc/Gcm1+
(involves: 129S1/Sv * 129X1/SvJ * CD-1)
|
increased cell proliferation
|
J:186528
|
Gcn1em2Itohk/Gcn1em2Itohk
(C57BL/6-Gcn1em2Itohk)
|
decreased fibroblast proliferation
|
J:287528
|
Gdnftm1Lmgd/Gdnf+
(B6.129-Gdnftm1Lmgd)
|
increased kidney cell proliferation
|
J:168650
|
Gdpd2tm1.1Soc/Y
(involves: 129/Sv * BALB/cJ * C57BL/6J)
|
increased neuronal precursor proliferation
|
J:291492
|
Gdpd2tm1.1Soc/Gdpd2tm1.1Soc
(involves: 129/Sv * BALB/cJ * C57BL/6J)
|
increased neuronal precursor proliferation
|
J:291492
|
Gdpd5tm1.1Itl/Gdpd5tm1.1Itl
(involves: 129 * C57BL/6J)
|
abnormal neuronal precursor proliferation
|
J:178550
|
Gfertm1(KOMP)Mbp/Gfer+
(involves: C57BL/6J * C57BL/6N)
|
decreased hepatocyte proliferation
|
J:224792
|
Gfertm1.1Crg/Gfertm1.1Crg Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129 * C57BL/6 * DBA)
|
increased hepatocyte proliferation
|
J:227242
|
Gfi1tm1Wep/Gfi1tm1Wep
(B6.129-Gfi1tm1Wep)
|
abnormal T cell proliferation
|
J:117105
|
Gfi1tm1Wep/Gfi1tm1Wep Tg(Cd4-cre)1Cwi/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA/2)
|
abnormal T cell proliferation
|
J:117105
|
Gfra1tm1Jmi/Gfra1tm2Jmi Tg(CAG-cre/Esr1*)5Amc/0
(involves: 129/Sv * C57BL/6 * CBA * SJL)
|
abnormal neuronal precursor proliferation
|
J:122607
|
Gfra3tm1Adav/Gfra3tm1Adav
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CD-1)
|
abnormal neuronal precursor proliferation
|
J:71959
|
Ggctem1.2Smoc/Ggctem1.2Smoc
(involves: C57BL/6J)
|
decreased fibroblast proliferation
|
J:317466
|
Ggctem1.2Smoc/Ggctem1.2Smoc Krastm4Tyj/Kras+
(involves: 129S4/SvJae * C57BL/6J)
|
decreased fibroblast proliferation
|
J:317466
|
Ghrtm1.1Dlr/Ghrtm1.1Dlr Tg(Ins2-cre)23Herr/0
(involves: 129S4/SvJae * C57BL/6J * CBA/J)
|
decreased pancreatic beta cell proliferation
|
J:284574
|
Ghrtm1.1Dlr/Ghrtm1.1Dlr Tg(Ins2-cre)25Mgn/0
(involves: 129S4/SvJae * C3H * C57BL/6 * DBA)
|
decreased pancreatic beta cell proliferation
|
J:173909
|
Gimap5m1Btlr/Gimap5m1Btlr
(involves: C57BL/6J)
|
abnormal B cell proliferation
|
J:160090
|
decreased B cell proliferation
|
J:160090
|
Gins1tm1Ntak/Gins1tm1Ntak
(involves: 129P2/OlaHsd * C57BL/6J)
|
absent inner cell mass proliferation
|
J:119867
|
Gins4tm1Ntak/Gins4tm1Ntak
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased inner cell mass proliferation
|
J:209708
|
Gipc1Gt(OST93079)Lex/Gipc1Gt(OST93079)Lex
(B6.129S-Gipc1Gt(OST93079)Lex)
|
decreased cell proliferation
|
J:122652
|
increased cell proliferation
|
J:122652
|
Git1tm1Bcb/Git1tm1Bcb
(involves: 129 * C57BL/6)
|
decreased vascular endothelial cell proliferation
|
J:158935
|
Gja1M1Jrt/Gja1+
(involves: C3H/HeJ * C57BL/6J)
|
decreased granulosa cell proliferation
|
J:146211
|
Gja1tm3.1Clo/Gja1tm3.1Clo
(B6.Cg-Gja1tm1.1Clo)
|
abnormal vascular smooth muscle cell proliferation
|
J:212895
|
Gjb2tm2.2Kwi/Gjb2+ Tg(Pgk1-cre)1Lni/0
(involves: 129/Sv * 129P2/OlaHsd * BALB/c * C57BL/6)
|
increased keratinocyte proliferation
|
J:166732
|
Gli1tm1Alj/Gli1tm1Alj Tg(Shh)#Dje/0
(involves: 129S1/Sv * 129X1/SvJ * Swiss Webster)
|
abnormal cell proliferation
|
J:94461
|
Gli1tm2Alj/Gli1+ Gli2tm1Alj/Gli2tm1Alj Gli3Xt/Gli3Xt
(involves: 101/H * 129S1/Sv * 129S6/SvEvTac * 129X1/SvJ * C3H/HeH * C57BL * CBA/H * Swiss Webster)
|
abnormal neuronal precursor proliferation
|
J:87948
|
Gli2tm1Alj/Gli2tm1Alj
(involves: 129S1/Sv * 129X1/SvJ * CD-1)
|
decreased mesenchymal cell proliferation involved in lung development
|
J:49603
|
Glrx3Gt(RRF094)Byg/Glrx3Gt(RRF094)Byg
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased fibroblast proliferation
|
J:190794
|
Glrxtm3Ysh/Glrxtm3Ysh
(involves: 129S1/Sv * 129X1/SvJ)
|
decreased cell proliferation
|
J:141903
|
Gmnntm1.1Kio/Gmnntm1.2Kio Tg(CD2-icre)4Kio/0
(involves: 129S4/SvJae * C57BL/10 * CBA/Ca)
|
decreased T cell proliferation
|
J:159657
|
Gmnntm1Nyma/Gmnntm1Nyma
(involves: C57BL/6)
|
decreased cell proliferation
|
J:123394
|
Gmnntm1Tjm/Gmnntm1Tjm Tg(Mx1-cre)1Cgn/0
(involves: 129/Sv * C57BL/6 * C57BL/6J * CBA)
|
decreased hematopoietic stem cell proliferation
|
J:171741
|
Gna12tm1Citb/Gna12tm1Citb Gna13tm2.1Soff/Gna13tm2.1Soff Tg(Lck-cre)548Jxm/0
(involves: 129S1/Sv * C57BL/6 * CBA)
|
increased T cell proliferation
|
J:149560
|
Gnai2tm1Lbi/Gnai2tm1Lbi
(involves: 129S7/SvEvBrd)
|
increased T cell proliferation
|
J:30507
|
Gnb1Gt(prvSStrap)4B8Yiw/Gnb1Gt(prvSStrap)4B8Yiw
(involves: 129P2/OlaHsd * C57BL/6J)
|
abnormal neuronal precursor proliferation
|
J:157907
|
decreased cell proliferation
|
J:157907
|
Gng5tm1.1Rbs/Gng5tm1.1Rbs
(B6J.Cg-Gng5tm1.1Rbs)
|
decreased fetal cardiomyocyte proliferation
|
J:215128
|
Gnl3Gt(S4-4B1)Sor/Gnl3Gt(S4-4B1)Sor
(involves: 129S4/SvJaeSor * C57BL/6)
|
decreased cell proliferation
|
J:185271
|
Gnl3Gt(W223E05)Wrst/Gnl3+
(Not Specified)
|
decreased cell proliferation
|
J:118144
|
Gnl3Gt(W223E05)Wrst/Gnl3Gt(W223E05)Wrst
(Not Specified)
|
decreased cell proliferation
|
J:118144
|
Gnl3Gt(W223E05)Wrst/Gnl3Gt(W223E05)Wrst Trp53tm1Tyj/Trp53tm5Tyj
(involves: 129S2/SvPas * 129S4/SvJae)
|
decreased cell proliferation
|
J:118144
|
Gnl3tm1Rylt/Gnl3+
(involves: 129X1/SvJ * C57BL/6)
|
decreased fibroblast proliferation
|
J:117592
|
Gnl3tm2.1Rylt/Gnl3tm2.1Rylt Tg(CAG-cre/Esr1*)5Amc/0
(involves: 129 * 129S2/SvPas * C57BL/6 * CBA)
|
decreased fibroblast proliferation
|
J:198698
|
Gnl3tm2.1Rylt/Gnl3tm2.1Rylt Trp53tm1Tyj/Trp53tm1Tyj Tg(CAG-cre/Esr1*)5Amc/0
(involves: 129 * 129S2/SvPas * C57BL/6 * CBA)
|
decreased fibroblast proliferation
|
J:198698
|
Gnpnat1tm1Mak/Gnpnat1tm1Mak
(either: (involves: C57BL/6J) or (involves: CD-1))
|
decreased cell proliferation
|
J:111395
|
Gpc6tm1Lex/Gpc6tm1Lex
(B6N.129S5(B6)-Gpc6tm1Lex/Mmucd)
|
decreased chondrocyte proliferation
|
J:245694
|
Gpr37l1tm1.2Gtva/Gpr37l1tm1.2Gtva
(involves: 129S/SvEv * BALB/c * C57BL/6J)
|
abnormal neuronal precursor proliferation
|
J:201190
|
Gpr37l1tm1.2Gtva/Gpr37l1tm1.2Gtva Ptch1tm1Zim/Ptch1+
(STOCK Gpr37l1tm1.2Gtva Ptch1tm1Zim/Cnrm)
|
decreased cerebellar granule cell precursor proliferation
|
J:272049
|
Gpr132tm1Witt/Gpr132tm1Witt
(involves: 129X1/SvJ * BALB/c)
|
increased B cell proliferation
|
J:69473
|
increased T cell proliferation
|
J:69473
|
Gpr161tm1.2Smuk/Gpr161tm1.2Smuk H2az2Tg(Wnt1-cre)11Rth/H2az2+
(involves: C57BL/6J * CBA/J)
|
increased neuronal precursor proliferation
|
J:316181
|
Gpr174tm1Cys/Y
(B6.129-Gpr174tm1Cys)
|
increased T cell proliferation
|
J:222307
|
Gpr183tm1.2Rbr/Gpr183tm1.2Rbr Ightm1Rbr/Ightm1Rbr Tg(IgkHyHEL10)1Rbr/0
(involves: C57BL/6 * FVB/N * SJL)
|
abnormal B cell proliferation
|
J:151883
|
Gpx1tm1Kola/Gpx1tm1Kola
(involves: 129S2/SvPas * CF-1)
|
decreased cell proliferation
|
J:87985
|
Graptm1Gsf/Graptm1Gsf
(B6.129-Graptm1Gsf)
|
increased T cell proliferation
|
J:76243
|
Grb2tm1Lnit/Grb2tm1Lnit Cd79atm1(cre)Reth/Cd79a+
(involves: BALB/c * BALB/cJ)
|
increased B cell proliferation
|
J:171222
|
Grb2tm1Paw/Grb2tm1Paw
(involves: 129S1/Sv * 129X1/SvJ)
|
absent inner cell mass proliferation
|
J:51424
|
Grb10tm1.1Fliu/Grb10tm1.1Fliu Tg(Pdx1-cre)6Tuv/0
(involves: 129S/SvEv * C57BL/6 * FVB/N)
|
increased pancreatic beta cell proliferation
|
J:208498
|
Grhl3tm1Bogi/Grhl3tm1Bogi
(involves: C57BL/6J)
|
increased keratinocyte proliferation
|
J:114626
|
Grhl3tm1Jane/Grhl3tm1Jane
(involves: 129S1/Sv)
|
increased keratinocyte proliferation
|
J:178952
|
Grm1Tg(p18A4.B)1352Szc/0
(Not Specified)
|
abnormal melanocyte proliferation
|
J:32786
|
Gsk3btm1Jrw/Gsk3b+ Irs2tm1Mfw/Irs2tm1Mfw
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
increased pancreatic beta cell proliferation
|
J:135659
|
Gt(ROSA)26Sortm1(Bcor*A)Vjba/Gt(ROSA)26Sortm1(Bcor*A)Vjba
(involves: 129S1/Sv)
|
decreased cell proliferation
|
J:231455
|
Gt(ROSA)26Sortm1(Bmi1)Aiwa/Gt(ROSA)26Sor+ Tg(Tek-cre)1Ywa/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL)
|
increased hematopoietic stem cell proliferation
|
J:198331
|
Gt(ROSA)26Sortm1(CAG-Bcl3,-EGFP)Hoev/Gt(ROSA)26Sor+ Cd19tm1(cre)Cgn/Cd19+
(involves: 129P2/OlaHsd)
|
decreased B cell proliferation
|
J:208980
|
Gt(ROSA)26Sortm1(CAG-Bgeo,-Insc/GFP)Jakn/Gt(ROSA)26Sortm1(CAG-Bgeo,-Insc/GFP)Jakn Tg(Nes-cre)1Wmz/0
(involves: C57BL/6)
|
abnormal neuronal precursor proliferation
|
J:178712
|
Gt(ROSA)26Sortm1(CAG-Wnt5a,-AcGFP)Skde/Gt(ROSA)26Sor+ Pgrtm2(cre)Lyd/Pgr+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal trophoblast giant cell proliferation
|
J:233595
|
Gt(ROSA)26Sortm1(CARD14*)Ribt/Gt(ROSA)26Sor+ Tg(KRT14-cre/ERT)20Efu/0
(involves: 129S6/SvEvTac * C57BL/6NCrl * CD-1)
|
increased keratinocyte proliferation
|
J:292094
|
Gt(ROSA)26Sortm1(cre/ERT2)Thl/Gt(ROSA)26Sor+ Kat8tm1Thl/Kat8+
(involves: 129S1/Sv)
|
decreased fibroblast proliferation
|
J:128936
|
Gt(ROSA)26Sortm1(cre/ERT2)Thl/Gt(ROSA)26Sor+ Kat8tm1Thl/Kat8tm1Thl
(involves: 129S1/Sv)
|
decreased fibroblast proliferation
|
J:128936
|
Gt(ROSA)26Sortm1(cre/ERT)Brn/Gt(ROSA)26Sor+ Lin9tm1.1Sgau/Lin9tm1.1Sgau
(involves: 129P2/OlaHsd * 129S6/SvEvTac * C57BL/6 * SJL)
|
abnormal small intestinal crypt cell proliferation
|
J:162678
|
decreased fibroblast proliferation
|
J:162678
|
Gt(ROSA)26Sortm1(cre/ERT)Brn/Gt(ROSA)26Sor+ Ppp1r13ltm1Xlu/Ppp1r13ltm1Xlu
(involves: 129P2/OlaHsd * 129S/SvEv * C57BL/6J)
|
decreased fibroblast proliferation
|
J:177360
|
Gt(ROSA)26Sortm1(DTA)Vlcg/Gt(ROSA)26Sortm1(DTA)Vlcg Tg(BGLAP-cre/ERT2)#Stko/0
(involves: 129S1/Sv * FVB/N)
|
decreased pancreatic beta cell proliferation
|
J:201507
|
Gt(ROSA)26Sortm1(ETV6/SYK)Hjum/Gt(ROSA)26Sor+ Cd79atm3(cre/ERT2)Reth/Cd79a+
(involves: 129S6/SvEvTac * BALB/c)
|
increased B cell proliferation
|
J:208904
|
Gt(ROSA)26Sortm1(EYFP)Cos/Gt(ROSA)26Sor+ Plcg1tm1Gcrp/Plcg1tm1Rwen Tg(Cd4-cre)1Cwi/0
(involves: 129X1/SvJ * C57BL/6 * DBA/2)
|
decreased T cell proliferation
|
J:157757
|
Gt(ROSA)26Sortm1(EYFP)Cos/Gt(ROSA)26Sor+ Cd19tm1(cre)Cgn/Cd19+ Rev3ltm1.1Diaz/Rev3ltm1.1Diaz
(involves: 129P2/OlaHsd * 129X1/SvJ * BALB/c * C57BL/6 * C57BL/6NTac)
|
decreased B cell proliferation
|
J:188723
|
Gt(ROSA)26Sortm1(Gck)Ydor/Gt(ROSA)26Sor+ Tg(Pdx1-cre/Esr1*)#Dam/0
(involves: C57BL/6 * CBA)
|
decreased pancreatic beta cell proliferation
|
J:210493
|
Gt(ROSA)26Sortm1(GNAQ*)Cvrk/Gt(ROSA)26Sor+ Tg(Mitf-cre)7114Gsb/0
(C3FeJ.Cg-Gt(ROSA)26Sortm1(GNAQ*)Cvkr Tg(Mitf-cre)7114Gsb/Cvrk)
|
abnormal melanocyte proliferation
|
J:225597
|
Gt(ROSA)26Sortm1(GNAQ*)Cvrk/Gt(ROSA)26Sortm14(CAG-tdTomato)Hze Tg(Mitf-cre)7114Gsb/0
(C3FeJ.Cg-Gt(ROSA)26Sortm1(GNAQ*)Cvrk/Gt(ROSA)26Sortm14(CAG-tdTomato)Hze Tg(Mitf-cre)7114Gsb/Cvrk)
|
abnormal melanocyte proliferation
|
J:312561
|
Gt(ROSA)26Sortm1(Grem1)Svok/Gt(ROSA)26Sor+ Tg(Prrx1-cre)1Cjt/0
(involves: 129S1/Sv * C57BL/6J * SJL/J)
|
increased cell proliferation
|
J:214075
|
Gt(ROSA)26Sortm1(HBEGF)Awai/Gt(ROSA)26Sor+ Tg(Krt1-15-cre/PGR*)22Cot/0
(involves: C57BL/6J * SJL/J)
|
increased cell proliferation
|
J:244536
|
Gt(ROSA)26Sortm1(ITK/SYK)Jrld/Gt(ROSA)26Sor+ Tg(Cd4-cre)1Cwi/0
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2)
|
increased T cell proliferation
|
J:160931
|
Gt(ROSA)26Sortm1(Smo/EYFP)Amc/Gt(ROSA)26Sor+ Hk2tm1.1Uku/Hk2tm1.1Uku Tg(GFAP-cre)25Mes/0
(involves: 129P2/OlaHsd * 129X1/SvJ * C57BL/6 * FVB/N)
|
abnormal neuronal precursor proliferation
|
J:210113
|
Gt(ROSA)26Sortm1(Wnt4)Bhr/Gt(ROSA)26Sor+ Tg(Col2a1-cre)1Bhr/0
(involves: 129S7/SvEvBrd * C57BL/6 * SJL)
|
decreased chondrocyte proliferation
|
J:129327
|
Gt(ROSA)26Sortm1.1(CAG-Mirc20)Eem/Gt(ROSA)26Sor+ Nkx2-5tm1(cre)Rjs/Nkx2-5+
(involves: 129S7/SvEvBrd * C57BL/6)
|
increased fetal cardiomyocyte proliferation
|
J:233994
|
Gt(ROSA)26Sortm1.1(MYC/ERT2)Gev/Gt(ROSA)26Sortm1.1(MYC/ERT2)Gev
(involves: C57BL/6 * FVB/N)
|
increased cell proliferation
|
J:142030
|
Gt(ROSA)26Sortm1.1(Ubc-BCL3)Sbn/Gt(ROSA)26Sor+ Cd79atm1(cre)Reth/Cd79a+
(involves: BALB/c * C57BL/6)
|
decreased B cell proliferation
|
J:207111
|
Gt(ROSA)26Sortm1Sor/Gt(ROSA)26Sor+ Tg(Nphs1-cre)33Mska/0 Tg(Nphs1-IL2RA)18Mska/0
(involves: 129S4/SvJaeSor * C57BL/6 * C57BL/6N * DBA/2)
|
increased kidney cell proliferation
|
J:126591
|
Gt(ROSA)26Sortm2(CAG-Dsred2/EGFP)Luo/Gt(ROSA)26Sortm1(Notch3*)Sfr Notch3tm1.1(cre/ERT2)Sat/Notch3+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6NTac)
|
decreased mammary gland epithelial cell proliferation
|
J:201985
|
Gt(ROSA)26Sortm2(CAG-Notch2*)Uzs/Gt(ROSA)26Sor+ Cd19tm1(cre)Cgn/Cd19+
(involves: 129P2/OlaHsd * 129S6/SvEvTac * C57BL/6J)
|
increased B cell proliferation
|
J:179036
|
Gt(ROSA)26Sortm2(H1/tetO-RNAi:Kdm1a)Arte/Gt(ROSA)26Sor+
(involves: C57BL/6)
|
increased hematopoietic stem cell proliferation
|
J:192055
|
Gt(ROSA)26Sortm2(Lmp1/CD40)Uzs/Gt(ROSA)26Sor+ Cd19tm1(cre)Cgn/Cd19+
(involves: 129P2/OlaHsd * BALB/c * C57BL/6)
|
increased B cell proliferation
|
J:137122
|
Gt(ROSA)26Sortm2(Rnf187)Jhai/Gt(ROSA)26Sor+ Krastm4Tyj/Kras+ Tg(Vil1-cre)20Syr/0
(involves: 129S4/SvJae * 129S6/SvEvTac * C57BL/6 * DBA/2)
|
abnormal enterocyte proliferation
|
J:173145
|
Gt(ROSA)26Sortm2.1(MYC/ERT)Hsc/Gt(ROSA)26Sor+
(involves: 129P2/OlaHsd * 129S4/SvJaeSor)
|
increased cell proliferation
|
J:89756
|
Gt(ROSA)26Sortm2Bet/Gt(ROSA)26Sortm2Bet Speer6-ps1Tg(Alb-cre)21Mgn/?
(involves: BALB/c * C57BL/6 * DBA)
|
increased hepatocyte proliferation
|
J:174261
|
Gt(ROSA)26Sortm2Sho/Gt(ROSA)26Sor+ Sp8tm1Smb/Sp8tm1Smb H2az2Tg(Wnt1-cre)11Rth/H2az2+
(involves: 129S1/Sv * 129S4/SvJaeSor * 129X1/SvJ * C57BL/6J * CBA/J)
|
decreased cranial neural crest cell proliferation
|
J:200761
|
Gt(ROSA)26Sortm3(CAG-MIR17-92,-EGFP)Rsky/Gt(ROSA)26Sortm3(CAG-MIR17-92,-EGFP)Rsky Tg(CD2-icre)4Kio/0
(involves: C57BL/6 * C57BL/10 * CBA/Ca)
|
increased B cell proliferation
|
J:133215
|
Gt(ROSA)26Sortm3(HIF1A*)Kael/Gt(ROSA)26Sortm4(HIF2A*)Kael Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S6/SvEvTac * BALB/c * C57BL/6 * DBA)
|
increased hepatocyte proliferation
|
J:144666
|
Gt(ROSA)26Sortm4(ACTB-tdTomato,-EGFP)Luo/Gt(ROSA)26Sor+ H2az2Tg(Wnt1-cre)11Rth/H2az2+ Srsf3tm1Pjln/Srsf3tm1Pjln
(involves: 129S1/Sv * 129X1/SvJ * BALB/c * C57BL/6J * CBA/J)
|
decreased cranial neural crest cell proliferation
|
J:308882
|
Gt(ROSA)26Sortm4(ACTB-tdTomato,-EGFP)Luo/Gt(ROSA)26Sor+ Pfkfb3tm1Pec/Pfkfb3tm1Pec Tg(Cdh5-cre/ERT2)1Rha/0
(involves: 129S1/Sv * 129X1/SvJ)
|
decreased endothelial cell proliferation
|
J:200070
|
Gt(ROSA)26Sortm4(ACTB-tdTomato,-EGFP)Luo/Gt(ROSA)26Sor+ Pfkfb3tm1Pec/Pfkfb3tm1Pec Tg(Pdgfb-icre/ERT2,-EGFP)1Frut/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA)
|
decreased endothelial cell proliferation
|
J:200070
|
Gt(ROSA)26Sortm4(H1/tetO-RNAi:Ezh2)Arte/Gt(ROSA)26Sor+
(C57BL/6-Gt(ROSA)26Sortm4(H1/tetO-RNAi:Ezh2)Arte)
|
decreased mammary gland epithelial cell proliferation
|
J:202724
|
Gt(ROSA)26Sortm4(HIF2A*)Kael/Gt(ROSA)26Sor+ Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S6/SvEvTac * BALB/c * C57BL/6 * DBA)
|
increased hepatocyte proliferation
|
J:144666
|
Gt(ROSA)26Sortm4(HIF2A*)Kael/Gt(ROSA)26Sor+ Tg(KRT14-cre)1Ipc/0
(involves: 129S6/SvEvTac * BALB/c * C57BL/6 * SJL)
|
increased keratinocyte proliferation
|
J:144666
|
Gt(ROSA)26Sortm5(H1/tetO-RNAi:Ezh2)Arte/Gt(ROSA)26Sor+
(C57BL/6-Gt(ROSA)26Sortm5(H1/tetO-RNAi:Ezh2)Arte)
|
decreased mammary gland epithelial cell proliferation
|
J:202724
|
Gt(ROSA)26Sortm7(Pik3ca*,EGFP)Rsky/Gt(ROSA)26Sor+ Tg(CAG-cre/Esr1*)5Amc/0
(B6.Cg-Gt(ROSA)26Sortm7(Pik3ca*,EGFP)Rsky Tg(CAG-cre/Esr1*)5Amc)
|
increased cell proliferation
|
J:264410
|
Gt(ROSA)26Sortm9(cre/ESR1)Arte/Gt(ROSA)26Sor+ Map3k14tm1.1Gne/Map3k14tm1.1Gne
(B6(Cg)-Map3k14tm1.1Gne Gt(ROSA)26Sortm9(cre/ESR1)Arte)
|
decreased B cell proliferation
|
J:240453
|
Gt(ROSA)26Sortm9(cre/ESR1)Arte/Gt(ROSA)26Sor+ Pkn2tm1c(KOMP)Wtsi/Pkn2tm1c(KOMP)Wtsi
(involves: C57BL/6N * C57BL/6NTac)
|
decreased fibroblast proliferation
|
J:229595
|
Gt(ROSA)26Sortm10(Lmp1)Rsky/Gt(ROSA)26Sor+
(involves: BALB/cJ)
|
increased B cell proliferation
|
J:181546
|
Gt(ROSA)26Sortm10(Lmp1)Rsky/Gt(ROSA)26Sor+ Cd19tm1(cre)Cgn/Cd19+
(involves: 129P2/OlaHsd * BALB/cJ)
|
increased B cell proliferation
|
J:181546
|
Gt(ROSA)26Sortm11(Lmp1)Rsky/Gt(ROSA)26Sor+
(involves: C57BL/6)
|
increased B cell proliferation
|
J:181546
|
Gt(ROSA)26Sortm11(Lmp1)Rsky/Gt(ROSA)26Sor+ Cd19tm1(cre)Cgn/Cd19+
(involves: 129P2/OlaHsd * C57BL/6)
|
increased B cell proliferation
|
J:181546
|
Gtf2itm1Vcam/Gtf2itm1Vcam
(involves: 129S1/Sv * 129X1/SvJ * CD-1)
|
decreased embryonic epiblast cell proliferation
|
J:204278
|
Guca2atm1.1Mcoh/Guca2atm1.1Mcoh
(involves: 129P2/OlaHsd * BALB/c)
|
abnormal enterocyte proliferation
|
J:80545
|
Gys1Gt(OST33395)Lex/Gys1Gt(OST33395)Lex
(involves: 129S5/SvEvBrd * 129X1/SvJ * C57BL/6J)
|
abnormal fetal cardiomyocyte proliferation
|
J:92245
|
H2-Ab1b-tm1Doi/H2-Ab1b-tm1Doi
(involves: 129S2/SvPas)
|
abnormal neuron proliferation
|
J:170591
|
H2-DMatm2Liz/H2-DMatm2Liz
(involves: C57BL/6 * C57BL/10 * C57BR * CBA)
|
decreased T cell proliferation
|
J:111565
|
H2b/H2b Nfkbidtm1Clay/Nfkbidtm1Clay Rag2tm1Fwa/Rag2tm1Fwa Tg(TcraN15,TcrbN15)L2Elre/?
(involves: 129S/SvEv * 129S6/SvEvTac * C57BL/6)
|
decreased T cell proliferation
|
J:132071
|
H2b/H2b Rag2tm1Fwa/Rag2tm1Fwa Tg(TcraN15,TcrbN15)L2Elre/?
(involves: 129S/SvEv * C57BL/6)
|
increased T cell proliferation
|
J:133112
|
H2axtm1Nus/H2axtm1Nus
(Not Specified)
|
decreased cell proliferation
|
J:76360,
J:149487
|
decreased vascular endothelial cell proliferation
|
J:194603
|
Hand1tm1(tTA)Prri/Hand1+ Tg(tetO-Hand1)1Prri/0
(involves: 129/Sv * C57BL/6)
|
abnormal fetal cardiomyocyte proliferation
|
J:116090
|
Hand1tm2(Hand1)Abfi/Hand1tm2(Hand1)Abfi
(Not Specified)
|
decreased cell proliferation
|
J:164028
|
Hand1tm2.1(Hand1)Abfi/Hand1tm2.1(Hand1)Abfi
(Not Specified)
|
decreased cell proliferation
|
J:164028
|
Hand2tm1Cse/Hand2+ H2az2Tg(Wnt1-cre)11Rth/H2az2+
(involves: 129S1/Sv * C57BL/6J * CBA/J)
|
abnormal fetal cardiomyocyte proliferation
|
J:155265
|
Hap1tm2Xjl/Hap1tm2Xjl Tg(CAG-cre/Esr1*)5Amc/0
(involves: 129 * C57BL/6 * CBA)
|
abnormal neuron proliferation
|
J:224698
|
Hap1tm2Xjl/Hap1tm2Xjl Tg(Camk2a-cre)159Kln/0
(involves: 129S6/SvEvTac * BALB/c * C57BL/6)
|
abnormal neuron proliferation
|
J:224698
|
Hapstr1tm1.1Menm/Hapstr1tm1.2Menm Edil3Tg(Sox2-cre)1Amc/Edil3+
(involves: C57BL/6 * C57BL/6J * CBA)
|
decreased fibroblast proliferation
|
J:348964
|
Hat1tm1.1Mrpa/Hat1tm1.1Mrpa
(involves: C57BL/6J)
|
decreased fibroblast proliferation
|
J:199077
|
Hat1tm1.1Mrpa/Hat1tm1.1Mrpa
(B6.Cg-Hat1tm1.1Mrpa)
|
decreased fibroblast proliferation
|
J:296531
|
Havcr2tm1Bmed/Havcr2tm1Bmed
(B6.Cg-Havcr2tm1Bmed)
|
decreased T cell proliferation
|
J:189839
|
Hbs1ltm1c(KOMP)Wtsi/Hbs1ltm1c(KOMP)Wtsi En1tm2(cre)Wrst/En1+
(involves: 129S1/Sv * 129S4/SvJaeSor * 129X1/SvJ * C57BL/6NTac)
|
increased neuronal precursor proliferation
|
J:306384
|
Hccstm1Tcc/Y Nkx2-5tm2(cre)Rph/Nkx2-5+
(involves: 129S1/Sv)
|
decreased fetal cardiomyocyte proliferation
|
J:143285
|
Hccstm1Tcc/Hccs+ Nkx2-5tm2(cre)Rph/Nkx2-5+ Tg(CAG-EGFP)D4Nagy/0 Tg(Hmgcr-lacZ)H253Sest/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA/2)
|
abnormal fetal cardiomyocyte proliferation
|
J:143285
|
Hcfc1tm1Lwh/Hcfc1+ Edil3Tg(Sox2-cre)1Amc/Edil3+
(involves: C57BL/6 * CBA)
|
decreased cell proliferation
|
J:231596
|
Hcfc1tm1Lwh/Hcfc1tm1Lwh Edil3Tg(Sox2-cre)1Amc/Edil3+
(involves: C57BL/6 * CBA)
|
decreased cell proliferation
|
J:231596
|
Hcls1tm1Wtn/Hcls1tm1Wtn
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased T cell proliferation
|
J:28146
|
Hcls1tm2Wtn/Hcls1tm2Wtn
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased T cell proliferation
|
J:28146
|
Hdac1tm1.1Mrl/Hdac1tm1.1Mrl Hdac2tm1.1Rdp/Hdac2tm1.1Rdp Gt(ROSA)26Sortm2(cre/ERT2)Brn/Gt(ROSA)26Sor+
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6)
|
decreased fibroblast proliferation
|
J:197818
|
Hdac1tm1.1Pmt/Hdac1tm1.1Pmt
(involves: 129P2/OlaHsd * C57BL/6 * FVB/N)
|
decreased cell proliferation
|
J:157903
|
Hdac1tm1.1Pmt/Hdac1tm1.1Pmt Hdac2tm1.1Pmt/Hdac2tm1.1Pmt Tg(Fcer2a-cre)5Mbu/0
(involves: 129P2/OlaHsd * C57BL/6 * CBA * FVB/N)
|
decreased B cell proliferation
|
J:157903
|
Hdac1tm1.1Shmc/Hdac1tm1.1Shmc Hdac2tm1.1Shmc/Hdac2tm1.1Shmc Tg(Lck-cre)1Cwi/0
(involves: 129S7/SvEvBrd)
|
increased T cell proliferation
|
J:194769
|
Hdac2Gt(W035F03)Joe/Hdac2Gt(W035F03)Joe
(Not Specified)
|
increased fetal cardiomyocyte proliferation
|
J:121697
|
Hdac2tm1.2Eno/Hdac2tm1.2Eno
(involves: 129S/SvEv * C57BL/6 * CD-1)
|
abnormal fetal cardiomyocyte proliferation
|
J:123173
|
Hdac3tm1Swh/Hdac3tm1.1Swh
(involves: 129S6/SvEvTac * FVB/N)
|
decreased cell proliferation
|
J:134665
|
Hdac3tm1Swh/Hdac3tm1.1Swh Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S6/SvEvTac * C57BL/6 * DBA)
|
increased hepatocyte proliferation
|
J:134288
|
Hdgfl2tm1Lex/Hdgfl2tm1Lex
(involves: 129S5/SvEvBrd * C57BL/6J)
|
decreased fibroblast proliferation
|
J:171883
|
Hecw2tm1.1Fhe/Hecw2tm1.1Fhe
(involves: C57BL/6J)
|
decreased neuronal precursor proliferation
|
J:306367
|
Hellstm1Rarc/Hellstm1Rarc
(involves: 129X1/SvJ * C57BL/6J)
|
decreased cell proliferation
|
J:107145
|
Hey1tm1Kkb/Hey1tm1Kkb Heyltm1Kkb/Heyltm1Kkb
(B6.Cg-Hey1tm1Kkb Heyltm1Kkb)
|
abnormal skeletal muscle satellite cell proliferation
|
J:178310
|
Hgftm1Jmw/Hgftm1Jmw
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
decreased hepatocyte proliferation
|
J:97145
|
Hgftm1Jmw/Hgftm1Jmw Rag2tm1Fwa/Rag2tm1Fwa
(involves: 129S/SvEv * 129S1/Sv * 129X1/SvJ * C57BL/6)
|
decreased hepatocyte proliferation
|
J:97145
|
Hgftm1Jmw/Hgftm1Jmw Tg(Mx1-cre)29-4Her/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * SJL)
|
decreased hepatocyte proliferation
|
J:97145
|
Hhiptm1Amc/Hhiptm1Amc
(involves: 129S1/Sv * 129X1/SvJ)
|
decreased pancreatic beta cell proliferation
|
J:85472
|
Hhipl1tm1a(KOMP)Wtsi/Hhipl1tm1a(KOMP)Wtsi
(B6J.B6N-Hhipl1tm1a(KOMP)Wtsi)
|
decreased vascular smooth muscle cell proliferation
|
J:280707
|
Hif1atm1Rsjo/Hif1atm1Rsjo Hif1antm1.2Rsjo/Hif1antm1.2Rsjo
(involves: 129S1/Sv * 129X1/SvJ)
|
decreased cell proliferation
|
J:160941
|
Hif1atm3Rsjo/Hif1atm3Rsjo
(involves: 129S1/Sv * 129X1/SvJ)
|
decreased cell proliferation
|
J:116762
|
decreased hepatocyte proliferation
|
J:152724
|
Hif1atm3Rsjo/Hif1atm3Rsjo Tg(Tek-cre)1Ywa/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL)
|
decreased vascular endothelial cell proliferation
|
J:94773
|
Hint1tm1Ibw/Hint1tm1Ibw
(involves: 129 * C57BL/6)
|
increased fibroblast proliferation
|
J:84504
|
Hipk1tm1Hko/Hipk1tm1Hko Hipk2tm1Hko/Hipk2tm1Hko
(involves: C57BL/6)
|
decreased cell proliferation
|
J:106931
|
Hipk2tm1Afus/Hipk2tm1Afus
(involves: 129X1/SvJ * C57BL/6)
|
decreased cell proliferation
|
J:156574
|
Hipk3Gt(OST51087)Lex/Hipk3Gt(OST51087)Lex
(involves: 129S5/SvEvBrd)
|
decreased pancreatic beta cell proliferation
|
J:194563
|
Hk2tm1.1Uku/Hk2tm1.1Uku Tg(GFAP-cre)25Mes/0
(B6.Cg-Hk2tm1.1Uku Tg(GFAP-cre)25Mes)
|
abnormal neuronal precursor proliferation
|
J:210113
|
Hltftm1.1Arte/Hltftm1.1Arte
(Not Specified)
|
abnormal neuronal precursor proliferation
|
J:193813
|
Hmgn1tm1Mbus/Hmgn1tm1Mbus
(involves: 129X1/SvJ)
|
increased fibroblast proliferation
|
J:100773
|
Hmox1tm1.1Gkl/Hmox1tm1.1Gkl Lyz2tm1(cre)Ifo/Lyz2+
(involves: 129 * 129P2/OlaHsd * BALB/cJ * C57BL/6)
|
increased splenocyte proliferation
|
J:148498
|
Hmox1tm1Mlee/Hmox1tm1Mlee
(B6.129S2-Hmox1tm1Mlee)
|
increased vascular smooth muscle cell proliferation
|
J:106600
|
Hnf1atm1Mya/Hnf1atm1Mya
(involves: 129S2/SvPas)
|
increased hepatocyte proliferation
|
J:31627
|
Hnf1atm2Mya/Hnf1atm2Mya
(involves: 129S2/SvPas)
|
increased hepatocyte proliferation
|
J:31627
|
Hnrnpltm1.1Tmo/Hnrnpltm1.1Tmo Tg(Lck-cre)548Jxm/0
(B6.Cg-Hnrnpltm1.1Tmo Tg(Lck-cre)548Jxm)
|
increased T cell proliferation
|
J:188749
|
Hopxtm1Eno/Hopxtm1Eno
(involves: 129S6/SvEvTac)
|
abnormal fetal cardiomyocyte proliferation
|
J:79152
|
Hoxb3osem1Kabo/Hoxb3osem1Kabo
(C57BL/6J-Hoxb3osem1Kabo)
|
increased kidney cell proliferation
|
J:345935
|
Hoxb3osem1Kabo/Hoxb3osem1Kabo Pkd1tm1.1Pcha/Pkd1tm1.1Pcha
(involves: 129 * C57BL/6J)
|
increased kidney cell proliferation
|
J:345935
|
Hoxb3osem1Kabo/Hoxb3osem1Kabo Pkd1tm2Ggg/Pkd1tm2Ggg Tg(Pkhd1-cre)1Igr/0
(involves: 129S4/SvJae * C57BL/6J)
|
increased kidney cell proliferation
|
J:345935
|
Hprt1b-m3/Y Impdh1tm1Bmi/Impdh1tm1Bmi
(involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * C57BL/6)
|
decreased splenocyte proliferation
|
J:85443
|
decreased T cell proliferation
|
J:85443
|
Hprt1tm1(CAG-NRIP1)Vcls/Y
(involves: 129 * C57BL/6)
|
abnormal enterocyte proliferation
|
J:211324
|
Hprt1tm1(CAG-NRIP1)Vcls/Hprt1+
(involves: 129 * C57BL/6)
|
abnormal enterocyte proliferation
|
J:211324
|
Hprt1tm1(Rcan1)Zyga/Hprt1+
(B6.129P2-Hprt1tm1(Rcan1)Zyga)
|
decreased vascular endothelial cell proliferation
|
J:150286
|
Hprt1tm4(CAG-Tbx18*,-Venus)Akis/Y Tbx18tm4(cre)Akis/Tbx18+
(involves: 129S1/SvImJ * NMRI)
|
decreased fetal cardiomyocyte proliferation
|
J:210076
|
Hprt1tm86(NR2E1,bEMS223)Ems/Y
(B6.Cg-Hprt1tm86(NR2E1,bEMS223)Ems)
|
abnormal neuronal precursor proliferation
|
J:183689
|
Hprt1tm86(NR2E1,bEMS223)Ems/Y Nr2e1frc/Nr2e1frc
(involves: 129P2/OlaHsd * 129S1/SvImJ * C57BL/6)
|
abnormal neuronal precursor proliferation
|
J:183689
|
Hrhr/Hrhr
(HRS/J)
|
decreased T cell proliferation
|
J:6375
|
Hrhr/Hrhr Ptgs1tm1Unc/Ptgs1+
(involves: 129P2/OlaHsd * C57BL/6 * SKH1)
|
increased cell proliferation
|
J:121635
|
Hrhr/Hrhr Ptgs2tm1Unc/Ptgs2+
(involves: 129P2/OlaHsd * C57BL/6 * SKH1)
|
increased cell proliferation
|
J:121635
|
Hrhr/Hrhr Tg(KRT14-Ptgs2)1Sumf/0
(involves: C57BL/6 * DBA/2 * FVB/N * SKH1)
|
decreased cell proliferation
|
J:121635
|
Hrh1tm1Wtn/Hrh1tm1Wtn
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased B cell proliferation
|
J:111704
|
decreased T cell proliferation
|
J:111704
|
Hs6st1tm1Kkm/Hs6st1tm1Kkm Hs6st2tm1.1Kkm/Hs6st2tm1.1Kkm
(involves: 129P2/OlaHsd)
|
decreased cell proliferation
|
J:136555
|
Hsd11b1tm1a(KOMP)Wtsi/Hsd11b1+
(involves: C57BL/6Jcl * C57BL/6N)
|
increased fibroblast proliferation
|
J:214146
|
Hsd11b1tm1a(KOMP)Wtsi/Hsd11b1tm1a(KOMP)Wtsi
(involves: C57BL/6Jcl * C57BL/6N)
|
abnormal fibroblast proliferation
|
J:214146
|
increased fibroblast proliferation
|
J:214146
|
Hsd11b2tm1Yko/Hsd11b2tm1Yko
(involves: 129P2/OlaHsd * MF1)
|
abnormal fetal cardiomyocyte proliferation
|
J:53391
|
Hsd17b12Gt(A030E06)Wrst/Hsd17b12Gt(A030E06)Wrst
(involves: 129S2/SvPas * C57BL/6N)
|
decreased inner cell mass proliferation
|
J:160025
|
Hsh2dtm1Viss/Hsh2dtm1Viss
(B6.129-Hsh2dtm1Viss)
|
increased T cell proliferation
|
J:111408
|
Hspa5baffled/Hspa5baffled
(FVB.Cg-Hspa5baffled)
|
abnormal neuron proliferation
|
J:191772
|
Hspa5tm1.1Alee/Hspa5tm1.1Alee
(involves: 129 * C57BL/6 * FVB/N)
|
absent inner cell mass proliferation
|
J:111416
|
Hspb1tm1.1Jdn/Hspb1tm1.1Jdn
(B6.129S2(Cg)-Hspb1tm1.1Jdn)
|
decreased fibroblast proliferation
|
J:209117
|
Hspb7tm1.2Chen/Hspb7tm1.2Chen
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA)
|
decreased fetal cardiomyocyte proliferation
|
J:256653
|
Hspg2tm1Nid/Hspg2tm1Nid
(involves: 129X1/SvJ * C57BL/6)
|
decreased chondrocyte proliferation
|
J:67299
|
Htatip2tm1Hx/Htatip2+
(involves: 129P2/OlaHsd * C57BL/6J)
|
increased fibroblast proliferation
|
J:87066
|
Htatip2tm1Hx/Htatip2tm1Hx
(involves: 129P2/OlaHsd * C57BL/6J)
|
increased fibroblast proliferation
|
J:87066
|
Htr1btm1Rhn/Htr1btm1Rhn
(involves: 129S2/SvPas)
|
increased osteoblast proliferation
|
J:146078
|
Htr2btm1Kry/Htr2btm1Kry Tg(Ins2-cre)23Herr/0
(involves: C57BL/6J * CBA/J)
|
decreased pancreatic beta cell proliferation
|
J:284574
|
Htr2btm1Lum/Htr2btm1Lum
(129S2/SvPas-Htr2btm1Lum)
|
abnormal fetal cardiomyocyte proliferation
|
J:64067
|
Htttm3Szi/Htttm3Szi
(involves: 129S1/Sv)
|
abnormal cell proliferation
|
J:106763
|
decreased cell proliferation
|
J:106763
|
Hus1tm1Led/Hus1tm1Led
(either: (involves: 129S6/SvEvTac) or (involves: 129S6/SvEvTac * Black Swiss))
|
absent fibroblast proliferation
|
J:63869
|
Hus1tm1Led/Hus1tm2Rsw
(involves: 129S6/SvEvTac * C57BL/6)
|
decreased cell proliferation
|
J:118898
|
Huwe1tm1Alas/Y Tg(Nes-cre)1Kag/0
(involves: 129S7/SvEvBrd)
|
abnormal neuronal precursor proliferation
|
J:152966
|
Icmttm1Mbrg/Icmttm1Mbrg Tg(Mx1-cre)1Cgn/?
(involves: 129S4/SvJae * C57BL/6 * CBA)
|
decreased cell proliferation
|
J:88170
|
Icostm1Mak/Icostm1Mak
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased T cell proliferation
|
J:66702
|
Id1tm1Zhu/Id1tm1Zhu
(involves: 129S1/Sv * C57BL/6J)
|
decreased lung endothelial cell proliferation
|
J:125521
|
Id1tm1Zhu/Id1tm1Zhu Id3tm1Zhu/Id3tm1Zhu
(involves: 129S1/Sv * 129S4/SvJaeSor)
|
abnormal neuronal precursor proliferation
|
J:86480,
J:170418
|
Id1tm3Bene/Id1tm3Bene Id2tm1Xdz/Id2tm1Xdz Id3tm1Zhu/Id3tm1Zhu Tg(Nes-cre)1Kln/0
(involves: 129S4/SvJaeSor * C57BL/6 * SJL)
|
abnormal neuronal precursor proliferation
|
J:185426
|
Id2tm1Mcha/Id2tm1Mcha
(involves: C57BL/6 * CD-1)
|
abnormal neuronal precursor proliferation
|
J:143882
|
Id3tm1Zhu/Id3tm1Zhu
(involves: 129/Sv * C57BL/6)
|
decreased B cell proliferation
|
J:56950
|
Idd4C57BL/6/Idd4C57BL/6
(involves: C57BL/6 * DBA/2)
|
increased T cell proliferation
|
J:25969
|
Idd4C57BL/6/Idd4C57BL/6
(involves: C57BL/6 * NOD)
|
increased T cell proliferation
|
J:25969
|
Idd6C57BL/6/Idd6NOD
(involves: C57BL/6 * NOD)
|
decreased T cell proliferation
|
J:72360
|
Idd6NOD/Idd6NOD
(involves: C57BL/6 * NOD)
|
decreased T cell proliferation
|
J:72360
|
Ier3ip1tm1Arvn/Ier3ip1tm1Arvn Tg(Ins1-cre/ERT)1Lphi/0
(involves: 129S4/SvJaeSor * C57BL/6J * CD-1)
|
decreased pancreatic beta cell proliferation
|
J:336782
|
Ier3ip1tm1Arvn/Ier3ip1tm1Arvn Tg(Ins2-cre)25Mgn/0
(involves: C57BL/6 * C57BL/6J * DBA)
|
decreased pancreatic beta cell proliferation
|
J:336782
|
Ifnb1tm1Acgp/Ifnb1tm1Acgp
(involves: 129P2/OlaHsd)
|
increased T cell proliferation
|
J:86527
|
Ifngtm1Ts/Ifngtm1Ts
(involves: 129S7/SvEvBrd * C57BL/6)
|
increased splenocyte proliferation
|
J:66802
|
Ifngr1tm1Agt/Ifngr1tm1Agt
(involves: 129S7/SvEvBrd)
|
increased hepatocyte proliferation
|
J:38363
|
Ifngr1tm1Agt/Ifngr1tm1Agt
(involves: 129S7/SvEvBrd * C57BL/6)
|
increased splenocyte proliferation
|
J:99347
|
Ift20tm1.1Gjp/Ift20tm1.1Gjp Tg(Hoxb7-cre)13Amc/0
(involves: 129S4/SvJaeSor * 129S7/SvEvBrd * C57BL/6)
|
increased kidney cell proliferation
|
J:141071
|
Ift27tm1a(EUCOMM)Hmgu/Ift27tm1a(EUCOMM)Hmgu
(involves: C57BL/6N)
|
decreased keratinocyte proliferation
|
J:224085
|
Ift140tm1b(KOMP)Wtsi/Ift140tm1c(KOMP)Wtsi Tg(Hoxb7-cre)13Amc/?
(B6J.B6-Ift140tm1b(KOMP)Wtsi/Ift140tm1c(Komp)Wtsi Tg(Hoxb7-cre)13Amc)
|
increased kidney cell proliferation
|
J:181533
|
Igf1rtm1Jcbr/Igf1rtm1Jcbr Ndor1Tg(UBC-cre/ERT2)1Ejb/0
(involves: 129S/SvEv * C57BL/6)
|
increased hepatocyte proliferation
|
J:221618
|
Igf2tm1Rob/Igf2+
(involves: 129S/SvEv * C57BL/6J)
|
abnormal fetal cardiomyocyte proliferation
|
J:77413
|
increased hepatocyte proliferation
|
J:77413
|
Igf2bp1Gt(OST33739)Lex/Igf2bp1Gt(OST33739)Lex
(involves: 129S5/SvEvBrd * C57BL/6)
|
decreased cell proliferation
|
J:89882
|
Igf2bp1Gt(OST33739)Lex/Igf2bp1Gt(OST33739)Lex
(involves: 129S5/SvEvBrd)
|
decreased cell proliferation
|
J:207231
|
Igfbp7tm1.1Dds/Igfbp7tm1.1Dds
(involves: CD-1)
|
decreased fibroblast proliferation
|
J:212964
|
decreased mammary gland epithelial cell proliferation
|
J:212964
|
Igh-Vtm1(Igh-Vx24)Hmb/Igh-Vtm1(Igh-Vx24)Hmb
(involves: 129/Sv * C57BL/6)
|
increased cell proliferation
|
J:54380
|
Ightm1(Myc)Janz/Igh+
(involves: 129X1/SvJ * C57BL/6)
|
increased B cell proliferation
|
J:96785
|
Ightm1(Myc)Janz/Igh+ Mdm4tm1.1Wahl/Mdm4tm1.1Wahl
(involves: 129S/Sv * C57BL/6)
|
increased splenocyte proliferation
|
J:150341
|
Ightm1.2Rsky/Ightm1.2Rsky
(BALB/c-Ightm1.2Rsky)
|
abnormal B cell proliferation
|
J:125719
|
Ightm1Mnz/Ightm1Mnz
(B6.129P2-Ightm1Mnz)
|
increased B cell proliferation
|
J:75653
|
Ightm1Mnz/Ightm1Mnz Lyntm1Sor/Lyntm1Sor
(involves: 129P2/OlaHsd * 129S4/SvJaeSor * C57BL/6)
|
increased B cell proliferation
|
J:75653
|
Ightm2Mnz/Ightm2Mnz
(B6.129P2-Ightm2Mnz)
|
increased B cell proliferation
|
J:75653
|
Ightm2Mnz/Ightm2Mnz Lyntm1Sor/Lyntm1Sor
(involves: 129P2/OlaHsd * 129S4/SvJaeSor * C57BL/6)
|
increased B cell proliferation
|
J:75653
|
Ighatm1(Myc)Janz/Igha+
(involves: 129S1/Sv * C57BL/6)
|
increased B cell proliferation
|
J:90901
|
Ighatm1Grh/Ighatm1Grh
(involves: 129S7/SvEvBrd * C57BL/6)
|
decreased T cell proliferation
|
J:125472
|
Ighmtm1(Bcl6)Rdf/?
(involves: 129/Sv * C57BL/6)
|
abnormal B cell proliferation
|
J:98937
|
Ighmtm1.1(IGH-2)Cog/Ighmtm1.1(IGH-2)Cog
(involves: 129P2/OlaHsd * C57BL/6 * FVB/N)
|
decreased B cell proliferation
|
J:157575
|
increased B cell proliferation
|
J:157575
|
Ighmtm1Cgn/Ighm+ Tgfb1tm1Doe/Tgfb1tm1Doe
(involves: 129S2/SvPas * C57BL/6 * CF-1)
|
increased cell proliferation
|
J:99033
|
Ighmtm1Cgn/Ighmtm1Cgn
(involves: 129S2/SvPas)
|
decreased T cell proliferation
|
J:112160
|
Ighmtm1Cgn/Ighmtm1Cgn
(NOD.129S2-Ighmtm1Cgn/DvsJ)
|
abnormal T cell proliferation
|
J:80859
|
Ighmtm1Cgn/Ighmtm1Cgn Tg(IghelMD4)4Ccg/Tg(IghelMD4)4Ccg
(NOD.Cg-Ighmtm1Cgn Tg(IghelMD4)4Ccg/DvsJ)
|
abnormal T cell proliferation
|
J:80859
|
Ighmtm3Bgmn/Ighmtm3Bgmn
(involves: 129)
|
decreased B cell proliferation
|
J:131633
|
Ighmtm4Bgmn/Ighmtm4Bgmn
(involves: 129)
|
decreased B cell proliferation
|
J:131633
|
Ihhtm1Amc/Ihhtm1Amc
(involves: 129S1/Sv * 129X1/SvJ)
|
decreased chondrocyte proliferation
|
J:73071
|
Ikbkgtm1.1Chtr/Ikbkgtm1.1Chtr Map3k7tm1Aki/Map3k7tm1Aki Tg(Alb1-cre)7Gsc/0
(involves: 129P2/OlaHsd * FVB/N)
|
increased hepatocyte proliferation
|
J:160521
|
Ikbkgtm1.1Chtr/Ikbkgtm1.1Chtr Tg(Alb1-cre)7Gsc/0
(involves: FVB/N)
|
increased hepatocyte proliferation
|
J:160521
|
Ikbkgtm1.1Mpa/Ikbkgtm1.1Mpa Tg(Alb1-cre)7Gsc/0
(involves: C57BL/6 * FVB/N)
|
increased cell proliferation
|
J:118336
|
Ikzf1tm1Kast/Ikzf1tm1Kast
(involves: 129S2/SvPas)
|
decreased B cell proliferation
|
J:82813
|
Ikzf1tm1Kge/Ikzf1+
(involves: 129S4/SvJae * C57BL/6)
|
increased T cell proliferation
|
J:29355
|
Ikzf1tm1Kge/Ikzf1+
(involves: 129S4/SvJae * BALB/c)
|
increased T cell proliferation
|
J:29355
|
Ikzf1tm2Kge/Ikzf1tm2Kge
(involves: 129S4/SvJae)
|
increased T cell proliferation
|
J:37317
|
Ikzf3tm1Kge/Ikzf3tm1Kge
(involves: 129S4/SvJae * C57BL/6)
|
increased B cell proliferation
|
J:50626
|
increased T cell proliferation
|
J:50626
|
Ikzf4tm1.1Etms/Ikzf4tm1.1Etms
(Not Specified)
|
decreased T cell proliferation
|
J:295208
|
Il1r1tm1Roml/Il1r1tm1Roml
(C.Cg-Il1r1tm1Roml)
|
decreased T cell proliferation
|
J:82863
|
Il1rntm1.1Cga/Il1rntm1.1Cga Lyz2tm1(cre)Ifo/Lyz2+
(D1.Cg-Il1rntm1.1Cga Lyz2tm1(cre)Ifo)
|
increased T cell proliferation
|
J:162760
|
Il2tm1Hor/Il2tm1Hor
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased splenocyte proliferation
|
J:79241
|
decreased T cell proliferation
|
J:39989,
J:26198
|
increased B cell proliferation
|
J:16662
|
increased T cell proliferation
|
J:15223,
J:16662
|
Il2tm1Hor/Il2tm1Hor
(C.129P2-Il2tm1Hor)
|
increased B cell proliferation
|
J:29799
|
increased T cell proliferation
|
J:29799
|
Il2tm1Hor/Il2tm1Hor
(B6.129P2-Il2tm1Hor)
|
increased T cell proliferation
|
J:28924
|
Il2tm1Hor/Il2tm1Hor
(B6.129P2-Il2tm1Hor/J)
|
abnormal T cell proliferation
|
J:190168
|
Il2tm1Hor/Il2tm1Hor Il4tm1Cgn/Il4tm1Cgn
(involves: 129P2/OlaHsd * C57BL/6)
|
increased B cell proliferation
|
J:16662
|
increased T cell proliferation
|
J:16662
|
Il2tm1Hor/Il2tm1Hor Tg(DO11.10)10Dlo/?
(C.Cg-Il2tm1Hor Tg(DO11.10)10Dlo)
|
increased T cell proliferation
|
J:88349
|
Il2rbtm1Mak/Il2rbtm1Mak
(B6.129-Il2rbtm1Mak)
|
decreased T cell proliferation
|
J:113547
|
Il2rbtm1Mak/Il2rbtm1Mak
(C.129-Il2rbtm1Mak)
|
decreased T cell proliferation
|
J:113547
|
Il2rgtm1Cgn/Y
(involves: 129 * CB20)
|
decreased T cell proliferation
|
J:22521
|
Il2rgtm1Cgn/Il2rgtm1Cgn
(involves: 129 * CB20)
|
decreased T cell proliferation
|
J:22521
|
Il2rgtm1Wjl/Y
(involves: 129S4/SvJae * C57BL/6)
|
decreased T cell proliferation
|
J:24117
|
Il4ratm1Tch/Il4ratm1Tch
(involves: 129X1/SvJ * BALB/c)
|
decreased T cell proliferation
|
J:86215
|
Il5ratm1Ktk/Il5ratm1Ktk
(B6.129P2-Il5ratm1Ktk)
|
decreased B cell proliferation
|
J:89849
|
Il6tm1Kopf/Il6tm1Kopf
(involves: 129S2/SvPas * C57BL/6)
|
abnormal skeletal muscle satellite cell proliferation
|
J:131016
|
Il6tm1Poli/Il6tm1Poli
(CAnNCrl.129S(Cg)-Il6tm1Poli)
|
abnormal B cell proliferation
|
J:42869
|
Il6ratm1.2Jcbr/Il6ratm1.2Jcbr
(involves: C57BL/6)
|
decreased hepatocyte proliferation
|
J:202764
|
Il6sttm1Ard/Il6sttm1Ard
(involves: 129S1/Sv * C57BL/6)
|
increased cell proliferation
|
J:79555
|
Il7rtm1Abra/Il7rtm1Abra
(B6.129S4-Il7rtm1Abra)
|
abnormal T cell proliferation
|
J:125360
|
Il7rtm1Imx/Il7rtm1Imx Tg(Lck-Il7r)1676Trma/?
(involves: 129S7/SvEvBrd * C57BL/6 * SJL)
|
decreased T cell proliferation
|
J:66400
|
Il10tm1Cgn/Il10tm1Cgn
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased T cell proliferation
|
J:125760
|
Il10tm1Cgn/Il10tm1Cgn Vdrtm1Mbd/Vdrtm1Mbd
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6)
|
decreased T cell proliferation
|
J:107077
|
Il10ratm1.1Tlg/Il10ratm1.1Tlg Tg(Cd4-cre)1Cwi/?
(B6.Cg-Tg(Cd4-cre)1Cwi Il10ratm1.1Tlg)
|
decreased splenocyte proliferation
|
J:189797
|
Il15ratm1.1Nsl/Il15ratm1.1Nsl
(B6.129X1-Il15ratm1.1Nsl)
|
abnormal T cell proliferation
|
J:92705
|
increased T cell proliferation
|
J:92705
|
Il15ratm1.1Nsl/Il15ratm1.1Nsl Tg(TcrAND)53Hed/?
(involves: 129X1/SvJ * C57BL/6 * SJL)
|
increased T cell proliferation
|
J:92705
|
Il15ratm1Ama/Il15ratm1Ama
(involves: 129X1/SvJ)
|
decreased T cell proliferation
|
J:142570
|
Il15ratm1Wjl/Il15ratm1Wjl
(involves: 129 * C57BL/6)
|
decreased T cell proliferation
|
J:142570
|
Il17a/Il17ftm1.1Impr/Il17a/Il17ftm1.1Impr
(involves: C57BL/6)
|
increased T cell proliferation
|
J:187400
|
Il17a/Il17ftm1.1Impr/Il17a/Il17ftm1.1Impr
(involves: C57BL/6)
|
increased T cell proliferation
|
J:187400
|
Il17ctm1Lex/Il17ctm1Lex
(B6.129S5-Il17ctm1Lex)
|
decreased keratinocyte proliferation
|
J:178967
|
Il20rbtm1Uwe/Il20rbtm1Uwe
(B6.129P2-Il20rbtm1Uwe)
|
increased T cell proliferation
|
J:143497
|
Il21rtm1Wjl/Il21rtm1Wjl
(NOD.Cg-Il21rtm1Wjl)
|
decreased T cell proliferation
|
J:139075
|
Il23atm1.1Thak/Il23atm1.1Thak
(C57BL/6-Il23atm1.1Thak)
|
decreased T cell proliferation
|
J:143970
|
Il27ratm1Mak/Il27ratm1Mak
(B6.129P2-Il27ratm1Mak)
|
increased T cell proliferation
|
J:89509
|
Il31ratm1Ngh/Il31ratm1Ngh
(involves: C57BL/6)
|
increased T cell proliferation
|
J:123198
|
Ilktm1Star/Ilktm1Star Tg(KRT14-cre)1Amc/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA)
|
decreased keratinocyte proliferation
|
J:172934
|
Ilktm3Ref/Ilktm3Ref Tg(Col2a1-cre)1Asz/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA)
|
decreased cell proliferation
|
J:110783
|
Impdh1tm1Bmi/Impdh1tm1Bmi
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
decreased T cell proliferation
|
J:85443
|
Impdh1tm1Bmi/Impdh1tm1Bmi Impdh2tm1Bmi/Impdh2+
(involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * C57BL/6)
|
decreased splenocyte proliferation
|
J:85443
|
decreased T cell proliferation
|
J:85443
|
Inca1tm1Cmt/Inca1tm1Cmt
(involves: 129 * C57BL/6N)
|
decreased fibroblast proliferation
|
J:175667
|
Ing1Gt(F066C08)Irpa/Ing1Gt(F066C08)Irpa
(involves: 129S2/SvPas)
|
increased fibroblast proliferation
|
J:126798
|
Ing1Gt(OST206270)Lex/Ing1Gt(OST206270)Lex
(involves: 129S5/SvEvBrd * C57BL/6)
|
increased fibroblast proliferation
|
J:118602
|
Ing1Gt(OST206270)Lex/Ing1Gt(OST206270)Lex Trp53tm1Brd/Trp53tm1Brd
(involves: 129S5/SvEvBrd * 129S7/SvEvBrd * C57BL/6)
|
increased cell proliferation
|
J:118602
|
Inhatm1Bay/Inhatm1Bay
(involves: 129S7/SvEvBrd * C57BL/6)
|
increased Sertoli cell proliferation
|
J:125349
|
Ino80tm1Schg/Ino80tm1Schg Tg(CAG-cre/Esr1*)5Amc/0
(involves: C57BL/6 * CBA)
|
decreased fibroblast proliferation
|
J:221224
|
Ins1tm1Jja/Ins1tm1Jja Ins2tm1Jja/Ins2tm1Jja
(involves: 129S2/SvPas * C57BL/6)
|
increased pancreatic alpha cell proliferation
|
J:106827
|
increased pancreatic beta cell proliferation
|
J:106827
|
Ins2Akita/Ins2Akita Jazf1tm1c(EUCOMM)Wtsi/Jazf1tm1c(EUCOMM)Wtsi Tg(Ins2-cre)23Herr/0
(involves: 129S4/SvJaeSor * C57BL/6N * C57BL/6NSlc * CBA/J)
|
decreased pancreatic beta cell proliferation
|
J:303318
|
Insctm1Jakn/Insctm1Jakn Tg(Nes-cre)1Wmz/0
(involves: C57BL/6)
|
abnormal neuronal precursor proliferation
|
J:178712
|
Insm1tm1.1(GFP/cre)Mgn/Insm1tm1.1(GFP/cre)Mgn
(involves: 129S6/SvEvTac * CD-1 * SJL)
|
decreased pancreatic endocrine progenitor cell proliferation
|
J:214095
|
Ip6k2tm1Dlin/Ip6k2tm1Dlin
(involves: 129X1/SvJ * Black Swiss * C57BL/6)
|
increased fibroblast proliferation
|
J:151345
|
Irak4tm1Aki/Irak4tm1Aki
(involves: 129X1/SvJ * C57BL/6)
|
decreased B cell proliferation
|
J:125729
|
Irak4tm1Yeh/Irak4tm1Yeh
(involves: 129P2/OlaHsd * C57BL/6J)
|
decreased B cell proliferation
|
J:76098
|
Irak4tm2Aki/Irak4tm2Aki
(involves: 129X1/SvJ * C57BL/6)
|
decreased B cell proliferation
|
J:125729
|
Irf1tm1Cwe/Irf1tm1Cwe
(involves: 129)
|
abnormal T cell proliferation
|
J:84367
|
Irf2tm1Mak/Irf2tm1Mak
(either: (involves: 129S2/SvPas * C57BL/6J) or (involves: 129S2/SvPas * C57BL/6J * DBA/2))
|
decreased B cell proliferation
|
J:64286
|
Irf4tm1.1Rdf/Irf4tm1.1Rdf
(involves: 129S1/Sv * 129S4/SvJae * C57BL/6)
|
decreased B cell proliferation
|
J:112643
|
Irf4tm1Mak/Irf4tm1Mak
(involves: 129P2/OlaHsd)
|
decreased B cell proliferation
|
J:42683
|
decreased T cell proliferation
|
J:42683
|
Irf6Gt(OST398253)Lex/Irf6Gt(OST398253)Lex
(involves: 129S5/SvEvBrd * C57BL/6)
|
increased keratinocyte proliferation
|
J:115343
|
Irs1Sml/Irs1Sml
(C3.Cg-Irs1Sml H2b/GrsrJ)
|
decreased osteoblast proliferation
|
J:163661
|
Irs1tm1Tka/Irs1tm1Tka
(involves: C57BL/6 * CBA)
|
decreased cell proliferation
|
J:89532
|
Irs2tm1.1With/Irs2tm1.1With
(B6.129S6-Irs2tm1.1With)
|
decreased granulosa cell proliferation
|
J:122064
|
Itga11tm1Dgul/Itga11tm1Dgul
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
decreased cell proliferation
|
J:122349
|
Itgadtm1Bll/Itgadtm1Bll
(B6.129S7-Itgadtm1Bll)
|
decreased T cell proliferation
|
J:90954
|
Itgaltm1Bll/Itgaltm1Bll
(B6.129S7-Itgaltm1Bll)
|
decreased T cell proliferation
|
J:90954
|
Itgamtm1Bll/Itgamtm1Bll
(B6.129S7-Itgamtm1Bll)
|
decreased T cell proliferation
|
J:90954
|
Itgaxtm1Bll/Itgaxtm1Bll
(B6.129S7-Itgaxtm1Bll)
|
increased T cell proliferation
|
J:122187
|
Itgb1tm1Ehi/Itgb1tm1Ehi
(either: (involves: 129S1/Sv * 129X1/SvJ) or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6))
|
decreased cell proliferation
|
J:76216
|
decreased fibroblast proliferation
|
J:76216
|
Itgb1tm1Ref/Itgb1tm1Ref Tg(Col2a1-cre)1Asz/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA)
|
decreased chondrocyte proliferation
|
J:85994
|
Itgb1tm1Ref/Itgb1tm2Ref Tg(Col2a1-cre)1Asz/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA)
|
decreased chondrocyte proliferation
|
J:85994
|
Itgb1tm1Ref/Itgb1tm5.1Ref Tg(KRT5-cre)5132Jlj/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * DBA/2J)
|
decreased keratinocyte proliferation
|
J:148885
|
Itgb1tm1Ref/Itgb1tm15.1Ref Tg(KRT5-cre)5132Jlj/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * DBA/2J)
|
decreased keratinocyte proliferation
|
J:203018
|
Itgb1tm1Ross/Itgb1tm1Ross Tg(Hoxb7-cre)13Amc/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
increased kidney cell proliferation
|
J:149831
|
Itgb2tm1.1Arte/Itgb2tm1.1Arte
(involves: C57BL/6NTac)
|
decreased T cell proliferation
|
J:202261
|
Itgb2tm2Bay/Itgb2tm2Bay
(involves: 129S7/SvEvBrd * C57BL/6J)
|
abnormal T cell proliferation
|
J:48542
|
Itgb2tm2Bay/Itgb2tm2Bay
(involves: 129S7/SvEvBrd)
|
decreased T cell proliferation
|
J:90954
|
Itgb3tm1Hyn/Itgb3tm1Hyn
(involves: 129S2/SvPas)
|
decreased keratinocyte proliferation
|
J:96049
|
Itgb4tm1Fgg/Itgb4tm1Fgg
(involves: 129S1/Sv * C57BL/6)
|
abnormal enterocyte proliferation
|
J:48924
|
Itih4tm1Mish/Itih4tm1Mish Sptbn1tm1Mish/Sptbn1+
(involves: 129S6/SvEvTac * C57BL/6 * NIH Black Swiss)
|
decreased hepatocyte proliferation
|
J:132133
|
Itkm1Btlr/Itkm1Btlr
(C57BL/6J-Itkm1Btlr)
|
abnormal cell proliferation
|
J:236673
|
increased CD8-positive, alpha-beta memory T cell proliferation
|
J:236673
|
Itktm1Litt/Itktm1Litt
(involves: 129S4/SvJae * C57BL/6J)
|
decreased T cell proliferation
|
J:31230
|
Itktm1Litt/Itktm1Litt
(involves: 129S4/SvJae)
|
decreased T cell proliferation
|
J:54449
|
Itktm1Litt/Itktm1Litt
(B6.129S4-Itktm1Litt)
|
decreased T cell proliferation
|
J:141390
|
Itktm1Litt/Itktm1Litt Txktm1Pls/Txktm1Pls
(involves: 129S4/SvJae * 129S6/SvEvTac)
|
decreased T cell proliferation
|
J:54449
|
Itln1em1Cya/Itln1em1Cya
(involves: C57BL/6)
|
decreased osteoblast proliferation
|
J:282124
|
Jak3tm1Flv/Jak3tm1Flv
(involves: 129S1/Sv)
|
abnormal T cell proliferation
|
J:95794
|
Jak3tm1Ljb/Jak3tm1Ljb
(involves: 129S4/SvJae * C57BL/6)
|
decreased T cell proliferation
|
J:29722
|
Jak3tm1Ljb/Jak3tm1Ljb
(involves: 129S4/SvJae)
|
decreased T cell proliferation
|
J:128694
|
Jak3tm1Ljb/Jak3tm1Ljb Tg(Lck-Jak3)1Ljb/0
(involves: 129S4/SvJae * C3H * C57BL/6 * C57BL/10)
|
decreased T cell proliferation
|
J:128694
|
Jak3tm1Ljb/Jak3tm1Ljb Tg(Lck-Jak3)2Ljb/0
(involves: 129S4/SvJae * C3H * C57BL/6 * C57BL/10)
|
decreased T cell proliferation
|
J:128694
|
Jarid2Gt(ROSA)1Gel/Jarid2Gt(ROSA)1Gel
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal fetal cardiomyocyte proliferation
|
J:100923
|
Jdp2tm1Kkyo/Jdp2tm1Kkyo
(involves: 129P2/OlaHsd * C57BL/6)
|
increased cell proliferation
|
J:166559
|
Juntm1Pa/Juntm1Pa
(either: (involves: 129S/SvEv * 129X1/SvJ) or (involves: 129X1/SvJ * C57BL/6J))
|
decreased fibroblast proliferation
|
J:13175
|
Juntm1Rsjo/Juntm1Rsjo Tg(KRT14-cre)8Brn/0
(involves: 129S1/Sv * 129X1/SvJ * FVB/N)
|
decreased keratinocyte proliferation
|
J:84743
|
Juntm1Wag/Juntm1Wag
(involves: 129S2/SvPas)
|
decreased cell proliferation
|
J:175212
|
Juntm1Wag/Juntm1Wag
(involves: 129S2/SvPas * C57BL/6)
|
decreased hepatocyte proliferation
|
J:55508
|
Juntm1Wag/Juntm1Wag Tg(Junb)1598Angl/0
(involves: 129S2/SvPas * C57BL/6)
|
abnormal cell proliferation
|
J:75359
|
Juntm2.1Wag/Juntm2.1Wag
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA)
|
decreased cell proliferation
|
J:53481
|
Juntm5.1(Junb)Wag/Juntm5.1(Junb)Wag
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal cell proliferation
|
J:75359
|
Juntm6.1(Jund)Wag/Juntm6.1(Jund)Wag
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
decreased cell proliferation
|
J:175212
|
Juntm6.1(Jund)Wag/Juntm6.1(Jund)Wag Jundtm1Mya/Jundtm1Mya
(involves: 129S1/Sv * 129S2/SvPas * 129X1/SvJ * C57BL/6)
|
decreased fibroblast proliferation
|
J:175212
|
Jundtm1Mya/Jundtm1Mya
(either: 129S2/SvPas or (involves: 129S2/SvPas * C57BL/6))
|
decreased fibroblast proliferation
|
J:65879
|
increased cell proliferation
|
J:65879
|
increased T cell proliferation
|
J:89085
|
Kank4em1Jhhu/Kank4em1Jhhu
(C57BL/6J-Kank4em1Jhhu)
|
decreased endothelial cell proliferation
|
J:326312
|
Kat2atm2Roth/Kat2atm2Roth
(involves: 129S7/SvEvBrd * C57BL/6J)
|
decreased fibroblast proliferation
|
J:121357
|
Kat8tm1.1Avo/Kat8tm1.1Avo
(involves: BALB/cJ * C57BL/6)
|
absent inner cell mass proliferation
|
J:139761
|
decreased trophectoderm cell proliferation
|
J:139761
|
Katna1tm1a(KOMP)Wtsi/Katna1+
(involves: C57BL/6J * C57BL/6N)
|
abnormal neuronal precursor proliferation
|
J:284578
|
decreased neuronal precursor proliferation
|
J:284578
|
Katnb1tm1a(EUCOMM)Hmgu/Katnb1tm1a(EUCOMM)Hmgu
(C57BL/6-Katnb1tm1a(EUCOMM)Hmgu)
|
abnormal neuronal precursor proliferation
|
J:220901
|
decreased fibroblast proliferation
|
J:220901
|
Kcna5tm1Hket/Kcna5tm1Hket
(involves: 129S6/SvEvTac * 129S7/SvEvBrd)
|
abnormal cell proliferation
|
J:116545
|
Kdf1shd/Kdf1shd
(involves: C3HeB/FeJ * C57BL/6J)
|
increased keratinocyte proliferation
|
J:203995
|
Kdm2atm1d(KOMP)Mtok/Kdm2atm1d(KOMP)Mtok
(involves: C57BL/6 * C57BL/6JJcl * C57BL/6N)
|
abnormal neuron proliferation
|
J:217589
|
Kdm2btm1Nobu/Kdm2btm1Nobu
(either: (involves: 129S/SvEv * 129P2/OlaHsd) or (involves: 129P2/OlaHsd * C57BL/6J))
|
abnormal neuronal precursor proliferation
|
J:171291
|
Kdm4btm1.1Okad/Kdm4btm1.1Okad
(involves: 129P2/OlaHsd)
|
decreased mammary gland epithelial cell proliferation
|
J:171678
|
Kdm5atm1.1Kael/Kdm5a+ Rb1tm1Tyj/Rb1tm1Tyj
(involves: 129S2/SvPas * 129S6/SvEvTac * FVB/N)
|
increased fibroblast proliferation
|
J:175625
|
Kdm6btm1.1Cdcn/Kdm6btm1.1Cdcn
(involves: C57BL/6)
|
decreased chondrocyte proliferation
|
J:233350
|
Kdm6btm1.1Rfw/Kdm6btm1.1Rfw
(Not Specified)
|
increased cell proliferation
|
J:228713
|
Kdm8tm1Tasu/Kdm8tm1Tasu
(involves: 129S4/SvJae * C57BL/6)
|
decreased cell proliferation
|
J:181189
|
Kif3atm2Gsn/Kif3atm2Gsn H2az2Tg(Wnt1-cre)11Rth/H2az2+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * CBA/J)
|
increased cranial neural crest cell proliferation
|
J:158523
|
Kif14lag/Kif14lag
(B6.D2(129X1)-Kif14lag)
|
decreased cell proliferation
|
J:195809
|
Kif18agcd2/Kif18agcd2
(CAST.129S1(B6)-Kif18agcd2/JcsMmjax)
|
decreased fibroblast proliferation
|
J:222418
|
Kif18atm1Zgwg/Kif18atm1Zgwg
(either: 129-Kif18atm1Zgwg or (involves: 129 * C57BL/6J))
|
decreased cell proliferation
|
J:211103
|
Kif20bmagoo/Kif20bmagoo
(involves: BALB/c * C57BL/6 * C57BL/6J * FVB/N)
|
abnormal neuronal precursor proliferation
|
J:205043
|
Kif26atm1.1Noh/Kif26atm1.1Noh
(involves: 129S6/SvEvTac * C57BL/6 * C57BL/6J)
|
abnormal neuronal precursor proliferation
|
J:154859
|
Kittm1Hntr/Kittm1Hntr
(either: (involves: 129/Sv * C57BL/6 * DBA/2) or (involves: 129S1))
|
abnormal spermatogonia proliferation
|
J:60192
|
KitW-e/KitW-e
(involves: 101 * C3H)
|
decreased primordial germ cell proliferation
|
J:16216
|
KitlSl-36R/KitlSl-36R
(C3H-KitlSl-36R)
|
decreased primordial germ cell proliferation
|
J:115437
|
KitlSl-39R/KitlSl-39R
(C3.B10Rl-KitlSl-39R)
|
decreased primordial germ cell proliferation
|
J:115437
|
KitlSl-d/KitlSl-d
(C3.D2-KitlSl-d)
|
decreased primordial germ cell proliferation
|
J:115437
|
KitlSl-gb/KitlSl-gb
(C3.Cg-KitlSl-gb)
|
abnormal primordial germ cell proliferation
|
J:115437
|
Kitltm2.1Pbes/Kitltm2.1Pbes
(involves: 129S1/Sv * C57BL/6J * FVB/N)
|
decreased cell proliferation
|
J:157170
|
Klf4tm1Khk/Klf4tm1Khk Tg(Klf4-cre/ERT)1Wai/0
(involves: 129S6/SvEvTac * C57BL/6 * CBA)
|
increased keratinocyte proliferation
|
J:187932,
J:189337
|
Klf5Gt(XB751)Byg/Klf5Gt(XB751)Byg
(B6.129P2-Klf5Gt(XB751)Byg)
|
decreased inner cell mass proliferation
|
J:168150
|
decreased trophectoderm cell proliferation
|
J:168150
|
Klf5tm1.1Jwel/Klf5tm1.1Jwel
(Not Specified)
|
decreased inner cell mass proliferation
|
J:168150
|
decreased trophectoderm cell proliferation
|
J:168150
|
Klf5tm1Jaw/Klf5tm1Jaw Tg(Pax6-cre,GFP)1Pgr/0
(involves: FVB)
|
increased cell proliferation
|
J:175263
|
Klf6tm1Fdmn/Klf6tm1Fdmn
(involves: C57BL/6)
|
decreased cell proliferation
|
J:122926
|
Klf10tm1Wkle/Klf10tm1Wkle
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
increased keratinocyte proliferation
|
J:182595
|
Kmt2atm1.1Jjdh/Kmt2atm1.1Jjdh
(involves: 129X1/SvJ)
|
decreased fibroblast proliferation
|
J:112159
|
Kmt2atm1.1Jjdh/Kmt2atm1.1Jjdh Kmt2btm1Jjdh/Kmt2btm1Jjdh
(involves: 129X1/SvJ)
|
decreased fibroblast proliferation
|
J:112159
|
Kmt2ctm1.1Jwle/Kmt2ctm1.1Jwle
(involves: 129S4/SvJae * 129X1/SvJ)
|
decreased cell proliferation
|
J:116064
|
Kmt2dtm1.1Kaig/Kmt2dtm1.1Kaig Cd19tm1(cre)Cgn/Cd19+
(involves: 129P2/OlaHsd * C57BL/6)
|
increased B cell proliferation
|
J:228913
|
Kmt2dtm1.1Kaig/Kmt2dtm1.1Kaig Tg(Tnnt2-cre)5Blh/0
(B6.Cg-Kmt2dtm1.1Kaig Tg(Tnnt2-cre)5Blh)
|
decreased fetal cardiomyocyte proliferation
|
J:229890
|
Kmt5btm1.1Jnw/Kmt5btm1.1Jnw Kmt5ctm1.1Jnw/Kmt5ctm1.1Jnw
(involves: 129 * C57BL/6J)
|
decreased fibroblast proliferation
|
J:139510
|
Knstrntm1d(KOMP)Wtsi/Knstrntm1d(KOMP)Wtsi
(involves: C57BL/6J * C57BL/6N)
|
abnormal spermatogonia proliferation
|
J:232595
|
Krastm1.1Hbji/Krastm1.1Hbji Trp53tm5Tyj/Trp53tm5Tyj
(involves: 129S4/SvJae)
|
increased fibroblast proliferation
|
J:220921
|
Krastm1Bbd/Kras+ Polr2atm1(cre/ERT2)Bbd/Polr2atm1(cre/ERT2)Bbd Raf1tm2Bacc/Raf1tm2Bacc
(involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ)
|
decreased cell proliferation
|
J:172200
|
Krastm1Bbd/Kras+ Tg(CMV-cre)1Cgn/?
(involves: 129S1/Sv * 129X1/SvJ * BALB/cJ * C57BL/6)
|
abnormal cell proliferation
|
J:86101
|
Krastm1Bbd/Kras+ Tg(CMV-cre/ERT)1Ipc/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL)
|
abnormal fibroblast proliferation
|
J:86101
|
Krastm1Bbd/Krastm2Bbd Polr2atm1(cre/ERT2)Bbd/Polr2atm1(cre/ERT2)Bbd
(involves: 129S1/Sv * 129X1/SvJ)
|
increased cell proliferation
|
J:161780
|
Krastm1Mok/Krastm1Mok
(involves: 129S/SvEv * C57BL/6J)
|
abnormal fetal cardiomyocyte proliferation
|
J:42943
|
Krastm4.1Bbd/Krastm4.1Bbd
(involves: 129S1/Sv * 129S2/SvPas * 129X1/SvJ * C57BL/6J * FVB/N)
|
increased cell proliferation
|
J:223433
|
Krastm4Tyj/Kras+ Krt19tm1(cre/ERT)Ggu/Krt19+
(involves: 129S4/SvJae * 129S6/SvEvTac)
|
increased cell proliferation
|
J:172048
|
Krastm4Tyj/Kras+ Tg(Mx1-cre)1Cgn/0
(involves: 129S4/SvJae * C57BL/6 * CBA)
|
increased splenocyte proliferation
|
J:87429
|
Krastm4Tyj/Krastm4Tyj
(B6.129S4-Krastm4Tyj)
|
increased cell proliferation
|
J:187371
|
Krt2tm1a(KOMP)Wtsi/Krt2tm1a(KOMP)Wtsi
(involves: C57BL/6N)
|
increased keratinocyte proliferation
|
J:214772
|
Krt7tm1Whim/Krt7tm1Whim
(involves: 129P2/OlaHsd * C57BL/6)
|
increased cell proliferation
|
J:196575
|
Krt9tm1(KOMP)Vlcg/Krt9tm1(KOMP)Vlcg
(involves: C57BL/6J * C57BL/6NTac)
|
increased keratinocyte proliferation
|
J:206051
|
Krt16tm1(KOMP)Vlcg/Krt16tm1(KOMP)Vlcg
(C57BL/6-Krt16tm1(KOMP)Vlcg)
|
increased cell proliferation
|
J:184621
|
Ksr1tm1Kole/Ksr1tm1Kole
(involves: 129S1/Sv * C57BL/6)
|
decreased cell proliferation
|
J:84644
|
Ksr1tm1Shaw/Ksr1tm1Shaw
(Not Specified)
|
decreased T cell proliferation
|
J:75739
|
Ksr1tm1Shaw/Ksr1tm1Shaw Tg(DO11.10)10Dlo/0
(involves: BALB/c * C3H * C57BL/6)
|
decreased T cell proliferation
|
J:75739
|
Lama5tm1Jhm/Lama5tm2Jhm Tg(SFTPC-rtTA)5Jaw/? Tg(tetO-cre)1Jaw/?
(involves: 129S1/Sv * 129X1/SvJ)
|
decreased cell proliferation
|
J:104565
|
Lamtor2tm1.1Lah/Lamtor2tm1.1Lah Tg(KRT5-cre)1Tak/0
(involves: 129P2/OlaHsd * C3H * C57BL/6 * SJL)
|
decreased cell proliferation
|
J:119075
|
Lancl1tm1.1Pfw/Lancl1tm1.1Pfw
(involves: 129 * C57BL/6)
|
abnormal spermatogonia proliferation
|
J:324139
|
Laptm5tm1Jow/Laptm5tm1Jow
(C57BL/6-Laptm5tm1Jow)
|
increased T cell proliferation
|
J:137841
|
Larp7tm1Ymat/Larp7tm1Ymat
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased primordial germ cell proliferation
|
J:191206
|
Lat2tm1Wz/Lat2tm1Wz
(B6.Cg-Lat2tm1Wz)
|
increased T cell proliferation
|
J:116157
|
Lattm1.1Lov/Lattm1.1Lov
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
decreased T cell proliferation
|
J:77099
|
increased T cell proliferation
|
J:77099
|
Lattm1.1Mal/Lattm1.1Mal
(involves: 129S2/SvPas)
|
increased T cell proliferation
|
J:77098
|
Lattm1.1Mal/Lattm1.1Mal
(involves: 129S2/SvPas * C57BL/6)
|
abnormal T cell proliferation
|
J:131351
|
Lats1tm1Noj/Lats1tm1Noj
(involves: 129S2/SvPas * C57BL/6)
|
increased fibroblast proliferation
|
J:200232
|
Lats2tm1Raz/Lats2tm1Raz
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal cell proliferation
|
J:93191
|
decreased cell proliferation
|
J:93191
|
Lbca1C57BL/6Igc/Lbca1C57BL/6Igc
(involves: BALB/cIgc * C57BL/6Igc)
|
increased B cell proliferation
|
J:139348
|
Lbca2BALB/cIgc/Lbca2C57BL/6Igc
(involves: BALB/cIgc * C57BL/6Igc)
|
increased B cell proliferation
|
J:139348
|
Lbca2C57BL/6Igc/Lbca2C57BL/6Igc
(involves: BALB/cIgc * C57BL/6Igc)
|
increased B cell proliferation
|
J:139348
|
Lbrlym3/Lbrlym3
(C57BL/6-Lbrlym3)
|
decreased T cell proliferation
|
J:180355
|
Lcktm1Dbs/Lcktm1Dbs
(involves: C3H * C57BL/6)
|
decreased T cell proliferation
|
J:114660
|
Lcktm1Dbs/Lcktm1Dbs Tg(TcraTcrb)1100Mjb/0
(involves: C3H * C57BL/6)
|
decreased T cell proliferation
|
J:114660
|
Lcktm1Litt/Lcktm1.1Litt Tnfrsf4tm2(cre)Nik/Tnfrsf4+
(involves: 129X1/SvJ)
|
decreased T cell proliferation
|
J:152472
|
Lcp2tm1.1Wz/Lcp2tm1.1Wz
(B6.Cg-Lcp2tm1.1Wz)
|
decreased T cell proliferation
|
J:150304
|
Ldlrtm1Her/Ldlrtm1Her Lrp1tm2Her/Lrp1tm2Her Tg(Tagln-cre)1Her/0
(involves: 129S7/SvEvBrd * C57BL/6J * SJL)
|
increased vascular smooth muscle cell proliferation
|
J:82871
|
Lepob/Lepob
(involves: C57BL/6)
|
decreased T cell proliferation
|
J:164339
|
Leprtm4Mgmj/Leprtm4Mgmj
(B6.Cg-Leprtm4Mgmj)
|
decreased T cell proliferation
|
J:164339
|
Lgals7tm1Ijmfp/Lgals7tm1Ijmfp
(involves: 129 * C57BL/6 * SJL)
|
increased keratinocyte proliferation
|
J:263069
|
Lgals9tm1.1Cfg/Lgals9tm1.1Cfg
(involves: C57BL/6)
|
increased B cell proliferation
|
J:217719
|
Lgr4tm1.1(cre/ERT2)Npa/Lgr4tm1.1(cre/ERT2)Npa
(involves: C57BL/6)
|
abnormal epidermal stem cell proliferation
|
J:212415
|
Lgr4tm1.1(cre/ERT2)Npa/Lgr4tm1.1(cre/ERT2)Npa Lgr5tm1.1(cre/ERT2)Npa/Lgr5tm1.1(cre/ERT2)Npa
(involves: C57BL/6)
|
abnormal epidermal stem cell proliferation
|
J:212415
|
decreased kidney cell proliferation
|
J:212415
|
Lgr4tm1.1Knis/Lgr4tm1.1Knis Lgr5tm2.1Cle/Lgr5tm2.1Cle Tg(Cyp1a1-cre)1Dwi/0
(involves: 129P2/OlaHsd * C57BL/6 * CBA)
|
abnormal small intestinal crypt cell proliferation
|
J:174842
|
Lgr4tm1.1Knis/Lgr4tm1.1Knis Tg(Cyp1a1-cre)1Dwi/0
(involves: 129P2/OlaHsd * C57BL/6 * CBA)
|
abnormal small intestinal crypt cell proliferation
|
J:174842
|
Lgr5tm1(cre/ERT2)Cle/Lgr5+ Stk26tm2.1Zzh/Stk26tm2.1Zzh
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal enterocyte proliferation
|
J:322311
|
Lhx5tm1Lmgd/Lhx5tm1Lmgd
(involves: 129S1/Sv * 129X1/SvJ * CD-1)
|
abnormal neuronal precursor proliferation
|
J:55103
|
Lhx9tm1Lmgd/Lhx9tm1Lmgd
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
decreased primordial germ cell proliferation
|
J:60621
|
Liftm1Phb/Lif+
(involves: 129S2/SvPas * C57BL/6 * DBA/2)
|
decreased T cell proliferation
|
J:77410
|
Liftm1Phb/Liftm1Phb
(involves: 129S2/SvPas * C57BL/6 * DBA/2)
|
decreased T cell proliferation
|
J:77410
|
Liftm1Stw/Liftm1Stw
(involves: 129S1/Sv * C57BL/6)
|
increased vascular endothelial cell proliferation
|
J:137720
|
Lig1tm1Dwm/Lig1tm1Dwm
(involves: 129P2/OlaHsd)
|
decreased fibroblast proliferation
|
J:75962
|
Lig1tm3Dwm/Lig1tm3Dwm
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased fibroblast proliferation
|
J:77902
|
Lig3tm1.1Pmc/Lig3tm1.1Pmc Tg(Nes-cre)1Kln/0
(involves: C57BL/6 * SJL)
|
abnormal neuronal precursor proliferation
|
J:170077
|
Lig4tiny/Lig4tiny
(C57BL/6-Lig4tiny)
|
decreased fibroblast proliferation
|
J:122725
|
Lig4tm1Fwa/Lig4tm1Fwa
(involves: 129S6/SvEvTac * C57BL/6)
|
decreased cell proliferation
|
J:50865
|
Lig4tm1Fwa/Lig4tm1Fwa Trp53tm1Brd/Trp53tm1Brd
(involves: 129S6/SvEvTac * 129S7/SvEvBrd)
|
increased fibroblast proliferation
|
J:63078
|
Lig4tm2.1Fwa/Lig4tm2.1Fwa
(involves: 129S6/SvEvTac)
|
decreased T cell proliferation
|
J:157574
|
Lims1tm1.2Chen/Lims1tm1.2Chen
(involves: 129S1/Sv * 129X1/SvJ * Black Swiss)
|
decreased cell proliferation
|
J:97635
|
Lin9Gt(RRI306)Byg/Lin9Gt(RRI306)Byg
(involves: 129P2/OlaHsd)
|
absent inner cell mass proliferation
|
J:162678
|
Llgl1tm1.1Vv/Llgl1tm1.1Vv
(Not Specified)
|
abnormal neuronal precursor proliferation
|
J:89028
|
Llgl1tm1Vv/Llgl1tm1Vv Meox2tm1(cre)Sor/Meox2+
(involves: 129 * 129S4/SvJaeSor * C57BL/6J)
|
abnormal neuronal precursor proliferation
|
J:89028
|
LmnaDhe/Lmna+
(B6(D2)-LmnaDhe/TyGrsrJ)
|
decreased fibroblast proliferation
|
J:171665
|
Lmnb1Gt(XA130)Byg/Lmnb1Gt(XA130)Byg
(involves: 129P2/OlaHsd * C57BL/6J)
|
decreased cell proliferation
|
J:91473
|
Lmnb1tm1Yxz/Lmnb1tm1Yxz
(involves: 129S4/SvJae * 129S6/SvEvTac * C57BL/6)
|
abnormal neuronal precursor proliferation
|
J:178993
|
Lmnb1tm1Yxz/Lmnb1tm1Yxz Lmnb2tm1Yxz/Lmnb2tm1Yxz
(involves: 129S4/SvJae * 129S6/SvEvTac * C57BL/6)
|
abnormal neuronal precursor proliferation
|
J:178993
|
Lmnb2tm1Ccof/Lmnb2tm1Ccof
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal neuronal precursor proliferation
|
J:158610
|
Lmnb2tm1Yxz/Lmnb2tm1Yxz
(involves: 129S4/SvJae * 129S6/SvEvTac * C57BL/6)
|
abnormal neuronal precursor proliferation
|
J:178993
|
Lmr7BALB/cHeA/?
(involves: BALB/cHeA * STS/A)
|
decreased splenocyte proliferation
|
J:108764
|
Lmr18BALB/cHeA/Lmr18BALB/cHeA
(involves: BALB/cHeA * STS/A)
|
decreased splenocyte proliferation
|
J:108764
|
Lmr18BALB/cHeA/Lmr18CcS20/Dem
(involves: BALB/cHeA * STS/A)
|
decreased splenocyte proliferation
|
J:108764
|
Lmx1adr-J/Lmx1adr-J
(involves: C3H * C57BL/6)
|
abnormal cell proliferation
|
J:1460
|
Lncucc1em1Bwu/Lncucc1em1Bwu
(C57BL/6-Lncucc1em1Bwu)
|
abnormal enterocyte proliferation
|
J:340220
|
Lrfn2Tg(CD2-Myb/en)5Kmw/Lrfn2+
(involves: C57BL/10 * CBA)
|
decreased T cell proliferation
|
J:126456
|
Lrfn2Tg(CD2-Myb/en)5Kmw/Lrfn2Tg(CD2-Myb/en)5Kmw
(involves: C57BL/10 * CBA)
|
decreased T cell proliferation
|
J:126456
|
Lrig1tm1Ita/Lrig1tm1Ita
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
increased keratinocyte proliferation
|
J:77286
|
Lrp5tm2Kry/Lrp5tm2Kry Tg(Vil1-cre)20Syr/0
(involves: C57BL/6 * DBA/2)
|
decreased osteoblast proliferation
|
J:146078
|
Lrrc8atm1.1Geha/Lrrc8atm1.1Geha
(B6.129S1(Cg)-Lrrc8atm1.1Geha)
|
decreased T cell proliferation
|
J:211308
|
Ltb4r1tm1Tksh/Ltb4r1tm1Tksh
(B6.Cg-Ltb4r1tm1Tksh)
|
decreased cell proliferation
|
J:118995
|
Ltftm1.2Smoc/Ltftm1.2Smoc
(involves: 129 * C57BL/6J)
|
increased cell proliferation
|
J:219007
|
Lumtm1Chak/Lumtm1Chak
(involves: 129S/Sv * CD-1)
|
increased fibroblast proliferation
|
J:89489
|
Ly6atm1Pmf/Ly6atm1Pmf
(B6.129P2-Ly6atm1Pmf)
|
abnormal T cell proliferation
|
J:42594
|
Ly9tm1Mckn/Ly9tm1Mckn
(involves: 129/Sv * C57BL/6)
|
decreased T cell proliferation
|
J:105482
|
Ly86tm1Kmiy/Ly86tm1Kmiy
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased B cell proliferation
|
J:109720
|
Ly96tm1Kmiy/Ly96tm1Kmiy
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased B cell proliferation
|
J:92494
|
LyarGt(RRG292)Byg/Lyar+
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased fibroblast proliferation
|
J:263530
|
LyarGt(RRG292)Byg/LyarGt(RRG292)Byg
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased fibroblast proliferation
|
J:263530
|
Lyntm1Sor/Lyntm1Sor
(involves: 129S4/SvJae)
|
increased B cell proliferation
|
J:42037
|
Lyntm1Sor/Lyntm1Sor
(involves: 129S4/SvJaeSor)
|
increased B cell proliferation
|
J:146161
|
Lyntm1Sor/Lyntm1Sor
(involves: 129S4/SvJaeSor * C57BL/6)
|
increased B cell proliferation
|
J:71174
|
Lyntm1Tya/Lyntm1Tya
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased B cell proliferation
|
J:29751
|
Lynweeb/Lynweeb
(C57BL/6-Lynweeb)
|
increased B cell proliferation
|
J:146161
|
Lztr1tm1a(EUCOMM)Wtsi/Lztr1+
(involves: C57BL/6N)
|
increased cell proliferation
|
J:268690
|
Lzts1tm1Cro/Lzts1tm1Cro
(involves: 129 * C57BL/6J)
|
decreased fibroblast proliferation
|
J:119989
|
X/m1Nish
(involves: C57BL/6N)
|
decreased T cell proliferation
|
J:204833
|
Mad2l1tm1Sorg/Mad2l1tm1Sorg
(involves: 129S2/SvPas * C57BL/6)
|
absent inner cell mass proliferation
|
J:62829
|
Mad2l1bptm1.2Itl/Mad2l1bptm1.2Itl
(involves: 129S6/SvEvTac * C57BL/6 * C57BL/6NTac)
|
decreased fibroblast proliferation
|
J:234643
|
Mad2l2repro22/Mad2l2repro22
(C3.B6(Cg)-Mad2l2repro22)
|
decreased cell proliferation
|
J:209515
|
Magtm1Rod/Magtm1Rod
(involves: 129S1/Sv * 129X1/SvJ)
|
increased B cell proliferation
|
J:217719
|
MagohMos2/Magoh+
(involves: BALB/cJ * C57BL/6J)
|
abnormal neuron proliferation
|
J:159625
|
Magt1Gt(IST13422E1)Tigm/Y
(involves: C57BL/6N)
|
increased B cell proliferation
|
J:260923
|
Malt1tm1Mak/Malt1tm1Mak
(involves: 129P2/OlaHsd)
|
decreased T cell proliferation
|
J:109545
|
Malt1tm1Vmd/Malt1tm1Vmd
(involves: C57BL/6N)
|
abnormal T cell proliferation
|
J:86770
|
Maml1tm1Mkit/Maml1tm1Mkit Maml3tm1Mkit/Maml3tm1Mkit
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal neuron proliferation
|
J:178680
|
Mamstrtm1.2Eno/Mamstrtm1.2Eno Mrtfatm1Eno/Mrtfatm1Eno
(involves: 129 * C57BL/6)
|
abnormal skeletal muscle satellite cell proliferation
|
J:179880
|
Map2k5tm1Ctr/Map2k5tm1Ctr
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
decreased cell proliferation
|
J:95388
|
Map3k2tm1Bisu/Map3k2tm1Bisu
(Not Specified)
|
increased T cell proliferation
|
J:78072
|
Map3k3tm1Bisu/Map3k3tm2Bisu Tg(Lck-cre)548Jxm/0
(involves: C57BL/6 * CBA)
|
abnormal T cell proliferation
|
J:145923
|
Map3k3tm1Kuro/Map3k3tm1Kuro Tg(Lck-cre)1Jtak/0
(involves: C57BL/6)
|
decreased T cell proliferation
|
J:147103
|
Map3k7tm1.1Aki/Map3k7tm1.1Aki
(involves: 129P2/OlaHsd * C57BL/6)
|
absent fibroblast proliferation
|
J:112597
|
Map3k7tm1Aki/Map3k7tm1Aki Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2)
|
increased hepatocyte proliferation
|
J:160521
|
Map3k7tm1Aki/Map3k7tm1Aki Tg(Alb1-cre)7Gsc/0
(involves: 129P2/OlaHsd * FVB/N)
|
increased hepatocyte proliferation
|
J:160521
|
Map3k7tm1Aki/Map3k7tm1Aki Tg(Lck-cre)1Jtak/0
(involves: 129P2/OlaHsd)
|
decreased T cell proliferation
|
J:112837
|
Map3k8tm1.1Gkl/Map3k8tm1.1Gkl Tg(Col6a1-cre)1Gkl/0
(involves: C57BL/6 * CBA * FVB/N)
|
abnormal enterocyte proliferation
|
J:193546
|
Map3k8tm1.2Gkl/Map3k8tm1.2Gkl
(involves: 129 * C57BL/6J * FVB/N)
|
abnormal enterocyte proliferation
|
J:193546
|
Map3k8tm1Tmat/Map3k8tm1Tmat
(involves: 129S/SvEv * C57BL/6)
|
increased T cell proliferation
|
J:92844
|
Map4k1tm1Tht/Map4k1tm1Tht
(involves: 129S7/SvEvBrd)
|
increased T cell proliferation
|
J:116613
|
Map4k3Gt(RRO270)Byg/Map4k3Gt(RRO270)Byg
(involves: 129P2/OlaHsd)
|
decreased T cell proliferation
|
J:177642
|
Mapk1tm1Hed/Mapk1tm1Hed Mapk3tm1Gpg/Mapk3tm1Gpg Tg(Lck-cre)1Cwi/0
(involves: 129/Sv * C57BL/6 * DBA/2)
|
abnormal T cell proliferation
|
J:113280
|
Mapk1tm1Hed/Mapk1tm1Hed Tg(Lck-cre)1Cwi/0
(involves: C57BL/6 * DBA/2)
|
decreased T cell proliferation
|
J:113280
|
Mapk1tm1Melo/Mapk1tm1Melo Tg(CAG-EGFP)B5Nagy/0
(chimera involves: 129S1/Sv * 129S2/SvPas * 129X1/SvJ * CD-1)
|
decreased fibroblast proliferation
|
J:162580
|
Mapk3tm1Gpg/Mapk3tm1Gpg
(involves: 129)
|
decreased T cell proliferation
|
J:58468
|
Mapk3tm1Gpg/Mapk3tm1Gpg
(involves: 129/Sv * C57BL/6 * CD-1)
|
decreased fibroblast proliferation
|
J:162580
|
Mapk8tm1Flv/Mapk8tm1Flv
(involves: 129S1/Sv)
|
increased T cell proliferation
|
J:51510
|
Mapk8tm1Flv/Mapk8tm1Flv Mapk9tm1.1Rjd/Mapk9tm1.1Rjd
(involves: 129S1/Sv * 129S6/SvEvTac * C57BL/6)
|
decreased fibroblast proliferation
|
J:112737
|
Mapk8tm1Rjd/Mapk8tm1Rjd Mapk9tm2.1Rjd/Mapk9tm2.1Rjd Lyz2tm1(cre)Ifo/Lyz2+
(B6J.Cg-Lyz2tm1(cre)Ifo Mapk9tm2.1Rjd Mapk8tm1Rjd)
|
decreased pancreatic beta cell proliferation
|
J:192551
|
Mapk8tm1Wag/Mapk8+ Mapk9tm1Mka/Mapk9+
(involves: 129)
|
decreased T cell proliferation
|
J:78190
|
Mapk8tm1Wag/Mapk8+ Mapk9tm1Mka/Mapk9tm1Mka
(involves: 129)
|
decreased T cell proliferation
|
J:78190
|
Mapk8tm1Wag/Mapk8tm1Wag
(involves: 129P2/OlaHsd)
|
decreased T cell proliferation
|
J:78190
|
Mapk8tm1Wag/Mapk8tm1Wag Mapk9tm1Mka/Mapk9+
(involves: 129)
|
decreased T cell proliferation
|
J:78190
|
Mapk9tm1Mka/Mapk9tm1Mka
(either: (involves: 129S2/SvPas) or (involves: 129S1/Sv * 129X1/SvJ))
|
decreased T cell proliferation
|
J:78129
|
Mapk11tm1Jda/Mapk11tm1Jda Mapk14tm1Jda/Mapk14tm1Jda
(involves: 129 * C57BL/6)
|
decreased T cell proliferation
|
J:165966
|
Mapk11tm1Jsca/Mapk11tm1Jsca
(involves: 129P2/OlaHsd)
|
increased fetal cardiomyocyte proliferation
|
J:176023
|
Mapk11tm1Jsca/Mapk11tm1Jsca Mapk14tm2Nbr/Mapk14tm2Nbr Edil3Tg(Sox2-cre)1Amc/Edil3+
(involves: 129P2/OlaHsd * C57BL/6 * CBA)
|
abnormal fetal cardiomyocyte proliferation
|
J:176023
|
abnormal neuron proliferation
|
J:176023
|
Mapk14tm1.1Dvb/Mapk14+
(B6(FVB)-Mapk14tm1.1Dvb)
|
decreased pancreatic beta cell proliferation
|
J:151980
|
increased pancreatic beta cell proliferation
|
J:151980
|
Mapk14tm1.1Lex/Mapk14tm1.1Lex
(involves: 129S4/SvJaeSor * 129S5/SvEvBrd * C57BL/6J)
|
increased myoblast proliferation
|
J:119724
|
Mapk14tm1Jda/Mapk14tm1Jda
(B6.Cg-Mapk14tm1Jda)
|
decreased T cell proliferation
|
J:146088
|
Mapk14tm1Lex/Mapk14tm1Lex Myl7tm1(cre)Krc/Myl7+
(involves: 129S1/Sv * 129S5/SvEvBrd * 129X1/SvJ * C57BL/6)
|
abnormal fetal cardiomyocyte proliferation
|
J:98514
|
Mapk14tm2Nbr/Mapk14tm2Nbr Polr2atm1(cre/ERT2)Bbd/Polr2a+
(involves: 129 * C57BL/6 * CD-1 * SJL)
|
increased cell proliferation
|
J:122397
|
Mapttm1(MAPT)Vln/Mapttm1(MAPT)Vln
(involves: FVB/N)
|
increased cell proliferation
|
J:129032
|
Marchf7Gt(ROSABetageo)1Summ/Marchf7+
(involves: BALB/c)
|
increased T cell proliferation
|
J:96167
|
Marchf7Gt(ROSABetageo)1Summ/Marchf7Gt(ROSABetageo)1Summ
(involves: BALB/c)
|
increased T cell proliferation
|
J:96167
|
Mark2tm1Hpw/Mark2tm1Hpw
(involves: 129X1/SvJ * C57BL/6)
|
decreased B cell proliferation
|
J:68830
|
increased B cell proliferation
|
J:68830
|
Mast4em1Sjkm/Mast4em1Sjkm
(C57BL/6J-Mast4em1Sjkm)
|
abnormal spermatogonia proliferation
|
J:340701
|
Mastltm1.1Mama/Mastltm1.1Mama
(Not Specified)
|
decreased fibroblast proliferation
|
J:201971
|
Matcap1em1Nki/Matcap1em1Nki Svbpem1Mjom/Svbpem1Mjom
(involves: C57BL/6)
|
decreased neuronal precursor proliferation
|
J:325393
|
Matn1tm1Ref/Matn1tm1Ref Matn2tm1Asz/Matn2tm1Asz Matn3tm1Asz/Matn3tm1Asz Matn4tm1.1Asz/Matn4tm1.1Asz
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
increased hematopoietic stem cell proliferation
|
J:237230
|
Matn3tm1Mbri/Matn3tm1Mbri
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
decreased chondrocyte proliferation
|
J:125104
|
Matn4tm1.1Asz/Matn4tm1.1Asz
(B6.129-Matn4tm1.1Asz)
|
increased hematopoietic stem cell proliferation
|
J:237230
|
Mau2tm1.1Hpt/Mau2tm1.1Hpt H2az2Tg(Wnt1-cre)11Rth/H2az2+
(involves: 129S2/SvPas * C57BL/6 * C57BL/6J * CBA/J * SJL)
|
decreased cranial neural crest cell proliferation
|
J:213338
|
Mavstm1Camb/Mavstm1Camb
(involves: 129S6/SvEvTac * C57BL/6)
|
decreased B cell proliferation
|
J:180356
|
Maxtm1Rdp/Maxtm1Rdp
(either: B6.Cg-Maxtm1Rdp or CD1.Cg-Maxtm1Rdp)
|
absent inner cell mass proliferation
|
J:59430
|
Mbd2tm1Bh/Mbd2tm1Bh
(NOD.129P2(B6)-Mbd2tm1Bh)
|
increased T cell proliferation
|
J:323838
|
Mbd3tm2Bh/Mbd3tm2Bh Tg(Vil1-cre)20Syr/0
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2)
|
abnormal small intestinal crypt cell proliferation
|
J:167984
|
Mbpshi/Mbpshi
(involves: BALB/c * C3HeB/Fe * SWV)
|
increased T cell proliferation
|
J:48412
|
Mcm2Gt(AB0178)Wtsi/Mcm2+ Mcm3Gt(RRR002)Byg/Mcm3+ Mcm4chaos3/Mcm4chaos3
(involves: 129P2/OlaHsd * C3HeB/FeJ * C57BL/6J)
|
decreased fibroblast proliferation
|
J:165667
|
Mcm2Gt(AB0178)Wtsi/Mcm2+ Mcm4chaos3/Mcm4chaos3
(involves: 129P2/OlaHsd * C3HeB/FeJ * C57BL/6J)
|
decreased fibroblast proliferation
|
J:165667
|
Mcm3tm1.1Geno/Mcm3tm1.1Geno
(involves: 129S2/SvPas * C57BL/6)
|
decreased hematopoietic stem cell proliferation
|
J:227638
|
Mcm3aptm1Imku/Mcm3aptm1Imku Cd19tm1(cre)Cgn/Cd19+
(involves: 129P2/OlaHsd * C57BL/6 * CBA)
|
decreased B cell proliferation
|
J:88276
|
Mcm4chaos3/Mcm4chaos3
(involves: C3HeB/FeJ * C57BL/6J)
|
decreased cell proliferation
|
J:117494
|
Mcm4chaos3/Mcm4Gt(RRE056)Byg
(B6.Cg-Mcm4chaos3 Mcm4Gt(RRE056)Byg)
|
decreased fibroblast proliferation
|
J:117494
|
Mcm4Gt(RRE056)Byg/Mcm4Gt(RRE056)Byg
(involves: 129P2/OlaHsd)
|
absent inner cell mass proliferation
|
J:117494
|
Mcm8tm1.1Geno/Mcm8tm1.1Geno
(involves: 129S2/SvPas * C57BL/6J)
|
decreased fibroblast proliferation
|
J:187623
|
Mcm9tm1.1Geno/Mcm9tm1.1Geno
(involves: 129S2/SvPas * C57BL/6J)
|
decreased fibroblast proliferation
|
J:187623
|
Mcm10tm1Hlee/Mcm10tm1Hlee
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased cell proliferation
|
J:177618
|
Mcph1tm1.1Zqw/Mcph1tm1.1Zqw
(Not Specified)
|
abnormal neuronal precursor proliferation
|
J:180706
|
Mcrs1tm1.1(KOMP)Vlcg/Mcrs1tm1.1(KOMP)Vlcg
(B6N(Cg)-Mcrs1tm1.1(KOMP)Vlcg/J)
|
decreased inner cell mass proliferation
|
J:285737
|
Mcutm1.1Jmol/Mcutm1.1Jmol Tg(Cdh5-cre)7Mlia/0
(involves: 129S6/SvEvTac * C57BL/6J * FVB/N)
|
decreased lung endothelial cell proliferation
|
J:235756
|
Mcur1tm1c(KOMP)Wtsi/Mcur1tm1c(KOMP)Wtsi Tg(Cdh5-cre)7Mlia/0
(involves: 129S4/SvJaeSor * C57BL/6N * FVB/N)
|
decreased lung endothelial cell proliferation
|
J:235756
|
Mdc1Gt(OST441263)Lex/Mdc1Gt(OST441263)Lex
(involves: 129S5/SvEvBrd * C57BL/6)
|
decreased cell proliferation
|
J:137341
|
Mdm2tm1.1Ypz/Mdm2tm1.1Ypz
(B6.129-Mdm2tm1.1Ypz)
|
increased cell proliferation
|
J:164200
|
Mdm2tm1Bay/Mdm2tm1Mep
(involves: 129S7/SvEvBrd * C57BL/6)
|
decreased cell proliferation
|
J:81065
|
Mdm2tm3.1Glo/Mdm2tm3.1Glo
(B6.129S6-Mdm2tm3.1Glo)
|
increased fibroblast proliferation
|
J:164201
|
Mdm4Gt(VICTR20)7Lex/Mdm4Gt(VICTR20)7Lex
(involves: 129S5/SvEvBrd)
|
decreased cell proliferation
|
J:77907
|
Mdm4Gt(VICTR20)7Lex/Mdm4Gt(VICTR20)7Lex
(involves: 129S5/SvEvBrd * 129S6/SvEvTac * C57BL/6 * FVB/N)
|
decreased cell proliferation
|
J:166152
|
Mdm4Gt(VICTR20)7Lex/Mdm4Gt(VICTR20)7Lex Trp53tm1Tyj/Trp53tm1Tyj
(involves: 129S2/SvPas * 129S5/SvEvBrd)
|
increased fibroblast proliferation
|
J:77907
|
Mdm4Gt(VICTR20)7Lex/Mdm4Gt(VICTR20)7Lex Trp53tm1Wahl/Trp53tm1Wahl
(involves: 129S5/SvEvBrd * C57BL/6)
|
decreased cell proliferation
|
J:108183
|
Mdm4Gt(VICTR20)7Lex/Mdm4Gt(VICTR20)7Lex Trp53tm3Wahl/Trp53tm3Wahl
(involves: 129S4/SvJae * 129S5/SvEvBrd)
|
decreased fibroblast proliferation
|
J:108183
|
Mdm4tm1Glo/Mdm4tm1Glo
(Not Specified)
|
decreased cell proliferation
|
J:71532
|
Mdm4tm1Zmy/Mdm4tm1Zmy
(involves: 129 * C57BL/6)
|
decreased cell proliferation
|
J:174359
|
Med1tm1Rgr/Med1tm1Rgr
(either: (involves: 129P2/OlaHsd * C57BL/6J) or (involves: 129P2/OlaHsd * 129X1/SvJ))
|
decreased fibroblast proliferation
|
J:61840
|
Med1tm2Rgr/Med1tm2Rgr
(B6.129P2-Med1tm2Rgr)
|
decreased mammary gland epithelial cell proliferation
|
J:159303
|
Med28tm1.2Vra/Med28tm1.2Vra
(involves: 129S4/SvJae * C57BL/6)
|
absent inner cell mass proliferation
|
J:243694
|
Med31l11Jus15/Med31l11Jus15
(involves: 129S5/SvEvBrd * C57BL/6J)
|
decreased cell proliferation
|
J:161417
|
decreased fibroblast proliferation
|
J:161417
|
Mef2ctm1Jjs/Mef2ctm1Jjs Tg(Slc5a2-cre)1Tauc/0
(involves: 129S6/SvEvTac * C57BL/6 * DBA/2)
|
increased kidney cell proliferation
|
J:158762
|
Mettm1Sst/Mettm1Sst Tg(Pdx1-cre)89.1Dam/0
(involves: 129P2/OlaHsd * C57BL/6 * CBA)
|
decreased pancreatic beta cell proliferation
|
J:196854
|
Metap2tm1.2Ccr/Metap2tm1.2Ccr
(involves: 129S6/SvEvTac * C57BL/6 * FVB/N)
|
decreased cell proliferation
|
J:111701
|
Mex3atm1.1(KOMP)Vlcg/Mex3atm1.1(KOMP)Vlcg
(involves: 129S4/SvJaeSor * C57BL/6J * C57BL/6NTac)
|
abnormal small intestinal crypt cell proliferation
|
J:287423
|
Mfngtm1.1Cfg/Mfngtm1.1Cfg
(involves: C57BL/6)
|
increased B cell proliferation
|
J:217719
|
Mgat3tm1Pst/Mgat3tm1Pst
(involves: 129/Sv * C57BL/6 * CD-1 * SJL)
|
decreased hepatocyte proliferation
|
J:86643
|
Miftm1Gfr/Miftm1Gfr
(C57BL/6-Miftm1Gfr)
|
decreased fibroblast proliferation
|
J:147772
|
Miftm2Gfr/Miftm2Gfr
(C57BL/6-Miftm2Gfr)
|
decreased fibroblast proliferation
|
J:147772
|
Mir24-1em1Smoc/Mir24-1em1Smoc Mir24-2em1Smoc/Mir24-2em1Smoc Tg(KRT14-cre)1Amc/0
(involves: C57BL/6J * CBA)
|
increased keratinocyte proliferation
|
J:306624
|
Mir26a-1em1Xfu/Mir26a-1em1Xfu Mir26a-2em1Xfu/Mir26a-2em1Xfu
(involves: C57BL/6)
|
increased pancreatic beta cell proliferation
|
J:286108
|
Mir34atm1.1Aven/Mir34atm1.1Aven
(involves: 129S4/SvJae * C57BL/6)
|
abnormal neuronal precursor proliferation
|
J:180144
|
Mir139em1Jwli/Mir139em1Jwli
(C57BL/6J-Mir139em1Jwli)
|
abnormal enterocyte proliferation
|
J:280467
|
Mir149em1Ydw/Mir149em1Ydw
(C57BL/6J-Mir149em1Ydw)
|
increased hepatocyte proliferation
|
J:294318
|
Mir184tm1Ics/Mir184tm1Ics
(Not Specified)
|
increased pancreatic beta cell proliferation
|
J:210552
|
Mir185em1Smoc/Mir185em1Smoc
(Not Specified)
|
increased osteoblast proliferation
|
J:278853
|
Mirc1tm1.1Tyj/Mirc1tm1.1Tyj Pkd1tm1.1Pcha/Pkd1tm2Som Tg(Cdh16-cre)91Igr/0
(involves: 129 * 129S4/SvJae * C57BL/6 * ICR)
|
decreased kidney cell proliferation
|
J:244067
|
Mirc1tm1.1Tyj/Mirc1tm1.1Tyj Pkd1tm2Som/Pkd1tm2Som Tg(Cdh16-cre)91Igr/0
(involves: 129S4/SvJae * C57BL/6 * ICR)
|
decreased kidney cell proliferation
|
J:244067
|
Mirc1tm1.1Tyj/Mirc1tm1.1Tyj Pkd2tm3Som/Pkd2tm3Som Tg(Pkhd1-cre)1Igr/0
(involves: 129S4/SvJae * C57BL/6)
|
decreased kidney cell proliferation
|
J:244067
|
Mirc14tm1.2Flv/Mirc14tm1.2Flv
(involves: C57BL/6 * C57BL/6N * FVB/N * SJL)
|
decreased T cell proliferation
|
J:203157
|
Mirc21tm1.1Kry/Mirc21tm1.1Kry Tg(Col1a1-cre)1Kry/0
(involves: 129S4/SvJaeSor * 129S6/SvEvTac * FVB/N)
|
increased osteoblast proliferation
|
J:185130
|
Mirc30tm1.2Rdf/Mirc30tm1.2Rdf
(involves: 129S1/Sv * 129S4/SvJaeSor * C57BL/6)
|
abnormal B cell proliferation
|
J:156946
|
Mirc55tm1.1Eno/Mirc55tm1.1Eno
(Not Specified)
|
decreased vascular endothelial cell proliferation
|
J:139708
|
Mis18atm1.1Kiik/Mis18atm1.2Kiik
(B6(129S)-Mis18atm1.1Kiik/Mis18atm1.2Kiik)
|
decreased fibroblast proliferation
|
J:188023
|
Mis18atm1.2Kiik/Mis18atm1.2Kiik
(B6(129S)-Mis18atm1.2Kiik)
|
decreased inner cell mass proliferation
|
J:188023
|
Mispem1Nsas/Mispem1Nsas
(FVB/NJcl-Mispem1Nsas)
|
abnormal enterocyte proliferation
|
J:333842
|
Mks1tm1a(EUCOMM)Wtsi/Mks1tm1a(EUCOMM)Wtsi
(involves: C57BL/6 * C57BL/6N)
|
increased cell proliferation
|
J:196290
|
increased kidney cell proliferation
|
J:196290
|
MmachcGt(AZ0348)Wtsi/MmachcGt(AZ0348)Wtsi
(involves: 129P2/OlaHsd * 129S6/SvEvTac * C57BL/6)
|
decreased trophectoderm cell proliferation
|
J:212387
|
Mmp9tm1Tvu/Mmp9tm1Tvu
(involves: 129S6/SvEvTac * C57BL/6)
|
increased T cell proliferation
|
J:88065
|
Mmp9tm1Tvu/Mmp9tm1Tvu Tg(KRT14-HPV16)wt1Dh/0
(involves: 129S6/SvEvTac * C57BL/6 * DBA/2 * FVB/N)
|
decreased keratinocyte proliferation
|
J:65699
|
Mmp13tm1Jdar/Mmp13tm1Jdar
(B6.129S-Mmp13tm1Jdar)
|
decreased cell proliferation
|
J:150790
|
Mmp13tm1Jdar/Mmp13tm1Jdar Mmp9tm1Tvu/Mmp9tm1Tvu
(involves: 129S6/SvEvTac * C57BL/6J * FVB/N)
|
decreased cell proliferation
|
J:150790
|
Mmp14tm1Ski/Mmp14tm1Ski
(B6.Cg-Mmp14tm1Ski)
|
decreased kidney cell proliferation
|
J:165029
|
Mmp19tm1Rase/Mmp19tm1Rase
(B6.129P2-Mmp19tm1Rase)
|
decreased T cell proliferation
|
J:137128
|
Mob1atm1.1Asuz/Mob1atm1.1Asuz Mob1bGt(CC0690)Wtsi/Mob1bGt(CC0690)Wtsi Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(B6.Cg-Mob1bGt(CC0690)Wtsi Mob1atm1.1Asuz Speer6-ps1Tg(Alb-cre)21Mgn)
|
increased hepatocyte proliferation
|
J:228499
|
Mob1atm1.1Asuz/Mob1atm1.1Asuz Mob1bGt(CC0690)Wtsi/Mob1bGt(CC0690)Wtsi Tg(KRT14-cre/ERT)20Efu/0
(involves: 129P2/OlaHsd * C57BL/6 * CD-1)
|
increased keratinocyte proliferation
|
J:193981
|
Mob1atm1.2Asuz/Mob1atm1.2Asuz Mob1bGt(CC0690)Wtsi/Mob1bGt(CC0690)Wtsi
(involves: 129P2/OlaHsd * C57BL/6)
|
absent inner cell mass proliferation
|
J:193981
|
Mocosem2(IMPC)Ics/Mocosem2(IMPC)Ics
(involves: C57BL/6N)
|
increased kidney cell proliferation
|
J:336718
|
Mogtm1Reid/Mogtm1Reid
(129/Sv-Mogtm1Reid)
|
increased T cell proliferation
|
J:86663
|
Mol1BALB/cByJ/Mol1BALB/cByJ
(involves: BALB/cByJ * C57BL/6ByJ)
|
decreased B cell proliferation
|
J:58921
|
Morf4l1tm1Kto/Morf4l1tm1Kto
(involves: 129S7/SvEvBrd)
|
decreased cell proliferation
|
J:97640
|
MpiGt(OST90588)Lex/MpiGt(OST90588)Lex
(involves: 129S5/SvEvBrd * C57BL/6)
|
abnormal cell proliferation
|
J:109220
|
Mpltm2.1Wsa/Mpltm2.1Wsa Tg(Pf4-icre)Q3Rsko/0
(involves: C57BL/6)
|
increased hematopoietic stem cell proliferation
|
J:208120
|
Mpztm3.1Wra/Mpz+
(FVB.129S2(Cg)-Mpztm3.1Wra)
|
increased Schwann cell proliferation
|
J:241742
|
Mpztm3.1Wra/Mpztm3.1Wra
(FVB.129S2(Cg)-Mpztm1.1Wra)
|
increased Schwann cell proliferation
|
J:241742
|
Mre11atm1Dof/Mre11atm2.1Dof
(involves: 129S6/SvEvTac)
|
decreased cell proliferation
|
J:147247
|
Mre11atm2.1Dof/Mre11atm2.2Dof
(Not Specified)
|
decreased cell proliferation
|
J:147247
|
Mrps12em1.2Afi/Mrps12em1.2Afi
(B6N(Cg)-Mrps12em1.2Afi)
|
increased hepatocyte proliferation
|
J:284101
|
Mt1tm1Bri/Mt1tm1Bri Mt2tm1Bri/Mt2tm1Bri
(129S7/SvEvBrd-Mt1tm1Bri Mt2tm1Bri/J)
|
decreased hepatocyte proliferation
|
J:109814
|
Mta2tm1.1Yzha/Mta2tm1.1Yzha
(involves: 129S4/SvJae * C57BL/6 * FVB/N)
|
increased kidney cell proliferation
|
J:137101
|
increased T cell proliferation
|
J:137101
|
Mta2tm1Yzha/Mta2tm1Yzha Tg(Lck-cre)#Zhu/0
(involves: 129S4/SvJae * C57BL/6 * SJL)
|
increased T cell proliferation
|
J:137101
|
Mtdhtm1.2Dsar/Mtdhtm1.2Dsar
(either: B6.129(FVB)-Mtdhtm1.2Dsar or (129S1/Sv * 129X1/SvJ * C57BL/6 * FVB/N))
|
decreased macrophage proliferation
|
J:216688
|
MtorGt(OST92090)Lex/MtorGt(OST92090)Lex
(involves: 129S5/SvEvBrd)
|
absent inner cell mass proliferation
|
J:137592
|
Mtortm1.2Koz/Mtortm1.2Koz Tg(Cd4-cre)1Cwi/0
(involves: 129S4/SvJae * C57BL/6 * DBA/2)
|
decreased T cell proliferation
|
J:150108
|
Mtortm1Lgm/Mtortm1Lgm
(involves: 129S1/Sv * C57BL/6)
|
decreased B cell proliferation
|
J:168600
|
decreased splenocyte proliferation
|
J:168600
|
Mtortm1Yam/Mtortm1Yam
(involves: 129S4/SvJae)
|
absent inner cell mass proliferation
|
J:92252
|
Mtss1Gt(RRI034)Byg/Mtss1Gt(RRI034)Byg
(involves: 129P2/OlaHsd * C57BL/6)
|
increased kidney cell proliferation
|
J:158762
|
Mtus1Gt(RRA048)Byg/Mtus1Gt(RRA048)Byg
(involves: 129P2/OlaHsd * C57BL/6)
|
increased cell proliferation
|
J:212144
|
Muc2eey/Muc2eey
(C57BL/6-Muc2eey)
|
abnormal enterocyte proliferation
|
J:194148
|
Muc2tm1Avel/Muc2tm1Avel
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal enterocyte proliferation
|
J:75047
|
increased cell proliferation
|
J:75047
|
Muc2wnn/Muc2wnn
(C57BL/6-Muc2wnn)
|
abnormal enterocyte proliferation
|
J:194148
|
Muc13tm1.1Mamg/Muc13tm1.1Mamg
(involves: 129 * C57BL/6)
|
abnormal enterocyte proliferation
|
J:313870
|
Mus81tm1Chmg/Mus81tm1Chmg
(involves: 129S4/SvJae * 129S5/SvEvBrd * C57BL/6)
|
decreased cell proliferation
|
J:100407
|
Mxi1tm1Rdp/Mxi1tm1Rdp
(involves: 129/Sv * C57BL/6J * SJL)
|
increased T cell proliferation
|
J:48236
|
Mybl2tm1.1Epr/Mybl2tm1.1Epr Tg(Mx1-cre)1Cgn/0
(involves: 129X1/SvJ * C57BL/6 * CBA * FVB/N)
|
decreased hematopoietic stem cell proliferation
|
J:206816
|
Myctm1.1Itl/Myctm1.1Itl
(involves: 129S6/SvEvTac * C57BL/6NTac)
|
abnormal enterocyte proliferation
|
J:188927
|
Myctm1Atp/Myc+
(involves: 129P2/OlaHsd * FVB/N)
|
decreased fibroblast proliferation
|
J:73369
|
decreased T cell proliferation
|
J:73369
|
Myctm1Atp/Myc+
(B6.129P2-Myctm1Atp)
|
decreased T cell proliferation
|
J:132730
|
Myctm1Atp/Myctm1Atp
(involves: 129P2/OlaHsd * FVB/N)
|
absent fibroblast proliferation
|
J:73369
|
Myctm1Atp/Myctm2.1Atp
(involves: 129P2/OlaHsd * C57BL/6 * FVB/N * SJL)
|
decreased T cell proliferation
|
J:73369
|
Myctm1Jlc/Myctm1Jlc
(involves: 129S7/SvEvBrd)
|
decreased cell proliferation
|
J:79427
|
Myctm1Lbox/Myctm1Lbox
(involves: 129S1/Sv * 129X1/SvJ * FVB/N)
|
increased B cell proliferation
|
J:97900
|
Myctm2.1Atp/Myc+
(involves: 129P2/OlaHsd * C57BL/6 * SJL)
|
decreased T cell proliferation
|
J:73369
|
Myctm2.1Atp/Myctm2.1Atp Tg(Mx1-cre)1Cgn/0
(involves: 129P2/OlaHsd * C57BL/6 * CBA * FVB/N * SJL)
|
absent fibroblast proliferation
|
J:73369
|
Myctm2Fwa/Myctm2Fwa Cd19tm1(cre)Cgn/Cd19+
(involves: 129P2/OlaHsd * 129S6/SvEvTac)
|
decreased B cell proliferation
|
J:67222
|
Mycntm1Jrt/Mycntm1Par
(involves: 129S2/SvPas * C57BL/6J)
|
abnormal fetal cardiomyocyte proliferation
|
J:15281
|
Mycntm1Psk/Mycntm1Psk Tg(Nes-cre)1Kln/0
(involves: 129 * C57BL/6 * SJL)
|
abnormal neuronal precursor proliferation
|
J:79489
|
Myd88tm1Aki/Myd88tm1Aki
(Not Specified)
|
decreased B cell proliferation
|
J:96773
|
Myf5tm2Tajb/Myf5tm2Tajb
(involves: 129S2/SvPas)
|
abnormal skeletal muscle satellite cell proliferation
|
J:128921
|
Myh10tm2Rsad/Myh10tm2Rsad
(involves: 129S4/SvJae)
|
decreased fetal cardiomyocyte proliferation
|
J:92230
|
Myh11tm1.1Dmmz/Myh11tm1.1Dmmz
(involves: 129S/SvEv * 129S4/SvJaeSor * C57BL/6)
|
increased vascular smooth muscle cell proliferation
|
J:212664
|
Myt1lem1Jdd/Myt1l+
(C57BL/6-Myt1lem1Jdd/J)
|
decreased neuronal precursor proliferation
|
J:321206
|
Nab1tm1Jmi/Nab1tm1Jmi Nab2tm1Jmi/Nab2tm1Jmi
(involves: 129X1/SvJ)
|
increased keratinocyte proliferation
|
J:99824
|
increased Schwann cell proliferation
|
J:99824
|
Nacatm1Dsr/Nacatm1Dsr
(129S6/SvEvTac-Nacatm1Dsr)
|
abnormal fetal cardiomyocyte proliferation
|
J:167169
|
Nae1tm1c(EUCOMM)Wtsi/Nae1tm1c(EUCOMM)Wtsi Tg(Myh6-cre)2182Mds/0
(involves: C57BL/6J * C57BL/6N * FVB/N * SJL)
|
decreased fetal cardiomyocyte proliferation
|
J:261328
|
Nap1l1em1Jwji/Nap1l1em1Jwji
(Not Specified)
|
decreased neuronal precursor proliferation
|
J:263406
|
Nbntm1Nus/Nbntm1Nus
(involves: 129 * C57BL/6)
|
decreased inner cell mass proliferation
|
J:68993
|
Nbntm1Nus/Nbntm2Nus Tg(CD19-cre/ERT2)1Cgn/0
(Not Specified)
|
decreased B cell proliferation
|
J:96102
|
Nbntm1Xu/Nbntm1Xu
(Not Specified)
|
decreased fibroblast proliferation
|
J:75272
|
Nbntm1Zqw/Nbntm1Zqw
(involves: 129S2/SvPas * C57BL/6)
|
absent inner cell mass proliferation
|
J:86563
|
Ncam2tm1.1Bdrt/Ncam2tm1.1Bdrt
(involves: 129S4/SvJae * C57BL/6)
|
abnormal neuron proliferation
|
J:233502
|
Ncapg2tm1Jdc/Ncapg2tm1Jdc
(involves: 129S1/Sv * C57BL/6)
|
absent inner cell mass proliferation
|
J:87685
|
Nckap1lm1Iri/Nckap1lm1Iri
(involves: C57BL/6)
|
decreased T cell proliferation
|
J:141377
|
Ncoa3tm1Jxu/Ncoa3tm1Jxu
(involves: 129S6/SvEvTac * C57BL/6J)
|
increased B cell proliferation
|
J:109522
|
increased T cell proliferation
|
J:109522
|
Ncoa3tm1Jxu/Ncoa3tm1Jxu Tg(MMTV-vHaras)SH1Led/0
(involves: 129S6/SvEvTac * C57BL/6J * CD-1)
|
decreased mammary gland epithelial cell proliferation
|
J:88789
|
Ncoa3tm1Rsd/Ncoa3tm1Rsd
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
decreased cell proliferation
|
J:66454
|
Ncoa4tm1Msnt/Ncoa4tm1Msnt
(B6.Cg-Ncoa4tm1Msnt)
|
decreased fibroblast proliferation
|
J:215322
|
Ncoa5tm1Hxia/Ncoa5+
(involves: 129 * C57BL/6)
|
increased hepatocyte proliferation
|
J:207622
|
Ncoa6tm1.1Jkr/Ncoa6tm1.1Jkr
(involves: 129P2/OlaHsd * C57BL/6 * FVB/N)
|
abnormal fetal cardiomyocyte proliferation
|
J:81217
|
Ncoa6tm1Hhs/Ncoa6tm1Hhs
(either: 129S6/SvEvTac or (involves: 129S6/SvEvTac * C57BL/6))
|
decreased fibroblast proliferation
|
J:91083
|
Ncoa6tm1Jxu/Ncoa6tm1Jxu
(involves: 129S6/SvEvTac * C57BL/6)
|
decreased fetal cardiomyocyte proliferation
|
J:80175
|
Ncor2tm1Rsd/Ncor2tm1Rsd
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal neuronal precursor proliferation
|
J:127720
|
Ndfip1Gt(RRD002)Byg/Ndfip1Gt(RRD002)Byg
(involves: 129P2/OlaHsd * C57BL/6)
|
increased T cell proliferation
|
J:116617
|
Ndfip1Gt(RRD002)Byg/Ndfip1Gt(RRD002)Byg
(involves: 129P2/OlaHsd)
|
increased T cell proliferation
|
J:205692
|
Ndor1Tg(UBC-cre/ERT2)1Ejb/Ndor1+ Rnpc3tm1c(EUCOMM)Wtsi/Rnpc3tm1c(EUCOMM)Wtsi
(involves: 129S/SvEv * C57BL/6 * C57BL/6N)
|
abnormal enterocyte proliferation
|
J:267519
|
abnormal small intestinal crypt cell proliferation
|
J:267519
|
Ndor1Tg(UBC-cre/ERT2)1Ejb/Ndor1+ Stag2tm1.1Alos/Y
(involves: 129S6/SvEvTac * C57BL/6NCrl)
|
abnormal enterocyte proliferation
|
J:298088
|
decreased fibroblast proliferation
|
J:298088
|
Ndor1Tg(UBC-cre/ERT2)1Ejb/Ndor1+ Stag2tm1.1Alos/Stag2tm1.1Alos
(involves: 129S6/SvEvTac * C57BL/6NCrl)
|
abnormal enterocyte proliferation
|
J:298088
|
decreased fibroblast proliferation
|
J:298088
|
Ndrg2tm1Kmori/Ndrg2+
(involves: C57BL/6 * C57BL/6NCrlj * CBA/JNCrlj)
|
increased fibroblast proliferation
|
J:210264
|
Ndrg2tm1Kmori/Ndrg2tm1Kmori
(involves: C57BL/6 * C57BL/6NCrlj * CBA/JNCrlj)
|
increased fibroblast proliferation
|
J:210264
|
Ndst1tm1Je/Ndst1tm1Je Tg(Tek-cre)1Ywa/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL)
|
decreased endothelial cell proliferation
|
J:208012
|
Neat1tm1.1Shna/Neat1tm1.1Shna
(involves: C57BL/6NCrlj * CBA/JNCrlj)
|
decreased mammary gland epithelial cell proliferation
|
J:228123
|
Nedd4Gt(XA209)Byg/Nedd4Gt(XA209)Byg
(involves: 129P2/OlaHsd)
|
decreased fibroblast proliferation
|
J:207675
|
decreased T cell proliferation
|
J:143560
|
Nedd4Gt(XB398)Byg/Nedd4Gt(XB398)Byg
(involves: 129P2/OlaHsd)
|
decreased T cell proliferation
|
J:143560
|
Neil3tm1Bjor/Neil3tm1Bjor
(involves: 129 * C57BL/6)
|
abnormal neuronal precursor proliferation
|
J:180177
|
Neurog2tm4Fgu/Neurog2tm4Fgu
(involves: MF1)
|
abnormal neuronal precursor proliferation
|
J:134976
|
Neurog3tm1Fgu/Neurog3tm3.1Ggr Tg(Vil1-cre)20Syr/0
(involves: 129S2/SvPas * C57BL/6 * CD-1 * DBA/2 * SJL)
|
abnormal small intestinal crypt cell proliferation
|
J:161480
|
Neurog3tm3.1Ggr/Neurog3tm3.1Ggr Tg(Vil1-cre)20Syr/0
(involves: 129S2/SvPas * C57BL/6 * CD-1 * DBA/2 * SJL)
|
abnormal small intestinal crypt cell proliferation
|
J:161480
|
Nf1tm1Fcr/Nf1+ Tg(GFAP-cre)#Gtm/0
(involves: 129S/SvEv * 129S4/SvJae * C57BL/6 * CBA)
|
abnormal neuron proliferation
|
J:176586
|
Nf1tm1Par/Nf1tm1Par Rnf7Gt(XE423)Byg/Rnf7Gt(XE423)Byg
(involves: 129 * C57BL/6)
|
decreased cell proliferation
|
J:178926
|
Nf1tm1Par/Nf1tm1Par Tg(Fabp7-cre,-lacZ)3Gtm/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA)
|
abnormal neuronal precursor proliferation
|
J:139866
|
Nf1tm1Par/Nf1tm1Par Tg(Prrx1-cre)1Cjt/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * SJL/J)
|
increased myoblast proliferation
|
J:173779
|
Nfat5tm1Skc/Nfat5tm1Skc
(involves: 129S7/SvEvBrd * C57BL/6)
|
abnormal fetal cardiomyocyte proliferation
|
J:175527
|
Nfat5tm1Snh/Nfat5+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
decreased T cell proliferation
|
J:91482
|
Nfatc1tm1Rao/Nfatc1tm1Rao Cd79atm1(cre)Reth/Cd79a+
(involves: BALB/c)
|
decreased B cell proliferation
|
J:177319
|
Nfatc1tm1Rao/Nfatc1tm1Rao Tg(Fcer2a-cre)5Mbu/0
(involves: C57BL/6 * CBA)
|
decreased B cell proliferation
|
J:177319
|
Nfe2l2tm1Mym/Nfe2l2tm1Mym
(involves: 129P2/OlaHsd * ICR)
|
increased kidney cell proliferation
|
J:104016
|
Nfe2l2tm1Ywk/Nfe2l2tm1Ywk
(involves: 129X1/SvJ)
|
decreased hepatocyte proliferation
|
J:130473
|
Nfkb1tm1Bal/Nfkb1tm1Bal
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased B cell proliferation
|
J:37184,
J:30268
|
Nfkb1tm1Brv/Nfkb1tm1Brv
(involves: 129S1/Sv)
|
decreased T cell proliferation
|
J:46912
|
increased B cell proliferation
|
J:46912
|
Nfkb1tm1Sley/Nfkb1tm1Sley
(involves: 129S4/SvJae * 129S8/SvEv)
|
decreased T cell proliferation
|
J:142340
|
Nfkb2Lym1/Nfkb2Lym1
(involves: BALB/c)
|
decreased B cell proliferation
|
J:154812
|
Nfkb2tm1Brv/Nfkb2tm1Brv
(involves: 129S1/Sv * C57BL/6)
|
increased B cell proliferation
|
J:43469
|
increased T cell proliferation
|
J:43469
|
Nfkb2tm2Brv/Nfkb2tm2Brv
(involves: 129S1/Sv * C57BL/6)
|
decreased B cell proliferation
|
J:76380
|
Nfkbiatm1.1Pjc/Nfkbiatm1.1Pjc
(involves: C57BL/6)
|
increased T cell proliferation
|
J:163686
|
Nfkbiatm1.1Smiy/Nfkbiatm1.1Smiy
(B6.129-Nfkbiatm1.1Smiy)
|
decreased B cell proliferation
|
J:168977
|
Nfkbiatm1Fey/Nfkbiatm1Fey
(involves: 129S6/SvEvTac * C57BL/6)
|
decreased T cell proliferation
|
J:110817
|
increased B cell proliferation
|
J:110817
|
Nfkbidm1Btlr/Nfkbidm1Btlr
(involves: C57BL/6J)
|
decreased B cell proliferation
|
J:185495
|
Nfkbidtm1Clay/Nfkbidtm1Clay
(involves: 129S6/SvEvTac * C57BL/6)
|
decreased T cell proliferation
|
J:132071
|
Nfyatm1Mait/Nfyatm1.1Mait
(involves: C57BL/6)
|
decreased fibroblast proliferation
|
J:87090
|
Ngfrtm1Jae/Ngfrtm1Jae Plgtm1Jld/Plgtm1Jld
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6)
|
increased hepatocyte proliferation
|
J:120368
|
Niban3tm1Jyw/Niban3tm1Jyw
(B6.Cg-Niban3tm1Jyw)
|
increased B cell proliferation
|
J:282961
|
Nipbltm1.1Hpt/Nipbltm1.1Hpt H2az2Tg(Wnt1-cre)11Rth/H2az2+
(involves: 129S2/SvPas * C57BL/6 * C57BL/6J * CBA/J * SJL)
|
decreased cranial neural crest cell proliferation
|
J:213338
|
Nkx2-3tm1Hha/Nkx2-3tm1Hha
(involves: 129S4/SvJae * C57BL/6)
|
abnormal cell proliferation
|
J:54198
|
Nkx2-5tm1.1Gum/Nkx2-5tm1.1Gum Tg(CAG-cre/Esr1*)5Amc/0
(involves: C57BL/6J)
|
decreased cell proliferation
|
J:228275
|
Nkx2-5tm1Siz/Nkx2-5tm1Siz
(involves: 129S4/SvJaeSor * C57BL/6J)
|
decreased cell proliferation
|
J:69976
|
Nkx2-5tm1Siz/Nkx2-5tm1Siz Nkx2-6tm1Siz/Nkx2-6tm1Siz
(involves: 129S1/Sv * 129S4/SvJaeSor * 129X1/SvJ * C57BL/6J)
|
decreased cell proliferation
|
J:69976
|
Nkx3-1tm1Hha/Nkx3-1tm1Hha
(involves: 129S4/SvJae * C57BL/6)
|
increased cell proliferation
|
J:63764
|
Nkx3-2tm1Tno/Nkx3-2tm1Tno
(involves: 129S4/SvJae * C57BL/6J)
|
decreased cell proliferation
|
J:77612
|
Nlrp3tm3.1Hhf/Nlrp3+
(involves: 129)
|
decreased cell proliferation
|
J:202147
|
Nlrp6tm1Macha/Nlrp6tm1Macha
(involves: 129S5/SvEvBrd * C57BL/6J)
|
abnormal enterocyte proliferation
|
J:173352
|
Nmt1tm1.1Poru/Nmt1tm1.1Poru Nmt2tm1.1Poru/Nmt2tm1.1Poru Tg(Lck-cre)1Cwi/0
(involves: C57BL/6 * DBA/2 * SJL)
|
decreased splenocyte proliferation
|
J:226234
|
decreased T cell proliferation
|
J:226234
|
Noc2ltm1.1Arte/Noc2ltm1.1Arte Tg(CD2-icre)4Kio/0
(involves: C57BL/6 * C57BL/10 * CBA/Ca)
|
abnormal T cell proliferation
|
J:216490
|
Nol3tm1.1Rnkt/Nol3tm1.1Rnkt
(B6.129-Nol3tm1.1Rnkt)
|
decreased cell proliferation
|
J:193803
|
NonoGt(YHA266)Byg/Y
(involves: 129P2/OlaHsd * C57BL/6J)
|
increased fibroblast proliferation
|
J:193286
|
NonoGt(YHA266)Byg/Y
(involves: 129P2/OlaHsd)
|
increased fibroblast proliferation
|
J:294120
|
Nos2tm1Lau/Nos2tm1Lau
(involves: 129P2/OlaHsd * C57BL/6)
|
increased T cell proliferation
|
J:90903
|
Nos2tm1Liew/Nos2tm1Liew
(involves: 129P2/Ola * MF1)
|
increased T cell proliferation
|
J:25755
|
Nos3tm1Plh/Nos3tm1Plh
(involves: 129S4/SvJae * C57BL/6)
|
abnormal neuronal precursor proliferation
|
J:101302
|
Nos3tm1Unc/Nos3tm1Unc
(B6.129P2-Nos3tm1Unc/J)
|
decreased kidney cell proliferation
|
J:148626
|
Nostrintm1.1Oess/Nostrintm1.1Oess
(B6.129S2(Cg)-Nostrintm1.1Oess)
|
decreased vascular endothelial cell proliferation
|
J:188414
|
Nostrintm1Oess/Nostrintm1Oess Tg(Tek-cre)12Flv/0
(involves: 129S2/SvPas * C3H * C57BL/6)
|
decreased vascular endothelial cell proliferation
|
J:188414
|
Notch2tm1Grid/Notch2tm1Grid
(involves: 129S1/Sv * C57BL/6J)
|
decreased kidney cell proliferation
|
J:67157
|
Notch3em1Ecan/Notch3+
(C57BL/6J-Notch3em1Ecan)
|
increased osteoblast proliferation
|
J:270682
|
Npffr2tm1.2Ics/Npffr2tm1.2Ics
(involves: C57BL/6N)
|
decreased macrophage proliferation
|
J:245025
|
Npm1Gt(VICTR37)704Lex/Npm1Gt(VICTR37)704Lex
(involves: 129S5/SvEvBrd * C57BL/6)
|
abnormal cell proliferation
|
J:101353
|
Npm1Gt(VICTR37)704Lex/Npm1Gt(VICTR37)704Lex Trp53tm1Tyj/Trp53tm1Tyj
(involves: 129S2/SvPas * 129S5/SvEvBrd * C57BL/6)
|
increased fibroblast proliferation
|
J:101353
|
Npm1tm1Ppp/Npm1+
(involves: 129S1/Sv * C57BL/6)
|
abnormal cell proliferation
|
J:101494
|
Npm1tm1Ppp/Npm1+ Trp53tm1Brd/Trp53tm1Brd
(involves: 129S1/Sv * 129S7/SvEvBrd * C57BL/6)
|
increased fibroblast proliferation
|
J:101494
|
Npm1tm1Ppp/Npm1tm1Ppp
(involves: 129S1/Sv * C57BL/6)
|
decreased fibroblast proliferation
|
J:101494
|
Npm1tm2Ppp/Npm1tm2Ppp
(involves: 129S1/Sv * C57BL/6)
|
decreased fibroblast proliferation
|
J:101494
|
Nr0b1tm1.1Lja/Y
(involves: 129S1/Sv * 129X1/SvJ)
|
increased Sertoli cell proliferation
|
J:71710
|
Nr1h2tm1Djm/Nr1h2tm1Djm
(involves: 129S6/SvEvTac * C57BL/6)
|
abnormal spermatogonia proliferation
|
J:120913
|
Nr1h2tm1Djm/Nr1h2tm1Djm Nr1h3tm1Djm/Nr1h3tm1Djm
(involves: 129S6/SvEvTac * C57BL/6)
|
abnormal spermatogonia proliferation
|
J:120913
|
Nr1h4tm1.2Auw/Nr1h4tm1.2Auw
(involves: 129 * C57BL/6J)
|
increased hepatocyte proliferation
|
J:157882
|
Nr1h4tm1Gonz/Nr1h4tm1Gonz
(involves: 129X1/SvJ * C57BL/6N)
|
increased hepatocyte proliferation
|
J:121075
|
Nr1i2tm1Sakl/Nr1i2tm1Sakl
(involves: 129S1/Sv * 129X1/SvJ)
|
decreased hepatocyte proliferation
|
J:157882
|
Nr2e1frc/Nr2e1frc
(involves: 129P2/OlaHsd * 129S1/SvImJ)
|
abnormal neuronal precursor proliferation
|
J:183689
|
Nr4a1tm1Jmi/Nr4a1tm1Jmi
(involves: 129S2/SvPas)
|
increased B cell proliferation
|
J:306652
|
Nr4a1tm1Pcn/Nr4a1tm1Pcn Tg(Cr2-cre)3Cgn/0
(involves: 129)
|
increased B cell proliferation
|
J:306652
|
Nrarptm1Vlcg/Nrarptm1Vlcg
(involves: C57BL/6J)
|
decreased vascular endothelial cell proliferation
|
J:144980
|
Nrastm1Tyj/Nrastm1Tyj Tg(Tyr-cre)1Lru/0
(involves: C57BL/6 * DBA/2)
|
abnormal melanocyte proliferation
|
J:198244
|
Nrbp1tm1.1Dja/Nrbp1tm1.1Dja Gt(ROSA)26Sortm1(cre/ERT)Brn/Gt(ROSA)26Sor+
(involves: 129P2/OlaHsd * 129S4/SvJaeSor * C57BL/6J)
|
abnormal enterocyte proliferation
|
J:184685
|
Nrbp1tm1.1Dja/Nrbp1tm1.2Dja Gt(ROSA)26Sortm1(cre/ERT)Brn/Gt(ROSA)26Sor+
(involves: 129P2/OlaHsd * 129S4/SvJaeSor * 129S7/SvEvBrd * C57BL/6J)
|
abnormal enterocyte proliferation
|
J:184685
|
Nrf1tm1Rcs/Nrf1tm1Rcs
(involves: 129X1/SvJ)
|
decreased cell proliferation
|
J:67376
|
Nrip1tm1Mpk/Nrip1tm1Mpk
(involves: 129 * C57BL/6J)
|
abnormal enterocyte proliferation
|
J:211324
|
Nrp2tm1Ddg/Nrp2tm1Ddg
(involves: C57BL/6)
|
decreased cell proliferation
|
J:156869
|
Nsrp1tm1.1Cdj/Nsrp1tm1.1Cdj Tg(Cd4-cre)1Cwi/0
(involves: C57BL/6 * DBA/2 * SJL)
|
increased T cell proliferation
|
J:306261
|
Ntan1tm1Avar/Ntan1tm1Avar
(involves: 129)
|
decreased splenocyte proliferation
|
J:62140
|
Ntn4tm1Wjbr/Ntn4tm1Wjbr
(B6.129-Ntn4tm1Wjbr)
|
increased cell proliferation
|
J:196758
|
Ntrk2tm1Rohr/Ntrk2tm1Rohr
(Not Specified)
|
decreased granulosa cell proliferation
|
J:88782
|
Nudt7em1Ejj/Nudt7em1Ejj
(involves: C57BL/6N)
|
decreased chondrocyte proliferation
|
J:266261
|
Numa1tm1.1Dwc/Numa1tm1.1Dwc Tg(CAG-cre/Esr1*)5Amc/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA * SJL)
|
absent fibroblast proliferation
|
J:146214
|
Nup98tm1Bmaf/Nup98+
(involves: 129S6/SvEvTac * C57BL/6)
|
decreased T cell proliferation
|
J:110907
|
increased T cell proliferation
|
J:110907
|
Nup160tm1Mdan/Nup160tm1Mdan Gt(ROSA)26Sortm1(cre/ERT2)Tyj/Gt(ROSA)26Sor+
(involves: 129S4/SvJae * C57BL/6)
|
decreased hematopoietic stem cell proliferation
|
J:301567
|
Nupr1tm1Jlio/Nupr1tm1Jlio
(involves: 129S1/Sv * 129X1/SvJ)
|
increased fibroblast proliferation
|
J:133728
|
Nus1tm1Wcsa/Nus1tm1Wcsa
(Not Specified)
|
decreased lung endothelial cell proliferation
|
J:230506
|
Nus1tm1Wcsa/Nus1tm1Wcsa Tg(Cdh5-cre/ERT2)1Rha/0
(Not Specified)
|
decreased endothelial cell proliferation
|
J:230506
|
Nxf2tm1.2Jw/Y
(B6.Cg-Nxf2tm1.2Jw)
|
abnormal spermatogonia proliferation
|
J:149228
|
Oas2M1Apb/Oas2M1Apb
(involves: C57BL/6J * CBA/CaJ)
|
decreased mammary gland epithelial cell proliferation
|
J:248944
|
Ociad1tm1.1Msin/Ociad1tm1.1Msin
(involves: BALB/cJ * C57BL/6NCrlj * CBA/JNCrlj)
|
increased hematopoietic stem cell proliferation
|
J:279239
|
OgaGt(YTC085)Byg/OgaGt(YTC085)Byg
(B6J.129P2-OgaGt(YTC085)Byg)
|
decreased fibroblast proliferation
|
J:218150
|
Ogttm1Gwh/Y
(involves: 129S1/Sv * 129X1/SvJ)
|
decreased cell proliferation
|
J:93112
|
Opa1tm1.1Hise/Opa1tm1.2Hise Tg(Ins2-cre)25Mgn/0
(involves: 129S/SvEv * C57BL/6 * DBA * SJL)
|
decreased pancreatic beta cell proliferation
|
J:183074
|
Oprm1tm1Lyu/Oprm1+
(involves: Black Swiss)
|
increased splenocyte proliferation
|
J:39864
|
Oprm1tm1Lyu/Oprm1tm1Lyu
(involves: Black Swiss)
|
increased splenocyte proliferation
|
J:39864
|
Orc1tm1.1Gle/Orc1tm1.1Gle
(involves: C57BL/6 * SJL)
|
absent fibroblast proliferation
|
J:272584
|
Orc1tm1.1Gle/Orc1tm1.1Gle Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: C57BL/6 * DBA * SJL)
|
increased hepatocyte proliferation
|
J:272584
|
Orc1tm1.1Gle/Orc1tm1.1Gle Tg(Cyp1a1-cre)1Dwi/0
(involves: C57BL/6 * CBA * SJL)
|
abnormal small intestinal crypt cell proliferation
|
J:272584
|
Orc3tm1.1Zhua/Orc3tm1.1Zhua Emx1tm1(cre)Krj/Emx1+
(involves: 129S2/SvPas)
|
decreased neuronal precursor proliferation
|
J:170581
|
Otud7btm1Dgen/Otud7btm1Dgen
(involves: 129 * C57BL/6)
|
increased B cell proliferation
|
J:194553
|
Otulintm1c(EUCOMM)Hmgu/Otulintm1c(EUCOMM)Hmgu Tg(KRT14-cre)1Cgn/0
(involves: C57BL/6 * C57BL/6N * DBA/2)
|
abnormal epidermal stem cell proliferation
|
J:312394
|
Otx1tm4(cre)Asim/Otx1+ Otx2tm6Asim/Otx2tm6.1Asim
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA/2)
|
abnormal neuronal precursor proliferation
|
J:83110
|
P2rx2em1Xzl/P2rx2+
(CBA/J-P2rx2em1Xzl)
|
decreased dermal fibroblast proliferation
|
J:315007
|
P2ry6tm1Jabo/P2ry6tm1Jabo Gt(ROSA)26Sortm9(cre/ESR1)Arte/Gt(ROSA)26Sor+
(involves: 129 * C57BL/6 * C57BL/6NTac)
|
increased T cell proliferation
|
J:179177
|
Pa2g4Gt(OST186047)Lex/Pa2g4Gt(OST186047)Lex
(involves: 129S5/SvEvBrd * C57BL/6)
|
decreased cell proliferation
|
J:151280
|
Pak1ip1mray/Pak1ip1mray
(involves: C57BL/6J * FVB/NJ)
|
decreased cell proliferation
|
J:204457
|
Pak2tm1.1Rjak/Pak2tm1.1Rjak
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
increased fibroblast proliferation
|
J:171914
|
Pak4tm1Amin/Pak4tm1Amin
(either: (involves: 129P2/OlaHsd * C57BL/6J) or (involves: 129S2/SvPas * C57BL/6J))
|
decreased cell proliferation
|
J:152821
|
Palb2Gt(CG0691)Wtsi/Palb2Gt(CG0691)Wtsi
(involves: 129P2/OlaHsd * C57BL/6N)
|
decreased inner cell mass proliferation
|
J:161528
|
Pald1tm1Vlcg/Pald1tm1Vlcg
(B6.Cg-Pald1tm1Vlcg)
|
increased lung endothelial cell proliferation
|
J:254363
|
Pals1tm1Caw/Pals1+ Emx1tm1(cre)Krj/Emx1+
(involves: 129S2/SvPas)
|
abnormal neuronal precursor proliferation
|
J:160624
|
Pals1tm1Caw/Pals1tm1Caw Emx1tm1(cre)Krj/Emx1+
(involves: 129S2/SvPas)
|
abnormal neuronal precursor proliferation
|
J:160624
|
Pals1tm1Caw/Pals1tm1Caw Tg(rx3-icre)1Mjam/0
(Not Specified)
|
abnormal cell proliferation
|
J:184469
|
decreased cell proliferation
|
J:184469
|
Paqr3tm1Ychn/Paqr3tm1Ychn
(involves: 129 * C57BL/6J)
|
increased keratinocyte proliferation
|
J:139058
|
Pargtm1Tmd/Pargtm1Tmd
(involves: 129X1/SvJ)
|
decreased cell proliferation
|
J:95214
|
Parp1tm1Zqw/Parp1tm1Zqw
(involves: 129S2/SvPas * C57BL/6)
|
decreased cell proliferation
|
J:23942
|
Parp14Gt(OST415485)Lex/Parp14Gt(OST415485)Lex
(involves: 129S5/SvEvBrd * C57BL/6)
|
decreased B cell proliferation
|
J:146533
|
increased B cell proliferation
|
J:146533
|
Patz1tm1Pchi/Patz1+
(involves: C57BL/6J)
|
increased fibroblast proliferation
|
J:190572
|
Patz1tm1Pchi/Patz1tm1Pchi
(Not Specified)
|
abnormal spermatogonia proliferation
|
J:133515
|
Patz1tm1Pchi/Patz1tm1Pchi
(involves: C57BL/6J)
|
decreased fibroblast proliferation
|
J:190572
|
Pawrtm1Jmos/Pawrtm1Jmos
(involves: 129/Sv * CD-1)
|
increased B cell proliferation
|
J:85495
|
increased T cell proliferation
|
J:85495
|
Pax1tm2.1Tlu/Pax1tm2.1Tlu
(involves: 129S1/Sv * 129S4/SvJaeSor * 129X1/SvJ)
|
decreased cell proliferation
|
J:198603
|
Pax3tm3.1(Pax7)Buck/Pax3Sp
(involves: 129S2/SvPas)
|
decreased cell proliferation
|
J:90568
|
Pax3tm3.1(Pax7)Buck/Pax3tm3.1(Pax7)Buck
(involves: 129S2/SvPas)
|
decreased cell proliferation
|
J:90568
|
Pax6tm1.1Zkoz/Pax6tm1.1Zkoz Tg(Rax-cre)1Zkoz/0
(Not Specified)
|
decreased cell proliferation
|
J:208421
|
Pax6tm2(Pax6_i5a,Pax2)Xzh/Pax6tm2(Pax6_i5a,Pax2)Xzh
(involves: 129S6/SvEvTac)
|
abnormal neuronal precursor proliferation
|
J:198381
|
Pax6tm2.1(Pax6_i5a,Pax2)Xzh/Pax6tm2.1(Pax6_i5a,Pax2)Xzh
(involves: 129S6/SvEvTac * C57BL/6 * FVB/N)
|
abnormal neuronal precursor proliferation
|
J:198381
|
Pax7tm1.1Thbr/Pax7tm1.1Thbr
(Not Specified)
|
abnormal skeletal muscle satellite cell proliferation
|
J:202693
|
Pax7tm1.1Thbr/Pax7tm2.1(cre/ERT2)Fan
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal skeletal muscle satellite cell proliferation
|
J:202693
|
Paxip1tm1Gdr/Paxip1tm1Gdr
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
decreased cell proliferation
|
J:82319
|
decreased inner cell mass proliferation
|
J:82319
|
Pbrm1tm1Zhwa/Pbrm1tm1Zhwa Tg(Cd4-cre)1Cwi/?
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2)
|
decreased T cell proliferation
|
J:236906
|
Pbx1tm1Mlc/Pbx1tm1Mlc
(involves: 129S6/SvEvTac * C57BL/6)
|
decreased chondrocyte proliferation
|
J:71996
|
Pcbp4Gt(D136D11)Wrst/Pcbp4Gt(D136D11)Wrst
(involves: 129S2/SvPas * C57BL/6)
|
increased fibroblast proliferation
|
J:231514
|
Pcsk2tm1Dfs/Pcsk2tm1Dfs
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
increased pancreatic alpha cell proliferation
|
J:85590
|
Pdcd1tm1.1Liux/Pdcd1tm1.1Liux
(involves: C57BL/6)
|
decreased cell proliferation
|
J:190150
|
Pdcd1tm1.1Shr/Pdcd1tm1.1Shr Tg(TcraTcrb)1100Mjb/0
(involves: C57BL/6)
|
decreased T cell proliferation
|
J:153040
|
increased T cell proliferation
|
J:153040
|
Pdcd1tm1Hon/Pdcd1tm1Hon
(involves: 129S2/SvPas * C57BL/6)
|
increased B cell proliferation
|
J:50688
|
Pdcd1lg2tm1Dmp/Pdcd1lg2tm1Dmp
(C.129-Pdcd1lg2tm1Dmp)
|
decreased T cell proliferation
|
J:99212
|
Pdgfratm12.1Sor/Pdgfra+
(involves: 129 * C57BL/6)
|
increased cell proliferation
|
J:146617
|
increased fibroblast proliferation
|
J:146617
|
increased mesenchymal cell proliferation involved in lung development
|
J:146617
|
Pdgfratm13.1Sor/Pdgfra+
(involves: 129 * C57BL/6)
|
increased fibroblast proliferation
|
J:146617
|
Pdgfrbtm1Msas/Pdgfrbtm1Msas
(involves: 129 * C57BL/6)
|
decreased cell proliferation
|
J:110798
|
Pdgfrbtm4Sor/Pdgfrbtm4Sor
(either: (involves: 129/Sv) or (involves: 129/Sv * C57BL/6))
|
decreased fibroblast proliferation
|
J:66516
|
decreased kidney cell proliferation
|
J:66516
|
Pdgfrbtm14(Pdgfrb)Sor/Pdgfrb+ Tg(Tagln-cre)1Her/0
(involves: 129S4/SvJaeSor * C57BL/6 * SJL)
|
increased vascular smooth muscle cell proliferation
|
J:173602
|
Pdpk1tm1Mlw/Pdpk1tm1Mlw Tg(Cd4-cre)1Cwi/0
(involves: C57BL/6 * DBA/2)
|
decreased T cell proliferation
|
J:165626
|
Pds5btm1.2Alos/Pds5btm1.2Alos
(involves: 129S2/SvPas)
|
decreased cell proliferation
|
J:205601
|
Pdx1tm1Cvw/Pdx1tm4Cvw Tg(Ins2-cre)25Mgn/0
(involves: 129S1/Sv * 129X1/SvJ * Black Swiss * C57BL/6 * DBA)
|
decreased pancreatic beta cell proliferation
|
J:130389
|
increased pancreatic alpha cell proliferation
|
J:130389
|
Pdx1tm1Egs/Pdx1+ Stk11tm1.1Gne/Stk11tm1.1Gne
(involves: 129S1/Sv * C57BL/6N)
|
increased cell proliferation
|
J:195229
|
Pdx1tm1Macd/Pdx1tm1Macd Tg(tetO-Ipf1,EGFP)956.6Macd/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL)
|
increased cell proliferation
|
J:101742
|
Peli1tm1Tigm/Peli1tm1Tigm
(involves: 129/Sv * C57BL/6)
|
decreased B cell proliferation
|
J:152781
|
Pelotm1Imad/Pelotm1Imad
(either: 129 or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J))
|
absent inner cell mass proliferation
|
J:81781
|
Pelotm1Slac/Pelotm1Slac En1tm2(cre)Wrst/En1+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
increased neuronal precursor proliferation
|
J:306384
|
Pelotm1Slac/Pelotm1Slac Tg(Atoh1-cre)1Bfri/0
(involves: C57BL/6J * CBA)
|
increased neuronal precursor proliferation
|
J:306384
|
Per1tm1Brd/Per1tm1Brd Per2tm1Brd/Per2tm1Brd
(involves: 129S7/SvEvBrd)
|
increased osteoblast proliferation
|
J:115188
|
Per2tm1Drw/Per2tm1Drw
(B6.129-Per2tm1Drw/J)
|
decreased hematopoietic stem cell proliferation
|
J:208598
|
Pgap3tm1.1Ymra/Pgap3tm1.1Ymra
(involves: 129 * C57BL/6)
|
decreased T cell proliferation
|
J:181221
|
increased T cell proliferation
|
J:181221
|
Pgap3tm1.1Ymra/Pgap3tm1.1Ymra
(B6.Cg-Pgap3tm1.1Ymra)
|
decreased B cell proliferation
|
J:203443
|
Pggt1btm1Mbrg/Pggt1btm1Mbrg
(involves: 129/Sv * 129P2/OlaHsd * C57BL/6)
|
absent fibroblast proliferation
|
J:122107
|
Pggt1btm1Mbrg/Pggt1btm1Mbrg Krastm4Tyj/Kras+
(involves: 129/Sv * 129P2/OlaHsd * C57BL/6)
|
decreased cell proliferation
|
J:122107
|
Pggt1btm1Mbrg/Pggt1btm1Mbrg Tg(KRT14-cre)1Amc/?
(involves: 129P2/OlaHsd * C57BL/6 * CBA)
|
decreased keratinocyte proliferation
|
J:158528
|
Pgptm1.2Ango/Pgptm1.2Ango
(involves: 129S4/SvJaeSor * C57BL/6J * FVB/N)
|
abnormal fibroblast proliferation
|
J:259970
|
Pgrtm1Bwo/Pgrtm1Bwo
(involves: 129S7/SvEvBrd)
|
decreased mammary gland epithelial cell proliferation
|
J:85196
|
Pgrtm1Bwo/Pgrtm1Bwo
(involves: 129S7/SvEvBrd * C57BL/6J)
|
increased pancreatic beta cell proliferation
|
J:125584
|
Pgrtm2(cre)Lyd/Pgr+ Wnt5atm1.1Tpy/Wnt5atm1.1Tpy
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal trophoblast giant cell proliferation
|
J:233595
|
Phb2tm1Tlan/Phb2tm1Tlan
(involves: C57BL/6 * SJL)
|
decreased fibroblast proliferation
|
J:131699
|
Phc2tm1Hko/Phc2tm1Hko
(B6.129-Phc2tm1Hko)
|
decreased fibroblast proliferation
|
J:100027
|
Phf6em1Wencc/Y Tg(Vav1-cre)#Cgp/0
(Not Specified)
|
increased hematopoietic stem cell proliferation
|
J:278804
|
Phf6em1Wencc/Phf6em1Wencc Tg(Vav1-cre)#Cgp/0
(Not Specified)
|
increased hematopoietic stem cell proliferation
|
J:278804
|
Phf6tm1.1Avo/Y Tg(Tek-cre)1Ywa/0
(involves: C57BL/6 * SJL)
|
increased hematopoietic stem cell proliferation
|
J:276228
|
Phf8tm1.1Hoch/Y
(involves: 129S4/SvJae * C57BL/6)
|
decreased cell proliferation
|
J:248400
|
Phf14tm1Take/Phf14tm1Take
(B6.Cg-Phf14tm1Take)
|
increased cell proliferation
|
J:184822
|
increased fibroblast proliferation
|
J:184822
|
Phf19tm1.1Ldc/Phf19tm1.1Ldc
(Not Specified)
|
increased hematopoietic stem cell proliferation
|
J:313068
|
Phox2btm1.1Heno/Phox2b+
(either: (involves: 129P2/OlaHsd * C57BL/6) or (involves: 129P2/OlaHsd * C57BL/6 * DBA/2))
|
abnormal neuronal precursor proliferation
|
J:190742
|
decreased enteric neural crest cell proliferation
|
J:190742
|
Phox2btm2.1Heno/Phox2b+
(either: (involves: 129P2/OlaHsd * C57BL/6) or (involves: 129P2/OlaHsd * C57BL/6 * DBA/2))
|
abnormal neuronal precursor proliferation
|
J:190742
|
decreased enteric neural crest cell proliferation
|
J:190742
|
Pik3ap1tm1Kuro/Pik3ap1tm1Kuro
(involves: 129P2/OlaHsd)
|
decreased B cell proliferation
|
J:84669
|
Pik3c3tm1.1Fawa/Pik3c3tm1.1Fawa
(involves: 129S4/SvJaeSor * C57BL/6J)
|
decreased cell proliferation
|
J:169569
|
Pik3c3tm1c(EUCOMM)Wtsi/Pik3c3tm1c(EUCOMM)Wtsi
(involves: C57BL/6N)
|
decreased cell proliferation
|
J:182628
|
Pik3catm1.1Waph/Pik3ca+
(involves: 129S1/Sv * C57BL/6)
|
increased fibroblast proliferation
|
J:184382
|
Pik3catm1.1Waph/Pik3ca+ Tg(MMTV-cre)#Mam/0
(involves: 129S1/Sv * C57BL/6 * FVB)
|
increased mammary gland epithelial cell proliferation
|
J:187299
|
Pik3catm1Nbm/Pik3catm1Nbm
(involves: 129S6/SvEvTac)
|
decreased cell proliferation
|
J:54237
|
Pik3cbtm1.1Ehi/Pik3cbtm1.1Ehi
(involves: 129/Sv * 129P2/OlaHsd * BALB/c * C57BL/6J)
|
decreased fibroblast proliferation
|
J:152332
|
Pik3cbtm1.1Ehi/Pik3cbtm1.1Ehi
(involves: 129/Sv * 129P2/OlaHsd * C57BL/6J)
|
abnormal spermatogonia proliferation
|
J:165087
|
Pik3cbtm1Jjz/Pik3cbtm1Jjz
(involves: 129 * C57BL/6)
|
decreased fibroblast proliferation
|
J:138565
|
Pik3cdtm1Jni/Pik3cdtm1Jni
(involves: 129P2/OlaHsd)
|
decreased B cell proliferation
|
J:80614
|
Pik3cdtm1Tnr/Pik3cdtm1Tnr
(involves: 129S4/SvJae)
|
decreased B cell proliferation
|
J:113491,
J:79133
|
Pik3cgtm1Pngr/Pik3cgtm1Pngr
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased T cell proliferation
|
J:60347
|
Pik3r1tm1Dfr/Pik3r1tm1Dfr
(involves: 129S6/SvEvTac * C57BL/6)
|
decreased B cell proliferation
|
J:52229
|
Pik3r1tm1Tka/Pik3r1tm1Tka
(involves: C57BL/6 * CBA)
|
decreased B cell proliferation
|
J:113491,
J:52228
|
Pim1tm1Pwl/Pim1tm1Pwl Pim2tm1Brn/Pim2tm1Brn Pim3tm1Brn/Pim3tm1Brn
(involves: 129P/Ola * FVB/N)
|
decreased B cell proliferation
|
J:91592
|
decreased T cell proliferation
|
J:91592
|
Pim2tm1Brn/Pim2tm1Brn
(involves: 129P/Ola * FVB/N)
|
decreased T cell proliferation
|
J:91592
|
Pin1tm1Tuc/Pin1tm1Tuc
(B6.129P2-Pin1tm1Tuc)
|
decreased primordial germ cell proliferation
|
J:83663
|
Pip4k2ctm1b(KOMP)Wtsi/Pip4k2ctm1b(KOMP)Wtsi
(involves: C57BL/6J * C57BL/6N)
|
increased T cell proliferation
|
J:234283
|
Pip5k1ctm1.2Ref/Pip5k1ctm1.2Ref Tg(TcraTcrb)425Cbn/0
(involves: BALB/c * C57BL/6)
|
increased T cell proliferation
|
J:164732
|
Piptm1Myal/Piptm1Myal
(involves: 129S/SvEv * C57BL/6)
|
increased cell proliferation
|
J:202016
|
Pirbtm1Ttk/Pirbtm1Ttk
(involves: 129X1/SvJ)
|
increased B cell proliferation
|
J:76770
|
Pkd1tm1.1Djmp/Pkd1tm1.2Djmp Tg(Cdh16-cre/ERT2)F427Djmp/0
(involves: 129P2/OlaHsd * C57BL/6 * C57BL/6NCrl * FVB/N)
|
increased kidney cell proliferation
|
J:130079
|
Pkd1tm1.1Pcha/Pkd1tm1.1Pcha Pparatm1Gonz/Pparatm1Gonz
(involves: 129 * 129S4/SvJae * C57BL/6)
|
increased kidney cell proliferation
|
J:244067
|
Pkd1tm1.1Pcha/Pkd1tm2Som Tg(Cdh16-cre)91Igr/0
(involves: 129 * 129S4/SvJae * C57BL/6 * ICR)
|
increased kidney cell proliferation
|
J:244067
|
Pkd1tm1.2Djmp/Pkd1+
(involves: 129P2/OlaHsd * FVB/N)
|
increased kidney cell proliferation
|
J:130079
|
Pkd1tm1Shh/Pkd1tm1.1Pcha
(involves: 129P2/OlaHsd * 129S1/Sv * C57BL/6)
|
increased cell proliferation
|
J:193544
|
Pkd1tm1Som/Pkd1+ Prkcshtm1Som/Prkcshtm1Som Tg(Cdh16-cre)91Igr/0
(involves: 129 * C57BL/6 * C57BL/6J * ICR * SJL)
|
increased kidney cell proliferation
|
J:188763
|
Pkd1tm1Som/Pkd1+ Sec63tm1Som/Sec63tm1Som Tg(Cdh16-cre)91Igr/0
(involves: 129 * C57BL/6 * C57BL/6J * ICR * SJL)
|
increased kidney cell proliferation
|
J:188763
|
Pkd1tm2Ggg/Pkd1+ Tg(Col1a1-cre)1Bek/0
(involves: 129S4/SvJae * CD-1)
|
increased osteoblast proliferation
|
J:191967
|
Pkd1tm2Ggg/Pkd1tm2Ggg Tg(Col1a1-cre)1Bek/0
(involves: 129S4/SvJae * CD-1)
|
increased osteoblast proliferation
|
J:191967
|
Pkd1tm2Ggg/Pkd1tm2Ggg Tg(Hoxb7-cre)13Amc/0
(involves: 129S4/SvJae * C57BL/6)
|
increased kidney cell proliferation
|
J:171619
|
Pkd1tm2Ggg/Pkd1tm2Ggg Tg(Nes-cre)Wme/0
(involves: 129S4/SvJae * C57BL/6 * CBA)
|
increased kidney cell proliferation
|
J:185855
|
Pkd1tm2Som/Pkd1tm2Som Tg(Cdh16-cre)91Igr/0
(involves: 129S4/SvJae * C57BL/6 * ICR)
|
increased kidney cell proliferation
|
J:244067
|
Pkd1tm3Jzh/Pkd1tm3Jzh
(involves: 129P2/OlaHsd * 129X1/SvJ)
|
decreased chondrocyte proliferation
|
J:139970
|
Pkd1tm3Jzh/Pkd1tm3Jzh H2az2Tg(Wnt1-cre)11Rth/H2az2+
(involves: 129P2/OlaHsd * C57BL/6 * CBA)
|
decreased chondrocyte proliferation
|
J:139970
|
Pkd2tm1.1Gwu/Pkd2tm1.1Gwu Tg(Vil1-cre)997Gum/0
(involves: C57BL/6 * C57BL/6J * SJL)
|
increased kidney cell proliferation
|
J:265516
|
Pkd2tm1Som/Pkd2tm2Som
(involves: 129/Sv * C57BL/6J * SJL)
|
increased kidney cell proliferation
|
J:158354
|
Pkd2tm3Som/Pkd2tm3Som Tg(Pkhd1-cre)1Igr/0
(involves: 129S4/SvJae * C57BL/6)
|
increased kidney cell proliferation
|
J:244067
|
Pkhd1tm1Gwu/Pkhd1tm1Gwu
(involves: C57BL/6)
|
decreased kidney cell proliferation
|
J:167782
|
Pkn1tm1Kik/Pkn1tm1Kik
(B6.129P2-Pkn1tm1Kik)
|
increased B cell proliferation
|
J:193187
|
Pkn2tm1a(KOMP)Wtsi/Pkn2tm1a(KOMP)Wtsi
(involves: C57BL/6N)
|
abnormal fibroblast proliferation
|
J:229595
|
Pknox1tm1Ngc/Pknox1+ Tg(IghMyc)22Bri/0
(involves: C57BL * SJL)
|
increased B cell proliferation
|
J:192251
|
Pkp1tm2d(KOMP)Wtsi/Pkp1tm2d(KOMP)Wtsi
(involves: C57BL/6J * C57BL/6N * SJL/J)
|
decreased keratinocyte proliferation
|
J:233599
|
Pkp3tm1.1Fvr/Pkp3tm1.1Fvr
(involves: 129P2/OlaHsd * C57BL/6 * CBA * SJL)
|
increased keratinocyte proliferation
|
J:136451
|
Plautm1Mlg/Plautm1Mlg
(B6.Cg-Plautm1Mlg)
|
decreased T cell proliferation
|
J:75303
|
Plcg1tm1Gcrp/Plcg1tm1Rwen Tg(Cd4-cre)1Cwi/0
(either: B6.Cg-Plcg1tm1Gcrp/Plcg1tm1Rwen Tg(Cd4-cre)1Cwi or (involves: 129X1/SvJ * C57BL/6 * DBA/2))
|
increased T cell proliferation
|
J:157757
|
Plcg2tm1Jni/Plcg2tm1Jni
(involves: 129P2/OlaHsd)
|
decreased B cell proliferation
|
J:80614
|
Plcg2tm1Jni/Plcg2tm1Jni
(involves: 129P2/OlaHsd * C57BL/6)
|
increased B cell proliferation
|
J:117023
|
Plcg2tm1Kuro/Plcg2tm1Kuro Tg(Mx1-cre)1Cgn/0
(involves: C57BL/6 * CBA)
|
decreased B cell proliferation
|
J:63744
|
Plcl2tm1Tta/Plcl2tm1Tta
(involves: 129P2/OlaHsd)
|
increased B cell proliferation
|
J:85960
|
Plgtm1Jld/Plgtm1Jld
(B6.129P2-Plgtm1Jld)
|
increased hepatocyte proliferation
|
J:120368
|
Plrg1tm2Jcbr/Plrg1tm2Jcbr
(Not Specified)
|
decreased cell proliferation
|
J:149153
|
Plxna1tm1Kik/Plxna1tm1Kik Tg(TcraTcrb)425Cbn/?
(involves: BALB/c * C57BL/6)
|
decreased T cell proliferation
|
J:161856
|
Plxnb1tm1Matl/Plxnb1tm1Matl Plxnb2tm1c(EUCOMM)Wtsi/Plxnb2tm1Matl Tg(Nes-cre)1Kln/0
(involves: 129P2/OlaHsd * C57BL/6 * C57BL/6J * C57BL/6N * SJL)
|
decreased neuronal precursor proliferation
|
J:228347
|
Plxnb2tm1Matl/Plxnb2tm1Matl
(involves: 129P2/OlaHsd * CD-1)
|
decreased neuronal precursor proliferation
|
J:190014
|
Pmltm1Ppp/Pmltm1Ppp
(involves: 129S7/SvEvBrd)
|
increased fibroblast proliferation
|
J:46381
|
Pmp22tm1Ueli/Pmp22tm1Ueli
(involves: 129S/SvEv * C57BL/6)
|
increased Schwann cell proliferation
|
J:98118
|
Pnkptm1.1Pmc/Pnkptm1.1Pmc Emx1tm1(cre)Krj/Emx1+
(involves: 129S1/Sv * 129S2/SvPas * C57BL/6)
|
decreased cell proliferation
|
J:226703
|
Pnkptm1.1Pmc/Pnkptm1.1Pmc Tg(Nes-cre)1Kln/0
(involves: 129S1/Sv * C57BL/6 * SJL)
|
decreased cell proliferation
|
J:226703
|
Pnkptm1Pmc/Pnkptm1Pmc
(involves: 129S1/Sv * C57BL/6)
|
decreased cell proliferation
|
J:226703
|
Pnpbata/Pnpbata
(C57BL/6JSfdAnu-Pnpbata)
|
decreased B cell proliferation
|
J:104190
|
Polbtm1.1Jbsw/Polbtm1.1Jbsw
(involves: 129/Sv * C57BL/6)
|
decreased cell proliferation
|
J:183837
|
decreased fibroblast proliferation
|
J:183837
|
Pold1tm1Uchi/Pold1tm1Uchi
(C57BL/6-Pold1tm1Uchi)
|
absent inner cell mass proliferation
|
J:144992
|
Pold1tyrn/Pold1tyrn
(C57BL/6J-Pold1tyrn)
|
decreased cell proliferation
|
J:327432
|
Pold3em1Linl/Pold3em1Linl
(involves: C57BL/6 * DBA/2)
|
abnormal trophoblast giant cell proliferation
|
J:263620
|
decreased inner cell mass proliferation
|
J:263620
|
Pole4tm1(KOMP)Vlcg/Pole4tm1(KOMP)Vlcg
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6NTac * FVB/N)
|
decreased fibroblast proliferation
|
J:261973
|
Polmtm1Crey/Polmtm1Crey
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal B cell proliferation
|
J:85190
|
Polr2mtm1.1Rgr/Polr2mtm1.1Rgr Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+ Trp53tm1Tyj/Trp53tm1Tyj
(involves: 129S2/SvPas * C57BL/6 * DBA)
|
increased hepatocyte proliferation
|
J:291184
|
Pomctm1Low/Pomctm1Low
(involves: 129S2/SvPas * C57BL/6)
|
increased splenocyte proliferation
|
J:102955
|
Pomgnt1tm1Stk/Pomgnt1tm1Stk
(involves: 129S/SvEv)
|
abnormal skeletal muscle satellite cell proliferation
|
J:144928
|
Pot1atm1.1Schg/Pot1atm1.1Schg
(involves: 129S7/SvEvBrd * C57BL/6)
|
decreased cell proliferation
|
J:112184
|
Pot1atm1Schg/Pot1atm1.1Schg
(involves: 129S7/SvEvBrd * C57BL/6)
|
decreased cell proliferation
|
J:112184
|
Pou2af1tm1Rgr/Pou2af1tm1Rgr
(either: (involves: 129P2/OlaHsd) or (involves: 129S1/Sv))
|
decreased B cell proliferation
|
J:35785
|
increased B cell proliferation
|
J:114816
|
Pou3f3tm1Tno/Pou3f3tm1Tno
(involves: 129S4/SvJae * C57BL/6J)
|
decreased kidney cell proliferation
|
J:84756
|
Ppardtm1Wwah/Ppard+
(Not Specified)
|
increased keratinocyte proliferation
|
J:71272
|
Ppardtm1Wwah/Ppardtm1Wwah
(Not Specified)
|
decreased keratinocyte proliferation
|
J:96826
|
Ppargtm1Tka/Pparg+
(involves: C57BL/6 * CBA * ICR)
|
increased B cell proliferation
|
J:58222
|
Ppm1dtm1Lad/Ppm1dtm1Lad
(involves: 129S7/SvEvBrd * C57BL/6)
|
decreased B cell proliferation
|
J:74284
|
decreased T cell proliferation
|
J:74284
|
Ppm1dtm1Lad/Ppm1dtm1Lad
(involves: 129S7/SvEvBrd)
|
decreased pancreatic beta cell proliferation
|
J:151980
|
Ppp1r13ltm1.1Xlu/Ppp1r13l+
(involves: 129 * BALB/cJ * C57BL/6J)
|
decreased fibroblast proliferation
|
J:177360
|
Ppp1r13ltm1.1Xlu/Ppp1r13ltm1.1Xlu
(involves: 129 * BALB/cJ * C57BL/6J)
|
decreased fibroblast proliferation
|
J:177360
|
decreased keratinocyte proliferation
|
J:177360
|
Ppp2r3ctm1Imku/Ppp2r3ctm1Imku Tg(CD19-cre/ERT2)1Cgn/?
(involves: C57BL/6)
|
decreased B cell proliferation
|
J:100706
|
Ppp3catm1Jse/Ppp3catm1Jse
(either: (involves: 129S4/SvJae * Black Swiss) or (involves: 129S4/SvJae * C57BL/6))
|
decreased T cell proliferation
|
J:71750
|
Ppp3cbM1Btlr/Ppp3cb+
(C57BL/6J-Ppp3cbM1Btlr)
|
increased CD8-positive, alpha-beta memory T cell proliferation
|
J:236670
|
Ppp3cbM1Btlr/Ppp3cbM1Btlr
(C57BL/6J-Ppp3cbM1Btlr)
|
increased CD8-positive, alpha-beta memory T cell proliferation
|
J:236670
|
Ppp3cbm2Btlr/Ppp3cb+
(C57BL/6J-Ppp3cbm2Btlr)
|
increased CD8-positive, alpha-beta memory T cell proliferation
|
J:236671
|
Ppp3cbm2Btlr/Ppp3cbm2Btlr
(C57BL/6J-Ppp3cbm2Btlr)
|
increased CD8-positive, alpha-beta memory T cell proliferation
|
J:236671
|
Ppp3cbtm1Jmk/Ppp3cbtm1Jmk
(involves: 129S6/SvEvTac * C57BL/6)
|
decreased T cell proliferation
|
J:77729
|
Ppp3cbtm1Jmk/Ppp3cbtm1Jmk
(involves: 129S6/SvEvTac)
|
decreased T cell proliferation
|
J:109586
|
Ppp3r1tm2Grc/Ppp3r1tm2.1Grc Tg(Pax3-cre)1Joe/0
(involves: 129S6/SvEvTac)
|
decreased cell proliferation
|
J:89217
|
Ppp3r1tm2Grc/Ppp3r1tm2Grc Tg(Pax3-cre)1Joe/0
(involves: 129S6/SvEvTac)
|
decreased cell proliferation
|
J:89217
|
Ppp5ctm1.2Rhon/Ppp5ctm1.2Rhon
(B6.129X1-Ppp5ctm1.2Rhon)
|
decreased fibroblast proliferation
|
J:178164
|
Pramel13em2Dean/Pramel13em2Dean
(involves: C57BL/6J * DBA/2J)
|
abnormal spermatogonia proliferation
|
J:282232
|
Prdm11tm1.1Ahl/Prdm11tm1.1Ahl
(B6.129(C)-Prdm11tm1.1Ahl)
|
increased megakaryocyte progenitor cell proliferation
|
J:222765
|
Prdm16tm1.1Brsp/Prdm16tm1.1Brsp Tg(myl7.L-cre)1118Tmhn/0
(involves: 129 * C57BL/6J * MF1)
|
decreased fetal cardiomyocyte proliferation
|
J:326525
|
Prdx1tm1Rave/Prdx1tm1Rave
(involves: 129S6/SvEvTac * C57BL/6)
|
decreased cell proliferation
|
J:84677
|
Prkab1Gt(RRR454)Byg/Prkab1Gt(RRR454)Byg
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal neuronal precursor proliferation
|
J:146618
|
Prkcbtilc/Prkcbtilc
(involves: C57BL/6JSfdAnu)
|
decreased B cell proliferation
|
J:221236
|
Prkcbtm1Tara/Prkcbtm1Tara
(involves: 129)
|
decreased B cell proliferation
|
J:34818
|
Prkcdtm1Kin/Prkcdtm1Kin
(involves: 129P2/OlaHsd * C57BL/6)
|
increased B cell proliferation
|
J:76135,
J:143854
|
Prkcdtm1Qxu/Prkcdtm1Qxu Tg(IghelMD4)4Ccg/0 Tg(ML5sHEL)5Ccg/0
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal B cell proliferation
|
J:76134
|
Prkcetm1Bsca/Prkcetm1Bsca
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased T cell proliferation
|
J:103337
|
Prkchtm1.2Gasc/Prkchtm1.2Gasc
(involves: C57BL/6 * FVB/N * SJL)
|
decreased T cell proliferation
|
J:186080
|
Prkchtm1.2Gasc/Prkchtm1.2Gasc Prkcqtm1Litt/Prkcqtm1Litt
(involves: 129P2/OlaHsd * C57BL/6 * FVB/N * SJL)
|
decreased T cell proliferation
|
J:186080
|
Prkcqtm1.1Bai/Prkcqtm1.1Bai
(involves: 129P2/OlaHsd * C57BL/6J)
|
decreased T cell proliferation
|
J:83733
|
Prkcqtm1Litt/Prkcqtm1Litt
(involves: 129P2/OlaHsd)
|
decreased T cell proliferation
|
J:83922,
J:123989
|
Prkcqtm1Litt/Prkcqtm1Litt
(B6.129P2-Prkcqtm1Litt)
|
decreased splenocyte proliferation
|
J:129421
|
decreased T cell proliferation
|
J:94285
|
Prkcqtm1Litt/Prkcqtm1Litt
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased T cell proliferation
|
J:186080
|
Prkcqtm1Litt/Prkcqtm1Litt
(either: (involves: 129/Sv * 129P2/OlaHsd) or (involves: 129P2/OlaHsd * C57BL/6))
|
decreased T cell proliferation
|
J:141930
|
Prkcqtm1Litt/Prkcqtm1Litt Tcratm1Mom/Tcratm1Mom
(involves: 129P2/OlaHsd * 129S2/SvPas)
|
decreased T cell proliferation
|
J:135589
|
Prkcqtm1Litt/Prkcqtm1Litt Tg(TcrLCMV)327Sdz/0
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2)
|
decreased splenocyte proliferation
|
J:123989
|
decreased T cell proliferation
|
J:123989
|
Prkdcscid/Prkdcscid
(C.BKa-Prkdcscid)
|
decreased B cell proliferation
|
J:6958
|
decreased T cell proliferation
|
J:6958
|
Prlrtm1Cnp/Prlr+
(B6.129P2-Prlrtm1Cnp/J)
|
abnormal neuron proliferation
|
J:83248
|
Prmt5Gt(RRA014)Byg/Prmt5Gt(RRA014)Byg
(involves: 129P2/OlaHsd)
|
absent inner cell mass proliferation
|
J:166736
|
Prmt5tm2c(EUCOMM)Wtsi/Prmt5tm2c(EUCOMM)Wtsi Tg(Nes-cre)1Kln/0
(B6.Cg-Prmt5tm2c(EUCOMM)Wtsi Tg(Nes-cre)1Kln)
|
abnormal neuronal precursor proliferation
|
J:201152
|
Prmt6tm1.2Rchd/Prmt6tm1.2Rchd
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * C57BL/6J * FVB/N)
|
decreased fibroblast proliferation
|
J:199753
|
Prnptm2Edin/Prnptm2Edin
(B6.129P2-Prnptm2Edin)
|
abnormal neuronal precursor proliferation
|
J:107170
|
Prnptm2Edin/Prnptm2Edin Tg(Prnp)a20Cwe/0
(B6.Cg-Prnptm2Edin Tg(Prnp)a20Cwe)
|
abnormal neuronal precursor proliferation
|
J:107170
|
Prnptm2Lnq/Prnptm2Lnq
(involves: 129P2/OlaHsd * C57BL/6N)
|
abnormal neuron proliferation
|
J:200974
|
Prnptm3Lnq/Prnptm3Lnq
(involves: 129P2/OlaHsd * C57BL/6N)
|
abnormal neuron proliferation
|
J:200974
|
Prox1tm1Gco/Prox1tm1Gco
(involves: 129S1/Sv * 129X1/SvJ * NMRI)
|
decreased hepatocyte proliferation
|
J:63128
|
Prpf19tm1Glri/Prpf19tm1Glri
(involves: 129/Sv * 129P2/OlaHsd * C57BL/6)
|
absent inner cell mass proliferation
|
J:121379
|
decreased cell proliferation
|
J:121379
|
Prss8em1Bug/Prss8em1Bug Spint2Gt(KST272)Byg/Spint2Gt(KST272)Byg
(involves: 129P2/OlaHsd * 129S6/SvEvTac * C57BL/6J * FVB/NJ * NIH Black Swiss)
|
abnormal enterocyte proliferation
|
J:261068
|
Psen1tm1Jzt/Psen1tm1Jzt Tg(Camk2a-cre)T29-1Stl/0
(involves: C57BL/6 * CBA)
|
decreased cell proliferation
|
J:73252
|
Psen1tm1Shs/Psen1tm1Shs
(involves: C57BL/6)
|
abnormal neuronal precursor proliferation
|
J:91975
|
Psmb10tm1Mgro/Psmb10tm1Mgro
(involves: 129S2/SvPas * C57BL/6)
|
decreased T cell proliferation
|
J:125058
|
Psmb11tm1(Psmb8)Khog/Psmb11tm1(Psmb8)Khog
(involves: C57BL/6)
|
increased T cell proliferation
|
J:196156
|
Psmd4tm1Smta/Psmd4tm1Smta
(involves: C57BL/6 * CBA)
|
absent inner cell mass proliferation
|
J:126546
|
Psme3tm1Jjm/Psme3tm1Jjm
(B6.129X1-Psme3tm1Jjm)
|
decreased fibroblast proliferation
|
J:88626
|
Psme3tm1Tchi/Psme3tm1Tchi
(involves: C57BL/6J * CBA)
|
decreased cell proliferation
|
J:89182
|
Psmg1tm1.1Smta/Psmg1tm1.1Smta Tg(Nes-cre)1Kln/0
(involves: C57BL/6 * CBA * SJL)
|
decreased cerebellar granule cell precursor proliferation
|
J:162790
|
Ptbp1tm1Msol/Ptbp1tm1Msol
(B6J.129-Ptbp1tm1Msol)
|
decreased cell proliferation
|
J:223915
|
Ptch1tm1Bjw/Ptch1tm1Bjw Tg(Atoh1-cre)1Bfri/0
(involves: 129T2/SvEms * C57BL/6 * CBA)
|
abnormal neuronal precursor proliferation
|
J:139573
|
Ptch1tm1Bjw/Ptch1tm1Bjw Tg(Atoh1-cre/Esr1*)14Fsh/0
(involves: 129T2/SvEms * FVB/N)
|
abnormal neuronal precursor proliferation
|
J:139573
|
Ptch1tm1Yy/Ptch1tm1.1Yy Tg(Col2a1-cre)1Bhr/0
(involves: C57BL/6 * SJL)
|
increased chondrocyte proliferation
|
J:112462
|
Ptentm1Engc/Ptentm1Engc
(involves: CD-1)
|
increased cell proliferation
|
J:210487
|
Ptentm1Hwu/Ptentm1Hwu Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S4/SvJae * C57BL/6 * DBA)
|
increased hepatocyte proliferation
|
J:218587
|
Ptentm1Hwu/Ptentm1Hwu Tg(CYP19A1-cre)1Jri/0
(involves: 129S4/SvJae)
|
increased granulosa cell proliferation
|
J:138315
|
Ptentm1Hwu/Ptentm1Hwu Tg(Gfap-cre)77.6Mvs/0
(involves: 129S4/SvJae * BALB/c * C57BL/6NHsd)
|
abnormal neuronal precursor proliferation
|
J:146630
|
Ptentm1Hwu/Ptentm1Hwu Tg(Ins2-cre)25Mgn/0
(involves: 129S4/SvJae * C57BL/6 * DBA)
|
increased pancreatic beta cell proliferation
|
J:106937
|
Ptentm1Hwu/Ptentm1Hwu Tg(Nkx2-1-cre)2Sand/0
(involves: 129S4/SvJae * BALB/c * C57BL/6)
|
increased lung endothelial cell proliferation
|
J:167962
|
Ptentm1Hwu/Ptentm1Hwu Tg(Vil1-cre)997Gum/0
(involves: 129S4/SvJae * BALB/c * C57BL/6J * SJL)
|
abnormal small intestinal crypt cell proliferation
|
J:150553
|
Ptentm1Hwu/Ptentm1Hwu Vhltm1Jae/Vhltm1Jae Tg(Cdh16-cre)91Igr/0
(involves: 129S4/SvJae * BALB/c * C57BL/6J * ICR)
|
increased kidney cell proliferation
|
J:137073
|
Ptentm2Mak/Ptentm2Mak Smad4tm2.1Cxd/Smad4tm2.1Cxd Tg(KRT5-cre)1Xya/0
(involves: 129P2/OlaHsd * 129S6/SvEvTac)
|
increased keratinocyte proliferation
|
J:101602
|
Ptentm2Mak/Ptentm2Mak Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129P2/OlaHsd * C57BL/6 * DBA)
|
increased hepatocyte proliferation
|
J:138099
|
Ptentm2Mak/Ptentm2Mak Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129P2/OlaHsd * C57BL/6 * C57BL/6J * DBA)
|
increased hepatocyte proliferation
|
J:90905
|
Ptentm2Mak/Ptentm2Mak Tg(SFTPC-rtTA)5Jaw/0 Tg(tetO-cre)1Jaw/0
(involves: 129 * 129P2/OlaHsd * C57BL/6 * C57BL/6J)
|
increased mesenchymal cell proliferation involved in lung development
|
J:127405
|
Ptger4tm1Sna/Ptger4tm1Sna
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased T cell proliferation
|
J:83725
|
Ptges3tm1Nkt/Ptges3tm1Nkt
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased fibroblast proliferation
|
J:125188
|
Pthlhtm2Ack/Pthlhtm2Ack
(involves: 129S2/SvPas * C57BL/6)
|
decreased cell proliferation
|
J:142669
|
decreased chondrocyte proliferation
|
J:142669
|
Ptk2tm1Heen/Ptk2tm1Heen
(involves: 129/Sv * C57BL/6)
|
decreased fibroblast proliferation
|
J:157804
|
Ptk2tm1Lfr/Ptk2tm1Ilic Tg(KRT5-cre)5132Jlj/0
(involves: 129X1/SvJ * C57BL/6 * CBA * DBA/2J)
|
decreased keratinocyte proliferation
|
J:107206
|
Ptmatm1.1Got/Ptma+
(involves: C57BL/6J * C57BL/6NTac)
|
abnormal neuron proliferation
|
J:240549
|
Ptp4a2Gt(AQ0673)Wtsi/Ptp4a2Gt(AQ0673)Wtsi
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased cell proliferation
|
J:190411
|
Ptpmt1tm1.1Jedi/Ptpmt1tm1.1Jedi
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL)
|
decreased cell proliferation
|
J:176087
|
Ptpmt1tm1Ckq/Ptpmt1tm1Ckq
(B6.Cg-Ptpmt1tm1Ckq)
|
absent inner cell mass proliferation
|
J:178313
|
Ptpn6me/Ptpn6me
(involves: C3H/HeN * C57BL/6J * NFS)
|
increased splenocyte proliferation
|
J:30994
|
Ptpn9tm1Dny/Ptpn9tm1Dny
(B6.129-Ptpn9tm1Dny)
|
decreased T cell proliferation
|
J:118880
|
Ptpn11tm1Bgn/Ptpn11+
(involves: 129S4/SvJae * C57BL/6J)
|
increased cell proliferation
|
J:91609
|
Ptpn11tm1Bgn/Ptpn11tm1Bgn
(involves: 129S4/SvJae * C57BL/6J)
|
increased cell proliferation
|
J:91609
|
Ptpn11tm1Gsf/Ptpn11tm1Gsf Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA)
|
increased hepatocyte proliferation
|
J:172422
|
Ptpn11tm1Paw/Ptpn11tm1Paw
(involves: 129S1/Sv * 129X1/SvJ)
|
decreased cell proliferation
|
J:106624
|
Ptpn11tm5Bgn/Ptpn11tm5Bgn
(involves: 129S4/SvJae * C57BL/6J)
|
decreased trophectoderm cell proliferation
|
J:106624
|
Ptpn12tm1Vei/Ptpn12tm1Vei Tg(Cd4-cre)1Cwi/0
(B6.Cg-Tg(Cd4-cre)1Cwi Ptpn12tm1Vei)
|
decreased T cell proliferation
|
J:163910
|
Ptpn22tm1.1Draw/Ptpn22+
(involves: 129 * C57BL/6)
|
increased B cell proliferation
|
J:201448
|
increased T cell proliferation
|
J:201448
|
Ptpn22tm1.1Draw/Ptpn22tm1.1Draw
(involves: 129 * C57BL/6)
|
increased B cell proliferation
|
J:201448
|
increased T cell proliferation
|
J:201448
|
Ptpn22tm1.1Kas/Ptpn22tm1.1Kas
(involves: C57BL/6)
|
increased B cell proliferation
|
J:176519
|
increased T cell proliferation
|
J:176519
|
Ptpn22tm1.1Kas/Ptpn22tm1.1Kas Tg(TcraTcrb)425Cbn/0
(involves: BALB/c * C57BL/6)
|
increased T cell proliferation
|
J:176519
|
Ptprctm1Mak/Ptprctm1Mak
(involves: 129/Sv * C57BL/6)
|
decreased B cell proliferation
|
J:13163
|
decreased T cell proliferation
|
J:13163
|
Ptprcaptm1Tkda/Ptprcaptm1Tkda
(involves: 129X1/SvJ)
|
decreased B cell proliferation
|
J:48387
|
decreased T cell proliferation
|
J:48387
|
PtprfGt(ST534)Byg/PtprfGt(ST534)Byg
(D.129P2-PtprfGt(ST534)Byg)
|
increased cell proliferation
|
J:108603
|
Ptprvtm1Asmi/Ptprvtm1Asmi
(involves: 129P2/OlaHsd * C57BL/6J)
|
increased pancreatic beta cell proliferation
|
J:152695
|
Ptprvtm1Kry/Ptprvtm1Kry Tg(Col1a1-cre)1Kry/0
(involves: FVB)
|
increased pancreatic beta cell proliferation
|
J:126780
|
Pttg1tm1Pzg/Pttg1tm1Pzg
(involves: 129S7/SvEvBrd * C57BL/6)
|
decreased cell proliferation
|
J:121688
|
Pttg1tm1Sme/Pttg1tm1Sme
(involves: 129S4/SvJae * C57BL/6)
|
decreased pancreatic beta cell proliferation
|
J:82724
|
Puratm1Herm/Pura+
(involves: 129P2/OlaHsd * BALB/c)
|
abnormal neuron proliferation
|
J:179606
|
Puratm1Herm/Puratm1Herm
(involves: 129P2/OlaHsd * BALB/c)
|
abnormal neuron proliferation
|
J:179606
|
Puratm1Kkh/Pura+
(involves: 129)
|
decreased cell proliferation
|
J:85759
|
Puratm1Kkh/Puratm1Kkh
(involves: 129)
|
decreased cell proliferation
|
J:85759
|
decreased neuronal precursor proliferation
|
J:85759
|
Pxdnmhdakta048/Pxdnmhdakta048
(involves: C3HeB/FeJ * C57BL/6J)
|
decreased cell proliferation
|
J:213336
|
Pygo2tm1.1Xdai/Pygo2tm1.2Xdai Tg(KRT14-cre)#Smr/0
(involves: 129P2/OlaHsd * C57BL/6J * SJL/J)
|
decreased mammary gland epithelial cell proliferation
|
J:163218
|
Pygo2tm1.2Xdai/Pygo2tm1.2Xdai
(involves: 129P2/OlaHsd)
|
decreased mammary gland epithelial cell proliferation
|
J:163218
|
R3hdmltm1Mita/R3hdmltm1Mita
(B6.Cg-R3hdmltm1Mita)
|
abnormal skeletal muscle satellite cell proliferation
|
J:282737
|
Rab7tm1.1Ale/Rab7tm1.1Ale Tg(Cd4-cre)1Cwi/?
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA/2)
|
decreased T cell proliferation
|
J:211733
|
Rab10tm1Tax/Rab10tm1Tax
(B6.Cg-Rab10tm1Tax)
|
decreased cell proliferation
|
J:262459
|
Rab11atm1.1Ngao/Rab11atm1.1Ngao Tg(Vil1-cre)997Gum/0
(involves: 129S4/SvJae * C57BL/6J * SJL)
|
abnormal small intestinal crypt cell proliferation
|
J:215917
|
Rab11atm1.1Ngao/Rab11atm1.1Ngao Tg(Vil1-cre/ERT2)23Syr/0
(involves: 129S4/SvJae * C57BL/6 * DBA/2)
|
abnormal small intestinal crypt cell proliferation
|
J:278932,
J:215917
|
Rac1tm1Djk/Rac1tm1Djk Tg(Nkx2-5-cre)9Eno/0
(involves: 129S4/SvJae * BALB/c * C57BL/6)
|
decreased fetal cardiomyocyte proliferation
|
J:321017
|
Rac1tm1Tyb/Rac1tm2Tyb Edil3Tg(Sox2-cre)1Amc/Edil3+
(involves: 129S4/SvJae * C3H * C57BL/6 * CBA)
|
decreased cell proliferation
|
J:173526
|
Rac2tm1Mddw/Rac2tm1Mddw
(involves: 129S/SvEv * C57BL/6)
|
decreased T cell proliferation
|
J:119437
|
Rac2tm1Mddw/Rac2tm1Mddw
(involves: 129S/SvEv)
|
decreased vascular endothelial cell proliferation
|
J:131305
|
Rac2tm1Mddw/Rac2tm1Mddw Tg(TcrAND)53Hed/0
(involves: 129S/SvEv * C57BL/6 * SJL)
|
decreased T cell proliferation
|
J:119437
|
Racgap1tm1Mahi/Racgap1tm1Mahi Tg(Stra8-icre)1Reb/0
(involves: C57BL/6 * FVB/NJ)
|
abnormal spermatogonia proliferation
|
J:206583
|
Rad50tm1Jpt/Rad50tm1Jpt
(involves: 129S7/SvEvBrd)
|
decreased cell proliferation
|
J:56083
|
Rad50tm1Jpt/Rad50tm3Jpt Tg(Mx1-cre)1Cgn/0
(involves: 129S7/SvEvBrd * C57BL/6 * CBA)
|
decreased hepatocyte proliferation
|
J:144766
|
Rad51tm1Hst/Rad51tm1Hst
(involves: 129S7/SvEvBrd * C57BL/6)
|
absent inner cell mass proliferation
|
J:36540
|
decreased cell proliferation
|
J:36540
|
Rad51tm1Hst/Rad51tm1Hst Trp53tm1Brd/Trp53tm1Brd
(involves: 129S7/SvEvBrd * C57BL/6)
|
decreased cell proliferation
|
J:36540
|
Rad54l2Gt(A016E03)Oaj/Rad54l2Gt(A016E03)Oaj
(involves: ICR)
|
decreased cell proliferation
|
J:121844
|
decreased fibroblast proliferation
|
J:121844
|
Raf1tm1Zim/Raf1tm1Zim
(involves: 129/Sv * CD-1)
|
decreased fibroblast proliferation
|
J:50696
|
Raf1tm3Ulb/Raf1tm3Ulb
(Not Specified)
|
decreased cell proliferation
|
J:141095
|
Rag1tm1Mom/Rag1tm1Mom
(involves: 129S7/SvEvBrd)
|
abnormal neuron proliferation
|
J:170591
|
Rag2tm1Avla/Rag2tm1Avla
(involves: 129/Sv * C57BL/6)
|
decreased T cell proliferation
|
J:122108
|
Rag2tm1Fwa/Rag2tm1Fwa Sos1tm1.1Les/Sos1tm1.1Les Tg(Lck-cre)1Cwi/0
(involves: 129S/SvEv * C57BL/6)
|
decreased T cell proliferation
|
J:174536
|
Rag2tm1Fwa/Rag2tm1Fwa Tg(TcrHEL3A9)1Mmd/0
(involves: 129S/SvEv * C57BL/6)
|
abnormal T cell proliferation
|
J:78309
|
Rag2tm1Fwa/Rag2tm1Fwa Tg(TcrHEL3A9)1Mmd/0 Tg(TLK2mHEL)2Ccg/0
(involves: 129S/SvEv * C57BL/6)
|
abnormal T cell proliferation
|
J:78309
|
Ralatm1.2Cjm/Ralatm1.2Cjm Ralbtm1.1Cjm/Ralbtm1.1Cjm
(involves: C57BL/6 * C57BL/6J)
|
decreased fibroblast proliferation
|
J:199742
|
Ranbp1Gt(S17-6E1)1.1Sor/Ranbp1Gt(S17-6E1)1.1Sor
(B6.129S4(129S6)-Ranbp1Gt(S17-6E1)1.1Sor)
|
abnormal neuronal precursor proliferation
|
J:235630
|
Ranbp9Gt(RHA056)Byg/Ranbp9Gt(RHA056)Byg
(B6.129P2-Ranbp9Gt(RHA056)Byg)
|
abnormal spermatogonia proliferation
|
J:173615
|
Rangrftm1.1Tke/Rangrftm1.1Tke
(involves: C57BL/6)
|
increased fibroblast proliferation
|
J:325055
|
Rap1atm1Tze/Rap1atm1Tze
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased T cell proliferation
|
J:144145
|
Rapgef2tm1.2Hous/Rapgef2tm1.2Hous
(involves: 129S1/Sv)
|
decreased cell proliferation
|
J:165879
|
Raratm3.1Ipc/Rara+ Trim24tm1.1Los/Trim24tm1.1Los
(involves: 129/Sv * C57BL/6 * SJL)
|
increased hepatocyte proliferation
|
J:130210
|
Raratm3Ipc/Rara+ Speer6-ps1Tg(Alb-cre)21Mgn/? Trim24tm1Los/Trim24tm1Los
(involves: 129/Sv * C57BL/6 * DBA * SJL)
|
increased hepatocyte proliferation
|
J:130210
|
Raratm3Ipc/Raratm3Ipc Speer6-ps1Tg(Alb-cre)21Mgn/? Trim24tm1Los/Trim24tm1Los
(involves: 129/Sv * C57BL/6 * DBA * SJL)
|
increased hepatocyte proliferation
|
J:130210
|
Rarres1tm1.2Mhl/Rarres1tm1.2Mhl
(involves: 129S1/SvImJ * C57BL/6 * FVB/N * NIH Black Swiss)
|
increased B cell proliferation
|
J:324270
|
Rasgrf2tm1Esn/Rasgrf2tm1Esn Vav1tm1Tyb/Vav1tm1Tyb
(involves: 129S1/Sv * 129S2/SvPas * C57BL/10 * C57BR/cd)
|
decreased T cell proliferation
|
J:128985
|
Rasgrp1lag/Rasgrp1lag
(involves: 129 * C57BL/6)
|
decreased T cell proliferation
|
J:85189
|
Rasgrp1tm1.1Wz/Rasgrp1tm1.1Wz
(B6.Cg-Rasgrp1tm1.1Wz)
|
decreased T cell proliferation
|
J:225109
|
Rassf5tm1Kina/Rassf5tm1Kina
(B6.Cg-Rassf5tm1Kina)
|
increased B cell proliferation
|
J:168749
|
increased T cell proliferation
|
J:168749
|
Rassf9Tg(PDLIM7*)2Cml/Rassf9Tg(PDLIM7*)2Cml
(involves: ICR)
|
increased keratinocyte proliferation
|
J:171677
|
Rb1tm1Brd/Rb1tm1Brd
(involves: 129S7/SvEvBrd * C57BL/6)
|
abnormal cell proliferation
|
J:2516
|
Rb1tm1Dwg/Rb1tm1Dwg
(involves: 129/Sv * C57BL/6)
|
increased fibroblast proliferation
|
J:105548
|
Rb1tm1Tyj/Rb1tm1Tyj
(involves: 129S2/SvPas)
|
increased fibroblast proliferation
|
J:105548
|
Rb1tm1Tyj/Rb1tm1Tyj
(involves: 129S2/SvPas * C57BL/6)
|
increased cell proliferation
|
J:81082
|
Rb1tm1Tyj/Rb1tm1Tyj Trim27Gt(XP0484)Wtsi/Trim27Gt(XP0484)Wtsi
(involves: 129P2/OlaHsd * C57BL/6)
|
increased cell proliferation
|
J:189317
|
Rb1tm1Tyj/Rb1tm2Brn Rbl1tm1Tyj/Rbl1tm1Tyj Trp53tm1Brn/Trp53tm1Tyj Tg(Chx10-EGFP/cre,-ALPP)2Clc/0
(involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6 * SJL)
|
abnormal cell proliferation
|
J:120315
|
Rb1tm2Brn/Rb1tm2Brn Rbl1tm1Htr/Rbl1+ Tg(En2-cre)22Alj/0
(involves: 129P2/OlaHsd * CD-1)
|
abnormal neuronal precursor proliferation
|
J:83783
|
Rb1tm2Brn/Rb1tm2Brn Rbl1tm1Htr/Rbl1tm1Htr Tg(En2-cre)22Alj/0
(involves: 129P2/OlaHsd * CD-1)
|
abnormal neuronal precursor proliferation
|
J:83783
|
Rb1tm2Brn/Rb1tm2Brn Tg(Col1a1-cre)1Bek/0
(involves: 129 * CD-1)
|
abnormal organ of Corti supporting cell proliferation
|
J:96345
|
Rb1tm2Brn/Rb1tm2Brn Tg(Cyp1a1-cre)1Dwi/0
(involves: 129 * C57BL/6 * CBA)
|
abnormal enterocyte proliferation
|
J:215358
|
Rb1tm2Brn/Rb1tm2Brn Tg(En2-cre)22Alj/0
(involves: 129P2/OlaHsd * CD-1)
|
abnormal neuronal precursor proliferation
|
J:83783
|
Rb1tm2Brn/Rb1tm2Brn Tg(Pou4f3-cre)1Devet/0
(involves: 129 * 129S/SvEv)
|
abnormal organ of Corti supporting cell proliferation
|
J:109453
|
Rb1cc1tm1.1Guan/Rb1cc1tm1.1Guan Tg(Tek-cre)12Flv/0
(B6.Cg-Rb1cc1tm1.1Guan Tg(Tek-cre)12Flv)
|
increased hematopoietic stem cell proliferation
|
J:167258
|
Rbfox2tm1.1Dblk/Rbfox2tm1.1Dblk Tg(Nes-cre)1Kln/0
(involves: 129S2/SvPas * C57BL/6 * C57BL/6J * SJL)
|
decreased cerebellar granule cell precursor proliferation
|
J:181631
|
Rbfox3tm1a(EUCOMM)Hmgu/Rbfox3tm1a(EUCOMM)Hmgu
(B6Dnk;B6N-Rbfox3tm1a(EUCOMM)Hmgu/H)
|
decreased neuronal precursor proliferation
|
J:240501
|
Rbl1tm1Mru/Rbl1tm1Mru
(involves: 129S4/SvJae * BALB/cJ)
|
increased cell proliferation
|
J:51060
|
increased fibroblast proliferation
|
J:51060
|
Rbl1tm1Mru/Rbl1tm1Mru
(involves: 129S4/SvJae * BALB/c * C57BL/6)
|
abnormal neuronal precursor proliferation
|
J:92520
|
Rbl1tm3.1Jsag/Rbl1tm3.1Jsag
(involves: C57BL/6)
|
increased fibroblast proliferation
|
J:161509
|
Rbl2tm1Mru/Rbl2tm1Mru
(involves: 129S4/SvJae * BALB/cJ)
|
abnormal cell proliferation
|
J:50516
|
Rbm3tm1Ttg/Rbm3tm1Ttg
(involves: 129P2/OlaHsd)
|
decreased fibroblast proliferation
|
J:174947
|
Rbp4tm1Gott/Rbp4tm1Gott
(involves: 129/Sv * C57BL/6 * CD-1)
|
abnormal fetal cardiomyocyte proliferation
|
J:82903
|
Rbpjtm1Hon/Rbpjtm1Hon Tg(Lck-cre)19Hhan/0
(involves: 129P2/OlaHsd * C57BL/6 * DBA)
|
increased T cell proliferation
|
J:168475
|
Rbpjtm1Kyo/Rbpjtm1Kyo
(involves: 129S2/SvPas)
|
abnormal fetal cardiomyocyte proliferation
|
J:119151
|
Rbx1Gt(XB674)Byg/Rbx1+
(involves: 129P2/OlaHsd * C57BL/6J)
|
decreased cell proliferation
|
J:147759
|
Rbx1Gt(XB674)Byg/Rbx1Gt(XB674)Byg
(involves: 129P2/OlaHsd * C57BL/6J)
|
decreased cell proliferation
|
J:147759
|
Rc3h1san/Rc3h1san
(involves: C57BL/6JSfdAnu)
|
increased T cell proliferation
|
J:199407
|
Rc3h1tm1.1Mass/Rc3h1tm1.1Mass Rc3h2tm1c(KOMP)Wtsi/Rc3h2tm1c(KOMP)Wtsi Tg(Cd4-cre)1Cwi/?
(involves: C57BL/6N * DBA/2)
|
increased T cell proliferation
|
J:196136
|
Rcan1tm1Fmc/Rcan1tm1Fmc
(involves: 129S4/SvJae)
|
decreased T cell proliferation
|
J:85148
|
Rcan1tm1Jmol/Rcan1tm1Jmol Rcan2tm1Jmol/Rcan2tm1Jmol
(involves: 129 * C57BL/6)
|
decreased T cell proliferation
|
J:109586
|
Rcan1tm1Jmol/Rcan1tm1Jmol Rcan2tm1Jmol/Rcan2tm1Jmol Ppp3cbtm1Jmk/Ppp3cbtm1Jmk
(involves: 129S6/SvEvTac * C57BL/6)
|
decreased T cell proliferation
|
J:109586
|
Rcor2tm1c(EUCOMM)Wtsi/Rcor2tm1c(EUCOMM)Wtsi Tg(Nes-cre)1Kln/0
(involves: C57BL/6 * C57BL/6N * SJL)
|
decreased neuronal precursor proliferation
|
J:235702
|
Recql4tm1Furu/Recql4tm1Furu
(Not Specified)
|
decreased inner cell mass proliferation
|
J:85891
|
Recqltm1Pjb/Recqltm1Pjb
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
decreased fibroblast proliferation
|
J:118989
|
Reg2tm1Lchr/Reg2tm1Lchr
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased hepatocyte proliferation
|
J:140235
|
Reltm1Grd/Rel+
(involves: 129S1/Sv * C57BL/6)
|
decreased B cell proliferation
|
J:28435
|
Reltm1Grd/Reltm1Grd
(involves: 129S1/Sv * C57BL/6)
|
decreased B cell proliferation
|
J:28435
|
decreased T cell proliferation
|
J:28435
|
Reltm1Grd/Reltm1Grd Relatm1Bal/Relatm1Bal Tnftm1Ljo/Tnftm1Ljo
(involves: 129P2/OlaHsd * 129S1/Sv * 129S4/SvJae)
|
decreased cell proliferation
|
J:91366
|
Reltm1Hcl/Rel+
(involves: 129S4/SvJae * C57BL/6)
|
decreased T cell proliferation
|
J:53513
|
Reltm1Hcl/Reltm1Hcl
(involves: 129S4/SvJae * C57BL/6)
|
decreased B cell proliferation
|
J:75621
|
decreased T cell proliferation
|
J:53513,
J:79107
|
Relatm1Yuo/Relatm1Yuo
(involves: 129S/SvEv)
|
decreased B cell proliferation
|
J:63099
|
decreased T cell proliferation
|
J:63099
|
RelbTg(H2-K1/GH1)106Bri/RelbTg(H2-K1/GH1)106Bri
(C57BL/6-RelbTg(H2-K1/GH1)106Bri)
|
decreased T cell proliferation
|
J:76450
|
Relbtm1Brv/Relbtm1Brv
(involves: 129S2/SvPas * C57BL/6)
|
decreased B cell proliferation
|
J:40630
|
Relbtm1Brv/Relbtm1Brv
(either: (involves: 129S2/SvPas) or (involves: C57BL/6) or (involves: 129S2/SvPas * C57BL/6))
|
increased keratinocyte proliferation
|
J:63950
|
Relttm1Hlee/Relttm1Hlee
(Not Specified)
|
increased T cell proliferation
|
J:266480
|
Rettm1Jmi/Rettm1Jmi
(involves: 129X1/SvJ)
|
increased cell proliferation
|
J:71881
|
Rev3ltm1Rsky/Rev3ltm1.1Rsky Tg(Cr2-cre)3Cgn/?
(involves: C57BL/6)
|
decreased B cell proliferation
|
J:146453
|
Rflnatm1Tfur/Rflnatm1Tfur Rflnbtm1Sia/Rflnbtm1Sia
(involves: 129S6/SvEvTac * C57BL/6 * C57BL/6NCrlj * CBA/JNCrlj)
|
decreased chondrocyte proliferation
|
J:210363
|
Rgcctm1Hrus/Rgcctm1Hrus
(involves: 129S6/SvEvTac * C57BL/6)
|
increased T cell proliferation
|
J:279555
|
Rgs2tm1Pngr/Rgs2tm1Pngr
(involves: C57BL/6J)
|
abnormal T cell proliferation
|
J:77273
|
Rhebtm1.1Yelg/Rhebtm1.1Yelg
(B6.129P2-Rhebtm1.1Yelg)
|
decreased fibroblast proliferation
|
J:170999
|
Rhoatm1.1Tpal/Rhoa+ Tg(Cd4-cre/ERT2)11Gnri/0
(involves: C57BL/6)
|
increased T cell proliferation
|
J:257764
|
Rhoatm1Jrel/Rhoatm1Jrel Tg(Pou3f4-cre)32Cren/0
(involves: CD-1)
|
abnormal neuronal precursor proliferation
|
J:171199
|
Rhoatm1Yuyo/Rhoatm1Yuyo H2az2Tg(Wnt1-cre)11Rth/H2az2+
(involves: C57BL/6J * CBA/J)
|
abnormal neuron proliferation
|
J:172044
|
Rhogtm1Tnr/Rhogtm1Tnr
(involves: 129)
|
increased B cell proliferation
|
J:87580
|
Rhohtm1Brak/Rhohtm1Brak
(involves: 129/Sv * C57BL/6)
|
abnormal T cell proliferation
|
J:143161
|
decreased T cell proliferation
|
J:143161
|
increased T cell proliferation
|
J:143161
|
Rictortm1.1Klg/Rictortm1.1Klg Tg(Mx1-cre)1Cgn/0
(B6.Cg-Rictortm1.1Klg Tg(Mx1-cre)1Cgn)
|
decreased T cell proliferation
|
J:189736
|
Rictortm1.1Mgn/Rictortm1.1Mgn Tg(Ins2-cre)25Mgn/0
(involves: 129S6/SvEvTac * BALB/c * C57BL/6 * DBA)
|
decreased pancreatic beta cell proliferation
|
J:170129
|
Rictortm1.2Mgn/Rictortm1.2Mgn
(involves: 129S6/SvEvTac * C57BL/6 * FVB/N * SJL)
|
decreased cell proliferation
|
J:119564
|
Rif1Gt(A045A01)Wrst/Rif1Gt(A045A01)Wrst
(involves: 129S2/SvPas * C57BL/6J)
|
decreased cell proliferation
|
J:155449
|
Rif1tm1.1Sbcb/Rif1tm1.1Sbcb
(involves: C57BL/6 * C57BL/6J)
|
decreased cell proliferation
|
J:155449
|
Ripk2tm1Flv/Ripk2tm1Flv
(involves: 129S1/Sv)
|
decreased T cell proliferation
|
J:75400
|
Ripk2tm1Ghc/Ripk2tm1Ghc
(involves: 129S4/SvJae * C57BL/6)
|
decreased T cell proliferation
|
J:75401
|
Ripply3tm1Sjt/Ripply3tm1Sjt
(involves: 129S1/Sv * C57BL/6)
|
increased pancreatic beta cell proliferation
|
J:214095
|
Rnaseh2btm1a(EUCOMM)Wtsi/Rnaseh2btm1a(EUCOMM)Wtsi
(involves: C57BL/6N)
|
decreased cell proliferation
|
J:186180
|
decreased fibroblast proliferation
|
J:186986
|
Rnaseh2btm1c(EUCOMM)Wtsi/Rnaseh2btm1c(EUCOMM)Wtsi Cd19tm1(cre)Cgn/Cd19+
(involves: 129P2/OlaHsd * C57BL/6 * C57BL/6N * SJL)
|
decreased B cell proliferation
|
J:186986
|
Rnf7Gt(XE423)Byg/Rnf7Gt(XE423)Byg
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased cell proliferation
|
J:178926
|
Rnf7tm1c(EUCOMM)Wtsi/Rnf7tm1c(EUCOMM)Wtsi Tg(Nes-cre)1Kln/0
(involves: C57BL/6 * C57BL/6N * SJL)
|
decreased cerebellar granule cell precursor proliferation
|
J:205551
|
Rnf8Gt(AS0574)Wtsi/Rnf8Gt(AS0574)Wtsi
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased fibroblast proliferation
|
J:161240
|
Rnf8Gt(RRR260)Byg/Rnf8Gt(RRR260)Byg
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased fibroblast proliferation
|
J:161240
|
Rnf19aGt(OST244733)Lex/Rnf19aGt(OST244733)Lex
(B6.129S5-Rnf19aGt(OST244733)Lex)
|
abnormal neuron proliferation
|
J:250032
|
Rnf43tm1Cle/Rnf43tm1Cle Znrf3tm1Cle/Znrf3tm1Cle Tg(Vil1-cre/ERT2)23Syr/0
(involves: C57BL/6 * DBA/2)
|
abnormal small intestinal crypt cell proliferation
|
J:186765
|
Rnf128tm1.1Flv/Y
(involves: 129S6/SvEvTac * C57BL/6)
|
increased T cell proliferation
|
J:153216
|
Rnf128tm1.1Flv/Y Tg(TcraTcrb)425Cbn/0
(involves: 129S6/SvEvTac * BALB/c * C57BL/6)
|
decreased T cell proliferation
|
J:153216
|
Rnf128tm1.1Flv/Rnf128tm1.1Flv
(involves: 129S6/SvEvTac * C57BL/6)
|
increased T cell proliferation
|
J:153216
|
Rnf128tm1.1Flv/Rnf128tm1.1Flv Tg(TcraTcrb)425Cbn/0
(involves: 129S6/SvEvTac * BALB/c * C57BL/6)
|
decreased T cell proliferation
|
J:153216
|
Rnf128tm1Cdon/Rnf128tm1Cdon
(involves: C57BL/6)
|
increased T cell proliferation
|
J:160681
|
Rnf128tm1Cdon/Rnf128tm1Cdon
(involves: 129 * C57BL/6)
|
increased splenocyte proliferation
|
J:160681
|
Rnf128tm1Cdon/Rnf128tm1Cdon Tg(TcraTcrb)425Cbn/0
(involves: 129 * BALB/c * C57BL/6)
|
increased splenocyte proliferation
|
J:160681
|
Rnf146tm1.1Rtpl/Rnf146tm1.1Rtpl Tg(Sp7-tTA,tetO-EGFP/cre)1Amc/0
(involves: C57BL/6J * CD-1)
|
decreased osteoblast proliferation
|
J:244583
|
Rnf149em1Staa/Rnf149em1Staa
(involves: BALB/c * C57BL/6)
|
increased cell proliferation
|
J:335358
|
Robo1tm1Matl/Robo1tm1Matl
(involves: 129X1/SvJ)
|
increased mammary gland epithelial cell proliferation
|
J:141875
|
Rock2tm1.1Itl/Rock2+ Tg(Tagln-cre)1Her/0
(B6.Cg-Rock2tm1.1Itl Tg(Tagln-cre)1Her)
|
decreased vascular smooth muscle cell proliferation
|
J:222206
|
Roratmgc26/Roratmgc26
(involves: D7R75M)
|
abnormal neuron proliferation
|
J:171777
|
decreased cerebellar granule cell precursor proliferation
|
J:171777
|
Rpa1tm1Wed/Rpa1tm1Wed
(involves: 129/Sv * C57BL/6J * SJL)
|
decreased cell proliferation
|
J:99303
|
Rpl27aSfa/Rpl27a+
(C57BL/6J-Rpl27aSfa)
|
increased hematopoietic stem cell proliferation
|
J:174216
|
Rpl29tm1Udel/Rpl29tm1Udel
(129S6/SvEvTac-Rpl29tm1Udel)
|
decreased fibroblast proliferation
|
J:117229
|
Rpl39lem1Hqi/Rpl39lem1Hqi
(involves: C57BL/6J)
|
abnormal spermatogonia proliferation
|
J:317811
|
Rps6ka4tm1Jsca/Rps6ka4tm1Jsca Rps6ka5tm1Jsca/Rps6ka5tm1Jsca
(Not Specified)
|
decreased T cell proliferation
|
J:124301
|
Rps12em1.1Nbakr/Rps12+
(involves: C57BL/6J * FVB/N)
|
abnormal hematopoietic stem cell proliferation
|
J:338970
|
Rptortm1Lex/Rptortm1Lex
(involves: 129S/SvEvBrd)
|
decreased inner cell mass proliferation
|
J:137592
|
Rr28tm1Tilg/Rr28+ Igf2tm1Rob/Igf2+
(involves: 129S/SvEv * 129S1/Sv * C57BL/6J)
|
abnormal fetal cardiomyocyte proliferation
|
J:77413
|
increased hepatocyte proliferation
|
J:77413
|
Rr170tm1.1Iku/Rr170tm1.1Iku
(B6.Cg-Rr170tm1.1Iku)
|
decreased T cell proliferation
|
J:333539
|
Rr273em1Issa/Rr273em1Issa
(involves: C57BL/6J * DBA/2J)
|
decreased cell proliferation
|
J:333875
|
Rragcem1Efe/Rragc+
(Not Specified)
|
decreased B cell proliferation
|
J:320567
|
Rras2Gt(OST361011)Lex/Rras2Gt(OST361011)Lex
(involves: 129S5/SvEvBrd)
|
decreased B cell proliferation
|
J:151653
|
Rreb1em1Rtpl/Rreb1+
(C57BL/6J-Rreb1em1Rtpl)
|
increased cell proliferation
|
J:296982
|
Rrm2bGt(OST85254)Lex/Rrm2bGt(OST85254)Lex
(involves: 129S5/SvEvBrd * C57BL/6J)
|
increased kidney cell proliferation
|
J:186071
|
Runx2tm1Jals/Runx2tm1Jals
(involves: 129S7/SvEvBrd * C57BL/6)
|
increased osteoblast proliferation
|
J:143532
|
Runx3tm1Yg/Runx3tm1Yg
(involves: 129S1/Sv * 129X1/SvJ * ICR)
|
decreased osteoblast proliferation
|
J:224290
|
Ruvbl1tm1.2Oxbk/Ruvbl1tm1.2Oxbk
(involves: 129P2/OlaHsd * BALB/cJ * C57BL/6 * SJL)
|
decreased inner cell mass proliferation
|
J:220926
|
Rxratm1Rev/Rxratm1Rev
(involves: 129S4/SvJae * C57BL/6)
|
decreased hepatocyte proliferation
|
J:18047
|
Rxratm2Ipc/Rxratm4Ipc Tg(KRT14-cre)1Ipc/0
(involves: 129S2/SvPas * C57BL/6 * SJL)
|
increased keratinocyte proliferation
|
J:67149
|
S1pr2tm1Rlp/S1pr2tm1Rlp
(involves: 129S6/SvEvTac * C57BL/6)
|
increased B cell proliferation
|
J:174313
|
Sac3d1tm1Hnaka/Sac3d1tm1Hnaka
(involves: 129P2/OlaHsd)
|
increased T cell proliferation
|
J:144601
|
Sall1tm4.1Ryn/Sall1tm4.1Ryn Sall4tm3Ryn/Sall4tm4Ryn
(involves: 129P2/OlaHsd)
|
decreased cell proliferation
|
J:159449
|
Sall4tm1Ryn/Sall4tm1Ryn
(involves: 129P2/OlaHsd * C57BL/6J)
|
decreased inner cell mass proliferation
|
J:118119
|
Sall4tm1Yam/Sall4tm1Yam
(involves: 129S4/SvJae * C57BL/6J)
|
decreased cell proliferation
|
J:158264
|
decreased inner cell mass proliferation
|
J:158264
|
Samsn1tm1Xyw/Samsn1tm1Xyw
(B6.129P2-Samsn1tm1Xyw)
|
increased B cell proliferation
|
J:158032
|
increased T cell proliferation
|
J:158032
|
Saraftm1c(KOMP)Wtsi/Saraftm1c(KOMP)Wtsi Tg(Pgk1-cre)1Lni/0
(involves: 129S4/SvJaeSor * BALB/c * C57BL/6J * C57BL/6N)
|
decreased fibroblast proliferation
|
J:337869
|
decreased neuronal precursor proliferation
|
J:337869
|
Sash3tm1Hlz/Sash3tm1Hlz
(B6.129P2-Sash3tm1Hlz)
|
decreased T cell proliferation
|
J:102171
|
Satb1tm1Kos/Satb1tm1Kos
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal T cell proliferation
|
J:61085
|
Sav1tm1.1Dupa/Sav1tm1.1Dupa Tg(Vil1-cre)997Gum/0
(involves: 129P2/OlaHsd * C57BL/6J * SJL)
|
abnormal enterocyte proliferation
|
J:165471
|
Sav1tm1.1Rjo/Sav1tm1.1Rjo Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S6/SvEvTac * C57BL/6 * CD-1 * DBA * SJL)
|
increased hepatocyte proliferation
|
J:156531
|
Sav1tm1Dlim/Sav1tm1Dlim
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal enterocyte proliferation
|
J:134270
|
Sbdstm1Jrom/Sbdstm1Jrom
(involves: 129S6/SvEvTac * C57BL/6J)
|
absent inner cell mass proliferation
|
J:112167
|
Sbno1tm1.1Hssk/Sbno1tm1.1Hssk
(involves: C57BL/6)
|
decreased cell proliferation
|
J:266780
|
Scube2tm1.1Rbya/Scube2tm1.1Rbya
(B6.129-Scube2tm1.1Rbya)
|
decreased chondrocyte proliferation
|
J:226676
|
Sdc1tm1Cma/Sdc1tm1Cma
(either: C.Cg-Sdc1tm1Cma or B6.Cg-Sdc1tm1Cma)
|
abnormal cell proliferation
|
J:80682
|
Sdc2tm1c(KOMP)Wtsi/Sdc2tm1c(KOMP)Wtsi Tg(Pdgfb-icre/ERT2,-EGFP)1Frut/0
(involves: C57BL/6J * C57BL/6N * CBA)
|
decreased endothelial cell proliferation
|
J:276769
|
decreased vascular endothelial cell proliferation
|
J:276769
|
Sdc2tm1d(KOMP)Wtsi/Sdc2tm1d(KOMP)Wtsi
(involves: C57BL/6J * C57BL/6N)
|
decreased vascular endothelial cell proliferation
|
J:276769
|
Sec61a1m1Gek/Sec61a1m1Gek
(C57BL/6J-Sec61a1m1Gek)
|
increased hepatocyte proliferation
|
J:164159
|
Sel1lGt(CA0017)Wtsi/Sel1lGt(CA0017)Wtsi
(involves: 129P2/OlaHsd)
|
decreased hepatocyte proliferation
|
J:158780
|
Selenoktm1.2Itl/Selenoktm1.2Itl
(involves: BALB/cJ * C57BL/6)
|
decreased T cell proliferation
|
J:169169
|
Selltm1Pest/Selltm1Pest
(involves: 129S4/SvJae)
|
increased T cell proliferation
|
J:111233
|
Selltm1Pest/Selltm1Pest
(involves: 129S4/SvJae * C57BL/6)
|
decreased T cell proliferation
|
J:112550
|
Sema4dtm1Kik/Sema4dtm1Kik
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased B cell proliferation
|
J:66033
|
Septin7tm1Mgl/Septin7tm1Mgl
(involves: 129P2/OlaHsd * C3H * C57BL/6)
|
decreased fibroblast proliferation
|
J:223786
|
Septin9tm2.1Emfu/Septin9tm2.1Emfu Tg(Lck-cre)548Jxm/0
(involves: C57BL/6 * CBA)
|
decreased T cell proliferation
|
J:205027
|
Serpina3gtm1.1Arp/Serpina3gtm1.1Arp
(involves: C57BL/6)
|
decreased T cell proliferation
|
J:189782
|
Serpina3gtm1.1Arp/Serpina3gtm1.1Arp Tg(TcrLCMV)#Sdz/0
(involves: C57BL/6 * DBA/2)
|
decreased T cell proliferation
|
J:189782
|
Serpinb5tm1Zha/Serpinb5+
(involves: 129)
|
decreased cell proliferation
|
J:89192
|
Serpinb5tm1Zha/Serpinb5tm1Zha
(involves: 129)
|
absent inner cell mass proliferation
|
J:89192
|
decreased cell proliferation
|
J:89192
|
decreased inner cell mass proliferation
|
J:89192
|
Serpine2tm1Dmn/Serpine2tm1Dmn
(B6.129P2-Serpine2tm1Dmn)
|
increased cell proliferation
|
J:121263
|
Serpine2tm1Dmn/Serpine2tm1Dmn Tg(Thy1-Serpine2)2Dmn/?
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased Schwann cell proliferation
|
J:121223
|
Sertad2Gt(OST98734)Lex/Sertad2Gt(OST98734)Lex
(involves: 129S5/SvEvBrd)
|
decreased fibroblast proliferation
|
J:196054
|
Sesn1tm1a(EUCOMM)Wtsi/Sesn1tm1a(EUCOMM)Wtsi
(involves: C57BL/6N)
|
increased T cell proliferation
|
J:240602
|
Sesn2Gt(W077E06)Wrst/Sesn2Gt(W077E06)Wrst
(B6.129S2-Sesn2Gt(W077E06)Wrst)
|
decreased lung fibroblast proliferation
|
J:160854
|
Setdb1tm1.1Yshk/Setdb1tm1.1Yshk Emx2tm2(cre)Sia/Emx2+
(involves: C57BL/6NCrlj * CBA/JNCrlj)
|
abnormal neuronal precursor proliferation
|
J:188109
|
Setdb1tm1Enl/Setdb1tm1Enl
(involves: 129S4/SvJae)
|
decreased inner cell mass proliferation
|
J:89058
|
Setdb1tm2.1Enl/Setdb1tm2.2Enl
(involves: 129/Sv * C57BL/6)
|
decreased cell proliferation
|
J:161089
|
Sf3b4em1Mce/Sf3b4+
(C57BL/6J-Sf3b4em1Mce)
|
decreased neuronal precursor proliferation
|
J:285287
|
Sfntm1Mak/Sfntm1Mak
(involves: 129P2/OlaHsd * C57BL/6)
|
increased B cell proliferation
|
J:168328
|
Sfntm1Mul/Sfntm1Mul Tg(MMTV-cre)7Mul/0
(involves: 129S1/Sv * 129X1/SvJ * FVB/N)
|
increased cell proliferation
|
J:159517
|
Sgpp1tm1(KOMP)Vlcg/Sgpp1tm1(KOMP)Vlcg
(involves: C57BL/6NTac)
|
increased keratinocyte proliferation
|
J:199597
|
Sgpp2tm1Rlp/Sgpp2tm1Rlp
(B6.129S6-Sgpp2tm1Rlp)
|
decreased pancreatic beta cell proliferation
|
J:235035
|
Sh2b1tm2.1Lr/Sh2b1tm2.1Lr Tg(Pdx1-cre)89.1Dam/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA * SJL)
|
increased pancreatic beta cell proliferation
|
J:209019
|
Sh2b3tm1Paw/Sh2b3tm1Paw
(either: (involves: 129S1/Sv * 129X1/SvJ) or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6))
|
increased cell proliferation
|
J:77248
|
Sh2d1atm1Cpt/Y
(involves: 129S4/SvJae * C57BL/6)
|
increased T cell proliferation
|
J:97756
|
Sh2d1atm1Cpt/Sh2d1a+
(involves: 129S4/SvJae * C57BL/6)
|
increased T cell proliferation
|
J:97756
|
Sh2d1atm1Cpt/Sh2d1atm1Cpt
(involves: 129S4/SvJae * C57BL/6)
|
increased T cell proliferation
|
J:97756
|
Sh2d1atm1Pls/Sh2d1atm1Pls
(either: 129S6/SvEvTac or (involves: 129S6/SvEvTac * C57BL/6))
|
increased T cell proliferation
|
J:70032
|
Sh2d2atm1Jbs/Sh2d2atm1Jbs
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
decreased T cell proliferation
|
J:64938
|
Sh3bp2tm1Geha/Sh3bp2tm1Geha
(Not Specified)
|
decreased B cell proliferation
|
J:110319
|
Sh3bp2tm1Rtpl/Sh3bp2tm1Rtpl
(B6.129P2-Sh3bp2tm1Rtpl)
|
decreased B cell proliferation
|
J:121380
|
Sharpincpdm/Sharpincpdm
(C57BL/KaLawRij-Sharpincpdm)
|
increased keratinocyte proliferation
|
J:31745
|
ShhDsh/Shh+
(B10Rl.Cg-ShhDsh)
|
decreased chondrocyte proliferation
|
J:97323
|
Shhtm1Amc/Shhtm1Amc
(involves: 129/Sv * C57BL/6J * CBA/J)
|
decreased keratinocyte proliferation
|
J:50051
|
Shmt2em1Jiha/Shmt2em1Jiha
(involves: C57BL/6JJcl)
|
decreased fibroblast proliferation
|
J:259713
|
Shroom3Gt(ROSA53)Sor/Shroom3Gt(ROSA53)Sor
(B6.129S4-Shroom3Gt(ROSA53)Sor/J)
|
increased fetal cardiomyocyte proliferation
|
J:293794
|
Sigirrtm1Lix/Sigirrtm1Lix
(involves: 129S6/SvEvTac * BALB/c)
|
abnormal splenocyte proliferation
|
J:85151
|
Siglechtm1.1Cfg/Siglechtm1.1Cfg
(involves: C57BL/6)
|
increased T cell proliferation
|
J:217719
|
Sirt2tm1.1Cxd/Sirt2tm1.1Cxd
(either: (involves: C57BL/6 * FVB/N) or (involves: FVB/N * NIH Black Swiss))
|
decreased fibroblast proliferation
|
J:177486
|
Sirt6tm1Fwa/Sirt6tm1Fwa
(involves: 129S6/SvEvTac * 129X1/SvJ)
|
decreased cell proliferation
|
J:112817
|
Sit1tm1Lsmn/Sit1tm1Lsmn
(B6.Cg-Sit1tm1Lsmn)
|
increased T cell proliferation
|
J:100408
|
Six1tm1Mair/Six1tm1Mair
(involves: 129S2/SvPas)
|
decreased otic epithelial cell proliferation
|
J:84417
|
Six1tm1Rsd/Six1tm1Rsd
(involves: 129S1/Sv * 129X1/SvJ)
|
decreased cell proliferation
|
J:86619
|
Skap1Gt713Lex/Skap1Gt713Lex
(B6.129S5-Skap1Gt713Lex)
|
decreased T cell proliferation
|
J:126545
|
Skap2Gt(VICTR20)21Lex/Skap2Gt(VICTR20)21Lex
(B6.129S5-Skap2Gt(VICTR20)21Lex)
|
decreased B cell proliferation
|
J:101373
|
Skitm1Cco/Ski+
(involves: 129P2/OlaHsd * C57BL/6)
|
increased fibroblast proliferation
|
J:73349
|
Skitm1Cco/Skitm1Cco
(involves: 129P2/OlaHsd * Black Swiss)
|
increased fibroblast proliferation
|
J:73349
|
Skiltm1.1Kluo/Skiltm1.1Kluo
(B6.129P2-Skiltm1.1Kluo)
|
decreased fibroblast proliferation
|
J:154718
|
Skiltm1Spw/Skiltm1Spw
(either: (involves: 129S1/Sv * 129X1/SvJ) or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6))
|
decreased T cell proliferation
|
J:84554
|
Skiltm2Spw/Skiltm2Spw
(either: (involves: 129S1/Sv * 129X1/SvJ) or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6))
|
decreased T cell proliferation
|
J:84554
|
Skor2Tn(sb-Tyr)1799B.CA7BOve/Skor2Tn(sb-Tyr)1799B.CA7BOve
(involves: FVB/N)
|
decreased cerebellar granule cell precursor proliferation
|
J:178891
|
Skor2Tn(sb-Tyr)1799B.CA7Ove/Skor2Tn(sb-Tyr)1799B.CA7Ove
(involves: FVB/N)
|
decreased cerebellar granule cell precursor proliferation
|
J:178818
|
Skp2tm1Kin/Skp2tm1Kin
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal cell proliferation
|
J:62130
|
Slc3a2tm1.1Merl/Slc3a2+ Tg(Vil1-cre)997Gum/0
(B6.Cg-Slc3a2tm1.1Merl Tg(Vil1-cre)997Gum)
|
abnormal enterocyte proliferation
|
J:173946
|
Slc6a4tm2.1Rbl/Slc6a4tm2.1Rbl
(involves: 129S4/SvJae * 129S6/SvEvTac)
|
abnormal small intestinal crypt cell proliferation
|
J:237081
|
Slc6a8tm1.1Lbar/Y Tg(Nes-cre)1Kln/0
(involves: 129 * C57BL/6 * C57BL/6J * C57BL/6N * SJL)
|
abnormal neuron proliferation
|
J:238578
|
Slc6a8tm1.2Lbar/Y
(involves: 129 * 129S1/Sv * C57BL/6J * C57BL/6N)
|
abnormal neuron proliferation
|
J:238578
|
Slc7a11m1Mtka/Slc7a11m1Mtka
(C57BL/6-Slc7a11m1Mtka)
|
decreased fibroblast proliferation
|
J:159323
|
Slc7a11tm1Hsat/Slc7a11tm1Hsat
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased fibroblast proliferation
|
J:102902
|
Slc8a1tm1Herc/Slc8a1+
(involves: 129 * CD-1)
|
increased pancreatic beta cell proliferation
|
J:186743
|
Slc18a1tm1Dgen/Slc18a1tm1Dgen
(B6.129P2-Slc18a1tm1Dgen/J)
|
abnormal neuron proliferation
|
J:194189
|
Slc20a1tm1.2Lbek/Slc20a1tm1.2Lbek
(involves: 129S2/SvPas * BALB/c * C57BL/6 * C57BL/6J)
|
decreased cell proliferation
|
J:157997
|
decreased hepatocyte proliferation
|
J:157997
|
Slc24a3em#Ebje/Slc24a3em#Ebje
(C57BL/6J-Slc24a3em#Ebje)
|
abnormal enterocyte proliferation
|
J:308448
|
Slc26a2tm1Aros/Slc26a2tm1Aros
(involves: 129S7/SvEvBrd * C57BL/6J)
|
decreased cell proliferation
|
J:97104
|
Slc26a3tm1Sole/Slc26a3tm1Sole
(involves: 129S6/SvEvTac * C57BL/6)
|
increased cell proliferation
|
J:117587
|
Slc27a4pskn/Slc27a4pskn
(involves: FVB)
|
increased keratinocyte proliferation
|
J:194779
|
Slc30a2tm1Kgna/Slc30a2tm1Kgna
(involves: 129 * C57BL/6)
|
decreased mammary gland epithelial cell proliferation
|
J:264481
|
increased mammary gland epithelial cell proliferation
|
J:264481
|
Slc35e1em1Cya/Slc35e1em1Cya
(C57BL/6J-Slc35e1em1Cya)
|
decreased keratinocyte proliferation
|
J:340684
|
Slc38a4em#Smtb/Slc38a4+
(C57BL/6NSlc-Slc38a4em#Ogu)
|
abnormal trophoblast giant cell proliferation
|
J:280426
|
Slc38a4em#Smtb/Slc38a4em#Smtb
(C57BL/6NSlc-Slc38a4em#Ogu)
|
abnormal trophoblast giant cell proliferation
|
J:280426
|
Slc39a4tm2Gka/Slc39a4tm2Gka Tg(Vil1-cre/ERT2)23Syr/0
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2)
|
abnormal small intestinal crypt cell proliferation
|
J:187178
|
Slc39a7tm1.1Tfk/Slc39a7tm1.1Tfk Tg(Vil1-cre/ERT2)23Syr/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA/2)
|
abnormal enterocyte proliferation
|
J:236234
|
Slc39a8tm1.2Mrl/Slc39a8tm1.2Mrl
(B6(Cg)-Slc39a8tm1.2Mrl)
|
increased fetal cardiomyocyte proliferation
|
J:258360
|
Slc39a14tm1Lex/Slc39a14tm1Lex
(involves: 129S5/SvEvBrd * C57BL/6J)
|
decreased hepatocyte proliferation
|
J:236296
|
Slfn2m1Btlr/Slfn2m1Btlr
(C57BL/6J-Slfn2m1Btlr)
|
abnormal T cell proliferation
|
J:158985
|
decreased T cell proliferation
|
J:158985
|
Slit2tm1Matl/Slit2tm1Matl Slit3tm1.1Dor/Slit3tm1.1Dor
(involves: 129S1/Sv * 129S2/SvPas)
|
increased mammary gland epithelial cell proliferation
|
J:141875
|
SlkGt(BC0415)Wtsi/SlkGt(BC0415)Wtsi
(involves: 129P2/OlaHsd * FVB/N)
|
decreased fibroblast proliferation
|
J:211339
|
Slpd1NZB/BlNJ/Slpd1NZB/BlNJ
(involves: DBA/2J * NZB/BlNJ)
|
increased B cell proliferation
|
J:124364
|
Slpitm1Nkw/Slpitm1Nkw
(involves: 129P2/OlaHsd * C57BL/6)
|
increased B cell proliferation
|
J:82214
|
Slurp1tm1Lex/Slurp1tm1Lex
(Not Specified)
|
increased keratinocyte proliferation
|
J:210836
|
Slurp2tm1Lex/Slurp2tm1Lex
(involves: 129P2/OlaHsd * 129S5/SvEvBrd * C57BL/6)
|
increased keratinocyte proliferation
|
J:231067
|
Smad1tm1Abr/Smad1tm1.1Abr Tg(Col1a1-cre)1Kry/0
(involves: BALB/cJ * C57 * FVB)
|
decreased osteoblast proliferation
|
J:172689
|
Smad2tm1.1Epb/Smad2tm1.1Epb Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129/Sv * C57BL/6 * DBA * SJL)
|
increased hepatocyte proliferation
|
J:119642
|
Smad2tm1Cxd/Smad2+ Smad3tm1Cxd/Smad3+
(involves: 129S6/SvEvTac * NIH Black Swiss)
|
decreased hepatocyte proliferation
|
J:70388
|
Smad3tm1Xfw/Smad3tm1Xfw
(involves: 129/Sv * C57BL/6)
|
abnormal B cell proliferation
|
J:53948
|
abnormal cell proliferation
|
J:53948
|
abnormal T cell proliferation
|
J:53948
|
Smad4tm1Cxd/Smad4tm1Cxd
(involves: 129S6/SvEvTac)
|
decreased cell proliferation
|
J:46852
|
decreased embryonic epiblast cell proliferation
|
J:46852
|
decreased inner cell mass proliferation
|
J:46852
|
Smad4tm1Mak/Smad4tm1Mak
(either: (involves: 129P2/OlaHsd * C57BL/6J) or (involves: 129P2/OlaHsd * C57BL/6J * CD-1))
|
decreased cell proliferation
|
J:45399
|
Smad4tm2.1Cxd/Smad4tm2.1Cxd Tg(KRT5-cre)1Xya/0
(involves: 129S6/SvEvTac)
|
increased keratinocyte proliferation
|
J:101602
|
Smad7Gt(YHC053)Byg/Smad7+ Tbx1tm1Bld/Tbx1+
(involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6J)
|
increased vascular smooth muscle cell proliferation
|
J:212881
|
Smad7tm1.1Ink/Smad7tm1.1Ink Tg(Cd4-cre)1Cwi/0
(involves: C57BL/6 * DBA/2)
|
decreased T cell proliferation
|
J:184670
|
Smad7tm1Rheu/Smad7tm1Rheu
(involves: 129S1/Sv * 129X1/SvJ * CD-1)
|
decreased B cell proliferation
|
J:120714
|
Smarca1tm1.1Pick/Y
(involves: 129S4/SvJae * CD-1)
|
abnormal neuronal precursor proliferation
|
J:183998
|
Smarca1tm1.1Pick/Smarca1tm1.1Pick
(involves: 129S4/SvJae * CD-1)
|
abnormal neuronal precursor proliferation
|
J:183998
|
Smarca5tm1Ais/Smarca5tm1Ais
(involves: 129/Sv * C57BL/6 * SJL)
|
absent inner cell mass proliferation
|
J:86695
|
Smarcal1tm1.1Cfbo/Smarcal1tm1.1Cfbo
(either: B6.129-Smarcal1tm1.1Cfbo or (involves: 129 * C57BL/6))
|
decreased fibroblast proliferation
|
J:183899
|
Smarcb1Gt(OST32815)Lex/Smarcb1Gt(OST32815)Lex
(either: (involves: 129 * 129S5/SvEvBrd) or (involves: 129S5/SvEvBrd * C57BL/6))
|
absent inner cell mass proliferation
|
J:69009
|
absent trophectoderm cell proliferation
|
J:69009
|
Smarcb1tm1Mya/Smarcb1tm2Mya Tg(Alb1-cre)7Gsc/0
(involves: 129S2/SvPas * FVB/N)
|
increased hepatocyte proliferation
|
J:103919
|
Smarcc1tm2.1Rhs/Smarcc1tm2.1Rhs Tg(Mx1-cre)1Cgn/0
(involves: BALB/c * C57BL/6 * CBA)
|
decreased B cell proliferation
|
J:184060
|
Smarcc2tm1.1Stoy/Smarcc2tm1.1Stoy
(involves: 129S1/Sv * C57BL/6)
|
abnormal neuronal precursor proliferation
|
J:197141
|
Smarcc2tm1.1Stoy/Smarcc2tm1.1Stoy Emx1tm1(cre)Krj/Emx1+
(involves: 129S1/Sv * 129S2/SvPas * C57BL/6)
|
abnormal neuronal precursor proliferation
|
J:197141
|
Smarcd3tm1.2Bbr/Smarcd3tm1.2Bbr
(either: (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL) or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * ICR * SJL))
|
decreased fetal cardiomyocyte proliferation
|
J:257963
|
Smg1Gt(RRT449)Byg/Smg1Gt(RRT449)Byg
(B6.129P2-Smg1Gt(RRT449)Byg)
|
decreased cell proliferation
|
J:196053
|
Smg6tm1.2Zqw/Smg6tm1.2Zqw
(involves: 129P2/OlaHsd * C57BL/6 * CBA)
|
decreased inner cell mass proliferation
|
J:222980
|
Smotm1Amc/Smotm2Amc Tg(Col2a1-cre)10Amc/0
(involves: 129X1/SvJ)
|
decreased chondrocyte proliferation
|
J:73071
|
Smotm2Amc/Smotm2Amc Nkx3-2tm1(cre)Wez/Nkx3-2+
(involves: 129S1/Sv * 129S7/SvEvBrd * 129X1/SvJ)
|
abnormal enterocyte proliferation
|
J:199664
|
Snap29tm1c(EUCOMM)Wtsi/Snap29tm1c(EUCOMM)Wtsi Tg(KRT14-cre)1Cgn/0
(involves: C57BL/6 * C57BL/6N * DBA/2)
|
increased keratinocyte proliferation
|
J:236759
|
Snrnp40em1Btlr/Snrnp40swp
(C57BL/6J-Snrnp40em1Btlr/Snrnp40swp)
|
decreased T cell proliferation
|
J:282417
|
Sod1tm1Cje/Sod1tm1Cje
(involves: C57BL/6J * CD-1)
|
decreased fibroblast proliferation
|
J:42265
|
Sod2tm1Smel/Sod2tm1Smel Tg(KRT14-cre/ERT)20Efu/0
(involves: C57BL/6J * CD-1)
|
decreased keratinocyte proliferation
|
J:226565
|
Sos1tm1.1Les/Sos1tm1.1Les Tg(Lck-cre)1Cwi/0
(involves: 129 * C57BL/6)
|
decreased T cell proliferation
|
J:174536
|
Sos1tm1.2Rak/Sos1+
(involves: 129S/Sv * C57BL/6 * FVB/N * SJL)
|
abnormal fetal cardiomyocyte proliferation
|
J:171873
|
Sos1tm1.2Rak/Sos1tm1.2Rak
(involves: 129S/Sv * C57BL/6 * FVB/N * SJL)
|
abnormal fetal cardiomyocyte proliferation
|
J:171873
|
Sostdc1tm1Snd/Sostdc1tm1Snd
(involves: C57BL/6)
|
decreased chondrocyte proliferation
|
J:216098
|
increased osteoblast proliferation
|
J:216098
|
Sox2tm1Okud/Sox2tm1Okud Tg(Nes-cre)1Sasa/?
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal neuronal precursor proliferation
|
J:138323
|
Sox2tm4.1Skn/Sox2tm4.1Skn Tg(Sox2-cre/ERT2)1Skn/0
(involves: 129S1/Sv * 129S4/SvJae)
|
abnormal neuronal precursor proliferation
|
J:154650
|
Sox9em1(cre/ERT2)Tchn/Sox9+ Stk26tm2.1Zzh/Stk26tm2.1Zzh
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal enterocyte proliferation
|
J:322311
|
Sox9tm1Gsr/Sox9tm1Gsr Shhtm1(EGFP/cre)Cjt/Shh+
(involves: 129P2/OlaHsd)
|
decreased cell proliferation
|
J:202984
|
Sox10tm7.1(Sox10)Weg/Sox10tm7.1(Sox10)Weg Tg(Dhh-cre)1Mejr/0
(involves: 129P2/OlaHsd * C57BL/6 * FVB/N * SJL)
|
abnormal neuron proliferation
|
J:162692
|
Sox11tm1.1Llei/Sox11tm1.1Llei Tg(Nes-cre/ERT2)73Lfp/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA/2)
|
abnormal neuronal precursor proliferation
|
J:198233
|
Sox11tm1.2Llei/Sox11tm1.2Llei
(involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ * C57BL/6)
|
abnormal neuronal precursor proliferation
|
J:198233
|
Sox11tm1.2Vlf/Sox11tm1.2Vlf Sox4tm1.1Vlf/Sox4tm1.1Vlf
(involves: 129 * C57BL/6 * FVB/N)
|
decreased cell proliferation
|
J:175338
|
Sox13tm1Jskg/Sox13tm1Jskg
(involves: C57BL/6)
|
increased T cell proliferation
|
J:117301
|
Sox17tm2Sjm/Sox17tm2Sjm Tg(Cdh5-cre/ERT2)1Rha/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
decreased endothelial cell proliferation
|
J:234137
|
Sp2tm1.1Htg/Sp2+ Tg(Nes-cre)1Kln/0
(involves: 129 * C57BL/6 * SJL)
|
decreased neuronal precursor proliferation
|
J:194076
|
Sp2tm1.1Htg/Sp2tm1.1Htg Tg(Nes-cre)1Kln/0
(involves: 129 * C57BL/6 * SJL)
|
decreased neuronal precursor proliferation
|
J:194076
|
Sp2tm1.2Sus/Sp2tm1.2Sus
(involves: 129P2/OlaHsd * C57BL/6)
|
absent fibroblast proliferation
|
J:158671
|
Sp8tm2.1Aman/Sp8tm2.1Aman Foxg1tm1(cre)Skm/Foxg1+
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal neuronal precursor proliferation
|
J:160653
|
Sp9tm1.1Zyan/Sp9tm1.1Zyan
(involves: 129S6/SvEvTac * C57BL/6J)
|
decreased neuronal precursor proliferation
|
J:238868
|
Spi1tm1Sing/Spi1+ Spibtm1Mcs/Spib+
(involves: 129S/SvEv * 129X1/SvJ)
|
decreased B cell proliferation
|
J:88257
|
Spi1tm1Sing/Spi1+ Spibtm1Mcs/Spibtm1Mcs
(involves: 129S/SvEv * 129X1/SvJ)
|
decreased B cell proliferation
|
J:88257
|
Spi1tm4.1Dgt/Spi1tm4.1Dgt
(B6.129(Cg)-Spi1tm4.1Dgt)
|
increased hematopoietic stem cell proliferation
|
J:196609
|
Spibtm1Mcs/Spibtm1Mcs
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
decreased B cell proliferation
|
J:88257
|
Spibtm1Mcs/Spibtm1Mcs
(involves: 129S1/Sv * 129X1/SvJ)
|
decreased B cell proliferation
|
J:45245
|
Spin4em1Jbn/Y
(involves: C57BL/6J)
|
increased chondrocyte proliferation
|
J:347154
|
Spin4em2Jbn/Y
(involves: C57BL/6J)
|
increased chondrocyte proliferation
|
J:347154
|
Spint1tm2.1Hk/Spint1tm2.1Hk Tg(Vil1-cre)997Gum/0
(involves: C57BL/6 * C57BL/6J * SJL)
|
abnormal enterocyte proliferation
|
J:179937
|
Spntm1Bam/Spntm1Bam
(involves: 129S4/SvJae * C57BL/6)
|
increased T cell proliferation
|
J:29272,
J:88252
|
Sppl2achompB/Sppl2achompB
(involves: C57BL/6)
|
decreased B cell proliferation
|
J:194595
|
Sprnem1Jvt/Sprnem1Jvt
(FVB/NJ-Sprnem1Jvt)
|
decreased mammary gland epithelial cell proliferation
|
J:289583
|
Sprtntm1.2Yjm/Sprtntm1.2Yjm
(involves: 129S/SvEv * C57BL/6)
|
decreased inner cell mass proliferation
|
J:225198
|
Sprtntm1Yjm/Sprtntm1.2Yjm
(involves: 129S/SvEv * C57BL/6)
|
decreased fibroblast proliferation
|
J:225198
|
Spta1sph-ha/Spta1sph-ha
(either: (B6.D1-Spta1sph-ha x WB.D1-Spta1sph-ha)F1 or (WB.D1-Spta1sph-ha x B6.D1-Spta1sph-ha)F1)
|
increased B cell proliferation
|
J:1967
|
increased T cell proliferation
|
J:1967
|
Sptan1Gt(RRQ171)Byg/Sptan1Gt(RRQ171)Byg
(B6.129P2-Sptan1Gt(RRQ171)Byg)
|
increased cell proliferation
|
J:186305
|
Sptbn1tm1a(EUCOMM)Wtsi/Sptbn1tm1a(EUCOMM)Wtsi
(involves: C57BL/6N)
|
decreased fetal cardiomyocyte proliferation
|
J:219548
|
Sptbn1tm1c(EUCOMM)Wtsi/Sptbn1tm1c(EUCOMM)Wtsi
(involves: C57BL/6J * C57BL/6N)
|
decreased fetal cardiomyocyte proliferation
|
J:219548
|
Sptbn1tm1Mish/Sptbn1+
(involves: 129S6/SvEvTac * C57BL/6)
|
decreased hepatocyte proliferation
|
J:132133
|
Srctm1Mul/Srctm1Mul Tg(MMTV-PyVT)#Mul/0
(involves: 129S1/Sv * 129X1/SvJ * FVB/N)
|
decreased cell proliferation
|
J:181822
|
Srpk1tm1Xdfu/Srpk1tm1Xdfu
(involves: 129)
|
decreased cell proliferation
|
J:213142
|
Srsf5em1Nju/Srsf5em1Nju
(C57BL/6JGpt-Srsf5em1Nju)
|
decreased fetal cardiomyocyte proliferation
|
J:311867
|
Ssbp3Tg(SOD1)1Hssk/Ssbp3Tg(SOD1)1Hssk
(involves: C3H/He * C57BL/6)
|
decreased cell proliferation
|
J:98485
|
Ssu72tm1Cwl/Ssu72tm1Cwl Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(B6.Cg-Ssu72tm1Cwl Speer6-ps1Tg(Alb-cre)21Mgn)
|
increased hepatocyte proliferation
|
J:309624
|
St3gal2tm1Jxm/St3gal2tm1Jxm
(Not Specified)
|
decreased T cell proliferation
|
J:217719
|
St6galnac2tm1.1Cfg/St6galnac2tm1.1Cfg
(involves: 129S1/Sv * 129X1/SvJ)
|
increased B cell proliferation
|
J:217719
|
St8sia1tm1Kfk/St8sia1tm1Kfk
(Not Specified)
|
increased T cell proliferation
|
J:73818
|
St14tm2Bug/St14tm3Bug Tg(Vil1-cre)997Gum/0
(involves: 129P2/OlaHsd * 129S6/SvEvTac * Black Swiss * C57BL/6 * SJL)
|
abnormal enterocyte proliferation
|
J:153070
|
Stag1Gt(P099A04)Wrst/Stag1+
(involves: 129S2/SvPas)
|
decreased cell proliferation
|
J:184720
|
Stag1Gt(P099A04)Wrst/Stag1Gt(P099A04)Wrst
(involves: 129S2/SvPas)
|
decreased cell proliferation
|
J:184720
|
decreased fibroblast proliferation
|
J:184720
|
Stag2tm1.1Alos/Y Tg(CAG-cre)1Nagy/0
(involves: 129S6/SvEvTac * C57BL/6NCrl)
|
decreased cell proliferation
|
J:298088
|
Stamtm2Sug/Stamtm2Sug Stam2tm1Sug/Stam2tm1Sug Tg(Lck-cre)I57Jxm/0
(involves: 129S4/SvJae * C57BL/6 * ICR)
|
decreased T cell proliferation
|
J:80617
|
Stat3tm1Aki/Stat3tm1Aki
(involves: 129P2/OlaHsd)
|
decreased inner cell mass proliferation
|
J:40106
|
Stat3tm1Xyfu/Stat3tm1.1Xyfu Tg(Ttr-cre)10-3Xyfu/?
(involves: 129S1/Sv * C57BL/6)
|
decreased hepatocyte proliferation
|
J:128719
|
Stat3tm2Aki/Stat3tm2Aki Tg(Lck-cre)1Jtak/0
(involves: 129P2/OlaHsd)
|
decreased T cell proliferation
|
J:50443
|
Stat4tm1Gru/Stat4tm1Gru
(involves: 129S2/SvPas * BALB/c)
|
abnormal T cell proliferation
|
J:34059
|
Stat5atm1.1Wjl/Stat5atm1.1Wjl Stat5btm2.1Wjl/Stat5btm2.1Wjl
(involves: 129S6/SvEvTac * C57BL/6J * FVB/N)
|
decreased T cell proliferation
|
J:187325
|
Stat5atm2Mam/Stat5atm2Mam Stat5btm1Mam/Stat5btm1Mam Tg(Mx1-cre)1Cgn/0
(involves: 129S6/SvEvTac * C57BL/6 * CBA)
|
decreased cell proliferation
|
J:155489
|
Stat5atm2Mam/Stat5atm2Mam Tg(Ins2-cre)23Herr/0
(involves: 129S6/SvEvTac * C57BL/6J * CBA/J)
|
decreased pancreatic beta cell proliferation
|
J:284574
|
Stat5btm1Hwd/Stat5btm1Hwd
(involves: C57BL/6)
|
decreased T cell proliferation
|
J:112035
|
Stat5btm1Mam/Stat5btm1Mam Tg(Mx1-cre)1Cgn/0
(involves: 129S6/SvEvTac * C57BL/6 * CBA)
|
decreased cell proliferation
|
J:155489
|
Stat6tm1Aki/Stat6tm1Aki
(involves: 129P2/OlaHsd)
|
decreased B cell proliferation
|
J:32561
|
decreased T cell proliferation
|
J:32561
|
Stat6tm1Gru/Stat6tm1Gru
(129S2/SvPas-Stat6tm1Gru)
|
decreased T cell proliferation
|
J:31932
|
Stat6tm1Gru/Stat6tm1Gru
(involves: 129S2/SvPas)
|
decreased mammary gland epithelial cell proliferation
|
J:184505
|
Stat6tm1Jni/Stat6tm1Jni
(involves: 129S/SvEv)
|
abnormal B cell proliferation
|
J:32607
|
Stim1tm1Kuro/Stim1tm1Kuro Cd79atm1(cre)Reth/Cd79a+
(involves: BALB/c * C57BL/6)
|
decreased B cell proliferation
|
J:172608
|
Stim1tm1Kuro/Stim1tm1Kuro Stim2tm1.1Kuro/Stim2tm1.1Kuro Cd79atm1(cre)Reth/Cd79a+
(involves: BALB/c * C57BL/6)
|
decreased B cell proliferation
|
J:172608
|
Stim1tm1Rao/Stim1tm1Rao Stim2tm1Rao/Stim2tm1Rao Tg(Cd4-cre)1Cwi/0
(involves: C57BL/6 * DBA/2 * SJL)
|
decreased T cell proliferation
|
J:133262
|
Stip1tm1.2Mamp/Stip1tm1.2Mamp
(involves: C57BL/6)
|
decreased fibroblast proliferation
|
J:201097
|
Stk3tm1.1Jav/Stk3tm1.1Jav Stk4tm1Kina/Stk4tm1Kina Tg(Nkx2-1-cre)2Sand/?
(involves: 129 * C57BL/6)
|
increased lung endothelial cell proliferation
|
J:197340
|
Stk3tm1.1Jav/Stk3tm1Jav Stk4Gt(AJ0315)Wtsi/Stk4Gt(AJ0315)Wtsi
(involves: 129 * C57BL/6)
|
increased hepatocyte proliferation
|
J:153945
|
Stk3tm1.1Rjo/Stk3tm1.1Rjo Stk4tm1.1Rjo/Stk4tm1.1Rjo Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S6/SvEvTac * C57BL/6 * CD-1 * DBA * SJL)
|
increased hepatocyte proliferation
|
J:156531
|
Stk3tm1.1Yy/Stk3tm1Yy Stk4tm1.1Yy/Stk4tm1.1Yy Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: C57BL/6 * CBA * DBA)
|
increased hepatocyte proliferation
|
J:156541
|
Stk3tm1.1Yy/Stk3tm1Yy Stk4tm1.1Yy/Stk4tm1.1Yy Tg(CAG-cre/Esr1*)5Amc/0
(involves: C57BL/6 * CBA)
|
increased hepatocyte proliferation
|
J:156541
|
Stk3tm1Dlim/Stk3tm1Dlim Stk4tm1Dlim/Stk4tm1Dlim
(Not Specified)
|
abnormal cell proliferation
|
J:155001
|
Stk3tm1Jav/Stk3tm1Jav Stk4Gt(AJ0315)Wtsi/Stk4Gt(AJ0315)Wtsi
(involves: 129 * C57BL/6)
|
increased hepatocyte proliferation
|
J:153945
|
Stk4Gt(AJ0315)Wtsi/Stk4Gt(AJ0315)Wtsi
(B6.129P2-Stk4Gt(AJ0315)Wtsi)
|
increased T cell proliferation
|
J:142674
|
Stk4tm1.1Kina/Stk4tm1.1Kina
(involves: C57BL/6)
|
increased T cell proliferation
|
J:148791
|
Stk17btm1Hed/Stk17btm1Hed
(involves: 129X1/SvJ * C57BL/6)
|
increased T cell proliferation
|
J:94685
|
Stk17btm1Hed/Stk17btm1Hed
(B6.129X1-Stk17btm1Hed)
|
increased T cell proliferation
|
J:94685
|
Stk26tm2.1Zzh/Stk26tm2.1Zzh
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal enterocyte proliferation
|
J:322311
|
Stx2tm1Dcru/Stx2+
(involves: 129X1/SvJ * C57BL/6J)
|
abnormal small intestinal crypt cell proliferation
|
J:110376
|
Stx2tm1Dcru/Stx2tm1Dcru
(involves: 129X1/SvJ * C57BL/6J)
|
abnormal small intestinal crypt cell proliferation
|
J:110376
|
Sucnr1tm1Dgen/Sucnr1tm1Dgen
(B6.129P2-Sucnr1tm1Dgen)
|
decreased T cell proliferation
|
J:143337
|
Sulf1tm1Clrm/Sulf1tm1Clrm
(involves: 129S2/SvPas * C57BL/6)
|
increased fibroblast proliferation
|
J:116527
|
Sulf2tm1Clrm/Sulf2tm1Clrm
(involves: 129S2/SvPas * C57BL/6)
|
increased fibroblast proliferation
|
J:116527
|
Sumo2tm1Weiy/Sumo2tm1Weiy
(involves: 129 * C57BL/6)
|
decreased cell proliferation
|
J:217019
|
Suz12Gt(Betageo)1Khe/Suz12Gt(Betageo)1Khe
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased cell proliferation
|
J:93307
|
Syislem1Bzuo/Syislem1Bzuo
(involves: C57BL/6)
|
decreased myoblast proliferation
|
J:266240
|
Syktm1.1Tara/Syktm1.1Tara
(involves: 129P2/OlaHsd * C57BL/6)
|
increased B cell proliferation
|
J:114816
|
tw73/tw73
(involves: M. m. musculus)
|
decreased embryonic epiblast cell proliferation
|
J:175675
|
Tab2tm2.1Aki/Tab2tm2.1Aki Tab3tm1Aki/Tab3tm1Aki Cd19tm1(cre)Cgn/Cd19+
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased B cell proliferation
|
J:195289
|
Tada3tm1.1Viba/Tada3tm1.1Viba
(involves: 129P2/OlaHsd * C57BL/6 * SJL)
|
decreased fibroblast proliferation
|
J:190249
|
Tada3tm1.2Viba/Tada3tm1.2Viba
(involves: 129P2/OlaHsd * C57BL/6 * FVB/N * SJL)
|
abnormal trophoblast giant cell proliferation
|
J:190249
|
Taf4tm1.1Idvd/Taf4tm1.1Idvd
(Not Specified)
|
increased fibroblast proliferation
|
J:125257
|
Taf4tm1Idvd/Taf4tm1Idvd Tg(KRT14-cre/ERT2)1Ipc/0
(involves: C57BL/6 * SJL)
|
increased keratinocyte proliferation
|
J:124111
|
Taf4btm1Rtj/Taf4btm1Rtj
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
decreased granulosa cell proliferation
|
J:119191
|
Taf4btm1Rtj/Taf4btm1Rtj
(B6.129-Taf4btm1Rtj)
|
abnormal spermatogonia proliferation
|
J:97245
|
Taf7tm1.1Dss/Taf7tm1.2Dss Tg(Cd8a*-cre)B8Asin/0
(involves: C57BL/6)
|
decreased T cell proliferation
|
J:185745
|
Taf10tm1.1Lzt/Taf10tm1.1Lzt
(involves: 129 * C57BL/6 * SJL)
|
absent inner cell mass proliferation
|
J:101819
|
Tamalintm1.1Tes/Tamalintm1.1Tes
(B6.129S1-Tamalintm1.1Tes)
|
abnormal neuron proliferation
|
J:181614
|
Tanktm1Aki/Tanktm1Aki
(involves: 129/Sv * C57BL/6)
|
increased B cell proliferation
|
J:151757
|
Tardbptm1.1Ckjs/Tardbptm1.1Ckjs
(involves: C57BL/6J * FVB/N)
|
absent inner cell mass proliferation
|
J:155958
|
Tarm1tm1Yiw/Tarm1tm1Yiw
(involves: C57BL/6 * C57BL/6NSlc)
|
decreased T cell proliferation
|
J:301164
|
Tasp1tm1.1Jjdh/Tasp1tm1.1Jjdh
(involves: 129X1/SvJ)
|
decreased cell proliferation
|
J:112159
|
Tbc1d10ctm1.2Psou/Tbc1d10ctm1.2Psou
(involves: 129S2/SvPas * C57BL/6J)
|
increased T cell proliferation
|
J:211913
|
Tbx1tm1Bld/Tbx1+
(involves: 129S7/SvEvBrd * C57BL/6J)
|
increased vascular smooth muscle cell proliferation
|
J:212881
|
Tbx20tm1.1Rph/Tbx20tm1.1Rph
(involves: C57BL/6)
|
abnormal fetal cardiomyocyte proliferation
|
J:98489
|
Tbx20tm1.1Sev/Tbx20tm1.1Sev
(involves: 129S6/SvEvTac * C57BL/6)
|
abnormal fetal cardiomyocyte proliferation
|
J:98516
|
Tbx20tm1Akis/Tbx20tm1Akis
(involves: 129S1/SvImJ * NMRI)
|
abnormal fetal cardiomyocyte proliferation
|
J:98806
|
Tcf3tm1Xhsu/Tcf3tm1Xhsu Tg(Lck-Stat5b*)1Mafa/0
(involves: 129X1/SvJ * C57BL/6 * FVB/N)
|
increased B cell proliferation
|
J:132669
|
Tcf3tm2Cmu/Tcf3tm2Cmu
(involves: 129P2/OlaHsd)
|
increased cell proliferation
|
J:118827
|
Tcf7l1tm1.1Efu/Tcf7l1tm1.1Efu Tcf7l2tm1Cle/Tcf7l2tm1Cle Tg(KRT14-cre)1Efu/0
(involves: 129/Sv * 129P2/OlaHsd)
|
decreased keratinocyte proliferation
|
J:155012
|
Tcf7l2tm1.1(EGFP/cre)Mrc/Tcf7l2tm1.1(EGFP/cre)Mrc
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal enterocyte proliferation
|
J:170088
|
Tcf7l2tm1.1(EGFP/cre)Mrc/Tcf7l2tm2.1Mrc
(involves: 129S1/Sv * 129S6/SvEvTac * 129X1/SvJ * C57BL/6NCrl)
|
abnormal enterocyte proliferation
|
J:170088
|
Tcf7l2tm1.1(EGFP/cre)Mrc/Tcf7l2tm2.2Mrc
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal enterocyte proliferation
|
J:170088
|
Tcf7l2tm2.1Cle/Tcf7l2tm2.1Cle Tg(Vil1-cre/ERT2)23Syr/0
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2)
|
abnormal enterocyte proliferation
|
J:185753
|
Tcf7l2tm2.2Mrc/Tcf7l2tm2.2Mrc
(involves: 129S1/Sv)
|
abnormal enterocyte proliferation
|
J:170088
|
Tcf12tm3Zhu/Tcf12tm3Zhu Tcf3tm4Zhu/Tcf3tm4Zhu Tg(Lck-cre)#Zhu/0
(involves: 129S4/SvJae * C57BL/6 * SJL/J)
|
increased T cell proliferation
|
J:129570
|
Tcof1tm1Mjd/Tcof1+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA/1)
|
decreased cranial neural crest cell proliferation
|
J:112900
|
Tcratm1Mjo/Tcratm1Mjo
(involves: 129P2/OlaHsd)
|
abnormal neuron proliferation
|
J:170591
|
decreased T cell proliferation
|
J:110898
|
Tdo2tm1Tnak/Tdo2tm1Tnak
(B6.129-Tdo2tm1Tnak)
|
abnormal neuronal precursor proliferation
|
J:177903
|
Tead1tm1Hssk/Tead1tm1Hssk Tead2tm1Hssk/Tead2tm1Hssk
(either: (involves: C57BL/6 * CBA) or (involves: C57BL/6 * CBA * CD-1))
|
decreased cell proliferation
|
J:131426
|
Tent5cem1Adki/Tent5cem1Adki
(involves: C57BL/6J * CBA)
|
decreased B cell proliferation
|
J:252302
|
Terctm1Rdp/Terctm1Rdp
(involves: 129/Sv * C57BL/6J * SJL)
|
abnormal fetal cardiomyocyte proliferation
|
J:110900
|
decreased B cell proliferation
|
J:60223
|
decreased T cell proliferation
|
J:60223
|
Terctm1Rdp/Terctm1Rdp
(involves: 129/Sv * C57BL/6 * C57BL/6J * SJL)
|
abnormal enterocyte proliferation
|
J:125218
|
Terf1tm1.1Blas/Terf1tm1.1Blas
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL)
|
decreased cell proliferation
|
J:152077
|
Terf1tm1Tdl/Terf1tm1Tdl
(involves: 129S2/SvPas)
|
absent inner cell mass proliferation
|
J:85440
|
Terttm1.1Phan/Terttm1.1Phan Tg(Col1a2-cre/ERT,-ALPP)7Cpd/0
(involves: C57BL/6 * DBA/2)
|
decreased lung fibroblast proliferation
|
J:239734
|
Terttm2.1Rdp/Terttm2.1Rdp
(involves: C57BL/6)
|
abnormal neuronal precursor proliferation
|
J:167227
|
Terttm3Rdp/Terttm3Rdp
(involves: C57BL/6)
|
decreased cell proliferation
|
J:186105
|
Tespa1tm1Smoc/Tespa1tm1Smoc
(B6.129-Tespa1tmSmoc)
|
decreased T cell proliferation
|
J:186446
|
increased T cell proliferation
|
J:186446
|
Tet1tm1.1Gxu/Tet1tm1.1Gxu Tg(Nes-EGFP)33Enik/0
(involves: 129 * BALB/cBy * C57BL/6 * C57BL/6J)
|
abnormal neuronal precursor proliferation
|
J:201001
|
Tet1tm1Gxu/Tet1tm1.1Gxu Tg(Nes-cre/ERT2)KEisc/0
(involves: 129 * C57BL/6J)
|
abnormal neuronal precursor proliferation
|
J:201001
|
Tet1tm1Gxu/Tet1tm1Gxu
(involves: 129 * C57BL/6J)
|
abnormal neuronal precursor proliferation
|
J:201001
|
Tex10tm1(KOMP)Vlcg/Tex10tm1(KOMP)Vlcg
(involves: C57BL/6NTac)
|
decreased inner cell mass proliferation
|
J:224684
|
Tfamtm1.1Ncdl/Tfamtm1.1Ncdl Tg(KRT14-cre)1Amc/0
(involves: C57BL/6 * CBA)
|
increased keratinocyte proliferation
|
J:213840
|
Tfrctm3.1Nca/Tfrctm3.1Nca Tg(Vil1-cre)20Syr/0
(involves: 129S4/SvJae * C57BL/6 * CD-1 * DBA/2)
|
abnormal enterocyte proliferation
|
J:224823
|
Tfrctm3.1Nca/Tfrctm3.1Nca Tg(Vil1-cre/ERT2)23Syr/0
(involves: 129S4/SvJae * C57BL/6 * CD-1 * DBA/2)
|
abnormal enterocyte proliferation
|
J:224823
|
Tg(Actb-Tnfsf4)1Nish/0
(B6.D2-Tg(Actb-Tnfsf4)1Nish)
|
increased T cell proliferation
|
J:80214
|
Tg(AGER)#Eca/0
(C57BL/6J-Tg(AGER)#Eca)
|
decreased lung endothelial cell proliferation
|
J:205092
|
Tg(AGER)#Eca/Tg(AGER)#Eca
(C57BL/6J-Tg(AGER)#Eca)
|
decreased lung endothelial cell proliferation
|
J:205092
|
Tg(Alb-E2F1)8Sst/0
(involves: C57BL/6J * CBA/J)
|
increased hepatocyte proliferation
|
J:65354
|
Tg(Alb-PDGFC)#Jcam/0
(involves: C57BL/6)
|
increased hepatocyte proliferation
|
J:96979
|
Tg(Alb-REG3A)24Lchr/0
(involves: C57BL/6 * CBA)
|
increased hepatocyte proliferation
|
J:140235,
J:84698
|
Tg(AMH-Fshr*D580H)#Hht/0
(involves: FVB/N)
|
increased cell proliferation
|
J:160015
|
increased granulosa cell proliferation
|
J:160015
|
Tg(AZIP/F)1Vsn/0
(FVB-Tg(AZIP/F)1Vsn/J)
|
increased pancreatic beta cell proliferation
|
J:145998
|
Tg(BCL2)36Wehi/?
(B6.Cg-Tg(BCL2)36Wehi/J)
|
abnormal B cell proliferation
|
J:90963
|
Tg(BCL2L1)2Cbt/0
(Not Specified)
|
increased keratinocyte proliferation
|
J:65162
|
Tg(BLG-STAT5A)15Itb/0
(involves: FVB/N)
|
increased mammary gland epithelial cell proliferation
|
J:80588
|
Tg(CAG-COX7A2L)#Sinos/0
(involves: C57BL/6)
|
increased fibroblast proliferation
|
J:215964
|
Tg(CAG-Lyn*)#Paau/0
(B6.Cg-Tg(CAG-Lyn*)#Paau)
|
increased keratinocyte proliferation
|
J:151886
|
Tg(CD2-Ceacam1*4L)1Rsb/0
(involves: C57BL/6)
|
decreased T cell proliferation
|
J:116136
|
Tg(CD2-Myb/en)2Kmw/?
(involves: C57BL/10 * CBA)
|
decreased T cell proliferation
|
J:126456
|
Tg(CD2-Myb/en)2Kmw/Tg(CD2-Myb/en)2Kmw
(involves: C57BL/10 * CBA)
|
decreased T cell proliferation
|
J:126456
|
Tg(CD2-Nfat5)1Snh/0
(involves: BALB/c * C57BL/6)
|
decreased splenocyte proliferation
|
J:80066
|
decreased T cell proliferation
|
J:80066
|
Tg(CD2-S1PR1)1Ejg/?
(involves: C57BL/6 * DBA/2)
|
decreased T cell proliferation
|
J:96558
|
Tg(CD2-Tgfbr2)1Grs/0
(C57BL/6-Tg(CD2-Tgfbr2)1Grs/Nci)
|
increased T cell proliferation
|
J:97523
|
Tg(CD2-Tgfbr2)1Grs/?
(C57BL/6-Tg(CD2-Tgfbr2)1Grs/Nci)
|
increased T cell proliferation
|
J:93665
|
Tg(Cd4-BCL2*G101A*D102A*D103A)AWnt/0
(involves: C57BL/6)
|
abnormal T cell proliferation
|
J:217939
|
Tg(Cd4-cre)1Cwi/0 Trmt6em1Hbgl/Trmt6em1Hbgl
(involves: C57BL/6 * DBA/2J)
|
decreased T cell proliferation
|
J:336736
|
Tg(Cd4-cre)1Cwi/0 Trmt61aem1Hbgl/Trmt61aem1Hbgl
(involves: C57BL/6 * DBA/2J)
|
decreased T cell proliferation
|
J:336736
|
Tg(Cd4-Dtx1)1Mzl/?
(involves: C57BL/6)
|
decreased T cell proliferation
|
J:151605
|
Tg(Cd4-TGFBR2)16Flv/?
(involves: C3H * C57BL/6 * C57BL/10 * C57BR/cd)
|
abnormal T cell proliferation
|
J:97554
|
Tg(Cd4-TGFBR2)16Flv/?
(involves: C3H * C57BL/6)
|
abnormal T cell proliferation
|
J:134473
|
Tg(CD19)1Tft/0
(involves: C57BL/6 * C57BL/6J * SJL)
|
increased B cell proliferation
|
J:27236
|
Tg(CD19)1Tft/Tg(CD19)1Tft
(involves: C57BL/6 * C57BL/6J * SJL)
|
increased B cell proliferation
|
J:27236
|
Tg(Cd79b-TCL1A)BKTeit/0
(involves: C3H * C57BL/6)
|
increased B cell proliferation
|
J:79703
|
increased T cell proliferation
|
J:79703
|
Tg(CMV-cat,-ROCK2*)3-1Koba/0 Tg(Tagln-cre)1Her/0
(involves: C57BL/6 * C57BL/6JJcl * DBA/2 * SJL)
|
abnormal fetal cardiomyocyte proliferation
|
J:242116
|
Tg(CMV-cre)1Cgn/0 Trp53tm4Att/Trp53+
(involves: 129S4/SvJae * BALB/cJ * C57BL/6J)
|
decreased cell proliferation
|
J:217080
|
Tg(Col1a1-Atf4)1Kry/0
(involves: FVB)
|
decreased pancreatic beta cell proliferation
|
J:152695
|
Tg(Col1a1-Cthrc1)1Haak/0
(B6.Cg-Tg(Col1a1-Cthrc1)1Haak)
|
increased osteoblast proliferation
|
J:143940
|
Tg(Col1a1-Mir34c)#Kry/0
(B6.Cg-Tg(Col1a1-Mir34c)#Kry)
|
decreased osteoblast proliferation
|
J:185130
|
Tg(Col1a1-Ptprv)1Kry/?
(Not Specified)
|
decreased pancreatic beta cell proliferation
|
J:126780
|
Tg(CYP1A1-PPARD)#Jfoe/0
(involves: C57BL/6J * CBA)
|
increased keratinocyte proliferation
|
J:158907
|
increased T cell proliferation
|
J:158907
|
Tg(Dct-Grm1)ESzc/0
(involves: C57BL/6J)
|
abnormal melanocyte proliferation
|
J:83183
|
Tg(Dct-Grm1)ESzc/0
(C57BL/6J-Tg(Dct-Grm1)ESzc)
|
abnormal melanocyte proliferation
|
J:230115
|
Tg(Dct-lacZ)A12Jkn/0 Tg(Tyr-Ctnnb1/EGFP)#Lru/0
(B6.Cg-Tg(Tyr-Ctnnb1/EGFP)#Lru Tg(Dct-lacZ)A12Jkn)
|
decreased melanoblast proliferation
|
J:176245
|
Tg(Disc1/EGFP)M19Sshe/0
(involves: C57BL/6JCrl * CBA/CaCrl)
|
abnormal neuron proliferation
|
J:143557
|
Tg(DYRK1A)36Wjs/0
(involves: C57BL/6NCrjBgi)
|
abnormal neuron proliferation
|
J:166796
|
abnormal neuronal precursor proliferation
|
J:166796
|
Tg(EIIa-cre)C5379Lmgd/0 Tg(Rnu6-RNAi:Bccip)4Zshn/0
(involves: C57BL/6 * FVB/N)
|
decreased cell proliferation
|
J:176115
|
decreased inner cell mass proliferation
|
J:176115
|
Tg(EmuSR-HDAC9)1468Kpet/0
(involves: C57BL/6 * CBA)
|
increased B cell proliferation
|
J:237420
|
Tg(Gfap-gp120)#Lms/0
(involves: C57BL/6 * SJL)
|
decreased neuronal precursor proliferation
|
J:170738
|
Tg(Gfap-TK)7.1Mvs/0
(involves: C57BL/10 * CBA * CFLP)
|
abnormal cell proliferation
|
J:113202
|
Tg(H2-Ea-G6pc2)69Tkay/?
(NOD-Tg(H2-Ea-G6pc2)69Tkay)
|
decreased T cell proliferation
|
J:117352
|
Tg(H2-Ea-Ins2)1Wehi/0
(NOD/ShiLtJWehi-Tg(H2-Ea-Ins2)1Wehi)
|
abnormal T cell proliferation
|
J:100232
|
Tg(H2-Ea-Ins2)1Wehi/Tg(H2-Ea-Ins2)1Wehi
(NOD/ShiLtJWehi-Tg(H2-Ea-Ins2)1Wehi)
|
decreased T cell proliferation
|
J:117352
|
Tg(H2-K-DUSP5)21Wjl/0
(involves: C57BL/6J * CBA)
|
decreased T cell proliferation
|
J:138077
|
Tg(H2-K-HLA-G,B2M)1Alm/0
(CBA/Ca-Tg(H2-K-HLA-G,B2M)1Alm/CmwJ)
|
increased T cell proliferation
|
J:140016
|
Tg(H2-K-MC159/EGFP)13Fkmc/0
(involves: C57BL/6)
|
increased B cell proliferation
|
J:138050
|
Tg(H2KmPCC)2939Stoe/0 Tg(Tcra2B4)1Mmd/0 Tg(Tcrb2B4)1Mmd/0
(involves: C3H/HeJ * C57BL/6 * SJL)
|
decreased T cell proliferation
|
J:50143
|
Tg(Hoxc13)61B1Awg/0
(FVB-Tg(Hoxc13)61B1Awg)
|
increased keratinocyte proliferation
|
J:68213
|
Tg(Hoxc13)61U4Awg/0
(FVB-Tg(Hoxc13)61U4Awg)
|
increased keratinocyte proliferation
|
J:68213
|
Tg(Igh-Lmp2a)ERlon/0
(involves: C57BL/6 * SJL)
|
abnormal B cell proliferation
|
J:129571
|
Tg(Igh-Mir29a,-Mir29b-1,-hrGFP)#Cro/0
(FVB/N-Tg(Igh-Mir29a,-Mir29b-1,-hrGFP)#Cro)
|
increased B cell proliferation
|
J:162077
|
Tg(Igh-Mir155)8Cro/0
(involves: FVB/N)
|
increased B cell proliferation
|
J:109591
|
Tg(Igh-V-CD40lg)#Tsub/0
(involves: C57BL/6)
|
increased splenocyte proliferation
|
J:89855
|
Tg(IghelMD4)4Ccg/Tg(IghelMD4)4Ccg
(NOD.B6-Tg(IghelMD4)4Ccg/DvsJ)
|
abnormal T cell proliferation
|
J:80859
|
Tg(IghMyc)22Bri/0 Xiaptm1Hs/Xiaptm1Hs
(B6.Cg-Xiaptm1Hs Tg(IghMyc)22Bri)
|
decreased B cell proliferation
|
J:138979
|
Tg(ILK3mHEL)3Ccg/0 Tg(TcrHEL3A9)1Mmd/0
(involves: C57BL/6JSfd * C57BL/10Sg * C57BR/cd)
|
abnormal T cell proliferation
|
J:78309
|
Tg(Ins2-HA)165Bri/0
(B10.Cg- H2d Tg(Ins2-HA)165Bri/ShrmJ)
|
decreased T cell proliferation
|
J:86430
|
Tg(Ins2-Mir184)4Mnpy/0
(Not Specified)
|
decreased pancreatic beta cell proliferation
|
J:210552
|
Tg(Ins2-Nos2)40Okam/0 Tg(Kdr-AGER)102Hyam/0
(involves: C57BL/6J * CBA/J * CD-1 * DBA/2)
|
increased kidney cell proliferation
|
J:70495
|
Tg(Ins2-rtTA)2Efr/0 Tg(tetO-Ago2)30Mnpy/0
(involves: C57BL/6 * CBA)
|
increased pancreatic beta cell proliferation
|
J:210552
|
Tg(Ins2-rtTA)2Efr/0 Tg(tetO-Mir184)#Mnpy/0
(involves: C57BL/6 * CBA)
|
decreased pancreatic beta cell proliferation
|
J:210552
|
Tg(Ins2-TCF1*P291)2Kya/0
(involves: C57BL/6 * SJL)
|
decreased pancreatic beta cell proliferation
|
J:73760
|
Tg(Ins2-TFRC/OVA)296Wehi/0 1700016L21RikTg(Itgax-HBEGF/EGFP)57Lan/0
(involves: C57BL/6 * FVB)
|
decreased T cell proliferation
|
J:122114
|
Tg(Ins-MYC/Er)1Gev/0
(involves: C57BL/6 * CBA)
|
increased cell proliferation
|
J:142030
|
Tg(IRS1)1Mhep/0
(FVB-Tg(IRS1)1Mhep)
|
increased hepatocyte proliferation
|
J:92999
|
Tg(KRT5-Akt1*)Jmpa/0
(involves: C57BL/6 * DBA/2 * DBA/2J * FVB/N)
|
decreased keratinocyte proliferation
|
J:144831
|
increased cell proliferation
|
J:144831
|
Tg(KRT5-IKBKB)2Armz/0
(involves: C57BL/6 * DBA/2)
|
increased keratinocyte proliferation
|
J:160072
|
Tg(KRT5-rtTA)1Glk/0 Tg(tetO-Tfrc/EGFP/Ova)#Sfz/0 Tg(tetO/CMV-Tslp)#Sfz/0
(involves: C3H * C57BL/6 * FVB/N)
|
increased T cell proliferation
|
J:199558
|
Tg(KRT5-rtTA)1Glk/0 Tg(tetO-TGFB1*C223S*C225S)1Glk/0
(involves: FVB/N)
|
abnormal cell proliferation
|
J:70670
|
decreased cell proliferation
|
J:70670
|
Tg(KRT5-rtTA)1Glk/0 Tg(tetO/CMV-Tslp)#Sfz/0
(C.Cg-Tg(KRT5-rtTA)1Glk Tg(tetO/CMV-Tslp)#Sfz)
|
increased B cell proliferation
|
J:182756
|
Tg(KRT5-rtTA)#Glk/0 Tg(tetO-cre)1Jaw/0 Wnt10atm1Smr/Wnt10atm1Smr
(involves: 129X1/SvJ * C57BL/6 * FVB/N)
|
decreased cell proliferation
|
J:242196
|
Tg(KRT5-rtTA)#Glk/0 Tg(tetO-Mir31)#Zhyu/0
(involves: C57BL/6J * FVB/N)
|
increased mammary gland epithelial cell proliferation
|
J:271420
|
Tg(KRT5-Stat3*A661C*N663C)1Jdg/0
(involves: FVB)
|
increased keratinocyte proliferation
|
J:95458
|
Tg(KRT5-Terf2)PMBlas/Y
(involves: C57BL/6 * CBA)
|
decreased keratinocyte proliferation
|
J:102653
|
Tg(KRT5-TGFB1)F2020Xjw/0
(involves: C57BL/6 * DBA/2 * ICR)
|
decreased keratinocyte proliferation
|
J:90118
|
Tg(KRT5-tTA)1216Glk/0 Tg(tetO-TGFB1*C223S*C225S)1Glk/0
(involves: FVB/N)
|
decreased cell proliferation
|
J:70670
|
Tg(KRT14-cre)8Brn/0 Tg(KRT5-Akt1*)Jmpa/0 Trp53tm1Brn/Trp53tm1Brn
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2 * DBA/2J * FVB/N)
|
increased cell proliferation
|
J:144831
|
increased keratinocyte proliferation
|
J:144831
|
Tg(KRT14-HPV16)wt1Dh/0
(FVB.Cg-Tg(KRT14-HPV16)wt1Dh/Nci)
|
increased keratinocyte proliferation
|
J:65699
|
Tg(KRT14-rtTA)F42Efu/0 Tg(tetO-EDN1,-lacZ)9Mhus/0
(involves: C57BL/6J * FVB)
|
abnormal melanocyte proliferation
|
J:231435
|
Tg(KRT14-Snai1)1Efu/0
(involves: CD-1)
|
increased keratinocyte proliferation
|
J:229072
|
Tg(KRT14-VP16/NR1I2)13Sdub/?
(involves: C57BL/6)
|
increased keratinocyte proliferation
|
J:258435
|
Tg(LANA,vFLIP,vCYC)801Dtmr/?
(involves: C57BL/6)
|
increased B cell proliferation
|
J:196403
|
Tg(Lck-Bcl2l1)1Cant/?
(B6.Cg-Tg(Lck-Bcl2l1)1Cant)
|
increased T cell proliferation
|
J:77507
|
Tg(Lck-Cxadr)1Jdgr/0
(FVB-Tg(Lck-Cxadr)1Jdgr)
|
decreased T cell proliferation
|
J:109884
|
Tg(Lck-FADD)1Hed/0
(involves: BALB/c * C57BL/6)
|
abnormal T cell proliferation
|
J:100451
|
Tg(LCK-NFKBIA)5Dwb/0
(involves: C57BL/6 * DBA/2)
|
decreased T cell proliferation
|
J:93003
|
Tg(Lck-Socs3)1Kubo/0
(Not Specified)
|
decreased T cell proliferation
|
J:128797
|
Tg(Lck-Sox13)#Jskg/0
(involves: C57BL/6)
|
decreased T cell proliferation
|
J:117301
|
Tg(Lck-Stat5b*)1Mafa/0
(Not Specified)
|
increased B cell proliferation
|
J:132669
|
Tg(Lck-Stk17b)26.1Wals/?
(B6.Cg-Tg(Lck-Stk17b)26.1Wals)
|
increased T cell proliferation
|
J:149973
|
Tg(Lck-Tnfsf4)1Nish/0
(B6.Cg-Tg(Lck-Tnfsf4)1Nish)
|
increased T cell proliferation
|
J:80214
|
Tg(Lck-Tnfsf14)24Yxf/?
(C57BL/6-Tg(Lck-Tnfsf14)24Yxf)
|
increased T cell proliferation
|
J:129951
|
Tg(Lck/Emu-Rftn1)1Ayos/?
(involves: C57BL/6)
|
increased T cell proliferation
|
J:150299
|
Tg(Ly6a-GCSAM)102AIsg/0
(involves: C57BL/6J * CBA)
|
increased B cell proliferation
|
J:221238
|
Tg(ML5sHEL)5Ccg/0 Tg(TcrHEL3A9)1Mmd/0
(involves: C57BL/6 * C57BL/10 * C57BR/cd)
|
abnormal T cell proliferation
|
J:78309
|
Tg(ML5sHEL)5Ccg/0 Tg(TcrHEL3A9)1Mmd/0 Tg(TLK2mHEL)2Ccg/0
(involves: C57BL/6JSfd * C57BL/10 * C57BR/cd)
|
abnormal T cell proliferation
|
J:78309
|
Tg(MMTV-NCOA3)#Mybr/0
(FVB/N-Tg(MMTV-NCOA3)#Mybr)
|
decreased mammary gland epithelial cell proliferation
|
J:93548
|
Tg(MMTV-PyVT)#Mul/0
(B6.FVB-Tg(MMTV-PyVT)#Mul)
|
decreased B cell proliferation
|
J:147923
|
decreased splenocyte proliferation
|
J:147923
|
decreased T cell proliferation
|
J:147923
|
Tg(MMTV-rtTA)1Lach/0 Tg(tetO-MYC)1Lach/0
(involves: FVB)
|
increased mammary gland epithelial cell proliferation
|
J:67498
|
Tg(Mpz-RAF1/ESR1)A668Ayld/0
(involves: C57BL/6J * CBA/J)
|
increased Schwann cell proliferation
|
J:182703
|
Tg(MT2A-TGFBR2)#Rser/0
(involves: C57BL/6 * DBA)
|
abnormal cell proliferation
|
J:158480
|
Tg(Myh6-Actc1dt)2Kwan/0
(involves: C57BL/6)
|
decreased fetal cardiomyocyte proliferation
|
J:297375
|
Tg(Myl2-FGF19)1Dfre/?
(involves: FVB)
|
increased hepatocyte proliferation
|
J:77160
|
Tg(Nes-cre)1Kln/0 Ube4bem1Bcgen/Ube4bem1Bcgen
(involves: C57BL/6N * SJL)
|
decreased neuronal precursor proliferation
|
J:332423
|
Tg(Nes-cre)1Kln/0 Zfp568tm1Ckjs/Zfp568tm1Ckjs
(involves: C57BL/6J * SJL)
|
abnormal neuronal precursor proliferation
|
J:192224
|
Tg(Nes-cre)1Wme/Tg(Nes-cre)1Wme
(involves: C57BL/6 * CBA)
|
decreased neuronal precursor proliferation
|
J:112466
|
Tg(Nes-cre/ERT2)1Imayo/0
(involves: C57BL/6)
|
decreased neuronal precursor proliferation
|
J:112466
|
Tg(Nes-cre/ERT2)4Imayo/0
(involves: C57BL/6)
|
decreased neuronal precursor proliferation
|
J:112466
|
Tg(Neurod2-Smo*A2)#Jols/0
(C57BL/6-Tg(Neurod2-Smo*A2)#Jols)
|
abnormal neuron proliferation
|
J:189258
|
Tg(Pgk-tetR,tetO-RNAi:Pum3)#Yuj/0 Tg(Pou5f1-EGFP)2Mnn/0
(involves: C57BL/6 * C57BL/6J * CBA/CaJ)
|
decreased primordial germ cell proliferation
|
J:338852
|
Tg(Pkd1)6Mtru/0
(involves: C57BL/6J * CBA/J)
|
increased hepatocyte proliferation
|
J:157952
|
increased kidney cell proliferation
|
J:157952
|
Tg(Pkd1)26Mtru/0
(involves: C57BL/6J * CBA/J)
|
increased hepatocyte proliferation
|
J:157952
|
increased kidney cell proliferation
|
J:157952
|
Tg(Pten)1Srn/0
(involves: C57BL/6 * CBA)
|
decreased cell proliferation
|
J:182671
|
Tg(Rnu6-RNAi:Bccip)4Zshn/0
(FVB/N-Tg(Rnu6-RNAi:Bccip)4Zshn)
|
decreased cell proliferation
|
J:176115
|
Tg(SFTPC-rtTA)5Jaw/0 Tg(tetO-Fgf9,-EGFP)#Dor/0
(involves: FVB)
|
increased mesenchymal cell proliferation involved in lung development
|
J:224791
|
Tg(Shh)#Dje/0
(involves: Swiss Webster)
|
abnormal cell proliferation
|
J:94461
|
Tg(Sox3)1Pqt/0 Tg(Sox3-EGFP)NrPqt/0
(involves: C57BL/6 * CBA)
|
increased cell proliferation
|
J:184232
|
Tg(Tagln-Ager)#Yon/?
(C57BL/6-Tg(Tagln-Ager)#Yon)
|
decreased vascular smooth muscle cell proliferation
|
J:82620
|
Tg(Tagln-tTA)1Mrab/0 Tg(tetO-Mcpt1)1Mrab/0
(involves: C57BL/6 * SJL)
|
increased cell proliferation
|
J:70031
|
Tg(Tcra2D2,Tcrb2D2)1Kuch/0
(involves: C57BL/6)
|
increased cell proliferation
|
J:83278
|
Tg(Tcra2D2,Tcrb2D2)1Kuch/0
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased T cell proliferation
|
J:189919
|
increased T cell proliferation
|
J:189919
|
Tg(Tcra,Tcrb)3Ayr/0
(involves: C57BL/6 * DBA/2)
|
decreased T cell proliferation
|
J:80775
|
Tg(Tcra,Tcrb)24Efro/0
(D1.Cg-Tg(Tcra,Tcrb)24Efro)
|
decreased T cell proliferation
|
J:104243
|
increased T cell proliferation
|
J:104243
|
Tg(TcrAND)53Hed/?
(involves: A/WySnSg * C57BL/6 * C57BL/10SnSg * SJL)
|
abnormal T cell proliferation
|
J:85777
|
Tg(TcraR28,TcrbR28)KRNDim/0
(involves: C57BL/6 * NOD * SJL)
|
abnormal T cell proliferation
|
J:36815
|
Tg(TcraTcrb)425Cbn/0 Trim30atm1Yjk/Trim30atm1Yjk
(involves: 129P2/OlaHsd * BALB/c * C57BL/6)
|
increased T cell proliferation
|
J:215171
|
Tg(TcraTcrb)1100Mjb/?
(involves: C57BL/6)
|
increased T cell proliferation
|
J:92867
|
Tg(TcrHEL3A9)1Mmd/0
(involves: C57BL/6)
|
increased T cell proliferation
|
J:73608
|
Tg(TcrHEL3A9)1Mmd/0
(involves: C57BL/6 * C57BL/10 * C57BR/cd)
|
abnormal T cell proliferation
|
J:78309
|
Tg(TcrHEL3A9)1Mmd/0 Tg(TLK2mHEL)2Ccg/0
(involves: C57BL/6 * C57BL/10 * C57BR/cd)
|
abnormal T cell proliferation
|
J:78309
|
Tg(TcrLCMV)327Sdz/0
(involves: C57BL/6 * DBA/2)
|
decreased T cell proliferation
|
J:77696
|
Tg(tetO-Mir24-1)#Smoc/0 Tg(KRT14-rtTA)F42Efu/0
(involves: FVB)
|
decreased keratinocyte proliferation
|
J:306624
|
X/Tg(Tlr7)6Boll
(involves: C57BL/6)
|
increased splenocyte proliferation
|
J:127600
|
Tg(Ttr-Cdkn1a)36Tvd/?
(B6.Cg-Tg(Ttr-Cdkn1a)36Tvd)
|
decreased hepatocyte proliferation
|
J:94077
|
Tg(Ttr-KLF6)1Fdmn/?
(Not Specified)
|
decreased hepatocyte proliferation
|
J:122903
|
Tg(Tyr-NRAS*Q61K)1Bee/0
(involves: C57BL/6J * DBA/2)
|
abnormal melanocyte proliferation
|
J:193443
|
Tg(UAS-Shh)1Rth/0 Tg(Wnt1-GAL4)1Rth/0
(involves: C57BL/6J * CBA/J)
|
increased cell proliferation
|
J:57948
|
Tg(Umod*C147W)958Lura/0
(involves: FVB)
|
increased kidney cell proliferation
|
J:161532
|
Tg(Vav1-Lin28b)C3Apla/0
(involves: C57BL/6)
|
increased T cell proliferation
|
J:189197
|
Tg(Vav1-STAT5B*N642H)726Biat/0
(C57BL/6NCrl-Tg(Vav1-STAT5B*N642H)726Biat)
|
increased T cell proliferation
|
J:257519
|
Tg(Vil-SLC3A2)HEMerl/0
(involves: FVB/N)
|
abnormal enterocyte proliferation
|
J:173946
|
Tgfbr1tm1.1Karl/Tgfbr1tm1.1Karl Tg(Mx1-cre)1Cgn/0
(involves: 129 * C57BL/6 * CBA)
|
increased hematopoietic stem cell proliferation
|
J:86262
|
Tgfbr2tm1.2Hlm/Tgfbr2tm1.2Hlm H2az2Tg(Wnt1-cre)11Rth/H2az2+
(involves: 129S6/SvEvTac * C57BL/6 * CBA)
|
decreased cranial neural crest cell proliferation
|
J:86042
|
Tgfbr2tm1Sjkm/Tgfbr2+
(Not Specified)
|
increased hepatocyte proliferation
|
J:71591
|
Tgfbr3tm1Stv/Tgfbr3tm1Stv
(involves: 129/Sv * C57BL/6)
|
abnormal fetal cardiomyocyte proliferation
|
J:83727
|
Tgif1tm1Dwot/Tgif1tm1Dwot Tgif2tm1Dwot/Tgif2tm1Dwot
(involves: 129S/SvEv * 129X1/SvJ * C57BL/6J)
|
decreased embryonic epiblast cell proliferation
|
J:157256
|
Tgif1tm1Pah/Tgif1tm1Pah
(involves: 129S/SvEv * CD-1)
|
decreased cell proliferation
|
J:109616
|
Thap11tm1.1Tpz/Thap11tm1.1Tpz
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
absent inner cell mass proliferation
|
J:136306
|
Themistm1Gasc/Themistm1Gasc
(B6.129S-Themistm1Gasc)
|
decreased T cell proliferation
|
J:151074
|
Themistm1Hasu/Themistm1Hasu
(involves: C57BL/6 * CBA)
|
increased T cell proliferation
|
J:153235
|
Thraem1Ffla/Thra+
(C57BL/6-Thraem1Ffla)
|
abnormal enterocyte proliferation
|
J:268664
|
Thraem2Ffla/Thra+
(C57BL/6-Thraem2Ffla)
|
abnormal enterocyte proliferation
|
J:268664
|
Thratm1Jas/Thratm1Jas
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal enterocyte proliferation
|
J:84537
|
Thratm2Jas/Thratm2Jas
(involves: 129)
|
abnormal enterocyte proliferation
|
J:84537
|
Thratm3Jas/Thratm3Jas
(involves: 129)
|
abnormal enterocyte proliferation
|
J:84537
|
Thypr1DBA/2J/?
(involves: C57BL/6J * DBA/2J)
|
increased T cell proliferation
|
J:76931
|
Thypr2DBA/2J/?
(involves: C57BL/6J * DBA/2J)
|
increased T cell proliferation
|
J:76931
|
Tiam1tm1Jgc/Tiam1tm1Jgc
(involves: 129P2/OlaHsd * FVB)
|
decreased cell proliferation
|
J:77148
|
Ticam1tm1Aki/Ticam1tm1Aki
(involves: 129P2/OlaHsd)
|
decreased splenocyte proliferation
|
J:84679
|
Tifabtm1.1Dsta/Tifab+
(involves: 129 * C57BL/6 * C57BL/6J)
|
decreased hematopoietic stem cell proliferation
|
J:229024
|
Tifabtm1.1Dsta/Tifabtm1.1Dsta
(involves: 129 * C57BL/6 * C57BL/6J)
|
decreased hematopoietic stem cell proliferation
|
J:229024
|
TigarGt(EUCE0047g05)Hmgu/TigarGt(EUCE0047g05)Hmgu
(involves: 129P2/OlaHsd)
|
abnormal small intestinal crypt cell proliferation
|
J:198650
|
Tigittm1Sdl/Tigittm1Sdl
(involves: C57BL/6)
|
increased T cell proliferation
|
J:168902
|
Timd4tm1Kuch/Timd4tm1Kuch
(C57BL/6-Timd4tm1Kuch)
|
increased splenocyte proliferation
|
J:160747
|
Tincrem1Kei/Tincrem1Kei
(Not Specified)
|
decreased keratinocyte proliferation
|
J:339811
|
Tiraptm1Medz/Tiraptm1Medz
(involves: 129S1/Sv * C57BL/6)
|
decreased B cell proliferation
|
J:96773
|
Tjp1tm1.1Whun/Tjp1tm1.1Whun Tjp2tm2Whun/Tjp2tm2Whun Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S6/SvEvTac * C57BL/6 * C57BL/6N * C57BL/6NTac * DBA/2)
|
increased hepatocyte proliferation
|
J:306936
|
Tjp2tm1Whun/Tjp2tm1Whun
(either: (involves: 129S6/SvEvTac) or (involves: 129S6/SvEvTac * C57BL/6))
|
decreased cell proliferation
|
J:132649
|
Tln2tm2Crit/Tln2tm2Crit
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased fibroblast proliferation
|
J:190037
|
Tlr2tm1Kir/Tlr2tm1Kir
(B6.129-Tlr2tm1Kir)
|
decreased splenocyte proliferation
|
J:121930
|
Tlr4tm1.1Djh/Tlr4tm1.1Djh
(involves: FVB/N)
|
abnormal enterocyte proliferation
|
J:192520
|
abnormal fibroblast proliferation
|
J:192520
|
Tlr4tm1Aki/Tlr4tm1Aki
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased B cell proliferation
|
J:76115
|
Tlr7em2Anu/Y
(C57BL/6NCrl-Tlr7em2Anu)
|
decreased B cell proliferation
|
J:324448
|
Tlr7tm1Flv/Y
(B6.129S1-Tlr7tm1Flv)
|
decreased splenocyte proliferation
|
J:127600
|
Tlr9m3Btlr/Tlr9m3Btlr
(C57BL/6J-Tlr9m3Btlr)
|
decreased B cell proliferation
|
J:128406
|
Tlr9m4Btlr/Tlr9+
(C57BL/6J-Tlr9m4Btlr)
|
decreased B cell proliferation
|
J:132489
|
Tmem258tm1.1(KOMP)Vlcg/Tmem258+
(involves: C57BL/6NTac)
|
abnormal enterocyte proliferation
|
J:240635
|
Tmpotm1.1Foi/Tmpotm1.1Foi
(involves: 129S1/Sv * C57BL/6)
|
abnormal enterocyte proliferation
|
J:145628
|
Tnftm1Gkl/Tnftm1Gkl
(involves: 129S/SvEv * C57BL/6)
|
decreased keratinocyte proliferation
|
J:56068
|
Tnftm2Gkl/Tnf+
(involves: 129S/SvEv * C57BL/6J)
|
increased cell proliferation
|
J:264147
|
increased fibroblast proliferation
|
J:264147
|
Tnfaip3tm2Ama/Tnfaip3tm2Ama Cd19tm1(cre)Cgn/Cd19+
(involves: 129P2/OlaHsd * C57BL/6)
|
increased B cell proliferation
|
J:163917
|
Tnfrsf1atm1Imx/Tnfrsf1atm1Imx
(C57BL/6-Tnfrsf1atm1Imx)
|
abnormal neuron proliferation
|
J:112713
|
Tnfrsf1btm1Mwm/Tnfrsf1btm1Mwm
(B6.129S2-Tnfrsf1btm1Mwm/J)
|
decreased T cell proliferation
|
J:107039
|
Tnfrsf4tm1Nik/Tnfrsf4tm1Nik
(involves: 129S4/SvJae * C57BL/6)
|
decreased T cell proliferation
|
J:58979,
J:64552
|
Tnfrsf9tm1Byk/Tnfrsf9tm1Byk
(B6.Cg-Tnfrsf9tm1Byk)
|
increased T cell proliferation
|
J:83996
|
Tnfrsf9tm1Byk/Tnfrsf9tm1Byk
(C.Cg-Tnfrsf9tm1Byk)
|
increased splenocyte proliferation
|
J:83722
|
increased T cell proliferation
|
J:83996
|
Tnfrsf13btm1Rjb/Tnfrsf13btm1Rjb
(involves: 129X1/SvJ * C57BL/6)
|
increased B cell proliferation
|
J:69474
|
Tnfrsf13btm1Vmd/Tnfrsf13btm1Vmd
(involves: C57BL/6)
|
increased B cell proliferation
|
J:70172
|
Tnfrsf13cBcmd1/Tnfrsf13cBcmd1
(A/WySnJ)
|
decreased B cell proliferation
|
J:122315
|
decreased T cell proliferation
|
J:92334
|
Tnfrsf14tm1Kpf/Tnfrsf14tm1Kpf
(B6.129P2-Tnfrsf14tm1Kpf)
|
increased T cell proliferation
|
J:99456
|
Tnfrsf18tm1Ppp/Tnfrsf18tm1Ppp
(involves: 129/Sv * C57BL/6)
|
increased T cell proliferation
|
J:77393
|
Tnfrsf21tm1Ddy/Tnfrsf21tm1Ddy
(involves: 129S1/Sv * 129X1/SvJ)
|
increased B cell proliferation
|
J:109341
|
increased T cell proliferation
|
J:70594
|
Tnfrsf21tm1Vmd/Tnfrsf21tm1Vmd
(involves: C57BL/6)
|
increased T cell proliferation
|
J:72761
|
Tnfsf4tm1Shr/Tnfsf4tm1Shr
(involves: 129S4/SvJae)
|
decreased T cell proliferation
|
J:59203
|
Tnfsf4tm1Sug/Tnfsf4tm1Sug
(B6.129S4-Tnfsf4tm1Sug)
|
decreased T cell proliferation
|
J:80214
|
Tnfsf13tm1Pod/Tnfsf13tm1Pod
(B6.Cg-Tnfsf13tm1Pod)
|
increased T cell proliferation
|
J:141374
|
Tnfsf13btm1Msc/Tnfsf13btm1Msc
(involves: 129S2/SvPas)
|
decreased T cell proliferation
|
J:92334
|
Tnfsf14tm1Ddy/Tnfsf14tm1Ddy
(involves: 129S1/Sv * 129X1/SvJ)
|
decreased T cell proliferation
|
J:84366
|
Tnfsf14tm1Kpf/Tnfsf14tm1Kpf
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased splenocyte proliferation
|
J:77250
|
decreased T cell proliferation
|
J:77250
|
Tnip1tm1.1Pcoh/Tnip1tm1.1Pcoh
(involves: 129P2/OlaHsd * C57BL/6)
|
increased B cell proliferation
|
J:176826
|
Tnni2tm1Sgao/Tnni2+
(involves: 129 * ICR)
|
decreased osteoblast proliferation
|
J:228857
|
Tnni3ktm1.1Tfo/Tnni3ktm1.1Tfo
(involves: C57BL/6)
|
abnormal cell proliferation
|
J:249318
|
Tnrc6aGt(XE786)Byg/Tnrc6aGt(XE786)Byg
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased cell proliferation
|
J:182447
|
Tns3Gt(XK294)Byg/Tns3Gt(XK294)Byg
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased chondrocyte proliferation
|
J:96666
|
Tob1tm1Tya/Tob1tm1Tya
(involves: 129S4/SvJae * C57BL/6)
|
increased cell proliferation
|
J:66504
|
Top1mttm1.1Hlzh/Top1mttm1.1Hlzh
(Not Specified)
|
decreased fibroblast proliferation
|
J:189886
|
Top3atm1Jcw/Top3atm1Jcw
(involves: 129S6/SvEvTac * C57BL/6)
|
abnormal inner cell mass proliferation
|
J:45652
|
Topbp1tm1.2Dsh/Topbp1tm1.2Dsh
(involves: 129P2/OlaHsd * 129S4/SvJaeSor * C57BL/6 * C57BL/6J)
|
decreased cell proliferation
|
J:170406
|
ToporsGt(DTM034)Byg/ToporsGt(DTM034)Byg
(involves: 129P2/OlaHsd * C57BL/6J)
|
decreased fibroblast proliferation
|
J:325276
|
Tph1tm1c(KOMP)Wtsi/Tph1tm1c(KOMP)Wtsi Tg(Ins2-cre)23Herr/0
(involves: 129S4/SvJae * C57BL/6J * CBA/J)
|
decreased pancreatic beta cell proliferation
|
J:284574
|
Tph1tm1Kry/Tph1tm1Kry Tg(Vil1-cre)20Syr/0
(involves: C57BL/6 * DBA/2)
|
increased osteoblast proliferation
|
J:146078
|
Tpt1tm1.1Atel/Tpt1tm1.1Atel
(involves: C57BL/6)
|
decreased cell proliferation
|
J:150991
|
Tpt1tm1.1Yen/Tpt1tm1.1Yen
(involves: 129 * C57BL/6)
|
decreased embryonic epiblast cell proliferation
|
J:127458
|
Tpx2Gt(D028B03)1.1Wrst/Tpx2Gt(D028B03)1.1Wrst
(involves: 129S2/SvPas * C57BL/6J)
|
decreased cell proliferation
|
J:184948
|
Traf1tm1Tsi/Traf1tm1Tsi
(involves: 129S4/SvJae * C57BL/6)
|
increased T cell proliferation
|
J:72327
|
Traf5tm1Hna/Traf5tm1Hna
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
abnormal B cell proliferation
|
J:57114
|
abnormal T cell proliferation
|
J:57114
|
Traf6tm1Mak/Traf6tm1Mak
(involves: 129P3/J)
|
decreased B cell proliferation
|
J:54467
|
Traiptm1Jarh/Traiptm1Jarh
(involves: C57BL/6J)
|
decreased cell proliferation
|
J:127324
|
Trap1Gt(E150H04)Wrst/Trap1Gt(E150H04)Wrst
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased fibroblast proliferation
|
J:226880
|
Trem2em2Bwef/Trem2em2Bwef
(involves: C57BL/6J * DBA/2J * FVB/N)
|
decreased macrophage proliferation
|
J:242126
|
Trim24tm1.1Los/Trim24tm1.1Los
(involves: 129/Sv * C57BL/6 * SJL)
|
increased hepatocyte proliferation
|
J:130210
|
Trim29tm1c(EUCOMM)Wtsi/Trim29tm1c(EUCOMM)Wtsi Tg(Myh6-cre)2182Mds/0
(involves: C57BL/6J * C57BL/6N * C57BL/6NTac)
|
increased T cell proliferation
|
J:349246
|
Trim30atm1Yjk/Trim30atm1Yjk
(B6.129P2-Trim30atm1Yjk)
|
increased T cell proliferation
|
J:215171
|
Trim71em1Ktka/Trim71+
(Not Specified)
|
abnormal neuron proliferation
|
J:335575
|
Trim71tm1695Arte/Trim71tm1695Arte Tg(Nes-cre)1Kln/0
(involves: C57BL/6 * C57BL/6J * C57BL/6NTac * SJL)
|
abnormal neuron proliferation
|
J:335575
|
Trmq3FVB/N/?
(involves: DBA/1J * FVB/N)
|
abnormal T cell proliferation
|
J:94347
|
Trp53tm1.1Manf/Trp53tm1.1Manf
(Not Specified)
|
decreased hematopoietic stem cell proliferation
|
J:201153
|
Trp53tm1.1Manf/Trp53tm1.1Manf
(involves: C57BL/6J)
|
decreased hematopoietic stem cell proliferation
|
J:201153
|
Trp53tm1.1Wgu/Trp53tm1.1Wgu
(involves: 129S6/SvEvTac * C57BL/6)
|
increased fibroblast proliferation
|
J:186159
|
Trp53tm1.2Awbr/Trp53tm1.2Awbr
(involves: C57BL/6)
|
increased cell proliferation
|
J:173271
|
increased splenocyte proliferation
|
J:173271
|
Trp53tm1Brd/Trp53tm1Brd
(involves: 129S7/SvEvBrd)
|
increased cell proliferation
|
J:110650,
J:118602
|
increased fibroblast proliferation
|
J:175018,
J:57882,
J:186159
|
Trp53tm1Sia/Trp53tm1Sia
(involves: C57BL/6 * CBA)
|
abnormal cell proliferation
|
J:36762
|
Trp53tm1Tyj/Trp53+
(involves: 129S2/SvPas)
|
increased fibroblast proliferation
|
J:95316
|
Trp53tm1Tyj/Trp53tm1.1Dgk
(involves: 129S * 129X1/SvJ * C57BL/6)
|
increased cell proliferation
|
J:180576
|
Trp53tm1Tyj/Trp53tm1Tyj
(involves: 129S2/SvPas * C57BL/6)
|
decreased cell proliferation
|
J:170976
|
increased fibroblast proliferation
|
J:95318
|
Trp53tm1Tyj/Trp53tm1Tyj
(involves: 129S2/SvPas)
|
increased fibroblast proliferation
|
J:77907
|
Trp53tm1Wahl/Trp53tm1Wahl
(involves: 129S4/SvJae)
|
increased fibroblast proliferation
|
J:64367
|
Trp53tm2.1Snj/Trp53+
(involves: 129S4/SvJae * C57BL/6)
|
increased fibroblast proliferation
|
J:175018
|
Trp53tm2.1Snj/Trp53tm2.1Snj
(involves: 129S4/SvJae * C57BL/6)
|
increased fibroblast proliferation
|
J:175018
|
Trp53tm2.1Tyj/Trp53+
(involves: 129S4/SvJae)
|
increased cell proliferation
|
J:95316
|
Trp53tm2.1Wgu/Trp53tm2.1Wgu
(involves: 129S6/SvEvTac * C57BL/6)
|
increased fibroblast proliferation
|
J:186159
|
Trp53tm2Xu/Trp53tm2Xu
(involves: 129S6/SvEvTac)
|
decreased T cell proliferation
|
J:109354
|
Trp53tm3.1Glo/Trp53+
(B6.129S7-Trp53tm3.1Glo)
|
increased fibroblast proliferation
|
J:95318
|
Trp53tm3.1Glo/Trp53tm3.1Glo
(B6.129S7-Trp53tm3.1Glo)
|
increased fibroblast proliferation
|
J:95318
|
Trp53tm3.1Tyj/Trp53+
(involves: 129S4/SvJae)
|
increased cell proliferation
|
J:95316
|
Trp53tm3Wahl/Trp53tm3Wahl
(involves: 129S4/SvJae)
|
increased cell proliferation
|
J:108183
|
Trp53bp1Gt(OST94324)Lex/Trp53bp1Gt(OST94324)Lex
(involves: 129S5/SvEvBrd)
|
decreased cell proliferation
|
J:83164
|
Trp53bp1tm1Jc/Trp53bp1tm1Jc
(involves: 129 * C57BL/6)
|
decreased cell proliferation
|
J:82512
|
Trp53bp2tm1Xlu/Trp53bp2tm1Xlu
(involves: 129S6/SvEvTac * C57BL/6J)
|
abnormal neuronal precursor proliferation
|
J:162396
|
Trp63tm1Sin/Trp63tm1Sin
(Not Specified)
|
decreased keratinocyte proliferation
|
J:181275
|
Trp63tm2Brd/Trp63tm2Brd
(involves: 129S7/SvEvBrd)
|
decreased cell proliferation
|
J:100483
|
Trp63tm3.1Aam/Trp63+
(involves: 129S7/SvEvBrd * BALB/c * C57BL/6)
|
decreased keratinocyte proliferation
|
J:294158
|
Trp63tm3.1Brd/Trp63tm3.1Brd
(involves: 129S7/SvEvBrd)
|
decreased cell proliferation
|
J:100483
|
Trp63tm3Aam/Trp63+
(involves: 129S7/SvEvBrd)
|
decreased keratinocyte proliferation
|
J:294158
|
Trpv1tm1Jul/Trpv1tm1Jul
(B6.129X1-Trpv1tm1Jul/J)
|
abnormal neuronal precursor proliferation
|
J:102006
|
Tsc22d3tm1.1Ric/Y
(involves: 129S7/SvEvBrd * C57BL/6)
|
abnormal spermatogonia proliferation
|
J:179667
|
Tsg101tm1Mak/Tsg101tm1Mak
(either: (involves: 129P2/OlaHsd * C57BL/6J) or (involves: 129P2/OlaHsd * CD-1))
|
absent inner cell mass proliferation
|
J:67553
|
decreased cell proliferation
|
J:67553
|
TsnGt(OST63223)Lex/TsnGt(OST63223)Lex
(involves: 129S5/SvEvBrd * C57BL/6J)
|
decreased cell proliferation
|
J:85466
|
Tspan32Gt(pMS-1)1Jmt/Tspan32Gt(pMS-1)1Jmt
(involves: 129S1/Sv)
|
increased T cell proliferation
|
J:78033
|
Tspyl5em1Yuya/Tspyl5em1Yuya
(C57BL/6-Tspyl5em1Yuya)
|
abnormal spermatogonia proliferation
|
J:350814
|
Ttc21btm2c(KOMP)Wtsi/Ttc21baln Gt(ROSA)26Sortm1(cre/ERT)Nat/Gt(ROSA)26Sor+
(involves: 129S1/Sv * 129X1/SvJ * A/J * C57BL/6N)
|
increased kidney cell proliferation
|
J:213263
|
Tuba1aem1Rstot/Tuba1aem1Rstot
(involves: C57BL/6J * C57BL/6N)
|
increased neuronal precursor proliferation
|
J:278765
|
Tuba1aquas/Tuba1aquas
(involves: C57BL/6J)
|
decreased neuronal precursor proliferation
|
J:278765
|
increased neuronal precursor proliferation
|
J:278765
|
Tubb2bbrdp/Tubb2bbrdp
(involves: A/J * FVB)
|
abnormal neuronal precursor proliferation
|
J:201099
|
Tubgcp4tm1Rzh/Tubgcp4tm1Rzh
(involves: 129S6/SvEv * C57BL/6)
|
decreased cell proliferation
|
J:282705
|
Tulp3m1Kflj/Tulp3m1Kflj
(involves: C57BL/6J * FVB/NJ)
|
increased kidney cell proliferation
|
J:284006
|
Tusc2tm1Avi/Tusc2tm1Avi
(involves: 129S1/Sv)
|
decreased T cell proliferation
|
J:309768
|
Txn1tm1Mmt/Txn1tm1Mmt
(involves: 129S2/SvPas * C57BL/6)
|
absent inner cell mass proliferation
|
J:35059
|
Txniptm1Yu/Txniptm1Yu
(involves: 129)
|
increased T cell proliferation
|
J:96677
|
Txnrd1tm1.1Marc/Txnrd1tm1.1Marc
(involves: 129P2/OlaHsd * C57BL/6J)
|
absent fibroblast proliferation
|
J:96818
|
decreased cell proliferation
|
J:96818
|
Txnrd2tm1.1Marc/Txnrd2tm1.1Marc
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased fetal cardiomyocyte proliferation
|
J:94136
|
decreased fibroblast proliferation
|
J:94136
|
Tyrobptm1Lll/Tyrobptm1Lll
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased T cell proliferation
|
J:64763
|
Tyrobptm1Ttk/Tyrobptm1Ttk
(B6.129P2-Tyrobptm1Ttk)
|
increased B cell proliferation
|
J:177613
|
Ubash3btm1Jni/Ubash3btm1Jni Ubash3atm1Jni/Ubash3atm1Jni
(Not Specified)
|
increased T cell proliferation
|
J:89761
|
Ubctm1Rrk/Ubctm1Rrk
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
decreased cell proliferation
|
J:122574
|
Ube2cem1Gpt/Ube2cem1Gpt
(C57BL/6J-Ube2cem1Gpt)
|
decreased cell proliferation
|
J:333347
|
Ube2nGt(OST374154)Lex/Ube2n+
(involves: 129S5/SvEvBrd * C57BL/6)
|
decreased B cell proliferation
|
J:120846
|
decreased T cell proliferation
|
J:120846
|
Ube2otm1.1(KOMP)Mbp/Ube2otm1.1(KOMP)Mbp
(involves: C57BL/6 * C57BL/6N * FVB/N)
|
decreased fibroblast proliferation
|
J:239679
|
Ubr4tm1.2Nkt/Ubr4tm1.2Nkt Edil3Tg(Sox2-cre)1Amc/Edil3+
(involves: 129S6/SvEvTac * C57BL/6 * CBA * SJL)
|
increased cell proliferation
|
J:203460
|
Ubr5tm1Ckww/Ubr5tm1Ckww
(involves: 129X1/SvJ * C57BL/6)
|
decreased cell proliferation
|
J:92269
|
Uhrf1tm1Smoc/Uhrf1tm1Smoc Tg(Amh-cre)8815Reb/0
(involves: C57BL/6J * FVB/N)
|
decreased Sertoli cell proliferation
|
J:324178
|
Uimc1tm1.2Amj/Uimc1tm1.2Amj
(involves: BALB/cJ * C57BL/6)
|
decreased fibroblast proliferation
|
J:191827
|
Unc93b1tm1.1Kmiy/Unc93b1tm1.1Kmiy
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased B cell proliferation
|
J:174308
|
increased B cell proliferation
|
J:174308
|
Upf2tm1Btp/Upf2tm1Btp En1tm2(cre)Wrst/En1+
(involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ)
|
increased neuronal precursor proliferation
|
J:306384
|
Upf2tm1Btp/Upf2tm1Btp Tg(Atoh1-cre)1Bfri/0
(involves: 129P2/OlaHsd * C57BL/6 * CBA)
|
increased neuronal precursor proliferation
|
J:306384
|
Upf2tm1Btp/Upf2tm1Btp Tg(Mx1-cre)1Cgn/0
(involves: 129P2/OlaHsd * C57BL/6 * CBA)
|
decreased T cell proliferation
|
J:134765
|
Upf3bGt(IST14619B5)Tigm/Y
(involves: C57BL/6J * C57BL/6N)
|
increased neuronal precursor proliferation
|
J:253157
|
Upf3bGt(IST14619B5)Tigm/Upf3bGt(IST14619B5)Tigm
(involves: C57BL/6J * C57BL/6N)
|
increased neuronal precursor proliferation
|
J:253157
|
Urahplt2/Urahplt2
(C57BL/6-Urahplt2)
|
increased T cell proliferation
|
J:267227
|
Usp11tm1Tac/Y
(involves: 129 * C57BL/6)
|
increased fibroblast proliferation
|
J:270214
|
Usp17lctm1Khb/Usp17lctm1Khb
(either: 129-Usp17lctm1Khb or (involves: 129S/SvEv * C57BL/6J))
|
decreased cell proliferation
|
J:191761
|
Utf1tm1Okud/Utf1tm1Okud
(B6.129P2-Utf1tm1Okud)
|
decreased cell proliferation
|
J:204409
|
Vav1tm1Tyb/Vav1tm1Tyb
(involves: 129S2/SvPas * 129S8/SvEv)
|
decreased T cell proliferation
|
J:113270
|
Vav1tm1Tyb/Vav1tm1Tyb
(involves: 129S2/SvPas)
|
decreased T cell proliferation
|
J:86654
|
Vav1tm1Tyb/Vav1tm1Tyb
(involves: 129S2/SvPas * C57BL/10 * C57BR/cd)
|
decreased T cell proliferation
|
J:128985
|
Vav1tm1Tyb/Vav1tm1Tyb Vav2tm1Kdf/Vav2tm1Kdf
(involves: 129S1/Sv * 129S2/SvPas)
|
decreased B cell proliferation
|
J:86654
|
decreased T cell proliferation
|
J:86654
|
Vav1tm1Tyb/Vav1tm1Tyb Vav2tm1Kdf/Vav2tm1Kdf Vav3tm1Swat/Vav3tm1Swat
(involves: 129S1/Sv * 129S2/SvPas * 129S6/SvEvTac * C57BL/6)
|
decreased B cell proliferation
|
J:86654
|
decreased T cell proliferation
|
J:86654
|
Vav1tm1Tyb/Vav1tm1Tyb Vav2tm1Tnr/Vav2tm1Tnr
(involves: 129P2/OlaHsd * 129S2/SvPas)
|
decreased B cell proliferation
|
J:69807
|
Vav1tm1Tyb/Vav1tm1Tyb Vav3tm1Swat/Vav3tm1Swat
(involves: 129S2/SvPas * 129S6/SvEvTac * C57BL/6)
|
decreased B cell proliferation
|
J:86654
|
decreased T cell proliferation
|
J:86654
|
Vav1tm2Bbd/Vav1tm2Bbd
(involves: 129S1/Sv * 129X1/SvJ * CD-1)
|
decreased T cell proliferation
|
J:47596
|
Vav1tm2Bbd/Vav1tm2Bbd
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
decreased B cell proliferation
|
J:55647,
J:69806
|
Vav1tm2Bbd/Vav1tm2Bbd Vav2tm1Kdf/Vav2tm1Kdf
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
decreased B cell proliferation
|
J:69806
|
Vav1tm2Tyb/Vav1tm2Tyb
(involves: 129S4/SvJae * 129S8/SvEv)
|
decreased T cell proliferation
|
J:113270
|
Vav2tm1Kdf/Vav2tm1Kdf
(involves: 129S1/Sv * C57BL/6)
|
decreased B cell proliferation
|
J:69806
|
Vav2tm1Tnr/Vav2tm1Tnr
(involves: 129P2/OlaHsd)
|
decreased B cell proliferation
|
J:69807
|
Vcltm1Eda/Vcltm1Eda
(involves: 129S1/Sv * 129X1/SvJ * Black Swiss)
|
increased fibroblast proliferation
|
J:45781
|
Vdrtm1Ska/Vdrtm1Ska
(involves: C57BL/6NCrlj * CBA/JNCrlj)
|
decreased splenocyte proliferation
|
J:112519
|
Vegfatm2Gne/Vegfatm2.1Nagy Tg(Nes-cre)1Kln/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CD-1 * SJL)
|
abnormal neuron proliferation
|
J:86207
|
Vegfatm2Gne/Vegfatm2Gne Tg(SFTPC-rtTA)5Jaw/0 Tg(tetO-cre)1Jaw/0
(involves: 129 * C57BL/6)
|
decreased mesenchymal cell proliferation involved in lung development
|
J:124125
|
Vgll4tm1b(EUCOMM)Hmgu/Vgll4tm1b(EUCOMM)Hmgu
(involves: C57BL/6N * CBA)
|
increased cell proliferation
|
J:273437
|
Vgll4tm1b(EUCOMM)Hmgu/Vgll4tm1c(EUCOMM)Hmgu Tg(Tek-cre)1Ywa/0
(involves: C57BL/6N * CBA * SJL)
|
increased cell proliferation
|
J:273437
|
Vhltm1Jae/Vhltm1Jae
(involves: 129S4/SvJae)
|
decreased cell proliferation
|
J:160941
|
Vhltm1Jae/Vhltm1Jae Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S4/SvJae * C57BL/6 * DBA)
|
increased hepatocyte proliferation
|
J:144666
|
Vhltm1Jae/Vhltm1Jae Tg(KRT14-cre)1Ipc/0
(involves: 129S4/SvJae * C57BL/6 * SJL)
|
increased keratinocyte proliferation
|
J:144666
|
Vipr1tm1Msod/Vipr1tm1Msod
(B6.129-Vipr1tm1Msod)
|
abnormal enterocyte proliferation
|
J:177616
|
Vps25m1Lis/Vps25m1Lis
(involves: C3H * C57BL/6J)
|
increased cell proliferation
|
J:223082
|
Vps35tm1.1Hckn/Vps35tm1.1Hckn Tg(Vil1-cre/ERT2)23Syr/0
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2)
|
abnormal small intestinal crypt cell proliferation
|
J:223191
|
Vrk1Gt(RRR178)Byg/Vrk1Gt(RRR178)Byg
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal spermatogonia proliferation
|
J:156653
|
Vsig4tm1Gne/Vsig4tm1Gne
(C57BL/6-Vsig4tm1Gne)
|
abnormal enterocyte proliferation
|
J:281762
|
Wapltm1.1Jmpt/Wapltm1.2Jmpt Gt(ROSA)26Sortm9(cre/ESR1)Arte/Gt(ROSA)26Sor+
(involves: 129 * C57BL/6 * C57BL/6NTac * SJL)
|
absent fibroblast proliferation
|
J:205429
|
Wastm1Itl/Y
(Not Specified)
|
decreased T cell proliferation
|
J:153247
|
Wastm1Itl/Wastm1Itl
(Not Specified)
|
decreased T cell proliferation
|
J:153247
|
Wastm1Sbs/Y
(involves: 129S6/SvEvTac)
|
decreased T cell proliferation
|
J:153247
|
Wastm1Sbs/Wastm1Sbs
(either: (involves: 129S6/SvEvTac) or (involves: 129S6/SvEvTac * C57BL/6))
|
decreased T cell proliferation
|
J:48836
|
Wastm1Sbs/Wastm1Sbs
(involves: BALB/c)
|
decreased T cell proliferation
|
J:84131
|
Wastm1Sbs/Wastm1Sbs
(involves: 129S6/SvEvTac)
|
decreased T cell proliferation
|
J:153247
|
Wastm2Itl/Y
(Not Specified)
|
decreased T cell proliferation
|
J:153247
|
Wastm2Itl/Wastm2Itl
(Not Specified)
|
decreased T cell proliferation
|
J:153247
|
Wasltm1.1Ttha/Wasltm1.1Ttha Tg(KRT14-cre)1Amc/0
(involves: C57BL/6 * C57BL/6N * CBA)
|
increased keratinocyte proliferation
|
J:271857
|
Wasltm1Sbs/Wasltm1Sbs
(either: (involves: 129P2/OlaHsd * 129S/SvEv) or (involves: 129P2/OlaHsd * C57BL/6))
|
decreased fibroblast proliferation
|
J:72053
|
Wdfy3disc/Wdfy3disc
(involves: C57BL/6J * FVB/NJ)
|
abnormal neuronal precursor proliferation
|
J:225200
|
Wdhd1em1Isyu/Wdhd1em1Isyu
(Not Specified)
|
decreased cell proliferation
|
J:306382
|
Wdr13tm1Kuma/Y
(involves: 129S1/Sv * 129X1/SvJ * CD-1)
|
increased pancreatic beta cell proliferation
|
J:225111
|
Wdr62tm1.1Jfch/Wdr62tm1.1Jfch
(involves: 129S1/SvImJ * C57BL/6N)
|
decreased cell proliferation
|
J:282438
|
Wee1tm1.1Cxd/Wee1tm1.1Cxd
(involves: 129S6/SvEvTac * FVB/N)
|
decreased embryonic epiblast cell proliferation
|
J:228492
|
Wipf1tm1Geha/Wipf1tm1Geha
(involves: 129S6/SvEvTac)
|
decreased T cell proliferation
|
J:74719
|
increased B cell proliferation
|
J:74719
|
Wlstm1.1Arte/Wlstm1.1Arte Krt14tm1(cre)Wbm/Krt14+
(involves: 129P2/OlaHsd * C57BL/6)
|
increased keratinocyte proliferation
|
J:202499
|
increased T cell proliferation
|
J:202499
|
Wlstm1Xzg/Wlstm1Xzg Tg(Msx2-cre)5Rem/0
(Not Specified)
|
decreased cell proliferation
|
J:184918
|
Wlstm1Xzg/Wlstm1Xzg Tg(Prrx1-cre)1Cjt/0
(involves: C57BL/6J * SJL/J)
|
decreased cell proliferation
|
J:184918
|
Wnt2tm1.1(rtTA)Eem/Wnt2tm1.1(rtTA)Eem
(involves: 129X1/SvJ * C57BL/6)
|
decreased mesenchymal cell proliferation involved in lung development
|
J:153098
|
Wnt6tm1Akis/Wnt6tm1Akis
(involves: 129P2/OlaHsd * CD-1 * NMRI)
|
decreased cell proliferation
|
J:193969
|
Wnt7btm1Eem/Wnt7btm1Eem
(either: (involves: 129S1/Sv * 129X1/SvJ) or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6))
|
abnormal mesenchymal cell proliferation involved in lung development
|
J:79395
|
Wnt7btm2Amc/Wnt7btm2.1Amc Edil3Tg(Sox2-cre)1Amc/Edil3+
(involves: 129X1/SvJ * C57BL/6 * CBA)
|
abnormal kidney cell proliferation
|
J:142685
|
decreased kidney cell proliferation
|
J:142685
|
decreased mesenchymal cell proliferation involved in lung development
|
J:134483
|
Xbp1tm1.2Geno/Xbp1tm1.2Geno
(involves: 129S2/SvPas * C57BL/6)
|
decreased cell proliferation
|
J:211440
|
Xbp1tm1Glm/Xbp1tm1Glm
(involves: 129S2/SvPas)
|
decreased hepatocyte proliferation
|
J:59916
|
Xrcc6tm1Fwa/Xrcc6tm1Fwa
(involves: 129S6/SvEvTac * C57BL/6J)
|
decreased cell proliferation
|
J:44361
|
X/Yaa
(B6.SB-Yaa/J)
|
increased splenocyte proliferation
|
J:127600
|
Yap1tm1.1Dupa/Yap1tm1.1Dupa Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129P2/OlaHsd * C57BL/6 * DBA)
|
increased hepatocyte proliferation
|
J:162628
|
Yap1tm1.1Dupa/Yap1tm1.1Dupa Tg(Vil1-cre)997Gum/0
(involves: 129P2/OlaHsd * C57BL/6J * SJL)
|
abnormal enterocyte proliferation
|
J:165471
|
Yap1tm1.1Fcam/Yap1tm1.1Fcam Tg(KRT14-cre)1Amc/0
(involves: 129S4/SvJae * C57BL/6 * CBA)
|
decreased cell proliferation
|
J:171057
|
increased cell proliferation
|
J:171057
|
Yap1tm1.1Fcam/Yap1tm2.1Fcam Tg(KRT14-cre)1Amc/0
(involves: 129S4/SvJae * C57BL/6 * CBA)
|
decreased cell proliferation
|
J:171057
|
Ybx1tm1Ley/Ybx1tm1Ley
(either: 129X1/SvJ-Ybx1tm1Ley or (involves: 129X1/SvJ * C57BL/6))
|
decreased fibroblast proliferation
|
J:99099
|
Ybx1tm1Tuch/Ybx1tm1Tuch
(involves: 129S/SvEv * C57BL/6)
|
decreased fibroblast proliferation
|
J:117725
|
Ywhaetm1Awb/Ywhaetm1Awb
(involves: 129S6/SvEvTac)
|
decreased fetal cardiomyocyte proliferation
|
J:192860
|
Yy1tm1Yshi/Yy1tm2Yshi
(involves: 129S4/SvJae)
|
decreased cell proliferation
|
J:108369
|
Zap70m1Saka/Zap70m1Saka
(involves: BALB/c)
|
decreased T cell proliferation
|
J:154166,
J:86607
|
Zap70m1Saka/Zap70m1Saka Tg(DO11.10)10Dlo/0
(involves: BALB/c * C3H * C57BL/6)
|
decreased T cell proliferation
|
J:86607
|
Zap70tm1.1Mmal/Zap70tm1.1Mmal Tg(TcrLCMV)327Sdz/0
(involves: 129P2/OlaHsd * BALB/cJ * C57BL/6 * DBA/2)
|
abnormal T cell proliferation
|
J:71099
|
Zap70tm2.1Weis/Zap70tm2.1Weis
(C.129S4-Zap70tm2.1Weis)
|
decreased T cell proliferation
|
J:154166
|
Zbtb7ctm1Mwhu/Zbtb7ctm1Mwhu
(involves: 129S4/SvJae * C57BL/6)
|
decreased cell proliferation
|
J:181490
|
Zbtb16tm1Ppp/Zbtb16tm1Ppp
(involves: 129S1/Sv)
|
abnormal spermatogonia proliferation
|
J:91129
|
Zbtb17tm1Cksn/Zbtb17tm1Cksn Krt14tm1(cre)Wbm/Krt14+
(involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ)
|
increased keratinocyte proliferation
|
J:123966
|
Zbtb17tm1Elr/Zbtb17tm1Elr
(involves: 129X1/SvJ * C57BL/6)
|
decreased cell proliferation
|
J:86265
|
Zbtb18tm1Haok/Zbtb18tm1Haok
(involves: 129)
|
abnormal neuronal precursor proliferation
|
J:196306
|
Zbtb32tm1Iho/Zbtb32tm1Iho
(involves: BALB/c)
|
increased T cell proliferation
|
J:94944
|
Zbtb32tm1Iho/Zbtb32tm1Iho
(involves: C57BL/6)
|
increased T cell proliferation
|
J:94944
|
Zbtb32tm2Ppp/Zbtb32tm2Ppp
(involves: 129S1/Sv)
|
increased T cell proliferation
|
J:95119
|
Zc3h4em1(IMPC)Mbp/Zc3h4em1(IMPC)Mbp
(C57BL/6NCrl-Zc3h4em1(IMPC)Mbp/Mmucd)
|
absent inner cell mass proliferation
|
J:279207,
J:301719
|
decreased cell proliferation
|
J:301719
|
Zc3h12dtm1Tom/Zc3h12dtm1Tom
(B6.Cg-Zc3h12dtm1Tom)
|
increased T cell proliferation
|
J:209383
|
Zcchc8em1Sgao/Zcchc8em1Sgao
(involves: C57BL/6 * DBA/2)
|
decreased cell proliferation
|
J:297024
|
Zeb1m1Btlr/Zeb1m1Btlr
(involves: C57BL/6J)
|
decreased B cell proliferation
|
J:185495
|
Zfattm2.1Sawa/Zfattm2.1Sawa Tg(Cd4-cre)1Cwi/0
(involves: C57BL/6 * C57BL/6JJcl * C57BL/6NCrSlc * DBA/2)
|
decreased T cell proliferation
|
J:187164
|
Zfp24tm1Jifu/Zfp24tm1Jifu
(involves: 129X1/SvJ * C57BL/6J)
|
absent inner cell mass proliferation
|
J:156988
|
Zfp36l1tm1.1Tnr/Zfp36l1tm1.1Tnr Zfp36l2tm1.1Tnr/Zfp36l2tm1.1Tnr Tg(CD2-icre)4Kio/0
(involves: C57BL/6 * C57BL/10 * CBA/Ca * SJL)
|
increased cell proliferation
|
J:162388
|
Zfp36l1tm1Pjb/Zfp36l1tm1Pjb
(Not Specified)
|
decreased cell proliferation
|
J:91579
|
Zfp131tm1.1Mytk/Zfp131tm1.1Mytk Tg(Cd4-cre)1Cwi/0
(involves: C57BL/6 * C57BL/6N * DBA/2)
|
decreased T cell proliferation
|
J:271921
|
Zfp131tm1.1Mytk/Zfp131tm1.2Mytk Tg(Lck-cre)1Jtak/0
(involves: C57BL/6N * FVB/N)
|
decreased T cell proliferation
|
J:271921
|
Zfp296tm1Miya/Zfp296tm1Miya
(B6.129P2-Zfp296tm1Miya)
|
decreased primordial germ cell proliferation
|
J:255491
|
Zfp423tm1Reed/Zfp423tm1Reed
(involves: 129 * C57BL/6)
|
abnormal cerebellar granule cell precursor proliferation
|
J:122606
|
Zfp750tm1b(EUCOMM)Wtsi/Zfp750tm1b(EUCOMM)Wtsi
(B6(Cg)-Zfp750tm1b(EUCOMM)Wtsi)
|
abnormal epidermal stem cell proliferation
|
J:335426
|
Zfp830tm1Cota/Zfp830tm1Cota
(either: (involves: 129S2/SvPas) or (involves: 129S2/SvPas * C57BL/6N))
|
absent inner cell mass proliferation
|
J:99352
|
absent trophectoderm cell proliferation
|
J:99352
|
decreased inner cell mass proliferation
|
J:99352
|
Zfp830tm2.1Cota/Zfp830tm2.2Cota Gt(ROSA)26Sortm2(cre/ERT2)Brn/?
(involves: 129P2/OlaHsd * 129S2/SvPas * BALB/c * C57BL/6)
|
decreased cell proliferation
|
J:171647
|
Zfp949tm1Htno/Zfp949tm1Htno
(involves: 129S1/Sv * 129X1/SvJ)
|
decreased cell proliferation
|
J:259302
|
Zfyve16tm2a(KOMP)Wtsi/Zfyve16tm2a(KOMP)Wtsi
(C57BL/6N-Zfyve16tm2a(KOMP)Wtsi)
|
decreased B cell proliferation
|
J:302014
|
Zglp1tm1Eem/Zglp1tm1Eem
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal spermatogonia proliferation
|
J:116977
|
Zmiz1tm1Zsu/Zmiz1tm1Zsu
(involves: 129S6/SvEvTac * C57BL/6J)
|
decreased cell proliferation
|
J:128915
|
Zpr1tm1Rjd/Zpr1tm1Rjd
(involves: 129S6/SvEvTac * C57BL/6J)
|
decreased inner cell mass proliferation
|
J:97582
|